Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ACAP1 "CENTB1, KIAA0050" ENSG00000072818 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 1" Q15027 17 7336529-7351477 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0" "Cell type enriched" "Detected in many" 6 "Late spermatids: 3430.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075570 Approved Approved "Golgi apparatus" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA075570: AB_2732295" "unprognostic (1.20e-2)" "prognostic favorable (3.66e-4)" "unprognostic (2.49e-1)" "prognostic favorable (2.97e-5)" "unprognostic (4.43e-4)" "prognostic favorable (4.17e-5)" "unprognostic (5.66e-3)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (2.48e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.14e-1)" "unprognostic (5.58e-2)" "unprognostic (2.90e-1)" "unprognostic (8.61e-3)" 5.6 1.1 0.4 18.9 0.5 41.0 2.1 0.5 0.8 2.3 0.5 7.4 4.1 1.5 0.3 4.2 4.0 3.6 2.1 0.3 0.4 4.6 5.2 16.1 39.5 0.6 0.5 0.9 1.2 0.1 1.3 0.5 0.6 3.8 2.1 0.2 3.6 0.4 0.9 2.5 43.3 0.9 0.5 96.0 5.0 0.8 0.8 25.8 5.2 0.8 22.6 4.3 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 23.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 8.8 0.1 0.0 0.1 11.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 42.4 0.0 29.4 0.0 0.0 14.5 37.9 0.4 0.0 0.0 15.1 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.0 0.1 0.0 0.0 9.1 8.2 10.9 0.1 24.9 0.0 28.8 7.9 30.8 29.6 2.4 33.3 20.2 31.5 32.1 13.7 21.3 26.7 27.5 22.6 32.5 0.4 17.3 39.0 22.3 0.4 0.5 0.5 0.8 0.3 0.4 0.6 0.5 0.6 0.5 0.8 0.6 3.8 9.6 5.5 1.6 150.9 8.3 7.6 25.1 2.8 15.8 7.0 8.1 32.9 7.2 12.3 5.5 18.8 3.9 160.7 2.0 7.9 3.9 498.1 8.3 5.4 5.0 3.6 22.9 0.3 3.7 3.2 8.0 5.6 3.4 40.5 1.8 7.1 5.3 7.5 0.0 1.9 2.7 8.2 26.2 39.5 3430.7 20.2 27.9 24.9 2.8 38.3 11.7 332.7 0.5 1.0 5.5 0.0 15.4 68.0 4.6 1.3 3.8 44.6 20.4 19.7 7.5 8.1 15.6 10.5 1.5 7.4 4.4 268.3 0.9 1.6 3.5 ACBD3 "GCP60, GOCAP1, GOLPH1, PAP7" ENSG00000182827 "Acyl-CoA binding domain containing 3" Q9H3P7 1 226144679-226186741 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015594 Approved Supported "Golgi apparatus" NA NA 29000 "Cluster 37: B-cells - Transcription" "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" "HPA015594: AB_1844491" "unprognostic (1.82e-3)" "unprognostic (1.53e-2)" "unprognostic (7.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.85e-1)" "unprognostic (5.34e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.66e-3)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-3)" "unprognostic (2.54e-3)" 21.6 16.9 11.6 20.4 12.4 25.9 24.4 13.1 13.0 27.6 16.6 23.2 17.5 22.8 20.6 30.8 17.8 23.5 21.4 10.9 13.7 20.2 24.3 22.4 21.3 12.6 13.9 23.2 22.7 28.0 14.6 31.7 12.9 22.8 25.4 16.1 24.1 16.4 21.5 19.3 17.5 21.7 13.1 17.8 31.7 18.8 13.1 18.0 28.8 20.3 25.7 26.9 20.2 13.5 43.7 29.3 24.3 15.1 73.6 65.4 47.2 53.7 55.7 31.5 40.3 38.0 53.2 46.3 48.0 69.7 28.5 33.5 34.6 35.2 43.9 19.4 40.4 22.5 30.3 34.8 47.2 36.5 26.7 48.7 46.0 39.1 51.1 44.7 36.6 22.2 42.6 32.0 51.3 22.1 27.2 28.5 36.1 72.5 38.0 25.0 53.3 47.1 29.4 39.2 27.6 39.8 47.8 52.7 53.0 34.0 54.2 41.5 46.2 31.4 22.0 76.7 51.5 60.4 67.4 57.3 37.3 24.2 52.8 2.1 1.4 1.4 0.9 1.8 1.6 5.0 1.3 0.9 1.0 4.4 1.4 1.3 1.5 1.0 1.5 1.4 1.7 0.7 11.6 12.4 13.1 13.0 10.9 13.7 12.6 13.9 12.9 13.1 13.1 13.5 53.5 67.3 41.5 14.0 50.4 52.0 63.4 17.9 38.7 35.1 50.6 37.2 35.7 27.1 37.9 35.0 56.3 45.3 44.2 46.1 15.6 25.0 24.0 56.6 84.0 47.6 43.5 10.7 29.8 34.7 60.7 55.8 50.4 85.8 24.6 29.8 28.2 52.0 37.9 26.9 31.3 71.9 28.5 25.1 51.0 7.3 40.7 39.4 49.8 20.6 18.0 52.1 18.6 27.6 29.2 39.0 28.4 32.7 87.3 61.7 26.7 32.1 26.9 39.4 32.9 46.6 51.4 72.1 55.8 46.7 77.7 62.4 34.0 33.1 35.6 98.3 ACCS "ACS, PHACS" ENSG00000110455 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive)" Q96QU6 11 44065925-44084237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018873, HPA021654" Approved Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA018873: AB_1855273, HPA021654: AB_1855274" "unprognostic (3.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.98e-1)" "unprognostic (1.86e-1)" "unprognostic (7.86e-3)" "unprognostic (2.01e-2)" "unprognostic (1.40e-1)" "unprognostic (7.57e-3)" "unprognostic (1.41e-1)" "unprognostic (3.38e-2)" "prognostic favorable (4.25e-4)" "unprognostic (6.51e-2)" "unprognostic (3.07e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-1)" "unprognostic (5.63e-3)" "unprognostic (1.92e-2)" 11.4 17.0 1.8 3.7 1.5 10.0 11.2 1.5 2.0 11.1 7.2 8.3 5.4 14.2 8.1 5.5 15.4 10.1 5.8 1.9 2.2 10.4 18.9 9.7 5.5 2.0 1.8 9.8 11.0 2.8 11.0 2.6 1.8 10.9 6.9 1.0 10.3 6.3 3.1 7.8 10.3 6.3 1.5 14.0 10.4 6.5 2.3 4.1 12.7 2.4 6.4 9.1 8.3 2.0 4.0 8.8 0.0 1.0 2.3 4.1 0.0 2.1 2.7 1.9 2.0 0.7 5.6 1.5 1.6 4.7 0.0 6.7 2.4 0.5 1.0 0.5 2.6 6.3 3.3 0.1 4.4 0.0 0.0 4.6 8.2 2.4 1.1 2.6 3.5 0.0 5.0 0.0 5.8 3.0 0.0 2.5 3.4 5.1 1.3 5.5 0.0 0.0 4.8 2.6 1.1 3.5 2.1 1.1 2.5 2.2 8.6 3.8 3.8 2.2 2.3 3.5 1.1 0.0 0.0 0.2 5.3 0.0 2.3 0.9 3.1 5.6 0.8 3.1 0.7 1.1 0.7 1.3 4.4 1.4 1.1 0.7 0.0 0.9 2.5 3.3 1.2 2.0 1.8 1.5 1.5 2.0 1.9 2.2 2.0 1.8 1.8 1.5 2.3 2.0 12.2 12.8 22.7 11.8 4.6 2.7 2.7 4.0 6.8 1.9 8.6 10.2 4.0 7.2 8.9 9.2 0.0 3.1 4.0 6.4 0.0 2.3 2.1 8.6 3.9 7.0 7.2 3.4 3.4 4.2 0.4 6.9 13.7 5.0 9.5 11.0 8.2 9.7 6.1 0.0 3.3 8.2 4.1 7.0 5.5 4.4 9.6 9.0 0.0 5.6 9.4 2.6 7.2 4.5 6.6 2.9 8.0 7.5 2.5 2.1 16.6 6.5 7.4 1.0 0.0 3.7 4.7 0.7 2.4 2.4 2.3 1.9 3.3 9.2 6.4 2.1 ADAMTSL5 THSD6 ENSG00000185761 "ADAMTS like 5" 19 1505022-1513604 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 33.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 9.8;Cardiomyocytes: 9.6;Leydig cells: 19.3;Peritubular cells: 18.0;Proximal enterocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 20.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044050 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 39: CACO-2 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA044050: AB_10962625" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (5.85e-2)" "unprognostic (2.45e-1)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (1.77e-2)" "unprognostic (1.89e-1)" "unprognostic (2.79e-2)" "unprognostic (2.89e-3)" "unprognostic (1.52e-1)" "unprognostic (5.03e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-3)" 1.8 1.5 1.7 0.7 2.2 0.3 2.2 2.3 2.0 33.0 8.3 3.2 9.8 19.8 5.0 15.1 9.5 0.5 20.7 1.8 0.4 1.5 4.2 1.4 0.6 0.8 1.0 1.3 1.0 1.4 2.6 4.2 0.6 4.5 1.1 0.9 3.9 3.3 15.1 2.1 8.4 12.5 0.2 0.8 1.4 3.6 1.6 0.2 1.5 5.9 1.5 3.8 22.5 1.4 8.1 3.5 0.1 0.1 4.1 3.0 3.8 14.7 9.8 5.6 8.1 20.7 4.0 0.0 3.6 12.3 1.6 6.7 3.5 4.2 4.2 7.9 0.4 1.7 11.0 3.8 4.6 0.2 10.2 1.8 4.6 1.3 3.5 7.4 0.0 2.5 5.0 9.8 0.6 7.5 0.4 0.4 0.1 2.3 1.8 0.2 0.8 2.1 4.5 0.0 0.1 0.3 3.5 0.4 4.4 1.9 9.2 3.0 0.9 0.0 5.4 10.9 0.6 6.2 4.2 1.0 0.1 0.8 2.4 0.2 0.0 0.4 1.4 0.5 0.9 0.0 1.6 1.1 0.0 0.0 2.0 1.3 0.1 0.0 0.9 0.0 0.5 0.5 1.7 2.2 2.3 2.0 1.8 0.4 0.8 1.0 0.6 0.2 1.6 1.4 0.2 0.0 1.1 3.6 0.3 0.4 2.4 9.8 6.2 0.3 1.9 0.8 9.6 0.0 3.4 0.0 0.0 0.8 0.7 0.6 0.0 0.6 0.6 0.3 4.5 0.4 0.0 0.0 0.1 1.7 2.1 5.8 1.1 0.4 0.0 0.5 0.0 1.8 0.3 0.0 0.1 1.8 4.1 0.0 0.4 2.6 19.3 0.4 1.8 1.0 0.0 3.7 0.0 0.0 0.1 7.0 1.5 18.0 1.8 2.7 12.5 0.5 1.3 2.1 0.0 0.9 3.3 0.6 1.9 8.4 0.4 0.7 1.2 0.3 1.6 3.5 ADCY6 AC6 ENSG00000174233 "Adenylate cyclase 6" O43306 12 48766194-48789089 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 68.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018365 Approved Approved "Golgi apparatus" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB018365: AB_2257941" "unprognostic (1.18e-2)" "unprognostic (2.20e-2)" "unprognostic (6.89e-2)" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (3.68e-2)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-3)" "unprognostic (5.10e-3)" "unprognostic (1.09e-1)" "unprognostic (3.09e-1)" "unprognostic (2.48e-2)" 43.2 15.0 8.9 6.1 7.9 1.3 23.7 5.0 9.2 19.3 10.3 26.3 18.7 20.7 19.0 10.3 17.1 13.9 57.2 8.0 11.2 21.1 9.6 13.5 3.9 5.5 5.4 22.3 22.3 20.7 14.6 14.5 6.6 16.3 20.3 5.7 33.5 16.5 12.1 15.3 21.4 13.6 1.9 4.8 25.1 4.0 14.4 2.8 17.9 12.7 3.2 12.3 12.8 6.4 14.0 25.9 30.2 18.9 32.0 15.9 32.0 16.7 17.1 19.8 13.8 45.7 45.3 0.0 37.2 15.3 8.2 10.9 9.2 11.6 7.9 0.1 13.4 12.5 37.8 8.4 17.6 0.0 10.1 20.0 13.6 17.1 6.5 37.9 18.7 0.8 1.7 4.5 15.6 23.1 0.0 0.5 10.3 21.6 12.3 4.6 11.4 7.7 23.4 41.5 4.5 18.4 17.2 68.0 15.2 13.3 53.3 3.5 21.1 18.3 13.1 9.7 7.4 7.0 3.7 0.4 16.9 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.9 7.9 5.0 9.2 8.0 11.2 5.5 5.4 6.6 1.9 14.4 6.4 11.6 0.0 6.4 18.3 0.6 2.7 3.3 7.5 4.0 10.1 22.7 15.0 8.2 7.2 9.8 18.4 20.9 7.4 0.4 38.8 0.0 5.8 0.8 6.8 8.0 8.1 8.4 0.0 17.5 4.0 2.7 7.6 14.3 11.3 1.3 14.6 5.0 7.7 2.5 10.1 18.8 24.9 8.2 0.6 2.8 1.1 11.5 0.7 7.2 7.5 0.6 3.4 0.0 15.1 7.0 9.5 30.3 9.4 0.3 6.3 26.0 2.8 5.8 9.3 19.7 9.5 26.6 1.9 1.7 3.6 2.0 5.1 0.8 13.9 23.7 9.3 AHSG "A2HS, FETUA, HSGA" ENSG00000145192 "Alpha 2-HS glycoprotein" P02765 3 186613060-186621318 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Mineral balance" "Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4302 "liver: 5817.6" "Cell type enriched" "Detected in some" 38 "Hepatocytes: 1242.5" "Cancer enriched" "Detected in some" 284 "liver cancer: 1231.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 78 "Hep G2: 2287.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001524, HPA001525, CAB026209" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 864000000000 110000000000 "Cluster 48: NK-cells - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849" "unprognostic (6.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (3.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (7.47e-3)" "unprognostic (3.05e-1)" "unprognostic (5.27e-2)" "unprognostic (8.64e-2)" "unprognostic (3.99e-7)" "unprognostic (5.21e-2)" "unprognostic (5.21e-2)" "unprognostic (1.04e-1)" 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 1.3 5817.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.9 1.0 2287.3 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 3.5 0.0 0.0 1.1 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.2 0.0 0.1 3.9 0.2 4.3 0.2 0.1 0.9 0.0 32.0 0.6 0.6 2.4 0.1 0.0 0.1 0.0 0.0 28.2 1242.5 1.3 0.0 0.1 0.0 0.0 32.4 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 2.0 0.0 0.0 0.1 AIG1 "AIG-1, dJ95L4.1, FLJ10485" ENSG00000146416 "Androgen induced 1" Q9NVV5 6 143060496-143341058 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 235.8" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 245.4;Proximal tubular cells: 261.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060766 Approved Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA060766: AB_2684356" "unprognostic (2.70e-2)" "prognostic unfavorable (3.26e-6)" "unprognostic (4.27e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.25e-7)" "unprognostic (1.91e-2)" "unprognostic (8.75e-3)" "unprognostic (2.17e-1)" "unprognostic (5.53e-2)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.11e-2)" "unprognostic (2.75e-1)" 42.0 29.8 43.7 10.4 44.6 31.6 30.0 43.3 46.1 17.6 48.2 23.0 46.6 14.4 33.0 34.1 34.4 24.5 54.1 44.1 49.1 102.0 235.8 19.9 10.7 45.0 43.4 34.7 31.0 31.0 36.6 11.9 46.4 22.7 18.8 33.9 19.8 24.1 23.7 16.8 45.9 15.2 47.1 20.1 20.8 15.7 51.0 6.8 42.9 32.5 14.8 29.4 26.1 52.5 32.6 25.2 20.6 56.9 29.7 22.3 7.6 28.3 57.1 26.8 61.9 37.5 81.5 20.0 40.5 66.1 41.7 42.0 26.5 79.2 64.2 67.2 63.0 5.6 35.6 157.3 40.8 46.0 2.7 32.9 76.7 35.7 129.6 88.2 10.9 30.8 4.0 67.6 59.3 45.6 14.2 9.8 40.8 37.4 27.6 20.2 61.6 36.6 100.6 77.6 75.5 42.4 35.5 33.2 17.2 36.0 31.7 96.0 3.0 25.2 27.8 22.7 33.4 99.6 95.1 2.1 59.7 9.5 26.9 12.0 6.2 9.6 6.6 29.3 15.1 9.6 12.4 10.6 33.0 5.6 13.1 10.0 11.3 11.8 35.4 2.9 9.7 9.2 43.7 44.6 43.3 46.1 44.1 49.1 45.0 43.4 46.4 47.1 51.0 52.5 40.8 16.0 27.7 114.9 22.0 25.0 51.8 82.5 27.9 68.3 69.9 65.4 73.7 72.9 66.9 51.5 25.0 79.6 8.6 12.6 52.8 60.3 22.4 99.8 25.9 32.8 39.5 29.3 204.3 31.5 10.5 42.2 26.0 83.1 36.8 90.9 36.8 229.6 32.7 53.8 245.4 33.3 59.0 40.1 42.3 7.0 32.0 37.2 55.2 100.2 18.2 74.3 8.2 105.1 172.9 25.8 65.2 38.4 47.7 35.3 232.9 261.5 69.1 36.9 32.9 41.7 50.8 5.6 17.3 53.1 45.7 108.1 18.5 61.5 42.4 53.2 AL132671.2 ENSG00000282218 "Novel protein, GOPC-ROS1 readthrough" 6 117318211-117573571 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "Alveolar cells type 2: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "U-138 MG: 8.9" "Low region specificity" "Detected in all" HPA019477 Uncertain Approved "Golgi apparatus" NA NA "Cluster 10: BJ & FHDF - ECM organization" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA019477: AB_1849890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136295.1 ENSG00000254692 "Novel protein" 14 24189157-24213473 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.4;granulocytes: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 8.1" HPA059249 Approved Approved "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 43: THP-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.45e-2)" 1.7 3.0 0.6 2.1 0.7 2.0 0.8 0.7 1.5 1.2 0.5 1.3 2.5 1.0 0.2 0.8 1.1 0.4 1.7 0.6 0.8 1.7 0.8 1.1 1.4 0.8 0.6 0.9 1.4 0.5 0.5 0.7 0.7 0.8 0.9 1.3 0.8 0.6 1.9 1.3 2.2 0.6 0.5 0.8 1.3 1.0 0.8 1.6 0.8 0.0 0.4 0.8 0.7 0.7 1.5 1.4 2.4 0.9 2.2 1.3 1.9 1.4 2.0 1.0 2.2 1.0 5.1 1.5 0.2 1.8 2.9 1.5 1.5 0.8 3.2 2.4 0.0 0.9 0.8 1.2 0.4 4.3 2.5 0.5 0.8 1.2 0.0 3.5 0.7 1.3 0.1 4.3 1.7 1.2 1.1 0.0 2.1 0.7 0.0 1.7 1.9 0.0 1.9 1.1 0.2 1.0 8.1 2.7 3.4 2.8 2.0 3.4 4.4 0.2 1.0 1.3 2.1 3.4 2.6 3.6 0.5 0.9 0.8 0.0 0.1 0.5 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.3 0.1 0.6 0.7 0.7 1.5 0.6 0.8 0.8 0.6 0.7 0.5 0.8 0.7 0.0 6.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ALG2 "CDG1I, CDGIi, FLJ14511, hALPG2, NET38" ENSG00000119523 "ALG2 alpha-1,3/1,6-mannosyltransferase" Q9H553 9 99216425-99221942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041512, HPA041601" Approved Approved "Golgi apparatus" NA No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA041512: AB_10794380, HPA041601: AB_10794302" "unprognostic (8.86e-3)" "unprognostic (4.39e-1)" "unprognostic (2.37e-1)" "prognostic favorable (8.44e-5)" "unprognostic (9.21e-3)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.06e-2)" "unprognostic (5.94e-2)" "unprognostic (3.31e-1)" "unprognostic (3.66e-1)" "unprognostic (2.99e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.28e-7)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-2)" "unprognostic (4.81e-1)" 17.7 38.2 13.4 19.4 14.6 23.0 27.1 16.6 18.4 35.1 19.8 24.9 21.9 23.8 74.0 15.1 29.5 26.2 13.4 14.5 15.0 34.3 47.4 24.3 20.8 14.7 16.1 30.2 42.0 37.0 21.8 29.9 15.1 32.8 27.3 15.0 37.9 34.5 15.3 17.9 20.5 24.2 14.8 17.9 25.0 19.2 14.7 16.7 42.3 13.5 27.5 31.7 10.9 16.9 22.9 28.7 22.7 34.4 82.6 52.7 42.0 46.7 75.3 45.6 39.3 34.9 31.2 24.6 18.8 54.3 60.0 85.3 37.9 49.1 45.7 35.2 16.2 14.4 23.7 54.0 99.7 28.2 26.2 61.9 65.2 37.7 72.8 45.8 52.3 15.1 23.2 56.2 44.7 47.8 12.9 29.8 27.6 75.0 39.6 14.0 43.4 38.1 65.2 31.1 22.5 19.3 33.5 63.8 61.6 33.5 24.4 23.3 38.8 31.4 27.9 40.9 28.6 45.8 28.0 10.5 58.6 20.5 16.3 38.7 35.5 22.0 33.7 28.2 49.2 30.8 32.0 33.9 45.1 26.3 27.7 27.4 9.3 38.0 28.4 79.9 38.3 36.0 13.4 14.6 16.6 18.4 14.5 15.0 14.7 16.1 15.1 14.8 14.7 16.9 12.6 12.8 22.9 6.8 22.1 23.3 26.8 56.2 10.2 11.3 22.6 16.6 6.9 32.9 35.8 23.9 2.1 50.3 30.2 20.0 21.5 36.1 28.7 16.9 30.9 19.8 12.5 12.0 8.1 35.2 34.2 30.4 15.3 26.4 7.6 14.1 21.8 55.5 28.1 10.1 8.3 26.3 38.7 25.8 45.4 20.3 26.8 23.0 21.4 10.3 64.2 15.5 15.5 9.5 9.7 31.9 16.0 25.2 47.0 37.3 18.7 36.6 33.1 8.3 6.6 17.2 18.2 22.6 24.6 15.0 23.7 89.2 16.6 25.6 20.8 31.3 ANGPTL2 "ARP2, HARP" ENSG00000136859 "Angiopoietin like 2" Q9UKU9 9 127087348-127122635 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 47.4;Endothelial cells: 34.6;Fibroblasts: 99.7;Oligodendrocyte precursor cells: 35.2;Skeletal myocytes: 39.3;Smooth muscle cells: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 140.4;ASC TERT1: 94.9;BJ hTERT+: 205.9;HSkMC: 98.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040933, HPA041299" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 2510000 2200000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA040933: AB_10795530, HPA041299: AB_10794552" "unprognostic (5.46e-2)" "unprognostic (4.96e-3)" "unprognostic (1.11e-2)" "unprognostic (2.07e-2)" "unprognostic (8.79e-2)" "unprognostic (3.13e-2)" "unprognostic (1.79e-2)" "unprognostic (2.04e-2)" "unprognostic (3.31e-1)" "unprognostic (1.17e-3)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.32e-5)" "unprognostic (1.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (4.15e-2)" 109.5 11.5 6.1 33.5 12.9 0.2 71.2 15.1 8.6 67.7 12.4 76.5 15.1 72.9 13.7 21.7 31.4 67.0 69.2 6.9 9.4 13.4 14.8 22.5 8.1 12.0 12.4 44.2 5.5 4.1 3.4 21.4 11.7 24.7 17.9 0.9 18.0 27.1 57.6 29.2 27.8 63.4 9.9 49.2 28.9 4.4 12.6 4.7 15.7 36.6 8.9 59.4 49.1 15.4 0.0 0.0 17.4 0.0 140.4 94.9 9.4 8.1 205.9 9.2 8.5 0.0 0.0 0.0 7.0 21.4 1.8 0.1 1.7 0.0 4.8 0.1 0.0 0.0 0.1 0.5 30.3 0.1 0.0 98.2 0.0 20.0 0.0 28.7 27.6 2.3 0.0 0.1 6.3 0.0 0.2 4.3 18.4 0.0 1.0 16.5 27.3 1.6 2.2 0.0 9.3 10.1 0.0 0.0 0.0 3.3 0.0 0.0 8.8 35.5 4.5 50.4 0.0 0.0 0.1 0.0 37.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 12.9 15.1 8.6 6.9 9.4 12.0 12.4 11.7 9.9 12.6 15.4 47.4 9.6 2.4 1.0 0.1 14.3 7.0 0.2 3.4 14.4 0.6 6.6 16.6 0.0 0.1 0.0 2.1 1.0 0.5 0.1 0.0 0.2 1.6 1.4 20.2 34.6 0.0 0.0 0.6 0.0 0.8 99.7 1.1 1.0 0.0 2.9 5.0 0.0 1.4 0.0 1.5 0.0 0.0 0.0 17.4 1.5 20.8 0.8 7.2 1.9 0.0 1.9 0.0 35.2 19.2 1.2 0.0 6.4 0.0 1.7 0.0 2.4 1.6 0.8 0.0 39.3 43.5 1.0 0.0 1.4 11.1 2.6 1.7 1.1 0.0 0.6 ANO9 "PIG5, TMEM16J, TP53I5" ENSG00000185101 "Anoctamin 9" A1A5B4 11 417933-442011 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.2;skin 1: 27.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.0;Intestinal goblet cells: 50.5;Paneth cells: 50.5;Proximal enterocytes: 87.7;Undifferentiated cells: 45.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 26.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 48 "B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2" "Cell line enhanced" "Detected in some" "BEWO: 9.2;CAPAN-2: 29.5;HaCaT: 16.8;RPMI-8226: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039948, HPA040112" Approved Uncertain "Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA039948: AB_2676765, HPA040112: " "unprognostic (3.62e-3)" "unprognostic (2.83e-2)" "unprognostic (4.68e-2)" "unprognostic (1.62e-1)" "unprognostic (1.41e-2)" "unprognostic (8.93e-2)" "unprognostic (6.98e-2)" "unprognostic (8.94e-3)" "unprognostic (1.39e-1)" "unprognostic (2.28e-3)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (1.91e-2)" "unprognostic (1.18e-2)" "unprognostic (2.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (8.81e-4)" 0.7 0.1 0.0 7.0 0.0 2.2 1.7 0.0 0.0 1.1 0.2 16.0 34.2 0.5 7.0 6.3 1.2 2.0 0.1 0.0 0.0 3.7 0.3 2.9 12.0 0.0 0.0 0.1 6.5 0.7 1.3 0.1 0.0 2.9 9.1 0.0 3.0 0.7 0.0 27.8 30.0 0.8 0.0 4.7 7.0 0.2 0.0 9.0 2.4 0.1 8.7 2.4 3.4 0.0 2.7 0.6 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 3.1 29.5 1.9 1.4 0.0 0.1 16.8 0.0 7.0 0.0 2.1 0.0 0.0 0.6 5.1 0.0 0.4 0.0 0.0 5.6 0.0 1.2 0.1 0.0 4.5 0.1 1.9 0.0 3.8 0.5 0.1 0.0 6.0 0.0 0.1 0.0 20.6 5.1 4.4 1.6 0.0 0.3 7.3 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 5.5 2.1 6.5 3.3 0.0 0.8 3.7 2.8 0.0 4.1 0.0 0.0 8.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.7 0.3 9.1 5.2 4.6 15.3 6.2 0.0 5.5 3.9 2.4 8.6 9.1 3.7 0.0 0.3 3.0 81.0 0.0 10.5 0.8 4.9 1.0 0.8 15.5 0.0 0.3 6.5 3.7 0.6 29.0 11.0 0.0 0.0 0.7 0.3 0.4 0.0 0.2 50.5 14.2 0.3 1.9 0.1 0.0 1.2 3.6 0.0 1.3 0.0 0.0 0.0 0.0 9.0 50.5 0.0 5.0 2.7 87.7 3.7 9.2 0.0 0.0 0.1 1.0 0.2 0.2 7.0 6.3 0.1 12.8 0.0 45.2 5.7 AP1AR "2C18, C4orf16, gamma-BAR, PRO0971" ENSG00000138660 "Adaptor related protein complex 1 associated regulatory protein" Q63HQ0 4 112231740-112273110 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035863, HPA058115" Approved Supported "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA035863: AB_10672098, HPA058115: AB_2683610" "unprognostic (1.11e-1)" "unprognostic (1.99e-1)" "unprognostic (2.49e-3)" "unprognostic (9.14e-2)" "unprognostic (2.19e-1)" "unprognostic (9.16e-2)" "unprognostic (1.86e-2)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (2.45e-1)" "unprognostic (2.69e-2)" "unprognostic (6.15e-2)" "prognostic favorable (4.05e-7)" "unprognostic (2.50e-2)" "unprognostic (1.36e-1)" "unprognostic (2.10e-3)" "prognostic favorable (7.79e-4)" 9.0 15.7 6.4 12.6 7.6 3.7 16.9 9.4 9.7 8.4 5.7 18.0 22.2 11.3 8.2 13.3 6.5 12.8 7.9 8.7 8.4 22.1 20.5 9.1 12.1 6.2 7.2 11.6 8.3 40.9 4.8 12.0 6.5 9.0 16.3 7.6 12.1 10.0 7.4 14.2 23.8 9.8 5.9 13.2 13.0 14.5 7.6 10.9 10.8 7.5 12.1 13.0 9.9 7.9 20.7 10.1 24.5 23.8 20.7 15.2 22.3 18.9 45.9 13.6 16.2 10.0 39.0 46.0 15.3 12.7 16.2 9.2 24.4 14.5 23.2 53.1 13.3 15.5 13.6 32.8 31.9 38.0 23.9 16.9 32.3 11.9 33.7 11.1 21.2 24.2 16.7 38.5 13.5 19.6 34.7 23.5 18.2 47.0 10.8 30.0 26.2 23.5 26.4 14.5 24.5 32.1 12.7 45.2 34.5 12.2 14.9 12.8 19.0 18.1 23.1 27.4 15.2 34.5 68.0 56.2 19.0 14.4 16.3 6.7 7.4 2.6 4.0 10.0 5.6 6.8 6.3 6.4 9.5 5.9 8.5 8.9 1.1 9.0 8.4 4.4 7.5 5.2 6.4 7.6 9.4 9.7 8.7 8.4 6.2 7.2 6.5 5.9 7.6 7.9 21.3 9.6 19.5 9.4 12.9 21.0 8.9 7.0 22.2 8.9 34.2 22.7 20.5 17.2 14.9 16.5 2.1 5.5 14.5 38.4 11.7 9.8 91.7 21.3 17.2 17.7 31.7 6.3 24.8 10.1 3.8 15.2 18.3 29.5 6.3 8.2 9.3 27.3 15.7 10.1 20.6 16.0 6.1 20.1 16.5 59.9 4.7 17.4 23.2 15.0 12.0 12.3 1.0 13.6 16.3 12.7 24.0 10.1 6.8 13.1 24.9 28.6 16.0 8.0 0.0 16.0 20.4 9.6 12.2 28.2 31.3 3.1 12.5 15.2 20.8 14.7 APBA1 "D9S411E, MINT1, X11" ENSG00000107282 "Amyloid beta precursor protein binding family A member 1" Q02410 9 69427532-69672371 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5" "Group enriched" "Detected in many" 7 "Astrocytes: 53.5;Excitatory neurons: 130.3;Horizontal cells: 69.0;Inhibitory neurons: 181.6;Microglial cells: 78.7;Oligodendrocyte precursor cells: 141.3;Oligodendrocytes: 106.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.2;BJ hTERT+: 6.0;HAP1: 17.2;SCLC-21H: 6.5;TIME: 7.8;U-138 MG: 6.9;U-266/70: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061287 Supported "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA061287: AB_2684467" "unprognostic (4.02e-2)" "unprognostic (4.64e-2)" "unprognostic (7.29e-2)" "unprognostic (8.94e-3)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (4.21e-3)" "unprognostic (8.49e-3)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.46e-5)" "unprognostic (1.60e-1)" "unprognostic (3.09e-2)" "unprognostic (4.99e-3)" "unprognostic (3.14e-2)" "unprognostic (2.28e-1)" "unprognostic (4.66e-3)" 2.9 1.2 14.1 0.7 13.1 0.0 2.5 0.0 16.5 3.6 0.0 2.9 0.6 4.1 0.1 1.8 2.5 1.3 3.0 16.0 9.5 2.2 11.9 1.4 0.6 15.1 13.8 5.3 1.9 6.8 6.3 1.4 16.1 1.9 1.9 3.2 2.9 1.1 2.0 3.9 1.8 0.8 0.0 3.8 2.0 2.8 7.9 0.2 2.0 0.6 0.3 2.8 3.6 0.9 0.0 0.0 0.6 0.0 3.1 2.2 0.1 7.2 6.0 0.1 0.1 0.0 0.0 0.0 3.2 3.0 0.0 0.1 17.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.0 2.9 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 2.5 6.5 4.2 0.4 0.9 0.1 0.2 0.0 0.0 7.8 6.9 0.8 0.0 0.5 7.1 3.3 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.1 0.0 16.5 16.0 9.5 15.1 13.8 16.1 0.0 7.9 0.9 1.0 0.0 0.0 53.5 0.0 1.8 1.2 0.2 0.0 15.4 2.0 2.2 4.9 0.0 0.2 0.0 4.2 0.8 0.0 3.7 0.0 0.1 0.3 0.9 1.7 1.4 4.2 0.0 130.3 0.0 0.6 1.7 0.0 1.0 0.0 1.3 3.3 5.8 3.1 69.0 181.6 1.6 0.0 3.7 1.4 0.6 2.5 1.4 0.0 78.7 1.0 3.2 0.0 141.3 106.2 0.2 0.4 10.9 0.0 0.6 0.0 0.4 0.1 9.1 0.0 1.6 2.3 1.1 1.3 0.5 2.4 0.4 0.5 6.0 1.2 0.4 APBA2 "D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L" ENSG00000034053 "Amyloid beta precursor protein binding family A member 2" Q99767 15 28884483-29118315 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;lymphoid tissue: 10.7" "Cell type enhanced" "Detected in many" "Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1" "Cancer enhanced" "Detected in many" "glioma: 17.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6" "Lineage enriched" "Detected in many" 4 "T-cells: 5.6" "Cell line enhanced" "Detected in some" "HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037065, HPA058796, HPA070376" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "CAB037065: AB_477178, HPA058796: , HPA070376: " "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.42e-1)" "unprognostic (5.96e-2)" "unprognostic (1.41e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-1)" "unprognostic (8.19e-2)" "unprognostic (4.71e-2)" "unprognostic (9.25e-2)" "unprognostic (4.21e-5)" "unprognostic (1.98e-2)" "unprognostic (4.74e-2)" "unprognostic (7.63e-3)" "unprognostic (4.28e-1)" 1.0 1.6 4.3 0.7 4.4 0.7 0.9 8.7 8.4 2.9 0.0 1.3 0.4 1.2 0.4 1.7 1.6 0.3 0.4 8.0 2.5 0.9 0.9 3.3 0.6 3.3 2.4 1.1 5.9 0.0 7.6 0.1 2.4 2.5 0.2 1.1 0.4 0.1 0.1 1.0 4.9 0.0 2.2 10.7 1.4 5.7 3.0 1.4 2.7 0.0 0.7 1.3 1.5 4.9 0.0 1.6 0.7 3.7 0.0 0.0 0.0 0.9 1.4 0.1 0.5 0.0 0.0 0.0 3.5 0.0 2.3 0.0 0.5 0.0 0.0 0.0 3.1 8.4 0.0 0.1 3.1 0.0 0.2 0.4 2.5 0.4 0.0 0.4 4.4 1.8 5.0 0.2 0.0 0.5 0.2 2.4 1.1 0.0 3.3 0.0 0.4 0.2 0.0 0.0 5.4 20.0 0.0 0.0 0.2 0.1 0.0 1.0 4.4 0.0 4.4 0.0 0.9 0.0 0.1 0.0 0.1 14.9 1.7 0.0 0.0 0.0 0.9 0.0 0.2 0.0 1.5 3.3 0.0 0.0 5.4 5.6 0.1 1.3 0.0 0.0 0.0 2.0 4.3 4.4 8.7 8.4 8.0 2.5 3.3 2.4 2.4 2.2 3.0 4.9 0.5 0.0 0.6 53.2 1.8 0.4 0.2 0.0 0.0 21.5 1.9 2.3 1.4 0.0 0.1 0.0 0.0 0.1 36.5 0.1 1.9 1.8 18.9 2.9 6.4 1.2 0.0 2.1 142.7 5.8 0.2 2.2 0.0 2.1 0.0 1.9 3.6 0.5 1.2 89.2 106.1 0.3 0.0 1.6 0.4 10.4 1.8 0.8 3.6 33.7 1.9 1.3 63.8 97.0 74.1 3.3 0.0 3.8 12.3 0.1 0.0 0.3 0.2 4.5 0.0 0.4 2.1 1.6 14.5 0.4 0.3 0.1 30.7 10.6 0.0 0.1 APOH "B2G1, BG" ENSG00000091583 "Apolipoprotein H" P02749 17 66212033-66256525 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 563 "liver: 17965.3" "Cell type enriched" "Detected in some" 41 "Hepatocytes: 7680.6" "Cancer enriched" "Detected in many" 232 "liver cancer: 2878.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "Hep G2: 1253.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001654, HPA003732, CAB022214" Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 247000000000 41000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.39e-7)" "unprognostic (1.26e-1)" "unprognostic (5.99e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.26e-2)" "unprognostic (5.76e-2)" 0.9 0.3 0.0 0.1 0.1 0.4 0.2 0.1 0.2 0.2 0.3 0.8 2.5 0.1 1.0 0.2 0.8 2.8 0.6 0.2 0.0 31.9 17965.3 5.6 0.3 0.2 0.1 0.2 10.9 0.0 0.2 0.4 0.1 0.2 0.7 0.2 0.1 0.3 0.1 0.2 1.0 0.0 0.1 4.3 3.8 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 33.5 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 60.8 0.0 1.4 0.1 0.0 1.7 1.1 0.0 0.0 0.0 0.4 0.0 2.6 1.4 1253.3 0.0 6.4 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.4 0.5 0.2 0.0 0.2 0.1 0.6 31.5 0.0 0.8 6.4 0.1 0.0 0.9 0.4 0.0 3.4 0.1 0.2 0.0 0.0 0.0 1.7 0.2 0.1 0.1 0.0 0.8 0.1 2.9 15.3 2.4 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.0 12.3 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 183.0 0.6 0.0 0.0 0.0 0.0 0.2 3.9 0.8 0.2 0.2 0.0 5.2 0.0 109.7 0.2 2.3 0.6 0.0 0.0 0.1 0.0 0.0 120.0 7680.6 0.5 0.0 0.2 0.4 0.0 182.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.8 0.0 0.0 0.0 0.4 25.6 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 8.8 0.0 0.8 0.0 APOM "G3a, NG20" ENSG00000204444 "Apolipoprotein M" O95445 6 31652416-31658210 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 390.7" "Group enriched" "Detected in many" 8 "Hepatocytes: 665.9;Proximal tubular cells: 681.1" "Cancer enriched" "Detected in all" 13 "liver cancer: 185.9" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 12 "Hep G2: 38.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034086, HPA051006" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 7400000000 8200000000 "Cluster 34: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "CAB034086: AB_1119033, HPA051006: AB_2681307" "unprognostic (2.76e-3)" "unprognostic (1.69e-2)" "unprognostic (8.66e-2)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (3.78e-1)" "unprognostic (1.97e-2)" "unprognostic (1.80e-1)" "unprognostic (6.04e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (7.28e-2)" "unprognostic (5.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.30e-1)" "unprognostic (3.20e-2)" 4.9 5.3 0.6 0.1 0.6 2.5 5.2 1.0 0.9 3.7 0.5 3.8 0.6 3.9 1.0 4.1 4.1 0.5 3.5 0.6 0.7 93.7 390.7 2.6 0.6 0.7 0.7 6.2 6.0 0.7 4.7 0.1 0.7 3.8 0.4 0.4 3.5 0.5 7.2 6.4 9.0 0.4 0.7 4.1 5.3 16.0 0.6 1.2 5.5 0.6 1.1 3.3 3.3 0.8 0.5 0.3 0.6 0.7 0.6 0.8 0.0 0.4 1.1 0.4 0.9 3.2 1.0 1.4 0.2 1.1 0.2 0.6 0.4 0.6 0.8 0.8 0.7 0.8 0.3 38.2 1.3 1.7 0.1 1.2 0.4 0.3 1.0 0.5 0.3 0.9 1.2 0.4 1.1 1.1 1.1 0.9 0.5 0.6 0.2 0.8 0.4 1.5 1.1 0.6 0.5 0.2 0.4 0.0 0.5 0.2 1.5 1.2 0.4 0.2 0.1 0.3 0.3 1.1 1.2 1.5 0.2 1.8 0.1 3.0 0.6 0.6 0.3 0.3 0.5 1.1 0.4 0.3 0.5 0.5 0.5 0.6 0.4 0.3 0.7 0.3 0.7 0.3 0.6 0.6 1.0 0.9 0.6 0.7 0.7 0.7 0.7 0.7 0.6 0.8 1.5 0.0 7.4 2.3 9.0 6.4 6.7 6.7 9.1 1.5 6.6 12.4 1.6 12.8 3.0 14.7 4.2 2.0 1.6 4.1 76.3 4.3 60.2 5.2 3.1 2.0 4.2 11.4 0.3 6.9 0.9 4.3 5.1 1.6 5.1 1.8 8.9 665.9 5.4 0.0 0.4 4.9 2.0 14.5 4.2 38.4 9.3 6.1 5.4 0.0 2.5 14.6 1.0 0.5 1.3 6.4 4.9 6.4 7.4 4.2 81.4 681.1 4.6 2.5 0.0 6.2 3.1 33.1 6.6 5.3 6.5 1.2 5.6 4.6 6.5 6.1 ARFGAP2 "FLJ14576, IRZ, Zfp289, ZNF289" ENSG00000149182 "ADP ribosylation factor GTPase activating protein 2" Q8N6H7 11 47164299-47177125 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016649, HPA018152" Enhanced Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA016649: AB_1844980, HPA018152: AB_1844979" "unprognostic (1.69e-2)" "unprognostic (9.11e-2)" "unprognostic (5.91e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-2)" "unprognostic (1.12e-1)" "unprognostic (4.81e-3)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.41e-1)" "unprognostic (3.42e-2)" "unprognostic (7.00e-2)" "prognostic favorable (7.65e-7)" "unprognostic (2.05e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" "unprognostic (9.20e-2)" 38.0 51.4 62.1 36.3 63.9 82.2 41.7 63.2 68.3 42.3 57.2 49.4 40.0 43.3 35.5 60.8 49.3 32.1 58.7 62.5 60.1 47.6 76.8 40.7 51.9 65.1 61.8 44.6 69.7 48.2 38.7 39.9 61.8 51.4 39.4 38.9 56.1 41.7 115.9 78.7 43.8 38.8 60.6 51.2 55.7 30.7 63.1 49.8 47.4 81.4 50.5 44.7 43.3 70.3 55.7 36.4 54.9 43.3 45.9 37.3 51.6 51.2 48.1 64.1 48.4 41.3 45.3 91.3 32.4 58.7 40.8 82.3 47.2 74.6 40.3 45.0 46.1 77.6 85.5 50.8 53.7 107.0 84.4 56.7 82.3 33.3 71.1 46.1 60.4 65.6 111.8 67.8 58.5 102.5 50.8 87.8 43.6 98.3 48.4 78.8 94.8 116.8 60.3 79.3 53.0 47.0 58.7 81.7 38.8 26.1 126.8 78.8 48.7 55.2 43.3 50.5 68.6 58.6 60.7 78.3 38.6 81.2 56.4 108.5 69.1 92.8 74.0 77.3 66.6 59.0 57.1 66.2 65.9 63.1 63.0 63.4 41.8 69.2 98.4 35.4 71.8 108.1 62.1 63.9 63.2 68.3 62.5 60.1 65.1 61.8 61.8 60.6 63.1 70.3 23.8 35.3 45.9 25.1 46.5 22.2 31.4 22.1 29.6 73.6 30.9 25.8 13.0 20.0 41.2 31.3 114.7 64.3 40.7 38.6 25.4 38.7 2.7 20.3 26.4 29.8 45.4 47.1 16.2 36.6 47.1 29.7 34.1 27.0 60.8 44.9 31.1 44.0 36.8 74.0 15.1 35.0 38.7 33.6 25.4 6.6 34.2 28.6 28.4 15.9 58.1 51.1 71.1 13.0 23.7 39.2 45.0 26.4 31.7 26.4 41.0 26.3 34.1 115.4 39.5 33.0 28.0 24.7 35.9 30.3 26.7 91.8 43.7 40.3 36.3 34.0 ARFRP1 "ARL18, ARP, Arp1" ENSG00000101246 "ADP ribosylation factor related protein 1" Q13795 20 63698642-63708025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047028, HPA050634" Approved Supported "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA047028: AB_2679908, HPA050634: AB_2681196" "unprognostic (6.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.95e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.70e-2)" "unprognostic (2.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.53e-2)" "unprognostic (5.58e-2)" "unprognostic (3.93e-2)" "unprognostic (1.72e-2)" "unprognostic (5.48e-2)" "unprognostic (3.39e-1)" 26.8 27.8 23.4 14.0 23.4 10.0 25.0 22.8 29.1 31.8 22.4 29.3 18.9 29.3 5.3 36.2 27.9 8.8 41.0 22.7 22.7 34.1 36.5 26.0 17.8 23.1 23.2 29.3 24.4 12.6 25.1 11.6 23.1 32.4 8.4 5.5 22.4 16.0 31.8 22.9 27.2 10.1 22.7 42.0 24.6 20.1 24.5 17.7 25.6 15.5 11.2 29.5 28.3 23.9 26.5 31.9 10.1 10.6 10.0 10.8 14.6 31.8 21.1 67.7 24.6 60.0 22.4 32.4 21.6 18.8 27.3 35.8 11.0 35.5 11.9 11.3 16.5 23.8 36.1 52.2 34.7 27.3 21.5 15.1 45.2 17.8 21.6 17.9 25.1 30.5 36.0 24.1 16.9 14.9 54.0 37.7 15.8 19.5 46.7 42.3 14.0 33.4 14.5 21.7 16.9 17.3 32.3 46.5 11.4 6.1 20.5 34.8 20.0 39.6 15.9 14.9 32.6 24.9 11.1 25.1 26.5 17.9 22.8 44.3 30.9 23.5 41.5 31.6 34.7 32.6 37.5 39.8 28.3 33.7 46.8 41.5 15.7 37.6 34.7 49.2 32.3 36.5 23.4 23.4 22.8 29.1 22.7 22.7 23.1 23.2 23.1 22.7 24.5 23.9 40.7 12.8 11.9 12.4 25.9 13.9 25.5 26.1 19.4 44.6 20.8 28.7 34.0 8.6 15.8 25.8 20.9 42.2 28.0 48.9 39.2 31.2 12.8 13.5 27.0 34.3 26.4 25.7 10.6 20.4 25.5 31.6 18.3 10.7 24.7 28.4 24.3 18.4 36.9 37.0 10.6 31.6 18.3 20.7 15.3 10.5 23.9 24.1 24.9 5.6 41.0 40.8 29.9 4.0 11.9 51.6 34.6 29.7 23.4 22.9 52.4 33.4 12.3 42.3 19.7 21.8 35.1 44.5 32.7 22.4 14.2 30.2 30.7 35.7 33.1 17.0 ARL1 ARFL1 ENSG00000120805 "ADP ribosylation factor like GTPase 1" P40616 12 101393116-101407772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062656, HPA073012" Approved Supported "Golgi apparatus" NA NA 13000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 1: Thyroid gland - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA062656: AB_2684821, HPA073012: AB_2686564" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.61e-4)" "unprognostic (6.41e-2)" "unprognostic (3.15e-2)" "unprognostic (2.62e-3)" "unprognostic (1.69e-1)" "unprognostic (1.97e-1)" "unprognostic (4.82e-2)" "unprognostic (2.28e-1)" "unprognostic (4.54e-2)" "unprognostic (1.04e-2)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (3.46e-2)" 46.4 66.0 25.3 40.0 27.0 16.5 62.5 26.6 31.6 86.5 41.8 56.6 48.0 51.3 71.2 49.1 50.1 43.6 65.5 27.1 33.6 76.6 68.6 36.6 33.2 30.1 29.3 65.2 44.6 92.6 59.1 51.5 31.9 73.4 60.5 48.7 73.9 69.1 51.9 27.8 43.2 59.7 28.5 28.9 57.5 32.8 28.0 32.8 84.7 56.7 48.7 53.0 35.9 27.7 64.9 61.2 58.8 51.6 162.0 161.5 77.8 129.2 155.2 85.9 81.9 71.4 46.9 58.4 77.3 150.7 76.4 44.3 67.1 88.6 98.0 47.0 51.5 54.9 32.9 110.7 120.2 63.7 40.2 97.7 77.1 85.6 135.7 146.1 93.1 39.7 74.1 33.5 113.3 76.1 55.4 63.4 56.6 93.9 82.5 40.8 58.8 67.1 130.5 128.6 38.8 25.5 62.1 80.5 104.2 82.6 136.0 43.5 70.4 65.1 37.3 88.5 56.4 55.5 59.5 58.9 93.3 47.4 71.5 50.4 25.3 18.2 21.8 30.7 32.5 30.1 25.8 28.4 32.8 28.8 25.6 20.1 2.5 23.7 34.2 39.6 34.1 24.6 25.3 27.0 26.6 31.6 27.1 33.6 30.1 29.3 31.9 28.5 28.0 27.7 57.0 41.7 46.7 13.4 39.4 51.2 71.4 175.5 38.7 42.1 65.1 64.4 75.2 41.5 119.1 69.9 18.8 102.6 30.5 42.3 125.2 97.0 90.2 54.8 68.4 44.6 47.5 24.6 14.5 64.3 119.4 88.4 36.2 60.6 37.4 37.4 36.8 50.2 65.8 32.0 19.5 125.6 75.3 27.7 31.9 31.8 78.6 31.6 55.2 6.5 39.6 81.9 25.7 12.5 15.8 62.1 52.2 71.1 79.3 117.2 70.4 131.3 100.0 48.9 46.0 51.2 75.7 134.6 86.1 46.2 55.4 135.3 28.8 54.6 65.7 100.1 ARR3 ARRX ENSG00000120500 "Arrestin 3" P36575 X 70268305-70281840 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 170 "retina: 392.2" "Cell type enriched" "Detected in some" 8 "Cone photoreceptor cells: 1538.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA063129 Enhanced Approved "Golgi apparatus" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 2: Karpas-707 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA063129: AB_2732696" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (2.82e-1)" "unprognostic (1.37e-2)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.02e-3)" "unprognostic (2.77e-7)" "unprognostic (8.64e-2)" "unprognostic (6.53e-2)" "unprognostic (6.06e-2)" "unprognostic (1.43e-1)" 0.2 0.3 0.1 0.5 0.2 0.5 0.0 0.0 0.1 0.0 0.6 0.3 0.6 0.3 0.0 0.2 0.1 0.4 0.4 0.1 0.1 0.1 0.0 0.2 0.9 0.4 0.3 0.3 0.4 0.0 0.0 0.3 0.3 0.3 0.2 392.2 0.3 0.0 0.3 2.3 0.9 0.0 0.1 0.5 0.4 0.2 0.3 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.1 0.2 1.2 0.8 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.2 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.5 1.2 0.1 0.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.1 2.2 0.0 0.2 0.4 0.2 0.3 0.2 0.2 0.4 0.2 0.0 0.0 0.5 0.1 0.3 0.2 0.0 0.0 0.7 0.0 0.1 0.9 0.5 0.7 0.5 0.0 0.5 0.3 0.3 0.5 0.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.4 0.3 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.3 0.0 0.0 0.0 1538.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.2 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 68.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 172.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARSB ENSG00000113273 "Arylsulfatase B" P15848 5 78777209-78986087 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 40.8;Excitatory neurons: 37.4;Inhibitory neurons: 42.5;Microglial cells: 40.3;Oligodendrocyte precursor cells: 71.4;Oligodendrocytes: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 25.6" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 25.6;monocytes: 8.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037770, HPA037771" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" "HPA037770: AB_10671719, HPA037771: AB_10671720" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.97e-2)" "unprognostic (1.09e-2)" "unprognostic (7.34e-2)" "unprognostic (2.65e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (7.20e-2)" "unprognostic (1.74e-1)" "unprognostic (3.59e-2)" "unprognostic (2.48e-2)" "unprognostic (9.57e-3)" "unprognostic (9.88e-2)" "unprognostic (6.54e-3)" "prognostic unfavorable (3.42e-4)" 6.9 4.5 3.9 8.1 3.9 8.1 2.6 3.1 4.6 5.3 4.2 5.5 3.1 6.4 3.5 4.8 2.9 7.3 8.3 4.7 3.6 21.3 7.6 7.0 5.4 4.6 5.3 2.2 4.6 6.6 2.5 11.5 4.0 5.0 8.2 6.7 3.1 6.6 3.8 2.1 3.6 14.1 4.3 5.2 3.9 2.6 5.2 2.6 4.2 4.3 4.8 8.0 2.3 5.0 5.0 11.3 18.6 6.3 41.9 16.4 16.7 29.2 23.0 18.9 23.0 9.9 8.4 6.5 31.5 25.5 29.0 3.9 7.0 7.4 18.5 55.6 6.2 9.2 11.2 40.1 9.7 10.5 10.4 19.4 2.4 19.7 6.5 15.6 22.4 3.9 2.0 12.9 19.6 9.2 5.8 19.3 5.6 1.1 6.7 7.7 10.9 5.9 12.0 6.2 6.8 15.9 20.3 6.2 12.1 12.7 6.9 26.2 16.2 17.5 10.4 7.6 26.4 14.8 28.0 7.2 21.6 21.4 40.3 19.0 8.3 25.6 1.0 6.7 0.6 2.0 0.4 0.4 7.8 1.3 0.3 0.5 4.6 0.2 5.6 5.7 0.7 2.7 3.9 3.9 3.1 4.6 4.7 3.6 4.6 5.3 4.0 4.3 5.2 5.0 3.9 0.0 2.0 40.8 5.1 0.8 1.4 1.3 0.6 3.7 1.6 1.0 7.2 1.5 0.7 3.7 6.2 2.2 5.5 1.4 3.9 3.7 0.5 1.9 7.2 4.5 1.2 16.2 37.4 9.2 5.1 6.6 2.6 9.0 0.0 6.3 13.6 3.8 16.7 6.7 42.5 6.0 0.0 25.2 14.3 0.5 4.4 15.9 14.2 40.3 16.1 3.6 2.1 71.4 56.2 4.0 3.0 3.8 8.1 2.2 0.5 18.8 2.5 2.7 6.6 5.0 4.4 2.2 3.1 0.7 1.3 2.6 3.4 1.6 2.2 1.3 ARSI "FLJ16069, SPG66" ENSG00000183876 "Arylsulfatase family member I" Q5FYB1 5 150296343-150339307 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 12.1;Fibroblasts: 10.8;Melanocytes: 21.4;Smooth muscle cells: 6.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 15.7;HaCaT: 31.4;Hep G2: 19.9;hTEC/SVTERT24-B: 30.9;U-87 MG: 39.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA038386, HPA038398" Uncertain Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA038386: AB_10669781, HPA038398: AB_2675995" "unprognostic (6.08e-2)" "unprognostic (1.70e-2)" "unprognostic (9.41e-3)" "unprognostic (4.77e-3)" "unprognostic (1.54e-3)" "unprognostic (2.83e-3)" "unprognostic (2.76e-1)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.06e-1)" "unprognostic (5.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.26e-1)" "unprognostic (3.39e-7)" "unprognostic (7.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.19e-4)" 1.2 0.3 1.6 2.3 2.6 0.6 0.4 2.5 2.1 2.7 0.7 1.6 0.6 3.1 0.6 1.8 2.1 1.1 1.3 1.4 1.8 0.7 0.4 4.5 0.3 3.6 2.4 0.4 0.4 0.6 1.0 2.8 3.9 1.7 0.4 0.4 0.5 0.8 0.8 4.8 0.7 2.8 2.6 0.8 0.8 0.4 2.8 0.3 0.2 0.5 0.4 3.8 2.7 5.5 1.0 3.8 1.1 0.0 0.0 0.8 0.0 8.1 12.1 15.7 11.5 1.1 1.8 0.0 3.1 11.5 1.3 31.4 0.2 5.3 5.6 0.0 0.1 0.0 0.4 19.9 1.5 0.0 0.0 0.8 3.4 30.9 0.9 10.7 0.2 0.0 0.0 0.2 2.5 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.2 0.0 6.7 0.9 1.3 11.2 0.0 0.0 0.0 0.3 10.2 0.3 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.6 2.5 2.1 1.4 1.8 3.6 2.4 3.9 2.6 2.8 5.5 0.1 0.0 0.0 0.3 0.0 12.1 0.0 2.4 0.0 0.1 0.1 0.4 1.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 1.1 10.8 0.0 0.0 4.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.1 0.0 0.8 0.2 0.6 0.0 21.4 0.0 0.0 3.9 0.0 0.0 2.5 0.4 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.3 0.0 1.8 6.6 0.1 0.9 0.9 4.7 1.4 1.1 0.0 0.0 0.0 ARSL "ARSE, CDPX, CDPX1" ENSG00000157399 "Arylsulfatase L" P51690 X 2934521-2968475 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.6;liver: 86.3;pancreas: 105.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "liver cancer: 34.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6" "Low region specificity" "Detected in all" "HPA060518, HPA070651" Approved Supported "Golgi apparatus" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA060518: AB_2684301, HPA070651: AB_2732160" "unprognostic (2.07e-1)" "unprognostic (6.60e-3)" "prognostic favorable (8.95e-4)" "unprognostic (8.74e-3)" "unprognostic (1.14e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-1)" "unprognostic (8.27e-2)" "unprognostic (5.45e-2)" "unprognostic (2.25e-1)" "unprognostic (2.27e-1)" "unprognostic (2.37e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (4.76e-2)" 0.4 0.7 2.6 2.2 2.7 0.3 1.1 2.1 2.8 1.7 4.5 20.8 17.9 3.2 2.2 0.4 4.1 8.2 1.0 2.8 2.6 36.6 86.3 2.7 0.1 2.8 2.8 7.1 105.2 0.0 0.7 0.7 2.9 0.5 16.7 0.3 1.3 2.9 0.2 0.2 13.6 1.9 2.4 0.0 2.9 0.4 2.6 0.0 0.2 0.3 0.1 0.5 1.6 2.3 4.5 68.9 8.2 0.0 3.3 4.0 1.3 3.9 6.4 4.0 4.0 42.7 0.0 0.0 13.7 0.1 30.8 0.0 0.0 0.9 2.3 0.0 4.5 0.0 0.0 64.1 1.8 0.0 0.1 9.6 0.0 3.8 0.0 7.3 3.8 0.0 0.0 0.1 10.5 0.1 0.0 0.0 33.6 2.4 0.2 2.8 1.1 0.3 7.1 0.0 0.1 0.2 0.0 0.0 2.6 13.7 0.0 0.2 5.0 0.1 0.2 0.0 7.4 0.0 0.0 0.1 9.1 0.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 2.1 2.8 2.8 2.6 2.8 2.8 2.9 2.4 2.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.7;pituitary gland: 22.0;retina: 6.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 223.4;Cone photoreceptor cells: 173.0" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 21.2;HMC-1: 6.2;K-562: 12.1;SH-SY5Y: 5.2" "Region enhanced" "Detected in many" "basal ganglia: 73.2" "Low region specificity" "Detected in many" HPA036042 Approved "Golgi apparatus" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 1: K-562 - Erythropoiesis" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA036042: AB_10672998" "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.1 1.1 6.1 0.0 4.2 0.0 0.0 4.1 8.4 0.4 2.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 3.9 4.9 0.0 0.0 0.1 0.0 5.5 8.4 0.0 0.0 0.0 22.0 0.0 4.4 0.1 0.0 6.4 0.0 0.1 0.0 0.1 0.0 0.0 5.7 0.0 0.0 1.3 10.7 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 4.2 4.1 8.4 3.9 4.9 5.5 8.4 4.4 5.7 10.7 3.9 0.1 0.0 0.0 0.3 0.0 0.1 1.6 0.1 0.0 223.4 0.9 1.0 1.1 0.0 0.0 0.0 173.0 2.5 0.0 0.7 0.0 0.0 6.1 0.0 0.9 0.4 0.0 0.0 0.3 0.4 1.0 0.9 0.0 0.3 17.8 0.4 0.0 0.0 0.1 0.0 11.6 0.6 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 39.2 0.4 0.0 2.5 0.4 0.1 1.1 1.3 0.2 0.0 12.8 0.0 3.1 0.6 0.3 0.6 0.0 0.3 2.9 0.4 0.5 0.9 0.3 ATP2C1 "ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1" ENSG00000017260 "ATPase secretory pathway Ca2+ transporting 1" P98194 3 130850595-131016712 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 162.6;Excitatory neurons: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010207, HPA035116, HPA069684" Supported Supported "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.06e-6)" "unprognostic (7.66e-2)" "unprognostic (6.52e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.44e-2)" "prognostic favorable (1.55e-4)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "unprognostic (3.06e-1)" 32.2 32.7 34.0 25.3 36.6 38.6 32.9 31.8 42.8 33.4 76.9 36.5 23.9 30.9 28.0 23.6 37.2 27.2 31.9 40.7 38.6 44.7 28.5 51.4 21.9 37.0 38.9 28.8 22.6 78.0 22.7 32.7 40.3 85.8 35.9 59.4 29.2 25.2 28.1 31.9 26.9 31.0 33.6 19.5 31.5 25.2 48.8 36.2 35.0 21.1 26.2 31.6 18.1 48.6 133.1 51.1 49.9 48.5 136.7 110.0 53.9 141.2 186.8 69.4 87.0 83.5 106.3 47.6 95.6 134.4 96.4 153.6 95.1 77.9 100.8 104.4 34.2 127.2 51.5 39.0 87.2 51.2 148.4 86.8 76.6 73.2 82.2 126.3 74.6 59.3 37.3 84.1 86.7 59.0 50.6 40.9 57.0 71.7 54.8 36.3 49.9 75.6 127.5 87.7 76.7 45.9 121.4 37.8 72.8 70.8 55.7 41.7 102.6 73.3 40.8 95.5 65.8 54.6 71.1 69.9 75.8 38.0 62.6 30.6 8.9 15.9 7.4 7.6 7.0 5.6 7.3 6.6 9.5 3.6 4.9 4.9 4.3 11.5 9.6 8.2 9.3 6.5 34.0 36.6 31.8 42.8 40.7 38.6 37.0 38.9 40.3 33.6 48.8 48.6 30.2 38.5 53.0 162.6 17.4 39.4 34.5 34.8 26.7 25.9 34.4 22.4 30.2 35.8 41.1 46.0 20.9 16.3 15.5 39.0 5.9 35.3 17.5 26.9 34.1 27.8 35.6 23.3 172.5 38.0 27.6 25.9 33.1 55.8 28.5 28.2 26.7 27.4 27.7 82.4 136.5 32.4 36.7 26.2 34.8 18.9 16.1 39.5 21.4 128.4 20.5 26.4 19.6 148.3 154.3 51.1 27.5 14.7 18.5 69.0 16.3 19.8 52.7 33.4 6.6 27.7 25.9 16.2 14.1 24.7 52.8 17.6 19.5 17.3 31.2 36.9 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ionocytes: 61.1;Microglial cells: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 2: Karpas-707 - Immune response" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA012887: AB_1845205, HPA048107: AB_2680266" "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 3.0 4.3 1.2 3.6 1.7 5.9 6.3 2.3 2.1 3.9 1.6 3.4 3.9 3.6 5.0 4.9 3.5 3.6 2.5 1.3 2.1 4.4 2.3 4.5 4.1 2.1 2.1 3.6 2.4 7.3 2.5 4.0 3.8 5.3 3.4 3.0 5.1 3.4 1.8 11.1 3.4 3.2 1.1 4.7 5.5 1.6 1.6 4.7 4.6 2.9 4.6 3.9 2.8 2.9 3.2 8.3 5.4 5.5 5.0 5.3 0.9 4.8 6.6 2.8 5.7 1.0 3.6 4.7 6.9 4.8 3.3 3.8 7.1 3.9 5.2 7.0 4.8 2.4 7.8 0.8 6.3 4.1 4.1 5.6 1.6 5.9 1.8 6.5 7.3 4.7 19.6 17.4 5.2 2.8 4.6 1.4 1.5 11.2 1.7 3.7 9.0 15.8 4.6 8.8 1.6 20.4 11.9 2.8 6.0 3.3 2.2 1.3 9.4 3.7 3.6 5.2 1.9 5.6 10.7 5.2 6.0 2.5 5.7 7.1 1.5 4.5 1.8 1.5 0.9 1.8 1.2 1.2 1.0 1.4 1.4 2.1 8.1 1.2 1.9 1.0 0.4 1.0 1.2 1.7 2.3 2.1 1.3 2.1 2.1 2.1 3.8 1.1 1.6 2.9 14.3 0.0 8.4 15.7 12.6 7.4 5.1 5.8 13.1 6.4 17.3 10.0 5.1 1.5 8.2 9.2 4.2 2.0 15.0 4.5 1.9 5.6 0.5 5.3 9.2 9.7 4.8 22.5 11.1 13.6 2.2 9.4 20.4 8.8 9.5 6.4 14.6 3.6 14.3 1.7 12.5 4.8 61.1 11.7 6.7 1.1 7.2 12.6 19.6 44.0 5.5 4.4 11.3 37.7 35.0 6.2 4.1 9.8 10.5 4.8 4.1 5.5 10.2 4.1 32.9 10.3 8.7 1.8 5.4 20.5 16.6 2.2 13.8 6.7 5.2 6.6 ATP7B WND ENSG00000123191 "ATPase copper transporting beta" P35670 13 51930436-52012125 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA009137, HPA013187" Supported Supported "Golgi apparatus" NA NA "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 36: HEL - Hemostasis" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA009137: AB_2668214, HPA013187: AB_1845206" "unprognostic (1.13e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (3.49e-1)" "unprognostic (5.51e-2)" "unprognostic (1.55e-2)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (8.29e-2)" "unprognostic (1.17e-1)" "unprognostic (3.26e-3)" "unprognostic (4.66e-2)" "unprognostic (3.54e-1)" "unprognostic (6.21e-3)" "unprognostic (1.40e-1)" 3.6 0.9 1.3 0.6 1.2 2.2 1.7 2.0 2.1 1.8 0.8 2.9 10.6 1.5 0.1 0.7 2.0 7.0 2.1 2.5 1.4 2.2 8.6 1.4 0.3 0.8 1.2 1.9 2.0 6.4 1.2 7.1 1.1 2.0 2.7 3.7 3.0 0.9 1.1 1.0 6.0 1.7 0.5 0.4 4.4 8.4 1.7 0.7 1.2 1.8 0.2 1.6 1.2 0.7 0.8 2.8 5.2 4.5 1.0 0.8 32.8 1.5 0.5 1.6 1.2 21.1 0.1 0.1 0.6 2.7 3.6 0.3 4.0 4.4 1.0 0.4 7.5 53.0 0.5 14.7 1.4 0.6 11.8 1.9 4.7 0.2 2.0 2.1 3.7 3.7 14.4 0.2 1.5 1.0 0.2 0.9 1.7 6.6 1.8 2.0 1.4 0.0 22.5 3.4 3.3 2.2 1.9 2.8 1.8 5.5 8.0 0.5 2.0 0.3 1.7 2.8 0.6 0.6 0.7 0.2 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 2.0 2.1 2.5 1.4 0.8 1.2 1.1 0.5 1.7 0.7 5.4 6.4 0.0 10.7 0.9 0.4 0.7 1.7 0.0 3.1 2.3 1.8 2.1 4.3 5.2 1.8 22.9 14.3 1.8 6.6 0.0 1.6 30.2 2.4 1.3 2.7 2.4 4.2 24.5 1.0 5.5 2.1 9.2 4.2 0.0 13.3 3.9 23.6 2.3 0.0 25.4 3.4 4.1 0.8 0.3 74.2 2.1 0.2 1.8 15.0 0.2 0.2 0.0 12.1 4.3 2.0 3.0 0.7 0.2 1.3 11.4 2.2 4.3 6.1 6.6 1.0 1.4 2.2 1.7 0.7 0.4 4.5 0.2 0.4 5.0 1.2 B3GALNT2 MGC39558 ENSG00000162885 "Beta-1,3-N-acetylgalactosaminyltransferase 2" Q8NCR0 1 235447190-235504452 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 252.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007846, HPA050662" Approved Uncertain "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA007846: , HPA050662: AB_2681209" "unprognostic (5.50e-2)" "unprognostic (3.16e-3)" "unprognostic (6.60e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (7.59e-3)" "unprognostic (1.96e-2)" "unprognostic (3.39e-2)" "unprognostic (3.38e-1)" "unprognostic (7.19e-3)" "unprognostic (2.89e-1)" "unprognostic (1.99e-1)" "unprognostic (5.52e-2)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (8.34e-3)" 4.7 5.4 2.3 2.8 2.2 1.6 4.0 2.5 2.4 5.3 5.7 8.1 3.2 7.3 4.8 8.9 5.5 5.3 6.1 2.4 2.6 3.3 3.2 3.4 2.2 2.4 2.7 5.1 22.3 6.7 3.8 4.3 2.3 7.3 5.3 3.9 6.0 6.6 23.3 6.2 5.1 10.6 2.3 2.7 8.9 5.9 2.5 3.6 7.3 16.7 3.4 7.9 5.4 2.2 15.0 10.4 11.1 16.2 14.2 15.7 21.6 14.1 11.8 9.8 10.0 7.7 13.1 8.2 15.3 15.5 7.0 17.3 21.3 14.8 12.5 14.5 11.7 5.8 12.7 9.3 10.0 17.9 4.3 9.9 9.5 10.4 21.5 7.0 14.1 19.2 10.9 10.9 9.2 7.3 10.0 8.8 15.7 7.9 3.1 10.6 19.9 18.8 6.4 21.1 14.2 16.8 23.7 7.8 12.2 3.9 18.5 15.6 13.1 9.7 13.3 16.6 18.1 11.3 14.8 5.0 6.7 12.1 21.7 1.1 1.1 0.5 0.6 1.6 0.8 0.6 0.6 0.7 2.3 0.5 0.5 0.9 0.2 1.2 1.4 1.9 0.3 0.4 2.3 2.2 2.5 2.4 2.4 2.6 2.4 2.7 2.3 2.3 2.5 2.2 9.6 9.6 5.0 38.8 7.8 31.2 39.0 15.1 36.5 33.1 8.9 6.7 6.7 1.5 9.5 5.5 252.3 20.3 14.6 5.2 0.0 6.9 26.7 20.2 14.8 7.0 9.0 5.0 38.4 7.2 7.0 11.5 10.7 19.9 5.7 11.9 4.6 4.7 3.9 28.6 56.2 6.2 4.1 3.0 16.3 7.3 10.5 6.9 1.8 23.4 11.5 11.2 7.2 29.1 21.7 9.2 5.4 16.1 14.0 27.6 9.7 2.3 8.1 18.4 0.0 21.0 20.5 35.8 40.3 28.5 29.7 22.4 9.0 17.6 7.0 33.1 B4GALT1 "beta4Gal-T1, GGTB2" ENSG00000086062 "Beta-1,4-galactosyltransferase 1" P15291 9 33104082-33167356 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 215.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 346.6;SiHa: 635.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010806, HPA010807" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 97000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 20: HeLa - Mitochondria" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "HPA010806: AB_1078255, HPA010807: AB_1078254" "unprognostic (7.57e-2)" "unprognostic (1.24e-2)" "unprognostic (2.09e-1)" "prognostic favorable (6.85e-7)" "unprognostic (1.83e-2)" "unprognostic (9.94e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-3)" "unprognostic (2.78e-1)" "unprognostic (7.93e-3)" "unprognostic (4.98e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.46e-2)" 52.4 39.2 5.6 43.9 5.1 80.2 91.1 7.3 6.4 64.9 17.9 38.0 21.9 35.7 35.7 49.7 49.3 47.8 55.4 5.4 6.8 42.1 89.4 50.1 33.3 8.6 6.4 77.4 43.9 77.1 21.2 52.9 7.7 38.8 34.3 26.2 70.3 34.0 30.9 35.8 28.1 55.2 8.1 39.7 52.1 38.3 8.3 26.8 60.8 16.7 41.2 79.4 44.9 9.4 99.1 71.8 13.1 18.1 64.9 113.7 235.9 100.6 125.7 59.5 58.8 44.0 112.1 37.8 62.4 147.3 77.2 51.9 13.7 124.5 59.4 346.6 13.6 21.6 277.6 34.1 127.4 17.9 35.0 128.0 218.1 68.0 82.2 127.6 64.0 11.5 24.9 45.5 57.0 86.1 16.3 35.4 8.1 54.1 21.8 21.0 12.2 25.1 177.0 84.6 9.8 12.7 635.5 122.2 25.8 40.4 154.8 32.3 59.9 42.2 49.4 137.2 39.8 7.6 17.9 23.3 131.0 24.2 15.8 30.6 33.2 20.3 45.2 30.5 59.2 87.1 30.4 40.7 23.3 69.9 17.9 23.3 96.5 72.4 24.8 215.3 22.0 24.0 5.6 5.1 7.3 6.4 5.4 6.8 8.6 6.4 7.7 8.1 8.3 9.4 104.4 86.6 71.9 3.3 112.0 141.9 53.0 59.2 75.7 3.8 215.8 66.7 37.2 88.6 59.5 167.3 20.9 94.9 206.2 146.1 15.6 78.2 21.9 108.6 39.7 60.6 8.4 12.8 4.1 125.9 155.8 99.9 80.0 163.7 36.8 19.6 91.1 195.4 53.9 0.0 4.5 64.0 24.4 82.3 333.3 11.1 50.7 129.0 96.0 33.7 31.3 7.7 39.1 3.0 1.0 157.8 57.4 44.4 116.4 89.0 23.9 57.7 33.8 40.1 52.6 80.0 50.8 6.4 13.8 86.1 108.4 173.9 92.7 33.9 41.6 93.2 B4GALT4 beta4Gal-T4 ENSG00000121578 "Beta-1,4-galactosyltransferase 4" O60513 3 119211732-119240946 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 76.0" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 123.6;Urothelial cells: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 125.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046819, HPA063546" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA046819: AB_2679824, HPA063546: AB_2685036" "unprognostic (4.07e-2)" "unprognostic (1.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.14e-3)" "unprognostic (4.59e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (6.30e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-1)" "unprognostic (6.10e-3)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" 12.4 9.1 6.8 10.7 8.4 20.1 11.1 6.5 8.1 16.4 8.7 30.6 28.6 14.8 76.0 17.7 21.8 33.2 12.9 7.0 6.9 24.1 16.6 9.9 9.9 6.9 6.7 18.4 19.5 15.1 18.2 25.7 6.9 13.7 35.2 9.9 12.2 14.7 6.3 14.1 32.5 13.6 7.0 9.4 29.3 8.3 7.5 7.4 16.4 6.5 11.5 37.6 10.5 7.2 60.1 100.3 12.8 9.8 36.0 31.1 65.3 125.8 54.4 54.4 56.2 65.4 18.3 11.8 23.9 61.3 32.2 78.6 20.7 15.0 59.9 23.5 6.8 15.1 20.3 31.7 25.3 8.9 15.7 21.2 21.4 23.0 19.3 21.6 5.8 8.0 11.2 11.7 25.5 18.4 5.3 10.7 17.6 34.0 27.2 4.9 11.8 4.7 31.2 60.3 10.9 24.0 29.4 14.6 27.9 28.2 30.2 5.7 4.9 27.3 24.0 15.2 13.5 27.2 21.5 16.1 23.5 10.1 23.5 20.1 4.1 8.3 13.3 5.2 7.3 4.2 7.3 7.9 5.5 3.2 13.6 7.1 2.5 14.8 5.0 3.4 2.7 5.7 6.8 8.4 6.5 8.1 7.0 6.9 6.9 6.7 6.9 7.0 7.5 7.2 8.5 0.0 9.4 7.2 17.1 10.7 22.2 48.9 12.0 10.8 14.9 12.4 9.2 61.5 69.1 7.3 4.2 36.2 46.0 43.2 1.9 30.7 2.1 40.1 16.9 8.4 13.8 7.8 11.9 33.2 123.6 24.0 36.2 74.5 13.3 35.0 3.9 10.8 14.4 18.5 11.1 78.7 16.2 9.8 14.8 2.4 14.9 14.9 14.2 6.5 10.9 22.2 39.1 10.6 10.2 40.5 50.2 28.2 27.4 30.7 59.3 22.6 52.6 10.2 19.7 13.9 16.9 1.7 8.4 14.0 10.5 52.3 23.1 20.0 23.6 171.6 BLOC1S3 "BLOS3, HPS8" ENSG00000189114 "Biogenesis of lysosomal organelles complex 1 subunit 3" Q6QNY0 19 45178784-45216933 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050111, HPA070609" Approved Approved "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA050111: AB_2681019, HPA070609: " "unprognostic (1.17e-1)" "unprognostic (3.97e-2)" "unprognostic (6.94e-3)" "unprognostic (6.26e-2)" "unprognostic (3.14e-1)" "unprognostic (3.04e-2)" "unprognostic (1.75e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-1)" "unprognostic (9.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.89e-9)" "unprognostic (1.92e-2)" "unprognostic (1.93e-1)" "unprognostic (3.29e-1)" "prognostic favorable (6.86e-4)" 6.7 6.3 7.8 5.9 7.8 12.4 5.7 7.0 8.2 5.7 4.4 5.7 5.3 5.6 5.9 6.4 4.7 3.2 5.2 7.5 6.4 5.7 7.8 5.5 7.6 9.3 8.0 5.6 6.1 4.8 4.4 3.9 8.4 5.7 4.3 3.3 5.6 4.5 4.4 13.2 6.7 4.1 6.8 11.0 7.6 7.2 8.1 4.7 4.7 3.4 7.5 6.6 5.9 9.2 10.4 11.6 3.2 8.1 10.8 7.3 9.7 5.1 8.2 9.5 9.8 7.0 6.6 9.0 12.2 11.9 10.8 16.0 8.5 11.6 6.8 7.9 17.3 12.3 5.5 8.0 15.4 6.0 19.5 10.8 16.3 12.3 17.3 5.4 10.6 5.9 13.2 18.2 5.6 17.8 6.2 9.2 1.8 14.9 14.5 8.9 4.3 7.5 7.0 13.2 6.3 6.0 13.6 22.8 5.1 5.6 9.4 11.1 5.7 9.7 5.5 10.4 8.2 12.7 14.0 6.1 10.6 11.1 7.5 51.1 34.4 30.2 37.4 42.8 31.0 18.4 31.6 28.3 21.4 24.8 25.5 25.5 35.2 24.2 39.9 18.5 29.8 17.8 7.8 7.8 7.0 8.2 7.5 6.4 9.3 8.0 8.4 6.8 8.1 9.2 3.4 0.0 1.7 1.0 5.4 12.7 2.6 1.7 2.2 5.7 4.2 3.2 2.3 1.5 1.5 3.7 0.0 3.7 5.9 4.6 1.9 4.4 17.7 1.9 3.2 5.2 7.2 1.7 2.7 3.7 4.0 3.2 2.0 2.7 8.2 3.0 6.1 6.3 6.1 5.0 2.8 5.0 0.0 8.8 8.9 39.3 6.2 4.7 3.6 1.0 6.8 3.4 11.3 3.5 2.9 5.1 3.2 7.9 4.0 4.9 4.6 4.2 1.7 2.0 0.0 1.9 3.1 1.5 5.1 2.7 13.9 4.5 6.7 3.0 4.1 1.9 BRSK2 "C11orf7, PEN11B, STK29" ENSG00000174672 "BR serine/threonine kinase 2" Q8IWQ3 11 1389899-1462689 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 37.8;pancreas: 104.2" "Cell type enhanced" "Detected in some" "Astrocytes: 22.9;Bipolar cells: 87.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 35.5;Horizontal cells: 69.0;Inhibitory neurons: 23.5;Rod photoreceptor cells: 28.6" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.8;AN3-CA: 17.3;CACO-2: 14.4;HAP1: 13.3;NTERA-2: 27.2;SCLC-21H: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073690 Approved "Golgi apparatus" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA073690: " "unprognostic (5.47e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.05e-2)" "unprognostic (3.63e-1)" "unprognostic (6.42e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.17e-7)" "unprognostic (3.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "unprognostic (1.86e-1)" 1.1 2.4 11.5 0.2 16.0 0.1 0.7 29.2 37.8 2.1 0.0 2.8 0.5 1.0 0.0 0.8 2.0 0.7 1.0 20.5 2.1 0.5 0.2 0.4 0.1 7.9 3.6 0.9 104.2 2.2 15.6 0.6 8.6 1.4 0.1 17.4 0.4 0.2 0.4 0.3 1.5 0.1 0.5 0.6 1.9 9.0 5.0 0.1 1.0 0.2 0.0 0.8 1.1 17.6 0.1 7.2 15.8 17.3 0.3 0.5 0.0 0.2 0.2 1.3 0.5 14.4 0.9 0.0 2.4 0.2 0.2 0.0 13.3 0.1 1.0 1.7 6.2 0.0 0.0 0.2 0.7 0.0 0.6 0.2 0.0 0.0 1.6 0.3 0.0 0.5 0.2 0.1 0.3 1.7 0.0 0.0 27.2 5.1 2.2 0.0 0.0 0.0 0.2 0.2 62.0 9.0 3.3 0.2 4.7 0.3 0.3 0.8 0.3 1.4 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 16.0 29.2 37.8 20.5 2.1 7.9 3.6 8.6 0.5 5.0 17.6 0.4 0.0 0.0 22.9 0.1 0.3 0.1 0.0 0.0 87.9 0.1 0.1 2.1 0.0 0.0 0.0 35.5 0.0 0.2 0.1 0.0 0.1 0.5 0.2 0.4 0.6 0.0 0.0 35.5 1.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.2 69.0 23.5 0.2 0.0 0.0 0.0 0.7 0.9 0.1 0.0 6.5 0.0 20.7 0.0 20.1 20.6 0.3 0.0 1.2 0.0 0.2 0.0 0.1 0.0 28.6 6.6 0.9 6.0 0.9 1.7 0.1 0.0 0.0 0.6 0.1 0.1 0.0 C19orf18 MGC41906 ENSG00000177025 "Chromosome 19 open reading frame 18" Q8NEA5 19 57958437-57974534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.4" "Cell type enriched" "Detected in many" 5 "Early spermatids: 131.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.0;HEK 293: 3.0;RT4: 2.0;U-266/84: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014527, HPA079195" Approved Approved "Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 77: Retina - Visual perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus" "HPA014527: AB_1845612, HPA079195: " "unprognostic (5.38e-2)" "unprognostic (6.36e-3)" "unprognostic (3.70e-2)" "prognostic favorable (5.07e-4)" "unprognostic (4.85e-2)" "unprognostic (9.50e-2)" "unprognostic (2.75e-1)" "unprognostic (5.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.64e-1)" "unprognostic (4.08e-5)" "unprognostic (1.11e-2)" "unprognostic (8.75e-5)" "unprognostic (1.53e-1)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (1.05e-3)" 1.3 1.9 2.8 0.4 3.8 0.6 2.6 2.8 8.1 1.5 6.5 2.0 0.8 1.3 4.0 0.6 2.3 1.2 4.8 3.0 3.1 2.5 1.8 1.0 0.6 4.2 4.3 1.8 1.1 0.9 3.9 0.8 3.9 3.3 0.8 5.1 1.2 1.3 3.5 1.3 1.2 0.9 3.6 1.2 1.1 12.4 3.7 0.6 1.7 0.6 0.7 1.6 0.9 3.6 0.1 0.0 0.8 2.0 0.4 0.6 0.6 1.0 0.2 0.2 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.0 0.0 0.0 0.6 0.0 3.0 0.1 0.0 0.7 0.7 0.0 0.5 0.7 1.2 0.0 0.2 0.7 0.1 0.4 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.0 0.5 0.5 2.0 0.8 0.2 0.4 0.0 0.3 0.6 0.7 0.6 0.4 0.1 0.2 0.2 0.2 0.4 1.8 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 2.8 3.8 2.8 8.1 3.0 3.1 4.2 4.3 3.9 3.6 3.7 3.6 1.9 3.2 2.2 17.9 0.8 0.4 0.3 0.6 0.0 0.9 2.2 1.8 3.6 1.5 2.1 0.0 0.0 0.5 0.6 0.8 0.0 2.0 131.6 5.7 0.9 2.1 0.0 2.7 2.5 0.2 0.6 0.7 0.0 1.4 0.0 0.7 4.6 1.9 0.4 0.0 3.2 1.9 0.0 0.8 1.4 24.2 2.1 0.4 1.8 1.0 0.6 1.5 0.0 8.5 8.0 1.0 0.3 0.7 0.2 0.6 0.5 0.3 4.0 3.4 6.6 0.9 1.2 5.3 2.2 0.2 0.6 0.3 0.6 1.2 1.1 0.5 C1QTNF3 "2310005P21Rik, Corcs, Cors, Cors-26, CTRP3" ENSG00000082196 "C1q and TNF related 3" Q9BXJ4 5 34017858-34043213 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.4;salivary gland: 52.0" "Cell type enhanced" "Detected in many" "Early spermatids: 161.6;Fibroblasts: 61.5;Late spermatids: 387.6;Muller glia cells: 227.2;Skeletal myocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 211 "U-266/84: 810.2" "HPA064996, HPA066011" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 44100000 24000000 "Cluster 37: Intestine - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA064996: AB_2685399, HPA066011: AB_2685597" "unprognostic (7.71e-2)" "unprognostic (2.81e-3)" "unprognostic (5.83e-2)" "unprognostic (6.58e-2)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-3)" "unprognostic (5.18e-2)" "unprognostic (1.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (4.89e-3)" "unprognostic (1.80e-1)" "unprognostic (9.38e-3)" "unprognostic (2.35e-1)" 7.3 0.5 4.1 1.7 5.0 0.6 6.8 6.8 4.0 3.6 2.6 11.2 3.5 2.7 1.0 33.4 3.0 5.9 0.9 3.9 7.0 4.8 1.1 4.1 0.8 5.3 4.3 1.4 1.7 0.3 1.3 0.6 4.5 2.2 10.0 23.7 52.0 4.9 2.2 2.3 8.9 23.3 5.8 0.7 10.7 11.4 4.2 1.0 1.6 9.9 0.4 13.2 3.6 5.1 0.7 0.1 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.2 0.1 0.0 0.2 0.2 0.9 0.2 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.2 0.7 0.8 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.8 3.2 0.0 0.0 0.0 1.1 0.1 0.0 0.1 0.2 0.2 1.6 0.0 0.1 0.6 0.1 0.0 3.8 0.6 0.1 1.0 0.0 1.0 0.9 810.2 1.3 0.0 0.8 3.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.1 5.0 6.8 4.0 3.9 7.0 5.3 4.3 4.5 5.8 4.2 5.1 2.3 3.2 2.0 0.0 2.0 5.7 0.6 0.4 1.8 5.1 3.0 2.3 1.0 8.6 0.8 3.7 0.0 0.9 1.5 0.7 1.9 1.2 161.6 2.6 1.0 7.2 1.8 1.3 0.0 1.4 0.5 61.5 1.5 2.6 0.0 1.8 0.4 1.3 1.3 8.4 0.0 1.4 2.0 0.6 9.6 387.6 1.8 1.1 7.2 0.0 0.3 227.2 1.0 0.0 0.0 0.5 1.5 2.6 0.2 0.8 0.8 2.1 1.2 11.9 0.0 77.5 4.5 6.2 2.0 1.1 5.8 0.4 1.3 1.0 2.0 0.5 C2orf80 "GONDA1, LOC389073" ENSG00000188674 "Chromosome 2 open reading frame 80" Q0P641 2 208165343-208190030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 31.8" "Group enriched" "Detected in some" 8 "Excitatory neurons: 25.8;Inhibitory neurons: 11.7;Oligodendrocyte precursor cells: 31.7" "Cancer enriched" "Detected in single" 41 "glioma: 11.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 3.2;neutrophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Cell line enhanced" "Detected in single" "NTERA-2: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042639 Approved "Golgi apparatus" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA042639: AB_10794915" "unprognostic (6.36e-2)" "unprognostic (2.12e-1)" "unprognostic (2.95e-1)" "unprognostic (3.05e-1)" "unprognostic (1.83e-1)" "unprognostic (2.98e-2)" 0.0 0.1 21.0 0.4 26.5 1.1 0.0 6.3 31.8 0.0 7.4 0.2 0.2 0.1 0.0 0.9 0.1 0.2 0.1 27.2 20.5 0.1 0.3 0.0 0.2 11.6 13.3 0.2 0.0 0.1 1.0 0.1 13.9 0.2 0.2 1.4 0.3 0.4 0.3 0.4 0.3 0.1 11.0 0.1 0.2 0.6 17.0 0.0 0.1 0.0 0.0 0.0 0.0 15.1 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.5 1.7 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.3 3.2 0.6 0.5 0.3 0.4 0.2 0.5 0.3 0.3 0.2 0.7 0.3 0.3 4.6 0.5 0.3 0.8 0.1 0.1 21.0 26.5 6.3 31.8 27.2 20.5 11.6 13.3 13.9 11.0 17.0 15.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.8 0.0 1.0 0.0 31.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4BPB C4BP ENSG00000123843 "Complement component 4 binding protein beta" P20851 1 207088860-207099993 "Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 471.3" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 597.6" "Cancer enriched" "Detected in many" 19 "liver cancer: 83.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 16 "CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1" "Not detected" "Not detected" "HPA000925, HPA051620" Approved Uncertain "Golgi apparatus" "Secreted to blood" NA NA 265000000000 1100000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 39: CACO-2 - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA000925: , HPA051620: AB_2681554" "unprognostic (1.73e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-1)" "unprognostic (2.07e-3)" "unprognostic (1.72e-1)" "unprognostic (2.54e-2)" "unprognostic (4.58e-3)" "unprognostic (9.49e-2)" "unprognostic (1.37e-1)" "unprognostic (4.25e-1)" "unprognostic (6.39e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (8.25e-2)" 3.0 0.1 0.0 3.4 0.0 0.0 1.8 0.0 0.1 2.8 0.0 3.6 3.8 0.1 0.0 0.2 0.5 3.1 0.1 0.0 0.0 0.4 471.3 1.5 0.4 0.0 0.0 44.2 9.1 0.0 0.0 6.2 0.1 0.0 1.8 0.0 0.5 0.0 0.1 0.2 4.4 0.6 0.0 0.4 8.4 0.7 0.0 0.1 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.4 5.8 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 46.2 151.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 12.8 2.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 7.3 2.2 0.5 54.3 3.2 0.0 0.0 1.0 0.2 10.2 1.9 11.4 4.1 0.7 0.1 0.8 1.8 8.0 0.1 88.8 0.3 3.4 5.6 0.8 0.0 0.3 9.7 597.6 2.1 0.0 0.2 5.6 0.0 13.1 0.3 2.8 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 69.2 15.9 0.0 0.1 0.2 4.3 0.0 2.2 0.0 0.0 1.1 0.4 0.1 0.4 0.0 0.0 0.1 1.1 143.8 4.8 0.1 C5orf15 "HTGN29, KCT2" ENSG00000113583 "Chromosome 5 open reading frame 15" Q8NC54 5 133955510-133968674 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011951, HPA039165" Uncertain Approved "Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA011951: AB_2668584, HPA039165: AB_10795580" "unprognostic (2.25e-1)" "unprognostic (3.01e-1)" "unprognostic (2.07e-1)" "unprognostic (4.91e-2)" "unprognostic (1.81e-1)" "unprognostic (2.26e-3)" "unprognostic (1.01e-2)" "unprognostic (7.72e-2)" "unprognostic (2.62e-2)" "unprognostic (7.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (9.07e-3)" "unprognostic (5.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.66e-1)" "unprognostic (2.14e-2)" 35.4 49.5 15.5 35.6 16.2 18.6 44.7 16.6 22.9 38.5 24.8 32.4 48.7 35.4 34.4 24.0 48.0 41.3 40.7 15.5 17.1 73.6 80.3 39.9 47.5 16.7 16.6 36.6 26.3 44.7 19.9 58.9 17.2 39.6 33.1 24.5 30.9 25.1 22.3 30.7 48.6 30.5 17.4 37.3 48.8 26.6 15.9 33.9 53.1 22.6 37.0 46.4 19.0 21.3 70.4 51.5 70.5 81.3 101.9 115.9 85.9 71.3 95.4 107.2 178.7 49.9 204.1 49.5 127.4 87.3 108.4 51.1 57.7 104.0 125.6 56.3 87.7 18.7 34.2 63.9 96.1 30.8 79.8 102.2 62.7 84.7 44.7 152.5 45.9 31.3 39.7 57.4 86.7 44.7 35.9 57.9 39.0 34.1 30.8 34.0 72.3 73.8 175.0 53.9 62.8 47.0 71.9 24.2 117.1 126.0 74.9 91.7 42.4 95.6 88.4 39.2 71.8 42.9 44.1 30.3 113.3 72.9 143.6 19.5 31.6 16.8 14.6 34.6 13.7 22.8 16.6 16.0 37.0 24.3 21.1 17.1 16.3 22.0 34.2 26.7 17.3 29.4 15.5 16.2 16.6 22.9 15.5 17.1 16.7 16.6 17.2 17.4 15.9 21.3 18.6 25.6 33.2 12.7 32.3 30.7 39.8 85.7 33.6 22.0 41.3 22.1 17.9 51.5 54.1 49.7 10.4 83.6 19.6 27.1 17.6 73.7 45.6 68.4 34.2 21.2 37.2 17.1 17.1 46.8 71.9 61.1 25.0 32.2 15.2 31.5 23.9 48.5 55.7 5.0 15.6 30.4 81.4 32.8 57.7 7.0 51.3 34.0 64.0 21.5 97.1 27.6 19.6 37.2 35.3 47.9 24.1 39.1 28.8 33.5 51.5 71.8 125.5 26.9 26.3 30.6 36.3 46.8 29.1 23.3 32.5 58.0 21.5 80.6 21.2 22.8 C9orf64 MGC10999 ENSG00000165118 "Chromosome 9 open reading frame 64" Q5T6V5 9 83938311-83956986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054903, HPA066190" Uncertain Approved "Golgi apparatus" NA NA 9400 "Cluster 15: NK-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA054903: AB_2682636, HPA066190: AB_2685633" "unprognostic (2.07e-1)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (1.04e-1)" "unprognostic (4.00e-3)" "unprognostic (2.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.49e-2)" "unprognostic (3.89e-1)" "unprognostic (1.63e-2)" "unprognostic (8.48e-3)" 8.1 9.2 4.7 8.4 5.6 2.3 7.9 5.1 5.6 8.9 11.0 7.9 23.6 10.2 11.3 5.9 11.4 6.3 8.4 4.8 5.8 13.5 24.5 8.8 8.4 5.7 6.0 10.9 6.1 14.0 4.6 8.0 5.7 8.8 8.2 5.5 6.6 8.7 7.7 4.3 22.1 10.4 5.3 6.6 9.7 8.2 5.5 10.0 16.1 7.1 8.1 7.7 4.9 6.7 23.4 19.7 0.3 0.1 9.9 13.4 23.7 15.0 4.3 14.2 15.8 17.9 20.5 0.1 12.5 16.9 5.7 14.2 0.0 0.5 18.4 25.2 13.1 10.4 25.6 34.9 22.8 0.0 30.1 15.4 19.8 13.6 0.0 3.2 9.3 0.1 25.3 0.3 17.4 23.0 4.9 0.8 18.7 14.8 9.6 0.1 29.9 1.1 11.4 3.7 19.2 18.9 27.0 6.4 21.1 0.3 8.4 20.1 2.9 1.7 20.0 31.7 4.4 6.3 0.3 0.9 13.1 0.8 10.2 7.0 10.4 9.8 6.5 11.8 6.2 2.4 4.9 6.6 11.9 3.3 5.3 6.3 4.2 12.6 12.9 8.3 5.8 4.6 4.7 5.6 5.1 5.6 4.8 5.8 5.7 6.0 5.7 5.3 5.5 6.7 6.5 12.8 10.8 2.0 3.6 2.2 4.5 5.2 4.0 4.3 5.5 4.2 5.4 4.3 3.3 3.7 4.2 12.7 4.1 6.2 11.7 11.6 6.7 11.1 9.0 5.4 4.2 3.4 2.6 8.7 19.4 8.5 8.6 8.4 9.5 6.0 4.6 24.7 12.3 3.3 2.9 7.2 14.2 12.8 4.6 2.9 8.1 8.7 1.8 1.9 13.2 11.9 7.2 3.0 3.8 10.6 10.4 10.9 3.6 3.7 22.1 17.3 6.5 7.3 0.0 11.3 6.7 9.6 5.5 3.7 1.4 4.4 4.2 10.7 10.5 3.0 CALHM5 "C6orf188, dJ493F7.3, FAM26E, MGC45451" ENSG00000178033 "Calcium homeostasis modulator family member 5" Q8N5C1 6 116511639-116524788 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 10.6;Endothelial cells: 2.6;Fibroblasts: 2.0;Granulosa cells: 2.6;Smooth muscle cells: 3.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.3;fHDF/TERT166: 5.6;HUVEC TERT2: 5.6;LHCN-M2: 5.9;TIME: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034969, HPA034970" Uncertain Approved "Golgi apparatus" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "HPA034969: AB_10670299, HPA034970: AB_2674390" "unprognostic (2.71e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-2)" "unprognostic (1.01e-1)" "unprognostic (1.36e-1)" "unprognostic (3.92e-1)" "unprognostic (1.93e-2)" "unprognostic (5.37e-2)" "unprognostic (4.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.06e-1)" "unprognostic (9.16e-2)" "unprognostic (1.24e-7)" "unprognostic (1.16e-2)" "unprognostic (2.98e-2)" "unprognostic (7.69e-2)" "unprognostic (6.65e-3)" 3.3 0.5 0.6 1.1 0.7 0.0 1.6 0.5 0.6 1.3 0.7 1.5 0.6 1.3 0.6 1.2 0.9 1.5 2.3 0.6 0.5 1.9 0.5 1.7 0.9 0.6 0.5 0.5 0.1 0.5 0.3 4.4 0.6 0.9 1.0 0.0 0.6 0.7 1.6 1.0 0.9 2.1 0.5 1.7 0.6 0.7 0.8 0.1 0.8 2.5 0.5 1.4 1.2 0.6 0.0 0.0 4.5 0.0 2.7 4.3 0.0 3.6 5.3 1.4 3.8 0.2 0.0 0.0 0.3 5.6 3.8 0.0 0.0 0.0 1.5 0.0 0.2 0.8 0.0 0.0 0.6 0.0 0.0 2.6 0.0 3.4 0.0 1.0 5.6 0.0 0.0 1.0 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 8.9 2.5 0.8 0.3 0.2 0.0 0.0 0.0 2.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.5 0.6 0.6 0.5 0.6 0.5 0.6 0.5 0.8 0.6 10.6 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.6 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 CANT1 "SCAN-1, SHAPY" ENSG00000171302 "Calcium activated nucleotidase 1" Q8WVQ1 17 78991716-79009867 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 139.5;Intestinal goblet cells: 155.6;Syncytiotrophoblasts: 101.5;Undifferentiated cells: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 445.4;T-47d: 282.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019627, HPA019639, HPA022818" Enhanced Supported "Golgi apparatus" NA Yes 3300000 "Cluster 52: Eosinophils - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971" "unprognostic (1.98e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-2)" "unprognostic (5.36e-2)" "unprognostic (2.13e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.41e-4)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.21e-4)" "unprognostic (7.04e-2)" "unprognostic (5.06e-2)" "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" 15.8 23.9 10.4 24.7 12.4 19.1 25.4 13.6 11.3 32.3 13.8 89.2 51.9 17.4 8.7 44.8 18.2 25.2 17.0 11.1 12.6 16.1 17.3 16.4 15.2 14.6 14.5 14.6 19.6 24.5 17.5 25.9 13.9 71.8 82.8 7.4 62.7 32.4 14.9 14.9 55.5 15.5 13.8 26.5 51.1 20.7 14.5 14.7 13.9 12.4 15.1 16.7 21.7 17.8 106.5 112.1 31.9 46.3 29.7 35.2 38.9 66.0 51.3 66.7 55.9 53.8 99.6 25.3 36.1 46.1 83.0 53.7 27.1 49.8 68.4 43.0 46.4 33.7 34.1 45.9 25.0 33.0 51.6 33.7 32.4 62.7 34.2 40.9 116.1 42.5 42.3 43.2 46.4 58.4 50.2 19.8 22.1 445.4 103.1 27.6 51.8 29.8 29.8 53.5 45.6 45.4 33.9 227.2 50.2 50.3 282.6 38.6 56.6 101.9 90.5 46.4 83.1 48.9 43.8 24.3 64.4 24.9 65.3 6.3 4.0 8.7 5.5 4.4 5.7 3.9 4.3 4.8 3.8 2.5 4.1 4.1 17.4 3.1 3.0 2.7 3.6 4.6 10.4 12.4 13.6 11.3 11.1 12.6 14.6 14.5 13.9 13.8 14.5 17.8 12.6 28.9 20.6 5.9 11.8 16.6 15.3 16.8 6.8 6.4 49.9 16.3 13.3 14.3 15.1 12.9 14.6 36.6 8.9 139.5 3.9 34.7 14.0 10.7 13.1 16.3 51.0 15.2 4.1 28.8 39.4 13.5 38.2 19.0 5.7 20.0 41.7 14.4 24.9 5.0 5.2 155.6 16.2 12.4 9.5 15.7 11.8 14.2 14.2 3.7 18.1 8.1 11.3 5.0 10.2 37.7 55.8 7.5 16.6 33.4 39.4 6.7 9.7 8.7 6.6 9.5 13.3 23.9 5.8 12.0 13.1 101.5 11.1 11.3 100.2 19.4 CAV1 CAV ENSG00000105974 "Caveolin 1" Q03135 7 116524994-116561179 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 14.6;memory B-cell: 5.1" "Group enriched" "Detected in many" 57 "B-cells: 5.1;granulocytes: 14.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 122.1" "CAB003791, HPA049326" Enhanced Supported "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "CAB003791: AB_562068, HPA049326: AB_2680714" "unprognostic (5.98e-2)" "unprognostic (1.35e-3)" "unprognostic (3.35e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-3)" "unprognostic (2.35e-3)" "unprognostic (8.07e-2)" "prognostic unfavorable (7.17e-5)" "unprognostic (1.31e-1)" "unprognostic (2.25e-1)" "unprognostic (1.79e-3)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.65e-3)" "unprognostic (2.72e-1)" "unprognostic (7.40e-2)" "unprognostic (6.14e-3)" 621.1 17.4 12.7 44.7 15.3 0.6 284.5 14.3 21.6 267.0 11.8 298.8 32.3 190.9 72.5 135.1 152.5 148.2 276.5 12.2 13.9 18.4 26.6 592.0 30.3 15.1 13.4 137.4 24.6 21.4 6.8 449.2 14.6 110.3 93.6 31.4 58.0 175.5 102.9 104.9 89.4 274.2 14.3 199.1 120.8 25.8 16.1 25.2 168.4 184.6 20.3 202.0 124.1 16.2 458.7 344.3 9.5 3.7 1406.6 2140.5 20.6 1055.8 2371.6 566.0 591.2 3.0 652.4 0.1 365.8 1228.5 494.8 828.2 2.2 2333.7 840.3 36.0 19.5 0.4 128.7 0.3 196.9 0.1 2.1 736.9 481.6 805.7 536.0 539.0 1749.9 0.2 0.3 23.4 2372.1 45.2 0.5 0.8 33.7 1.2 173.9 5.2 25.2 251.0 317.0 2.0 1.0 0.6 328.3 20.1 52.3 137.8 1.6 3.9 1349.3 1894.8 212.4 730.6 298.9 96.8 15.8 1.9 758.4 0.9 701.0 14.6 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 12.7 15.3 14.3 21.6 12.2 13.9 15.1 13.4 14.6 14.3 16.1 16.2 2160.5 3557.7 123.0 0.0 15.8 1375.3 392.0 534.8 316.4 8.3 17.9 190.8 286.6 107.2 342.0 7.3 2.1 64.3 7.0 0.3 5.9 76.8 2.6 17.5 102.3 1024.0 1.8 16.0 0.4 0.7 449.5 326.8 1.5 21.3 13.9 6.3 450.5 5.2 15.0 0.0 0.5 7.0 20.3 11.0 187.1 13.4 377.2 10.7 439.4 19.7 3.7 249.0 0.0 1.0 1.3 43.1 0.1 565.4 56.2 512.7 0.7 0.3 30.6 7.7 558.8 152.4 751.4 2.1 5.7 39.4 610.9 117.0 16.7 59.7 2.4 93.3 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597382-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.6" "Group enriched" "Detected in all" 18 "Early spermatids: 642.3;Late spermatids: 490.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "basophil: 479.0" "Lineage enriched" "Detected in all" 23 "granulocytes: 479.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010969, HPA026883" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 39000000 "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA010969: , HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.5 7.5 3.7 4.5 4.1 7.6 8.4 6.5 4.9 6.6 2.5 5.2 8.6 7.2 4.8 5.9 6.4 5.9 5.0 3.6 4.6 7.2 11.6 6.1 8.9 5.0 5.2 6.8 8.4 11.7 4.3 4.5 4.5 5.5 6.1 8.4 5.4 5.5 7.1 4.8 7.0 6.2 4.6 6.3 6.5 34.6 4.7 5.4 9.4 10.0 8.8 6.3 4.4 4.1 6.0 4.1 8.9 11.3 14.6 8.1 20.4 7.4 7.3 6.2 9.0 4.3 1.9 12.8 11.3 6.2 11.8 3.4 3.9 3.5 8.1 2.7 5.1 2.2 1.6 5.6 5.8 5.9 10.9 8.7 10.0 2.0 1.9 5.2 8.4 5.3 5.2 3.5 7.6 2.8 4.1 7.1 4.2 7.9 5.1 2.7 14.0 3.9 6.5 2.7 5.4 10.2 7.6 7.2 5.6 13.8 6.1 5.4 10.2 3.7 6.5 8.4 5.9 9.9 10.5 9.2 4.1 8.5 20.2 479.0 18.0 86.7 14.7 17.0 17.6 20.7 15.8 17.0 15.6 19.3 19.2 15.0 35.2 16.8 17.1 3.2 19.3 15.6 3.7 4.1 6.5 4.9 3.6 4.6 5.0 5.2 4.5 4.6 4.7 4.1 17.3 6.4 8.1 12.7 12.8 19.1 7.9 8.0 13.6 14.1 15.4 10.7 9.0 12.8 8.2 12.9 8.4 10.2 9.3 7.3 7.9 10.1 642.3 11.1 9.0 10.8 15.0 4.8 14.0 9.1 6.8 11.5 13.3 9.5 7.0 3.7 10.8 15.2 6.9 8.4 17.4 8.7 16.2 7.9 9.6 490.0 11.5 9.5 14.2 12.2 11.4 7.7 14.4 18.6 20.1 10.4 7.3 14.3 12.8 8.3 8.4 8.9 14.6 14.1 13.1 12.0 12.9 31.1 26.3 12.1 23.7 20.2 11.3 29.2 5.9 6.9 CCDC186 "C10orf118, CCCP-1, FLJ10188, FLJ35301, golgin104" ENSG00000165813 "Coiled-coil domain containing 186" Q7Z3E2 10 114120862-114174232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 49.3" "Group enriched" "Detected in all" 4 "dendritic cells: 49.3;granulocytes: 26.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014569, HPA018019" Approved Approved "Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA014569: AB_2066352, HPA018019: AB_1845513" "unprognostic (1.66e-2)" "unprognostic (1.76e-2)" "unprognostic (9.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.85e-3)" "unprognostic (2.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.06e-1)" "unprognostic (3.20e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "prognostic favorable (7.65e-8)" "unprognostic (8.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" 7.4 7.3 2.8 9.0 3.3 32.8 12.5 8.6 5.4 8.5 9.2 12.4 15.4 7.5 9.6 12.5 8.2 6.8 9.4 2.8 5.9 14.9 7.2 10.8 9.1 3.4 2.9 8.0 21.1 13.1 7.1 9.4 3.7 15.1 11.9 14.1 15.6 9.2 7.1 12.6 16.1 6.2 2.5 11.0 16.7 16.6 4.8 12.0 14.7 9.2 10.2 7.7 6.8 4.3 17.9 6.1 6.0 6.9 6.8 7.9 7.8 11.0 13.2 5.1 8.1 11.2 18.3 4.2 7.0 9.1 6.3 14.1 7.1 9.8 9.8 21.9 7.3 3.3 7.0 6.6 6.3 9.6 14.6 5.9 11.1 6.0 16.9 12.6 7.7 11.1 6.1 13.5 6.0 6.5 8.8 5.3 3.5 10.6 3.9 8.4 20.7 6.6 9.0 10.9 4.2 4.4 9.7 13.4 6.6 9.7 8.6 4.1 11.2 3.9 7.8 3.9 9.3 7.6 13.3 8.4 4.1 0.1 3.0 26.5 3.3 11.7 8.6 3.8 8.5 7.9 6.6 7.8 4.0 8.6 6.4 6.4 19.9 5.8 3.7 49.3 8.7 2.6 2.8 3.3 8.6 5.4 2.8 5.9 3.4 2.9 3.7 2.5 4.8 4.3 63.2 141.1 85.7 23.8 46.7 0.0 79.5 0.0 63.2 63.8 73.5 49.0 57.4 38.6 57.6 77.3 62.6 94.9 174.6 107.1 66.5 78.2 221.9 98.4 40.6 41.3 64.6 33.1 53.0 70.7 40.7 43.7 48.9 108.9 24.7 28.1 21.0 20.9 21.4 107.7 49.9 78.9 0.0 25.0 0.0 143.6 50.1 37.1 0.0 33.7 40.0 31.7 70.0 25.6 27.7 74.9 89.9 44.4 77.8 94.8 91.4 84.0 64.1 74.0 26.3 61.7 28.3 83.7 69.2 56.1 0.0 113.6 62.1 32.5 53.7 120.3 CD36 "FAT, GP3B, GP4, GPIV, SCARB3" ENSG00000135218 "CD36 molecule" P16671 7 80369575-80679277 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Transport" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 1533.6" "Cell type enhanced" "Detected in many" "Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1" "Group enriched" "Detected in all" 46 "dendritic cells: 507.1;monocytes: 962.6" "Group enriched" "Detected in some" 4 "ASC diff: 322.6;HEL: 158.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "spinal cord: 16.9" "HPA002018, CAB025866, HPA071026" Enhanced Enhanced "Golgi apparatus" NA NA 5300000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170" "unprognostic (7.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.06e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (9.35e-2)" "unprognostic (2.64e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (7.05e-3)" "unprognostic (4.87e-2)" "unprognostic (2.73e-3)" 1533.6 24.6 3.4 51.7 2.5 148.2 540.4 1.6 2.0 11.6 2.7 40.5 113.6 8.7 38.2 19.6 40.5 84.0 540.9 2.6 6.9 7.0 80.8 131.2 18.8 22.0 21.2 4.0 31.2 25.0 2.0 413.3 15.7 5.0 40.9 0.3 31.9 8.6 248.5 28.6 119.7 39.4 14.0 309.9 31.2 7.7 24.0 22.1 69.1 381.6 7.2 22.2 13.4 3.9 0.0 0.0 1.0 0.2 322.6 3.3 0.7 0.9 10.7 0.1 0.1 0.0 0.0 0.1 0.6 1.4 0.3 0.1 4.3 0.5 0.1 0.6 0.4 158.1 0.5 25.7 0.2 0.1 0.1 31.0 12.6 0.1 0.2 7.7 0.9 0.0 5.8 0.0 1.8 0.2 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.1 0.9 1.3 0.8 0.6 0.3 2.7 11.1 19.3 0.4 0.5 0.5 0.6 0.3 0.2 0.8 0.4 0.1 54.3 41.8 12.3 962.6 3.7 1.9 270.6 2.1 3.6 0.6 0.6 507.1 0.5 0.8 0.4 15.8 5.9 72.0 128.3 1.5 692.4 3.4 2.5 1.6 2.0 2.6 6.9 22.0 21.2 15.7 14.0 24.0 3.9 3219.2 6.4 63.1 0.0 7.9 7.4 0.2 3.0 0.6 0.2 189.9 24.8 623.1 4.3 9.8 7.3 0.0 10.1 55.0 0.0 0.0 0.2 11.7 5.0 5.9 303.3 0.0 419.5 6.3 0.0 11.1 69.6 1.1 38.4 15.2 0.6 406.2 9.0 1369.8 0.0 2.2 0.6 8.2 153.7 67.3 3.9 0.6 159.6 16.0 17.8 255.2 0.0 7.2 0.5 1.3 0.1 0.0 0.0 4.2 0.8 9.9 0.4 1.2 0.3 696.8 33.1 452.1 4.6 0.7 0.8 4.7 18.3 5.9 1.9 0.2 0.3 CD74 DHLAG ENSG00000019582 "CD74 molecule" P04233 5 150400041-150412969 "Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 5258.9" "Cell type enhanced" "Detected in many" "B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0" "Group enriched" "Detected in all" 6 "B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002506, HPA010592, CAB079994" Enhanced Supported "Golgi apparatus" NA NA 210000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482" "prognostic favorable (1.06e-4)" "unprognostic (1.48e-2)" "unprognostic (4.80e-3)" "prognostic favorable (6.53e-6)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (2.05e-1)" "unprognostic (3.69e-3)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (2.20e-2)" "unprognostic (2.64e-1)" "unprognostic (5.44e-3)" "unprognostic (1.73e-1)" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (4.24e-2)" 1512.1 976.5 338.1 2741.2 301.9 984.3 1157.2 365.5 474.4 1562.8 429.1 992.3 1826.2 593.6 490.6 618.8 1139.0 1477.9 604.0 306.7 506.8 1271.1 1142.0 3786.3 4995.6 598.7 431.8 464.3 392.4 390.6 469.3 305.7 533.4 556.7 1155.8 58.1 1999.3 911.8 307.2 682.4 2438.8 1014.2 514.2 4897.4 1511.5 207.5 514.4 2160.2 853.5 374.2 5258.9 1557.5 483.5 771.8 35.7 0.3 1.5 2.4 2.3 2.5 11.0 0.0 0.0 0.7 0.6 443.0 2171.7 3523.2 124.2 0.0 9.2 9.4 0.0 0.0 0.1 4787.6 0.0 109.1 1.2 250.2 6.6 9.2 6.5 24.5 0.0 0.8 0.0 0.6 0.0 0.0 8.0 1270.7 0.4 0.0 4.2 14.0 5.3 0.0 0.1 3026.0 5.2 2014.2 9.0 133.5 5.1 8.2 5.5 4.7 94.9 19.2 81.2 414.4 5.6 10.3 9.9 9.0 4.5 1443.4 170.7 1978.6 745.9 154.2 678.6 410.8 11041.2 3996.9 808.7 15961.1 899.9 26889.3 688.4 1188.4 23750.6 27930.3 378.9 646.6 839.6 2378.1 8003.3 16940.0 2157.2 17779.7 338.1 301.9 365.5 474.4 306.7 506.8 598.7 431.8 533.4 514.2 514.4 771.8 2080.4 419.9 2160.4 0.7 10167.0 715.9 154.0 762.2 398.4 1.7 220.3 437.5 69.6 401.7 1063.3 502.1 0.0 28.3 3199.0 139.7 117.4 1264.4 10.4 111.3 11.5 1787.6 242.9 562.5 0.7 527.5 32.6 278.6 538.2 85.5 417.2 113.4 514.7 52.5 4361.8 1.7 0.6 475.7 390.6 5201.6 23363.4 31.3 117.1 7290.2 1197.1 137.7 10305.9 16.8 403.7 0.5 1.4 384.2 487.3 17.7 2068.3 174.9 5034.4 815.8 1153.1 10.0 164.3 45.1 146.7 2.8 12.6 170.9 575.8 41.6 790.7 12.9 450.7 743.4 CD99 MIC2 ENSG00000002586 "CD99 molecule (Xg blood group)" P14209 X 2691187-2741309 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 1614.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000020, HPA035304" Supported Approved "Golgi apparatus" NA NA 62000000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "CAB000020: AB_2076419, HPA035304: AB_10672861" "unprognostic (3.71e-3)" "unprognostic (2.90e-1)" "unprognostic (5.97e-3)" "unprognostic (7.01e-3)" "unprognostic (2.14e-2)" "unprognostic (6.98e-3)" "unprognostic (3.89e-3)" "unprognostic (1.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.87e-7)" "unprognostic (2.11e-2)" "unprognostic (2.18e-1)" "unprognostic (5.37e-2)" "unprognostic (3.61e-2)" 476.3 143.3 132.0 119.2 142.1 105.4 327.7 148.8 135.4 367.4 126.5 353.2 148.5 305.5 132.4 208.8 249.4 264.5 343.7 128.8 247.5 112.7 227.7 256.5 146.6 210.9 178.1 303.0 234.6 46.8 132.9 194.8 216.8 270.3 152.9 15.1 184.2 258.4 163.7 284.7 210.0 226.1 224.4 186.0 209.1 199.6 139.4 562.1 152.6 168.3 129.2 296.3 314.6 227.6 259.4 276.5 308.5 424.8 1217.7 939.2 195.0 681.6 1050.1 419.2 604.8 412.3 179.1 18.3 130.0 929.4 217.5 99.4 124.1 168.4 337.5 350.8 321.2 53.1 179.5 353.4 390.1 81.7 375.0 580.1 204.9 223.7 155.6 271.8 766.4 256.3 66.4 0.9 391.9 191.2 672.3 266.8 107.5 28.6 310.0 118.7 273.2 513.5 240.7 165.4 1.0 141.2 168.7 138.2 432.6 744.9 129.6 229.4 750.2 509.7 86.1 487.1 230.2 1.0 0.8 116.1 338.1 203.1 323.8 23.6 526.0 18.3 1089.2 131.2 620.5 340.1 730.3 961.1 496.5 231.8 267.4 549.7 45.1 377.3 32.3 682.1 833.7 1421.2 132.0 142.1 148.8 135.4 128.8 247.5 210.9 178.1 216.8 224.4 139.4 227.6 297.7 64.1 68.3 20.5 172.0 250.6 207.4 274.4 138.9 5.1 66.9 48.3 86.6 112.9 88.4 71.7 0.0 223.6 507.7 68.4 13.7 145.3 8.8 180.2 279.7 387.7 80.8 136.5 0.9 138.4 189.7 604.7 116.7 188.8 230.4 1614.3 512.9 123.0 799.8 0.0 1.1 150.8 54.9 187.4 579.9 26.4 645.2 342.4 691.9 37.5 175.9 52.0 632.4 1.0 0.9 139.9 158.2 511.2 300.2 385.8 230.9 63.3 117.5 3.2 341.8 231.1 351.9 16.4 56.9 147.9 222.9 123.0 468.9 403.2 262.3 307.0 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880597-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;kidney: 5.7" "Group enriched" "Detected in some" 33 "Excitatory neurons: 307.2;Inhibitory neurons: 459.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 6.8;basal ganglia: 4.3;cerebral cortex: 6.4;hippocampal formation: 5.8" "Immune cell enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 4.9" "Cell line enhanced" "Detected in some" "K-562: 7.3;NTERA-2: 10.1;U-698: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Approved "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.3 0.2 6.8 0.6 4.3 1.9 0.3 0.0 6.4 0.0 0.0 0.4 0.5 0.5 0.6 0.4 0.2 0.4 0.1 5.8 0.0 5.7 0.1 0.3 1.0 0.0 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.5 0.6 1.3 0.2 0.1 0.1 1.0 0.8 0.4 0.0 0.4 0.5 2.2 0.0 0.2 1.0 0.1 1.0 0.3 0.0 0.9 1.9 0.7 0.4 0.6 0.2 0.0 1.2 0.0 0.3 0.1 0.2 0.0 0.7 1.0 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.4 0.6 2.2 0.0 0.0 1.2 0.2 0.3 0.0 0.0 0.0 0.1 0.6 7.3 1.8 0.0 1.3 0.6 0.4 10.1 0.2 0.4 0.2 0.2 0.3 0.3 0.4 2.2 0.2 0.0 0.3 0.3 1.8 0.3 0.7 1.3 0.1 0.7 0.6 0.2 2.0 0.8 4.6 0.6 0.8 0.6 1.2 0.1 0.2 0.1 0.4 0.3 2.3 0.1 0.1 0.1 1.6 0.1 0.3 4.9 0.0 0.7 0.5 0.5 0.6 6.8 4.3 0.0 6.4 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 10.4 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 459.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 11.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP20DC "C3orf67, FLJ42117, FLJ42930" ENSG00000163689 "CFAP20 domain containing" Q6ZVT6 3 58717365-59050084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "esophagus: 7.9;testis: 22.1" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 1.9;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069696 Approved "Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA069696: AB_2686174" "unprognostic (4.59e-1)" "unprognostic (4.63e-3)" "unprognostic (1.99e-1)" "unprognostic (4.49e-5)" "unprognostic (1.91e-1)" "unprognostic (9.33e-3)" "unprognostic (1.67e-3)" "unprognostic (3.72e-1)" "unprognostic (2.43e-1)" "unprognostic (6.68e-3)" "unprognostic (8.95e-2)" "unprognostic (6.19e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (3.06e-2)" "unprognostic (7.79e-2)" "unprognostic (2.81e-2)" 0.3 1.1 0.5 0.7 0.6 0.2 0.5 0.0 0.7 1.0 0.1 0.5 0.0 0.3 0.3 7.9 2.9 0.5 0.1 0.7 0.4 0.5 1.0 0.4 1.6 0.6 0.7 0.2 0.5 0.7 1.9 1.1 0.4 0.3 0.7 0.4 2.0 0.2 0.0 0.3 0.1 0.3 0.3 0.3 0.4 22.1 0.5 0.5 0.3 0.1 3.2 0.2 2.2 0.3 11.2 1.8 3.0 0.0 1.8 5.7 0.0 5.2 1.7 2.3 1.8 1.0 3.6 11.6 1.7 1.2 0.0 1.1 4.8 2.5 4.0 1.8 0.3 0.0 1.9 0.0 0.9 0.0 0.0 1.1 2.4 4.8 3.9 2.8 4.7 7.6 9.0 0.1 3.1 1.5 0.6 0.0 3.8 3.6 7.7 11.3 0.0 4.8 2.4 0.1 7.8 3.6 1.4 1.1 3.4 5.0 3.5 0.0 0.1 0.2 3.4 5.6 2.4 4.6 10.3 2.3 2.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.6 0.0 0.7 0.7 0.4 0.6 0.7 0.4 0.3 0.5 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 CGREF1 CGR11 ENSG00000138028 "Cell growth regulator with EF-hand domain 1" Q99674 2 27098889-27119128 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3;salivary gland: 25.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 12.6;Excitatory neurons: 16.6;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 12.5;Spermatogonia: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 40.1;SK-BR-3: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008241, HPA071103" Uncertain Approved "Golgi apparatus" "Secreted in brain" NA NA 700000 "Cluster 65: Brain - Ion transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA008241: AB_1846605, HPA071103: " "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (8.45e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" "unprognostic (1.92e-1)" "unprognostic (2.57e-1)" "unprognostic (2.27e-1)" "unprognostic (2.52e-3)" "unprognostic (1.05e-1)" "unprognostic (2.30e-2)" "unprognostic (7.24e-4)" "unprognostic (1.20e-2)" 4.2 2.3 20.4 1.0 21.7 1.9 6.3 17.1 28.3 3.5 2.1 2.6 3.9 11.6 1.4 3.5 12.4 3.9 4.9 27.0 18.1 3.8 14.9 1.1 0.5 12.8 12.1 13.9 2.1 0.2 3.3 0.3 12.8 4.2 3.8 3.7 25.3 0.9 6.5 2.3 5.6 5.4 10.2 0.6 11.4 3.8 17.2 0.2 1.8 6.9 0.4 3.7 1.5 16.4 7.6 6.3 0.3 8.1 18.3 6.8 0.7 9.1 0.0 0.8 0.4 1.7 6.2 0.1 2.4 18.2 2.2 0.4 1.4 2.1 0.5 0.7 3.7 0.1 10.4 16.4 16.9 5.3 0.6 4.7 18.1 2.6 2.1 11.6 0.7 1.3 0.2 0.4 1.2 24.0 4.0 6.8 2.1 40.1 16.8 0.3 0.0 0.6 0.1 0.3 17.8 26.6 17.7 78.7 9.4 0.2 25.3 13.3 0.0 0.0 6.9 0.0 0.7 2.3 0.8 0.7 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 21.7 17.1 28.3 27.0 18.1 12.8 12.1 12.8 10.2 17.2 16.4 0.1 0.0 0.0 2.6 0.4 0.6 0.2 0.0 1.8 9.2 9.2 12.6 1.4 0.0 0.0 0.0 4.2 0.0 0.1 0.2 0.0 0.1 1.1 0.3 3.0 0.4 0.0 5.5 16.6 1.5 0.2 3.8 4.6 0.1 0.0 0.4 3.6 5.0 0.4 0.0 15.9 6.8 0.0 0.6 0.7 3.1 4.4 0.2 0.0 1.9 0.0 0.5 0.0 12.5 0.8 2.1 0.0 8.6 1.1 1.8 3.4 4.4 0.0 2.2 0.0 1.7 0.7 3.2 16.2 2.2 0.4 0.1 0.1 3.2 0.9 0.1 CHST11 "C4ST, C4St-1, C4ST1, HSA269537" ENSG00000171310 "Carbohydrate sulfotransferase 11" Q9NPF2 12 104455295-104762014 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0;choroid plexus: 59.1" "Group enriched" "Detected in many" 4 "Microglial cells: 281.1;Oligodendrocyte precursor cells: 1012.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 12.7;eosinophil: 11.2;neutrophil: 15.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052828 Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 55000 "Cluster 5: Granulocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" "HPA052828: AB_2681966" "unprognostic (6.35e-2)" "unprognostic (2.68e-3)" "unprognostic (2.28e-2)" "unprognostic (7.53e-2)" "unprognostic (3.45e-2)" "unprognostic (2.64e-2)" "unprognostic (1.64e-3)" "unprognostic (9.21e-3)" "unprognostic (3.12e-1)" "unprognostic (9.02e-2)" "unprognostic (1.22e-2)" "unprognostic (5.44e-2)" "prognostic unfavorable (7.59e-11)" "unprognostic (1.64e-2)" "unprognostic (5.60e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (8.42e-4)" 5.0 10.2 14.5 20.1 13.9 39.0 3.5 11.1 14.1 5.6 59.1 4.2 3.0 11.9 13.3 3.4 3.7 9.4 4.5 15.0 16.0 3.6 3.0 12.2 15.2 17.9 16.4 6.2 4.6 1.3 4.5 15.5 17.1 3.9 4.0 2.2 2.2 8.0 1.1 1.7 6.2 10.9 13.1 12.8 6.3 2.3 17.3 19.5 3.3 1.0 11.7 8.3 3.8 17.5 38.8 18.2 8.2 5.3 20.5 10.0 27.8 3.1 1.2 1.8 1.5 0.0 51.2 0.2 5.6 5.4 42.3 9.9 4.9 20.8 2.2 0.4 7.1 53.2 4.8 0.2 3.1 62.4 60.6 3.7 2.9 32.9 5.4 30.7 13.2 74.4 82.8 13.2 3.5 9.7 47.8 73.1 6.6 0.4 7.0 54.0 27.3 12.9 17.0 0.4 13.6 21.9 2.1 26.3 48.3 7.2 7.7 62.7 29.2 5.7 6.2 29.4 32.3 67.2 75.9 10.6 26.3 43.5 57.7 12.7 1.4 11.2 3.0 1.4 1.7 1.0 1.5 2.2 0.8 2.8 0.7 1.9 15.6 1.6 1.3 2.9 3.2 0.8 14.5 13.9 11.1 14.1 15.0 16.0 17.9 16.4 17.1 13.1 17.3 17.5 8.4 16.0 13.1 142.4 33.8 2.8 18.2 2.6 4.0 3.1 0.5 1.1 5.7 1.5 6.4 5.5 0.0 41.6 45.6 0.1 0.0 4.9 0.9 1.3 24.7 12.9 0.0 36.2 43.8 61.4 12.0 9.5 2.6 0.9 41.3 1.4 18.2 0.5 42.6 10.1 114.4 0.0 0.0 26.8 42.9 2.0 7.5 56.5 3.6 281.1 65.6 2.3 30.9 1012.8 3.5 28.6 0.0 17.0 64.0 3.9 0.0 6.0 8.1 0.6 6.6 1.8 12.8 0.6 2.5 0.9 2.8 26.5 49.0 15.5 0.3 3.7 CHST12 "C4S-2, C4ST2" ENSG00000136213 "Carbohydrate sulfotransferase 12" Q9NRB3 7 2403588-2448484 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "dendritic cells: 158.7;Hepatic stellate cells: 152.8;NK-cells: 368.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 60.1;NB-4: 57.4;U-266/70: 88.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041680 Approved Approved "Golgi apparatus" NA NA 960000 "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA041680: AB_10959789" "unprognostic (4.12e-2)" "unprognostic (3.56e-1)" "unprognostic (3.04e-3)" "unprognostic (1.59e-1)" "unprognostic (2.05e-3)" "unprognostic (7.15e-2)" "unprognostic (2.01e-3)" "unprognostic (1.34e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-2)" "prognostic favorable (1.32e-5)" "unprognostic (9.61e-2)" "unprognostic (1.66e-3)" "unprognostic (4.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" 16.1 13.3 4.5 5.1 3.5 6.1 15.0 7.3 5.0 15.4 0.2 13.7 5.4 17.8 0.6 7.9 15.8 1.2 15.5 9.0 2.6 11.3 7.1 14.5 2.9 9.4 4.7 11.6 11.7 1.4 17.6 2.8 4.6 13.6 0.6 1.2 10.3 2.8 8.3 15.6 10.6 1.4 3.8 24.5 11.1 9.1 5.9 1.4 14.1 0.9 1.0 13.1 13.1 4.3 9.5 9.1 2.7 10.0 3.8 2.3 29.5 17.2 4.2 4.2 5.7 9.0 3.2 8.5 31.6 2.7 10.3 7.1 1.6 2.2 0.8 11.2 17.7 5.9 7.0 9.9 2.6 19.4 60.1 4.8 0.9 3.8 0.5 3.3 4.2 11.5 15.1 25.0 1.2 6.8 19.8 57.4 19.1 1.3 14.4 7.1 7.6 42.1 1.2 3.8 6.8 28.7 8.4 4.5 4.0 2.0 6.6 22.3 13.0 9.6 26.5 20.0 15.2 88.9 37.1 3.9 7.8 8.8 17.9 59.1 10.4 53.2 87.6 9.1 54.4 14.7 30.0 71.4 20.4 18.3 12.6 37.8 3.1 121.6 3.9 64.9 33.0 22.9 4.5 3.5 7.3 5.0 9.0 2.6 9.4 4.7 4.6 3.8 5.9 4.3 36.8 16.0 50.5 9.1 32.8 18.1 35.5 24.3 18.8 45.6 18.0 13.0 8.3 15.7 30.5 18.4 66.7 104.5 158.7 6.2 1.9 22.4 6.7 4.7 21.1 59.4 12.7 37.0 11.0 15.3 15.0 37.0 6.1 6.4 38.0 13.4 152.8 7.2 24.8 47.1 12.3 9.1 24.4 26.4 22.9 5.8 95.7 21.2 21.4 10.3 21.3 15.1 368.7 14.1 9.5 13.3 6.7 67.7 107.8 18.4 16.2 9.5 15.2 50.5 19.7 25.6 17.9 37.8 30.6 9.2 15.3 133.5 93.2 18.4 12.2 13.1 CHST13 C4ST3 ENSG00000180767 "Carbohydrate sulfotransferase 13" Q8NET6 3 126524155-126543291 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 59.6;testis: 18.3" "Group enriched" "Detected in some" 5 "Early spermatids: 104.0;Hepatocytes: 40.3;Spermatocytes: 126.2" "Group enriched" "Detected in many" 4 "liver cancer: 25.0;renal cancer: 6.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 5 "eosinophil: 155.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 155.2" "Group enriched" "Detected in some" 8 "CACO-2: 15.6;Hep G2: 28.4;NB-4: 19.0;THP-1: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA067960 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 62: Liver - Hemostasis" "Cluster 39: CACO-2 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA067960: " "unprognostic (5.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (6.42e-4)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (8.45e-3)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (5.75e-2)" "unprognostic (5.16e-2)" "unprognostic (6.68e-2)" "unprognostic (2.26e-1)" "unprognostic (1.59e-2)" 0.3 0.4 0.2 0.4 0.2 0.6 0.1 0.0 0.3 0.1 0.0 0.9 0.6 0.1 0.0 0.0 0.2 0.0 0.4 0.3 0.2 3.2 59.6 0.6 0.1 0.4 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 3.5 0.4 18.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.7 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.7 0.3 28.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.1 33.0 155.2 0.0 20.5 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 30.7 0.0 17.5 0.0 0.0 13.1 0.2 0.2 0.0 0.3 0.3 0.2 0.4 0.5 0.2 0.4 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 104.0 0.6 0.0 0.1 1.2 5.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.7 40.3 13.1 0.0 0.0 1.0 0.0 7.5 1.3 16.9 1.5 6.2 0.0 1.9 7.2 0.0 0.0 0.0 0.1 0.0 2.8 1.2 0.3 0.0 8.5 9.9 0.1 0.0 0.0 0.0 0.0 126.2 2.8 0.0 0.0 0.3 0.2 0.0 1.8 0.0 CHST14 "D4ST-1, D4ST1, HD4ST" ENSG00000169105 "Carbohydrate sulfotransferase 14" Q8NCH0 15 40470984-40473158 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.5;Extravillous trophoblasts: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057697, HPA071601" Enhanced Approved "Golgi apparatus" NA NA 20000 "Cluster 34: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" "HPA057697: AB_2683505, HPA071601: AB_2686425" "unprognostic (5.46e-2)" "unprognostic (9.23e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-2)" "unprognostic (6.94e-2)" "unprognostic (1.70e-1)" "unprognostic (9.95e-2)" "unprognostic (2.84e-1)" "unprognostic (3.17e-2)" "unprognostic (5.85e-3)" "unprognostic (2.01e-3)" "unprognostic (1.94e-1)" "unprognostic (6.34e-2)" "unprognostic (2.25e-2)" 14.2 9.6 6.8 7.7 7.5 3.4 13.7 7.0 6.5 22.0 7.3 11.8 4.5 21.6 8.0 8.7 16.5 11.3 13.8 6.2 7.0 10.1 8.8 13.0 8.5 8.0 7.1 21.1 8.1 11.3 14.4 27.0 7.2 14.6 4.6 1.6 11.0 15.4 5.0 9.1 9.9 12.6 7.5 13.6 9.4 7.9 7.0 8.6 15.8 7.4 7.5 16.1 16.1 7.3 26.2 17.1 26.4 71.6 40.4 31.0 43.0 25.2 47.3 43.5 40.9 21.2 12.8 4.3 37.6 42.7 76.7 43.7 23.7 14.2 20.3 31.5 15.0 13.4 16.9 19.8 22.5 5.7 33.4 38.3 11.6 15.4 11.6 47.8 39.2 15.1 13.6 15.0 32.6 20.1 9.6 29.8 17.0 7.9 20.1 26.2 33.4 7.6 29.5 13.3 19.7 30.2 22.2 24.4 8.4 31.9 35.7 23.9 31.9 73.0 27.1 23.3 25.5 30.3 22.6 12.2 32.8 19.6 53.7 7.6 1.1 2.2 2.2 1.1 0.6 0.3 1.1 1.9 2.0 1.1 0.9 0.8 0.1 3.3 0.6 0.7 0.8 0.7 6.8 7.5 7.0 6.5 6.2 7.0 8.0 7.1 7.2 7.5 7.0 7.3 10.6 12.8 1.1 2.0 5.8 3.4 5.4 4.1 9.1 0.6 5.8 9.7 3.2 7.2 4.6 3.7 0.0 46.5 3.5 0.5 0.0 7.7 1.8 3.2 14.5 10.2 2.4 10.7 0.1 4.9 32.4 19.3 0.0 5.6 4.5 14.9 15.4 3.7 9.3 1.7 0.1 1.4 2.0 5.6 3.3 1.3 17.7 5.6 5.4 2.8 3.4 9.8 6.2 2.0 0.5 5.2 0.3 11.7 1.9 3.6 0.2 1.1 3.0 0.8 6.6 11.8 9.2 7.5 1.3 5.6 2.6 13.5 4.9 3.9 1.9 1.3 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699553 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.5" "Cell type enhanced" "Detected in many" "B-cells: 128.6;dendritic cells: 112.0;Early spermatids: 95.5;monocytes: 81.6;NK-cells: 131.8;T-cells: 215.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 10 "gdT-cell: 188.1;MAIT T-cell: 114.5;memory B-cell: 95.0;memory CD4 T-cell: 183.3;memory CD8 T-cell: 208.7;naive B-cell: 127.5;naive CD4 T-cell: 192.3;naive CD8 T-cell: 223.0;T-reg: 175.2" "Group enriched" "Detected in all" 11 "B-cells: 127.5;T-cells: 223.0" "Group enriched" "Detected in many" 4 "Daudi: 67.9;HDLM-2: 53.3;Karpas-707: 31.0;U-698: 105.8" "HPA017649, HPA047584" Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.68e-7)" 6.1 1.8 3.6 16.7 3.5 16.0 5.6 3.3 4.9 6.4 3.1 4.8 3.3 4.5 11.8 3.2 5.3 5.5 5.3 3.2 3.7 3.9 2.9 8.6 53.5 4.0 3.4 6.0 2.4 0.8 2.3 2.6 3.9 7.3 3.9 2.2 6.5 4.5 2.9 3.7 20.3 2.0 3.5 26.6 5.5 9.5 4.1 31.6 4.5 1.3 41.7 5.7 4.6 4.2 1.2 2.5 3.5 0.3 0.5 1.4 4.0 1.7 2.5 0.6 2.1 1.9 2.1 67.9 0.3 1.8 1.0 0.7 1.2 0.2 1.1 53.3 0.9 2.1 1.6 2.9 5.7 1.7 1.7 2.3 1.7 0.5 2.1 8.0 0.1 1.2 0.5 31.0 1.5 4.5 0.7 5.9 3.2 0.2 0.4 14.9 1.6 2.2 3.4 3.6 0.6 1.3 0.9 2.8 3.0 6.6 0.6 1.8 0.6 1.3 1.8 1.0 1.2 4.4 1.1 105.8 2.8 3.1 2.1 6.8 2.1 1.5 188.1 1.4 114.5 95.0 183.3 208.7 2.3 127.5 192.3 223.0 6.0 16.5 1.3 1.6 175.2 109.8 3.6 3.5 3.3 4.9 3.2 3.7 4.0 3.4 3.9 3.5 4.1 4.2 8.9 6.4 20.7 11.8 128.6 4.1 39.7 2.1 1.8 1.3 6.5 6.1 9.6 4.3 7.1 1.8 4.2 10.4 112.0 0.8 7.9 3.0 95.5 3.6 6.9 13.0 0.0 21.5 6.3 1.9 6.0 12.2 4.6 6.2 20.2 18.1 12.5 2.3 9.2 5.0 6.8 2.5 0.0 20.9 17.8 28.3 8.4 19.4 1.8 56.2 81.6 3.2 131.8 27.6 4.4 2.8 2.0 9.8 71.5 17.2 0.5 2.1 7.4 2.3 19.7 26.2 8.7 5.7 6.3 1.9 4.8 4.8 215.1 7.4 3.5 24.3 COG2 LDLC ENSG00000135775 "Component of oligomeric golgi complex 2" Q14746 1 230642481-230693982 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 71.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076994 Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA076994: AB_2686823" "unprognostic (2.21e-1)" "unprognostic (7.35e-2)" "prognostic favorable (9.76e-4)" "unprognostic (2.91e-1)" "unprognostic (1.32e-3)" "unprognostic (3.59e-1)" "unprognostic (1.08e-1)" "unprognostic (4.06e-1)" "unprognostic (2.18e-1)" "unprognostic (5.87e-2)" "unprognostic (6.83e-3)" "unprognostic (1.08e-1)" "unprognostic (2.73e-2)" "unprognostic (2.61e-1)" "unprognostic (4.44e-2)" "unprognostic (2.18e-2)" "unprognostic (5.62e-2)" 10.1 22.0 10.7 11.0 11.8 9.1 12.9 14.7 13.1 13.1 13.5 19.0 13.5 10.0 13.8 8.9 14.2 10.9 17.2 10.0 10.9 16.6 9.9 10.0 16.3 11.0 11.2 10.0 14.1 71.2 8.5 8.9 10.9 12.1 22.7 10.9 12.8 10.9 20.1 11.8 13.3 11.7 11.1 15.1 14.4 10.9 11.5 16.6 15.0 19.9 16.2 11.1 9.1 12.4 15.6 18.0 21.1 20.4 20.6 16.0 30.7 13.2 20.4 21.4 18.6 24.2 23.2 47.6 20.2 18.1 13.8 22.8 20.1 23.6 20.3 38.8 39.8 16.8 17.0 24.9 25.4 43.6 25.1 21.7 25.6 13.6 19.5 13.7 18.0 29.1 29.5 25.8 17.4 12.5 39.7 21.2 30.5 47.1 33.1 33.8 33.8 56.7 22.1 22.8 21.7 29.7 15.5 27.9 30.5 9.4 33.6 41.9 15.3 10.3 9.5 12.8 25.9 31.7 28.3 37.7 17.2 17.7 22.1 18.7 15.7 20.5 16.0 19.4 18.5 13.9 15.1 15.5 18.1 15.2 21.6 19.0 0.8 22.9 29.4 9.1 13.5 18.2 10.7 11.8 14.7 13.1 10.0 10.9 11.0 11.2 10.9 11.1 11.5 12.4 12.5 22.4 19.5 22.9 21.0 5.2 6.1 7.8 8.6 16.1 12.3 10.8 25.9 20.0 15.1 12.9 29.2 13.1 19.6 19.8 27.4 18.7 19.3 17.6 15.2 10.7 18.6 14.9 22.3 23.3 11.8 10.8 15.8 10.7 23.4 14.2 11.0 14.1 14.0 25.2 20.5 37.1 12.2 20.1 6.0 6.4 11.5 12.3 7.2 17.8 19.0 20.5 21.6 23.1 22.6 18.0 12.8 14.7 13.0 9.0 15.2 20.3 28.9 42.9 13.1 13.9 13.3 23.3 25.2 10.0 4.8 9.2 18.4 21.0 21.6 6.0 COG7 ENSG00000168434 "Component of oligomeric golgi complex 7" P83436 16 23388493-23453189 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040758, HPA041824, HPA064645" Uncertain Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA040758: AB_2677120, HPA041824: , HPA064645: AB_2685311" "unprognostic (1.72e-1)" "unprognostic (1.02e-2)" "unprognostic (8.21e-2)" "prognostic favorable (6.95e-4)" "unprognostic (3.71e-1)" "unprognostic (2.15e-1)" "unprognostic (5.95e-2)" "unprognostic (2.70e-2)" "unprognostic (3.10e-1)" "unprognostic (4.15e-1)" "unprognostic (6.07e-3)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-4)" "unprognostic (3.77e-1)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 8.7 13.1 9.2 7.2 8.7 9.8 10.3 7.5 10.0 14.9 16.7 13.2 8.3 10.9 11.2 12.1 15.0 8.4 10.0 8.6 8.6 12.7 9.5 10.0 6.8 8.8 9.4 13.4 10.2 16.3 23.8 7.5 9.1 16.2 11.8 13.8 13.4 10.4 9.8 12.2 10.5 8.6 7.4 9.8 12.7 10.0 8.8 8.1 14.6 6.4 7.2 11.4 12.2 10.7 10.2 19.5 11.9 13.5 10.4 16.9 10.8 11.2 14.1 12.9 12.9 8.3 17.6 4.8 11.6 17.8 8.2 15.2 10.8 13.8 9.8 15.7 16.3 5.0 15.3 22.2 11.0 13.9 14.2 11.0 11.0 9.9 10.4 16.0 15.2 15.7 12.2 13.6 10.5 29.9 9.3 10.2 10.7 15.7 9.3 18.7 10.3 17.3 14.0 10.0 7.2 9.2 12.6 14.2 9.7 8.9 21.0 17.8 10.7 14.3 7.5 13.4 8.2 12.4 14.1 6.5 19.1 8.1 14.0 8.4 6.7 7.3 6.0 7.7 7.6 3.9 5.5 5.7 8.0 4.6 5.6 8.5 1.6 5.6 10.0 5.7 7.0 4.9 9.2 8.7 7.5 10.0 8.6 8.6 8.8 9.4 9.1 7.4 8.8 10.7 8.0 25.6 16.9 30.3 6.2 6.6 10.1 13.7 10.2 10.1 12.0 12.2 7.2 8.6 19.9 12.9 31.3 12.5 5.5 19.4 1.9 12.0 5.0 24.4 10.8 7.7 19.2 10.8 39.7 13.8 7.6 9.8 27.5 14.2 8.2 13.1 6.1 6.0 6.4 11.8 39.8 19.3 8.2 4.0 2.3 3.6 9.9 7.7 8.8 19.7 4.4 9.2 5.2 45.8 40.6 12.9 11.3 12.4 7.2 9.3 11.6 8.7 39.1 22.4 13.1 10.1 8.6 16.5 13.3 9.1 5.4 11.8 8.9 7.2 15.9 10.7 COG8 "DOR1, FLJ22315" ENSG00000213380 "Component of oligomeric golgi complex 8" Q96MW5 16 69320140-69339583 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041406, HPA049429" Approved Supported "Golgi apparatus" No No "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA041406: AB_2677459, HPA049429: AB_2680763" "unprognostic (4.02e-2)" "unprognostic (6.46e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-2)" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (4.35e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-1)" "prognostic favorable (3.12e-5)" "unprognostic (3.10e-1)" "prognostic favorable (2.47e-7)" "unprognostic (4.73e-2)" "unprognostic (2.58e-1)" "unprognostic (7.83e-2)" "unprognostic (1.35e-2)" 9.9 14.5 19.7 8.5 23.2 6.5 11.1 23.2 24.4 9.8 24.0 10.5 10.5 10.8 14.1 9.9 13.9 7.7 11.2 19.4 19.7 13.4 15.0 10.2 11.3 21.1 20.6 13.7 14.2 19.9 12.0 7.9 21.2 10.3 9.9 7.7 13.8 10.6 18.1 16.3 10.0 10.5 20.3 10.9 11.2 20.3 20.9 12.2 13.0 15.8 11.3 9.4 7.7 28.1 13.2 28.5 18.2 26.7 30.1 21.0 19.4 16.9 18.6 23.0 18.7 26.2 19.8 23.7 18.1 23.0 12.4 24.9 29.5 24.3 19.8 11.9 26.4 17.0 19.9 35.0 21.3 21.1 14.8 25.2 23.5 25.2 14.7 22.2 22.6 20.4 35.4 5.7 16.7 38.3 19.4 31.3 32.2 17.8 20.5 35.6 12.6 33.3 23.6 11.1 26.0 31.1 37.5 15.0 17.5 18.4 35.4 17.8 20.5 16.8 14.4 15.8 14.1 31.3 27.1 36.8 17.3 18.8 19.2 41.4 19.6 20.6 17.8 19.0 19.6 13.3 19.2 18.2 18.6 19.0 17.4 16.7 15.6 22.2 17.6 10.7 19.6 16.8 19.7 23.2 23.2 24.4 19.4 19.7 21.1 20.6 21.2 20.3 20.9 28.1 3.2 9.6 9.7 1.3 9.4 4.2 10.4 5.8 5.2 18.9 7.3 6.7 0.0 24.3 10.6 11.0 18.8 15.0 5.0 12.6 1.9 7.6 17.4 6.1 6.4 7.2 12.7 5.5 1.9 8.0 9.1 7.4 7.1 4.6 7.0 9.0 15.7 28.5 9.5 11.8 2.0 11.7 20.3 7.9 3.3 4.8 12.8 3.1 5.4 1.0 8.4 12.1 10.3 2.0 2.6 5.4 9.5 15.8 9.0 9.6 19.3 15.3 10.2 19.9 13.1 15.5 6.2 9.9 13.6 7.2 4.1 9.2 8.3 5.4 16.7 7.2 COL18A1 "KNO, KNO1, KS" ENSG00000182871 "Collagen type XVIII alpha 1 chain" P39060 21 45405165-45513720 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 561.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 479.6;Sertoli cells: 223.5;Smooth muscle cells: 268.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 139.0;EFO-21: 309.4;NTERA-2: 170.6;RPTEC TERT1: 131.6;TIME: 186.0" "Region enriched" "Detected in all" 6 "cerebellum: 22.1" "Low region specificity" "Detected in all" "HPA030933, HPA036104" Supported Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 290000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA030933: , HPA036104: AB_2674943" "unprognostic (4.32e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (3.47e-2)" "unprognostic (3.25e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.16e-4)" "unprognostic (4.23e-3)" "unprognostic (9.93e-2)" "unprognostic (3.48e-1)" "unprognostic (2.77e-1)" "unprognostic (5.50e-2)" "unprognostic (1.70e-1)" "unprognostic (1.83e-2)" "unprognostic (9.44e-2)" "unprognostic (9.10e-3)" "unprognostic (2.25e-3)" 136.4 87.6 14.5 33.9 22.3 15.9 97.1 26.4 21.8 229.4 34.4 91.2 30.4 135.6 35.4 50.1 118.3 28.9 122.2 15.7 18.1 218.2 561.9 83.2 19.8 43.7 28.6 257.3 102.3 7.9 106.5 40.7 39.1 91.0 5.5 5.4 35.8 46.8 26.5 77.8 65.7 28.5 26.6 86.8 44.5 30.0 27.0 9.0 101.1 7.4 7.2 109.8 112.2 45.4 10.5 84.0 20.6 18.0 38.6 31.9 3.3 82.0 139.0 39.1 10.5 48.8 28.9 1.5 309.4 82.8 21.6 37.9 4.6 5.0 7.4 0.7 20.0 47.9 1.4 69.6 37.3 0.7 4.4 37.6 3.3 3.8 4.5 8.5 121.3 0.5 49.6 0.3 14.4 16.7 0.8 3.2 170.6 3.2 30.7 0.7 12.6 4.0 131.6 1.3 22.8 16.3 7.6 7.8 26.6 73.0 7.5 9.9 186.0 0.5 11.4 0.4 17.7 0.4 0.8 1.5 0.1 1.7 32.7 0.8 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.0 0.1 0.0 0.1 14.5 22.3 26.4 21.8 15.7 18.1 43.7 28.6 39.1 26.6 27.0 45.4 156.9 0.0 4.1 6.5 3.9 67.7 15.5 19.0 67.7 13.5 9.3 32.1 15.7 61.5 5.0 112.2 4.2 1.9 3.4 0.1 9.8 117.5 1.5 58.3 99.5 91.2 0.0 33.0 4.9 5.8 1.1 101.1 3.6 144.2 57.8 6.6 75.0 479.6 2.4 0.0 15.8 0.1 4.1 12.1 32.5 6.7 79.9 6.5 49.8 82.4 3.2 141.9 7.2 4.0 28.0 9.9 0.0 126.0 4.6 14.0 0.0 72.9 0.7 6.3 223.5 138.2 268.6 4.1 6.0 7.9 28.6 2.5 15.3 47.5 0.4 2.6 COL8A2 "FECD, FECD1, PPCD, PPCD2" ENSG00000171812 "Collagen type VIII alpha 2 chain" P25067 1 36095239-36125222 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 10.2;Cardiomyocytes: 13.5;Fibroblasts: 13.4;Macrophages: 6.8;Melanocytes: 7.2;Microglial cells: 8.4;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.8;fHDF/TERT166: 4.3;HHSteC: 14.1;hTERT-RPE1: 18.2;THP-1: 4.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "spinal cord: 3.6" HPA049788 Uncertain Uncertain "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA049788: AB_2680882" "unprognostic (9.98e-2)" "unprognostic (3.26e-2)" "unprognostic (2.51e-2)" "unprognostic (8.41e-3)" "unprognostic (8.76e-2)" "prognostic favorable (9.44e-4)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (3.50e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.35e-5)" "unprognostic (1.08e-2)" "unprognostic (6.77e-2)" "unprognostic (2.24e-2)" "unprognostic (1.16e-3)" 5.2 1.2 2.5 4.4 2.2 0.5 5.6 6.1 2.4 9.0 18.3 5.9 1.4 5.7 1.6 5.8 4.2 4.8 5.4 2.3 2.9 1.1 0.6 4.6 3.1 9.0 4.2 3.3 0.8 0.7 4.0 12.8 7.1 6.1 2.0 0.4 7.4 11.4 0.6 5.5 2.4 3.7 6.1 8.5 9.1 0.9 4.2 4.9 7.5 2.1 3.5 13.3 5.9 5.7 0.0 0.0 0.0 0.0 0.5 1.0 0.1 5.8 1.7 1.6 0.9 0.2 0.1 0.0 0.8 4.3 0.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 14.1 0.0 0.0 1.7 0.1 0.7 0.0 18.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.1 0.1 0.0 0.5 0.5 0.5 0.0 0.2 0.4 0.0 4.7 0.1 2.3 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.5 2.2 6.1 2.4 2.3 2.9 9.0 4.2 7.1 6.1 4.2 5.7 0.6 0.0 1.8 0.3 0.0 2.2 2.2 1.8 0.0 0.1 1.3 10.2 13.5 0.0 0.7 0.0 0.0 0.4 1.4 0.0 0.0 0.4 0.1 0.2 0.2 0.7 0.0 0.0 0.2 0.2 0.3 13.4 0.5 0.3 2.5 0.5 1.1 0.0 6.2 0.0 0.4 0.0 0.0 2.0 2.7 0.2 3.1 6.8 7.2 8.4 1.2 0.3 0.0 0.5 0.1 0.6 0.0 6.0 0.1 5.3 0.0 0.0 0.2 0.2 6.6 0.7 1.4 0.0 0.3 0.1 1.3 0.8 1.2 0.3 0.0 0.4 COMP "EDM1, EPD1, MED, PSACH, THBS5" ENSG00000105664 "Cartilage oligomeric matrix protein" P49747 19 18782773-18791305 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cell adhesion" Heparin-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 77.6;heart muscle: 65.3;skin 1: 80.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 19.3;Early spermatids: 37.0;Fibroblasts: 32.0;Glandular and luminal cells: 32.0;Late spermatids: 75.3;Spermatocytes: 16.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 859.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077555 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 1500000000 "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA077555: " "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (9.08e-5)" "prognostic unfavorable (2.04e-4)" "unprognostic (8.05e-2)" "unprognostic (8.45e-2)" "unprognostic (3.62e-2)" "unprognostic (5.12e-2)" "unprognostic (1.65e-1)" "unprognostic (1.55e-2)" "unprognostic (2.18e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (5.96e-3)" "unprognostic (1.44e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (6.95e-4)" 77.6 0.2 0.0 1.1 0.2 0.0 11.0 1.3 0.2 7.5 0.0 2.3 0.0 4.6 7.6 9.5 1.2 16.1 65.3 0.0 0.0 5.2 0.3 8.0 3.6 0.3 0.1 0.4 2.8 2.2 0.4 8.2 0.1 10.2 0.0 0.0 14.1 6.7 18.0 80.6 0.9 12.1 0.3 0.3 2.5 14.9 0.0 0.1 10.3 0.6 0.3 6.5 22.7 0.1 0.0 0.0 0.0 0.0 178.4 0.4 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 859.6 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.3 0.0 0.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.2 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.1 3.2 0.5 0.0 0.0 11.5 0.6 19.3 0.0 1.4 0.3 0.3 0.8 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 37.0 2.8 3.7 1.0 0.0 0.0 0.1 0.2 0.2 32.0 0.0 32.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 1.3 0.0 0.0 10.7 75.3 0.9 0.7 10.6 0.0 0.1 1.6 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.3 0.0 0.0 0.7 0.4 6.6 2.4 4.2 16.8 1.6 0.0 7.1 0.5 1.0 0.0 0.2 0.3 COPE epsilon-COP ENSG00000105669 "COPI coat complex subunit epsilon" O14579 19 18899514-18919387 "Metabolic proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034345, HPA041605, HPA043576" Supported Enhanced "Golgi apparatus" NA NA 66000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563" "unprognostic (1.48e-1)" "prognostic favorable (2.41e-4)" "unprognostic (1.15e-1)" "unprognostic (5.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.40e-2)" "unprognostic (3.39e-2)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (1.97e-2)" "unprognostic (8.75e-2)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.26e-1)" "unprognostic (3.16e-2)" "unprognostic (6.75e-2)" 102.3 163.7 127.2 85.5 133.4 159.6 100.3 139.4 176.0 101.3 131.3 113.8 90.5 104.1 45.0 160.3 89.8 44.1 135.2 122.4 131.0 141.9 194.3 108.3 91.7 140.6 132.0 80.8 152.0 80.8 160.1 59.3 130.0 127.4 37.7 23.5 144.2 65.4 128.0 120.9 107.8 42.9 137.1 150.0 126.8 171.9 135.9 82.4 123.7 50.0 56.9 99.2 107.1 151.2 186.7 177.4 99.3 177.3 89.0 104.7 287.2 159.2 150.8 174.8 198.7 215.1 148.2 150.8 210.5 134.9 112.9 123.2 82.5 161.0 33.9 94.2 369.9 89.6 150.9 331.1 236.1 180.0 221.1 128.3 149.2 106.2 115.6 92.5 138.9 170.5 140.2 373.6 90.0 443.0 196.9 341.0 188.4 243.0 420.2 222.4 89.6 448.2 115.8 185.4 138.8 222.4 100.0 159.1 181.1 44.9 134.8 291.3 140.9 110.5 81.5 283.3 170.9 357.7 337.5 187.7 189.1 309.9 187.3 656.0 598.5 639.1 337.1 533.1 298.1 391.2 321.9 298.6 528.4 381.9 236.4 270.9 594.9 344.4 468.5 659.3 449.3 930.0 127.2 133.4 139.4 176.0 122.4 131.0 140.6 132.0 130.0 137.1 135.9 151.2 110.5 3.2 16.2 22.2 204.7 159.8 197.9 390.9 54.1 53.2 140.5 111.6 10.4 111.5 205.8 115.8 29.2 386.5 242.8 408.9 463.7 323.7 179.7 134.4 131.8 127.1 168.5 130.5 8.6 368.7 439.1 140.7 166.2 187.8 102.9 176.7 113.6 153.4 447.2 57.2 11.3 445.5 303.2 189.4 286.8 381.0 144.8 217.8 245.5 4.7 373.5 251.9 187.4 8.5 20.8 336.7 421.4 133.2 417.5 255.7 425.6 493.1 152.6 72.1 124.9 92.8 200.5 178.4 202.1 108.6 196.6 542.2 174.9 235.3 297.4 267.2 CORO6 FLJ14871 ENSG00000167549 "Coronin 6" Q6QEF8 17 29614756-29622907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 600.0;tongue: 252.6" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 38.1;Excitatory neurons: 64.1;Extravillous trophoblasts: 32.7;Horizontal cells: 30.3;Inhibitory neurons: 73.8;Skeletal myocytes: 25.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "REH: 16.5;RH-30: 17.8;SH-SY5Y: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021556 Approved "Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" "Golgi apparatus" "HPA021556: " "unprognostic (7.12e-3)" "unprognostic (2.68e-2)" "unprognostic (2.60e-4)" "unprognostic (9.25e-4)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.62e-1)" "unprognostic (3.00e-4)" "unprognostic (6.70e-2)" "unprognostic (6.61e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.61e-7)" "unprognostic (8.48e-2)" "unprognostic (4.09e-1)" "unprognostic (1.92e-1)" "unprognostic (1.13e-2)" 11.2 3.2 7.6 1.2 7.8 0.5 10.3 1.1 23.0 6.8 0.0 23.2 1.3 14.4 1.9 15.3 15.8 4.1 70.6 5.9 5.3 1.9 0.7 9.7 0.7 11.9 2.5 4.7 1.5 16.0 4.3 27.9 10.8 14.6 2.2 2.0 16.0 4.4 600.0 6.2 11.7 11.9 2.2 1.4 8.9 1.9 6.4 1.8 99.4 252.6 0.8 21.7 8.5 12.6 10.2 4.4 3.8 0.0 5.9 3.2 6.0 3.3 1.2 2.1 0.8 0.3 0.0 0.1 0.8 5.3 0.3 10.5 2.9 0.6 1.0 0.2 4.9 0.0 9.8 1.3 9.4 0.0 0.6 11.5 0.9 1.1 0.0 5.4 2.2 0.0 0.7 0.2 7.1 0.0 6.8 0.3 1.2 0.0 0.2 16.5 17.8 0.4 0.5 0.0 0.1 21.9 0.9 3.0 0.0 2.8 0.0 1.4 0.6 1.4 0.0 1.7 1.4 8.3 4.7 1.2 3.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 7.8 1.1 23.0 5.9 5.3 11.9 2.5 10.8 2.2 6.4 12.6 1.1 0.0 0.0 4.6 0.4 1.5 2.5 0.6 1.8 3.5 0.8 1.9 38.1 0.0 0.6 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.2 0.1 2.4 1.8 0.0 0.0 64.1 0.0 32.7 7.7 0.5 0.2 0.0 1.0 2.2 0.1 1.3 30.3 73.8 0.0 2.0 1.2 0.8 0.6 7.2 0.7 0.0 7.5 0.0 0.2 2.1 5.0 6.6 0.0 0.0 4.1 0.7 1.0 0.0 0.3 0.2 1.5 6.6 25.6 6.0 2.4 3.9 0.2 0.4 2.5 1.3 1.1 0.0 0.2 CPA2 ENSG00000158516 "Carboxypeptidase A2" P48052 7 130266863-130289798 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 416 "pancreas: 45360.2" "Cell type enriched" "Detected in some" 10 "Exocrine glandular cells: 4973.8" "Cancer enriched" "Detected in many" 60 "pancreatic cancer: 411.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.2;CACO-2: 3.8;RH-30: 3.0;SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA020342, HPA021317" Enhanced Approved "Golgi apparatus" "Secreted to digestive system" NA NA 1500000 "Cluster 25: Pancreas - Digestion" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "HPA020342: AB_1846007, HPA021317: AB_1846008" "unprognostic (1.12e-1)" "unprognostic (3.97e-1)" "unprognostic (4.21e-2)" "unprognostic (1.82e-2)" "unprognostic (1.38e-1)" "unprognostic (6.76e-2)" "unprognostic (4.65e-2)" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.66e-1)" "unprognostic (3.84e-5)" "unprognostic (7.52e-2)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (8.48e-2)" 5.5 1.0 0.3 0.7 0.8 0.4 2.6 1.0 0.9 1.9 0.2 1.3 17.4 0.8 0.1 1.5 0.7 0.0 8.4 0.3 0.6 0.9 2.6 0.7 1.4 2.8 1.3 19.7 45360.2 0.0 1.4 3.2 2.5 1.5 0.4 0.8 7.8 0.0 0.8 1.1 30.6 0.0 1.2 1.2 108.9 2.2 1.1 0.1 0.6 0.0 0.0 0.5 0.8 3.1 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.8 0.0 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 3.0 0.0 0.0 0.3 1.6 0.0 0.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.6 0.4 0.3 0.0 0.4 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.0 0.9 0.3 0.6 2.8 1.3 2.5 1.2 1.1 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.6 1.9 8.1 4.3 0.0 0.0 0.9 0.0 0.0 0.1 4973.8 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 10.5 0.3 0.5 0.0 0.0 13.9 4.6 0.0 0.5 1.0 471.3 52.9 0.0 0.0 0.0 9.9 0.0 0.0 0.3 0.0 0.0 1.3 0.4 2.0 0.0 0.1 0.3 0.0 0.2 1.5 0.2 CSF2RB "betaGMR, CD131, IL3RB, IL5RB" ENSG00000100368 "Colony stimulating factor 2 receptor subunit beta" P32927 22 36913628-36940439 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 54.5;lymphoid tissue: 65.5" "Cell type enhanced" "Detected in many" "dendritic cells: 44.8;Extravillous trophoblasts: 37.9;granulocytes: 91.2;Langerhans cells: 68.3;Late spermatids: 41.2;Macrophages: 34.7;monocytes: 42.3;Plasma cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basophil: 238.1;neutrophil: 76.0" "Lineage enriched" "Detected in many" 16 "granulocytes: 238.1" "Group enriched" "Detected in some" 5 "HEL: 107.3;HMC-1: 321.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA078677 Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA078677: AB_2732389" "unprognostic (1.67e-2)" "unprognostic (9.44e-3)" "unprognostic (1.03e-2)" "unprognostic (6.66e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.47e-5)" "unprognostic (1.86e-1)" "unprognostic (1.94e-2)" "unprognostic (4.38e-1)" "unprognostic (9.57e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (1.82e-3)" "unprognostic (5.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.95e-1)" "unprognostic (8.52e-2)" 10.1 2.0 1.0 65.5 1.1 54.5 5.4 1.2 5.2 2.5 1.3 9.9 10.3 2.0 0.7 6.6 2.6 9.8 2.3 0.9 1.6 1.8 2.6 15.1 40.1 2.6 2.1 0.5 2.1 0.9 0.7 31.3 3.1 1.6 8.5 0.0 4.9 1.5 1.0 5.4 11.0 7.0 2.3 22.8 9.3 2.1 3.0 9.8 2.7 4.0 62.5 18.3 2.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.3 0.0 0.0 0.1 16.1 0.0 107.3 0.0 0.0 0.1 1.7 321.1 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.1 12.6 0.0 0.0 0.1 11.2 0.0 0.0 0.0 10.7 0.0 40.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.1 0.1 9.6 0.3 1.0 0.1 0.3 0.0 1.6 1.1 6.8 0.2 15.6 0.1 238.1 9.1 23.5 0.0 7.7 0.0 1.6 0.2 0.0 4.8 1.1 0.0 0.0 76.0 0.0 7.0 14.4 2.3 10.3 1.0 1.1 1.2 5.2 0.9 1.6 2.6 2.1 3.1 2.3 3.0 2.9 4.3 0.0 9.1 1.6 9.1 7.1 0.0 0.0 0.0 0.0 0.2 0.3 1.2 2.8 1.8 0.0 0.0 3.4 44.8 0.0 0.0 0.0 13.4 0.0 0.2 22.0 0.0 32.0 0.1 0.2 37.9 2.8 0.0 0.0 91.2 0.0 4.6 0.0 20.1 0.0 0.1 0.0 0.0 31.9 68.3 41.2 0.0 34.7 12.4 5.6 42.3 0.0 2.1 0.0 0.0 0.0 0.0 0.4 49.5 0.1 0.0 0.1 2.9 0.0 0.0 0.3 0.5 0.0 0.0 0.1 6.3 16.6 2.9 0.1 0.0 0.2 CXCL8 "3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1" ENSG00000169429 "C-X-C motif chemokine ligand 8" P10145 4 73740541-73743716 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 3301.3" "Group enriched" "Detected in many" 5 "Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 9 "cerebral cortex: 136.1" "Immune cell enriched" "Detected in some" 451 "neutrophil: 483.0" "Lineage enriched" "Detected in single" 788 "granulocytes: 483.0" "Group enriched" "Detected in many" 5 "BJ hTERT+: 4072.6;GAMG: 1080.2" "Not detected" "Not detected" HPA057179 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 7260 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA057179: AB_2683362" "unprognostic (3.42e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (3.91e-3)" "unprognostic (8.49e-2)" "unprognostic (3.29e-2)" "unprognostic (3.03e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.37e-3)" "unprognostic (3.19e-1)" "unprognostic (4.46e-1)" "unprognostic (7.19e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.13e-6)" "unprognostic (4.73e-2)" "unprognostic (8.57e-2)" "unprognostic (1.64e-2)" "unprognostic (6.15e-2)" 67.9 13.5 1.8 209.9 2.8 3301.3 3.6 1.7 136.1 54.5 7.6 10.6 3.6 41.0 0.2 3.7 8.9 177.2 33.8 1.7 1.6 10.8 77.7 91.2 1.2 2.1 1.6 6.0 16.1 1.8 3.2 41.1 15.1 9.6 7.3 0.9 25.4 1.5 1.3 3.2 4.9 12.7 1.9 10.3 8.8 0.7 4.9 15.2 3.4 8.1 8.7 456.7 4.0 1.9 2.7 1.4 0.0 0.1 3.9 19.4 0.2 25.7 4072.6 35.9 117.0 0.2 13.0 0.2 547.6 1.3 1080.2 48.2 0.0 1.0 562.3 1.8 0.2 0.9 0.4 6.5 6.8 41.0 2.5 12.4 1.7 119.0 2.9 12.9 124.9 0.0 1.4 0.8 0.7 0.0 0.0 55.7 0.0 14.7 20.3 0.3 0.5 0.9 317.3 17.2 0.1 0.0 1.9 0.1 61.1 0.8 0.1 5.6 308.3 56.8 5.1 15.1 55.0 0.4 0.7 1.7 252.5 30.9 88.2 1.0 0.6 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 483.0 0.0 0.0 0.0 0.0 0.1 1.8 2.8 1.7 136.1 1.7 1.6 2.1 1.6 15.1 1.9 4.9 1.9 28.6 51.3 254.1 0.0 26.4 0.0 13262.1 0.0 164.4 0.5 40.2 15.4 23.8 127.2 426.5 0.0 0.0 4.3 17.7 14.4 0.0 1695.0 3.2 717.6 257.1 712.2 19.1 8.0 0.0 260.7 5.2 1475.1 54.0 1708.7 51.2 0.5 15.7 3.6 367.1 0.0 0.0 26.4 0.0 543.0 0.0 1.9 0.6 3685.4 0.0 0.0 1178.5 0.5 0.0 0.0 0.0 584.9 0.3 0.4 27.3 8869.1 0.9 1.0 178.6 1.1 39.5 44.3 263.0 0.3 2.5 124.9 0.0 21.3 138.8 0.0 18.5 13149.4 CYP2D6 "CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D" ENSG00000100197 "Cytochrome P450 family 2 subfamily D member 6" P10635 22 42126499-42130865 "Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 320.0" "Group enriched" "Detected in many" 35 "Hepatocytes: 512.8;Proximal enterocytes: 465.2" "Cancer enriched" "Detected in many" 35 "liver cancer: 90.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.8" "Low region specificity" "Detected in many" HPA045223 Enhanced Approved "Golgi apparatus" No No "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA045223: AB_10962927" "unprognostic (4.40e-3)" "unprognostic (7.68e-3)" "unprognostic (5.45e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.29e-4)" "unprognostic (3.83e-2)" "unprognostic (7.27e-3)" "unprognostic (1.13e-1)" "unprognostic (1.71e-1)" "unprognostic (4.03e-4)" "unprognostic (2.11e-2)" "unprognostic (5.61e-5)" "unprognostic (3.01e-1)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (4.82e-5)" 0.1 0.2 0.2 0.0 0.3 0.3 0.1 0.8 0.2 0.1 0.3 0.3 3.7 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.3 320.0 0.1 0.1 0.2 0.0 0.2 0.8 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.2 11.7 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.2 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.6 0.0 1.1 5.5 0.7 0.5 0.7 1.3 2.8 7.3 1.1 1.4 0.4 2.8 0.7 1.8 2.1 0.1 0.6 2.9 1.9 0.7 3.1 0.8 0.6 0.6 1.2 0.0 6.5 0.6 0.1 0.3 4.1 1.4 0.0 0.7 5.7 512.8 0.1 11.8 9.4 7.6 0.0 5.6 0.0 13.6 0.0 0.4 0.0 0.0 0.1 0.7 0.0 5.0 4.9 0.7 11.3 1.5 0.4 0.6 465.2 0.5 1.3 2.3 0.0 0.4 2.1 0.8 0.4 0.6 1.1 0.4 1.0 0.1 3.4 0.3 DCC "IGDCC1, NTN1R1" ENSG00000187323 "DCC netrin 1 receptor" P43146 18 52340197-53535903 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.9;testis: 7.6" "Cell type enhanced" "Detected in some" "Early spermatids: 205.7;Excitatory neurons: 439.7;Inhibitory neurons: 455.8;Late spermatids: 174.9;Oligodendrocyte precursor cells: 1305.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 36.4;U-266/70: 112.5;U-266/84: 57.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055376, HPA069552" Enhanced Approved "Golgi apparatus" NA NA 64000 "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" "HPA055376: AB_2682798, HPA069552: AB_2686151" "unprognostic (1.96e-3)" "unprognostic (1.69e-2)" "unprognostic (3.13e-1)" "unprognostic (3.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-3)" "unprognostic (2.59e-1)" "unprognostic (5.59e-2)" "unprognostic (2.00e-1)" "unprognostic (2.58e-1)" "unprognostic (8.22e-4)" "unprognostic (4.14e-2)" "unprognostic (1.27e-4)" "unprognostic (7.21e-2)" "unprognostic (1.84e-2)" "unprognostic (1.42e-1)" "unprognostic (2.69e-3)" 0.0 0.6 1.2 0.2 6.3 0.0 0.0 0.0 3.9 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 6.9 3.6 0.2 0.0 1.4 0.0 0.7 4.7 0.1 0.3 0.0 0.6 0.0 1.5 0.3 0.1 0.3 0.1 1.2 0.0 0.1 0.1 0.0 0.0 0.2 0.2 7.6 1.1 1.0 0.0 0.0 0.3 0.1 0.1 0.9 0.1 0.1 36.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.1 112.5 57.1 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.3 0.0 3.9 6.9 3.6 0.7 4.7 1.5 0.0 1.1 0.9 1.4 0.0 6.0 10.1 0.3 0.0 0.1 0.0 0.0 2.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 205.7 0.0 0.0 0.1 0.0 0.0 439.7 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 455.8 0.0 0.0 0.0 0.0 174.9 1.2 0.2 0.0 54.4 0.0 0.2 0.0 1305.9 58.6 0.0 0.0 1.2 5.7 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.1 2.6 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 DENND11 "KIAA1147, LCHN" ENSG00000257093 "DENN domain containing 11" A4D1U4 7 141656728-141702166 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 9.2;B-cells: 3.8;Cardiomyocytes: 4.3;dendritic cells: 8.5;Hofbauer cells: 7.6;Plasma cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "basophil: 1.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "HDLM-2: 5.5;HEK 293: 5.3;U-266/70: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029467, HPA061437" Approved Approved "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA029467: AB_10602915, HPA061437: AB_2684517" "unprognostic (1.27e-1)" "unprognostic (5.68e-2)" "unprognostic (7.05e-2)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "prognostic favorable (6.24e-4)" "unprognostic (6.49e-2)" "unprognostic (3.63e-2)" "unprognostic (3.02e-2)" "unprognostic (4.27e-1)" "unprognostic (7.62e-2)" "unprognostic (3.75e-2)" "prognostic favorable (8.01e-4)" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.91e-3)" "unprognostic (1.78e-1)" 8.7 5.9 7.1 1.0 8.0 0.9 9.6 5.4 10.2 8.0 4.3 11.0 3.6 7.0 0.5 12.5 8.1 0.5 6.8 10.7 5.3 8.8 14.7 13.3 1.6 9.0 7.7 7.5 17.4 1.0 11.8 0.3 8.6 9.0 1.5 2.8 20.6 0.7 5.7 8.7 14.4 0.6 7.0 14.2 17.8 1.4 6.9 0.6 12.4 0.5 1.2 8.5 11.3 10.6 1.9 1.5 0.9 1.2 0.5 0.2 0.3 0.4 0.3 0.3 0.3 1.9 1.3 0.1 3.1 0.3 0.8 0.6 1.0 0.8 0.7 5.5 5.3 0.9 0.8 0.3 0.1 1.7 0.3 0.2 0.7 0.2 0.3 0.8 1.3 1.0 0.0 0.3 0.2 0.7 1.5 1.2 1.5 2.1 1.0 3.6 0.2 1.7 0.6 1.0 1.4 2.7 1.2 2.1 0.2 0.5 0.8 0.2 4.3 0.2 1.0 0.4 2.2 7.5 1.8 2.4 0.6 2.3 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.1 8.0 5.4 10.2 10.7 5.3 9.0 7.7 8.6 7.0 6.9 10.6 9.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 DKK2 ENSG00000155011 "Dickkopf WNT signaling pathway inhibitor 2" Q9UBU2 4 106921802-107283806 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 15.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.6;Fibroblasts: 18.7;Hofbauer cells: 16.8;Inhibitory neurons: 32.5;Langerhans cells: 11.8;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 22.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebral cortex: 1.5;midbrain: 5.0;pons: 6.3;thalamus: 5.7" "CAB009727, HPA052611" Uncertain Supported "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "CAB009727: AB_2091492, HPA052611: AB_2732576" "unprognostic (3.14e-3)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (3.21e-2)" "unprognostic (9.75e-2)" "unprognostic (3.68e-1)" "unprognostic (1.04e-3)" "unprognostic (2.47e-2)" "unprognostic (5.11e-1)" "unprognostic (5.21e-2)" "unprognostic (3.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (6.86e-2)" "unprognostic (3.22e-1)" "unprognostic (4.58e-2)" 1.4 0.8 0.4 0.4 1.4 0.0 3.0 0.0 1.5 15.2 1.2 1.7 0.0 1.0 0.4 1.2 0.5 0.7 2.2 0.7 0.6 0.2 0.2 5.3 0.7 0.9 4.5 4.4 0.2 0.6 1.5 2.8 0.3 2.3 0.5 0.4 1.3 1.7 1.9 4.7 0.3 0.6 0.2 1.3 0.1 0.1 2.3 1.0 0.9 1.2 3.0 0.2 0.8 0.8 0.0 0.0 3.6 0.0 0.6 0.3 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 1.5 0.7 0.6 0.9 4.5 0.3 0.2 2.3 0.8 2.6 0.0 0.0 0.3 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.1 5.4 0.0 0.0 5.2 0.0 0.2 18.7 0.0 0.1 0.0 0.0 3.3 0.0 16.8 0.0 32.5 0.0 0.0 0.3 11.8 0.0 4.1 0.3 7.2 2.8 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 7.4 0.0 0.8 2.0 0.0 0.0 DLK1 "Delta1, FA1, pG2, Pref-1, ZOG" ENSG00000185559 "Delta like non-canonical Notch ligand 1" P80370 14 100725705-100738224 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 1330.8;pituitary gland: 772.9;placenta: 1631.2" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 576.5;Fibroblasts: 699.3;Leydig cells: 1357.0;Skeletal myocytes: 2360.1" "Cancer enhanced" "Detected in many" "liver cancer: 28.1;testis cancer: 25.4" "Region enhanced" "Detected in many" "hypothalamus: 163.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 120.0;Hep G2: 419.1;SH-SY5Y: 473.8" "Region enhanced" "Detected in many" "hypothalamus: 111.7" "Group enriched" "Detected in many" 5 "hypothalamus: 41.2;midbrain: 156.8" "CAB005872, HPA062262" Enhanced Approved "Golgi apparatus" NA NA 2600000 "Cluster 28: Placenta - Pregnancy" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "CAB005872: AB_731965, HPA062262: AB_2684729" "unprognostic (2.16e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (4.89e-3)" "unprognostic (5.75e-2)" "unprognostic (1.87e-2)" "unprognostic (1.12e-1)" "unprognostic (5.24e-1)" "unprognostic (3.11e-2)" "unprognostic (6.57e-2)" 3.1 1330.8 3.4 6.1 1.9 0.1 7.1 0.0 0.8 9.4 0.3 0.2 1.8 0.7 0.2 2.6 3.1 2.2 45.7 0.5 163.3 0.6 1.8 0.8 0.5 15.4 38.7 277.2 21.2 0.0 772.9 1631.2 81.7 1.4 0.0 0.0 26.9 0.0 17.5 1.2 1.3 0.2 2.1 1.1 1.0 40.9 14.7 1.7 0.2 83.1 0.0 1.0 1.5 0.9 0.0 0.0 120.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 12.6 0.3 419.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 1.4 0.1 0.0 0.5 33.7 473.8 0.0 0.1 0.0 2.9 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 1.9 0.0 0.8 0.5 163.3 15.4 38.7 81.7 2.1 14.7 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 1.3 1.0 2.6 0.0 0.0 0.0 0.0 55.2 0.2 0.0 0.0 4.8 7.1 0.0 0.0 6.7 0.0 0.0 0.0 576.5 45.3 699.3 0.0 0.0 0.0 0.8 0.0 0.0 84.3 0.0 0.0 0.0 0.0 0.0 0.3 35.0 1357.0 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.0 0.0 172.6 0.0 1.3 0.0 0.2 0.0 0.0 59.2 2360.1 3.0 13.5 69.9 0.0 0.4 105.8 0.8 63.2 0.0 0.2 DNM3 KIAA0820 ENSG00000197959 "Dynamin 3" Q9UQ16 1 171841498-172418466 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 66.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 365.7;Inhibitory neurons: 631.8;Oligodendrocyte precursor cells: 976.1;Oligodendrocytes: 1970.9" "Cancer enhanced" "Detected in many" "glioma: 2.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 22.9;HMC-1: 10.2;RPTEC TERT1: 19.0;U-251 MG: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064121 Approved "Golgi apparatus" NA NA 70000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA064121: AB_2685193" "unprognostic (8.21e-2)" "unprognostic (6.80e-3)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (8.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.52e-3)" "unprognostic (6.46e-2)" "unprognostic (5.52e-2)" "unprognostic (2.96e-2)" "unprognostic (2.45e-2)" "unprognostic (3.37e-1)" "unprognostic (6.10e-4)" "unprognostic (1.60e-3)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (2.70e-3)" 4.2 11.9 15.3 1.0 29.9 1.3 4.0 59.4 24.3 5.8 0.0 2.4 0.6 3.2 1.3 1.3 3.2 2.7 2.1 12.2 36.0 4.1 0.4 4.4 1.1 42.8 29.5 2.6 1.1 1.2 6.2 0.4 47.8 2.6 1.1 13.4 2.1 1.6 1.2 2.4 1.4 3.1 10.6 1.8 2.7 3.2 32.3 1.8 3.3 1.3 0.8 2.2 5.1 66.9 0.8 2.5 2.0 0.4 1.5 1.0 0.0 0.5 1.2 1.0 1.3 0.0 3.7 0.0 7.5 1.1 1.2 0.3 1.5 2.9 0.9 1.0 2.9 22.9 3.7 0.0 0.1 0.5 10.2 0.7 0.5 1.2 0.7 1.1 0.5 2.0 0.0 0.3 0.4 0.0 1.5 0.1 5.8 9.5 1.7 1.5 9.9 0.0 19.0 0.1 3.9 0.8 2.7 0.7 0.2 0.7 0.0 0.9 0.3 2.8 3.8 2.3 14.3 3.8 0.7 0.2 2.7 1.2 1.0 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.2 0.0 0.3 0.5 0.3 0.3 0.1 0.0 1.4 1.2 15.3 29.9 59.4 24.3 12.2 36.0 42.8 29.5 47.8 10.6 32.3 66.9 21.8 0.0 6.8 207.3 1.5 2.4 1.5 0.7 3.4 25.1 1.4 1.3 2.4 0.0 0.4 0.0 29.2 0.1 0.7 0.2 3.9 0.3 8.2 7.3 1.3 19.5 0.0 0.8 365.7 0.4 0.1 3.2 7.1 1.0 1.3 0.8 8.2 0.2 0.7 8.4 631.8 0.7 0.0 0.6 3.1 3.9 1.8 13.4 0.0 178.0 0.3 5.9 0.0 976.1 1970.9 2.5 0.1 2.6 0.3 0.7 0.0 0.8 2.2 29.0 0.0 4.5 2.2 5.3 0.4 1.1 1.7 0.3 0.9 10.3 0.8 0.7 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847158 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.6;pituitary gland: 4.2;retina: 1.9" "Cell type enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 4376.6" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019324, HPA057493" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA019324: AB_2670118, HPA057493: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.0 0.0 5.4 0.0 5.8 0.0 0.1 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.6 4.2 0.0 0.1 0.0 0.0 2.3 2.8 0.0 0.1 0.0 4.2 0.7 3.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.8 0.1 6.6 5.6 4.2 2.3 2.8 3.5 2.9 4.1 4.1 0.0 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 19.6 0.0 0.4 1.1 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.4 0.0 0.0 1083.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 16.8 649.1 0.0 0.0 2.4 0.0 4.2 0.0 0.0 0.0 200.5 0.0 0.7 0.0 4376.6 21.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.0 0.1 1.7 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 DYM "DMC, FLJ20071, SMC" ENSG00000141627 Dymeclin Q7RTS9 18 49036387-49461347 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 113.6;Early spermatids: 353.4;Excitatory neurons: 173.2;Inhibitory neurons: 204.1;Late spermatids: 176.1;Microglial cells: 149.9;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 299.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043551, HPA049187" Approved Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus" "HPA043551: AB_2678547, HPA049187: AB_2680668" "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (3.12e-3)" "unprognostic (1.33e-2)" "unprognostic (1.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.85e-3)" "unprognostic (1.77e-1)" "unprognostic (1.72e-1)" "unprognostic (8.30e-3)" "unprognostic (2.53e-2)" "unprognostic (2.58e-2)" "prognostic favorable (2.76e-5)" "unprognostic (3.89e-1)" "unprognostic (1.69e-1)" "unprognostic (4.26e-3)" "prognostic unfavorable (5.26e-5)" 17.9 19.2 17.3 14.8 19.6 24.0 23.3 24.9 20.4 24.9 24.4 20.7 15.8 19.8 20.2 25.3 18.6 17.7 21.1 16.7 20.4 21.1 19.7 15.7 17.0 22.8 21.1 29.4 80.7 28.6 9.9 14.6 24.5 20.6 16.8 36.0 36.6 22.0 49.6 18.2 14.1 25.1 19.0 12.7 16.6 44.0 19.1 33.0 32.6 46.0 20.7 23.2 22.3 23.9 32.9 19.8 30.6 47.0 56.9 63.9 24.1 32.2 42.1 37.7 36.8 14.6 20.7 102.1 27.8 60.1 27.9 41.0 48.1 42.1 46.0 38.6 24.7 23.8 16.9 43.4 56.7 83.5 41.5 50.1 49.1 44.1 112.7 63.3 59.0 51.6 25.7 60.5 30.4 35.0 56.5 35.5 9.8 27.1 15.2 29.2 39.2 48.3 34.8 37.2 56.5 36.5 21.9 26.1 30.2 34.5 36.7 29.8 32.6 35.6 16.9 15.5 18.9 67.8 52.7 57.4 19.1 51.6 40.5 20.9 26.9 32.7 20.2 23.4 27.2 17.0 19.3 18.7 29.2 13.9 19.6 15.2 11.9 30.6 20.6 8.4 21.4 21.4 17.3 19.6 24.9 20.4 16.7 20.4 22.8 21.1 24.5 19.0 19.1 23.9 16.0 6.4 6.9 113.6 29.1 11.6 20.4 8.1 29.0 20.1 17.9 15.4 24.5 17.2 8.4 3.7 6.2 19.5 17.4 10.5 13.7 18.1 353.4 11.6 17.2 16.3 16.2 17.9 173.2 20.3 22.2 20.6 17.3 14.8 16.5 23.3 14.3 11.5 16.7 21.9 204.1 15.1 6.1 23.0 15.1 176.1 27.7 20.5 3.6 149.9 19.7 16.1 24.7 167.9 299.4 14.7 11.4 27.1 23.8 25.0 16.1 22.5 13.4 24.9 13.1 22.4 15.4 49.8 16.2 19.4 11.4 35.2 21.6 18.1 16.2 20.2 EBAG9 "EB9, RCAS1" ENSG00000147654 "Estrogen receptor binding site associated antigen 9" O00559 8 109539711-109565996 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021153, HPA021154, CAB072810, CAB072811, CAB072812" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "CAB072810: , CAB072811: , CAB072812: , HPA021153: AB_1856151, HPA021154: AB_1856152" "unprognostic (3.04e-2)" "unprognostic (9.99e-2)" "unprognostic (2.08e-1)" "unprognostic (1.99e-1)" "unprognostic (5.06e-2)" "unprognostic (8.13e-2)" "unprognostic (2.63e-1)" "unprognostic (3.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.22e-2)" "unprognostic (1.04e-1)" "unprognostic (3.72e-1)" "unprognostic (9.72e-3)" "unprognostic (6.46e-2)" "unprognostic (5.16e-1)" "unprognostic (3.53e-1)" "unprognostic (3.71e-2)" 23.3 28.4 18.6 17.6 19.9 16.9 32.4 23.4 26.3 36.1 19.8 28.6 23.5 22.8 44.7 17.0 27.6 19.4 24.7 19.1 20.5 37.0 45.2 28.1 25.4 18.9 19.0 22.2 36.7 34.9 20.5 18.1 19.0 23.3 31.2 32.5 42.9 27.6 53.2 17.9 21.0 17.0 19.1 20.7 27.2 25.3 19.3 20.6 57.4 42.3 27.0 17.2 15.3 20.2 36.7 25.2 25.3 17.3 15.3 24.9 19.7 19.5 14.6 27.0 25.4 25.7 38.1 51.7 33.0 13.8 21.8 25.2 24.4 31.3 28.5 57.6 26.9 56.9 15.8 39.6 34.3 20.0 16.1 19.9 60.1 23.4 47.2 21.9 25.7 45.8 59.8 37.0 24.0 55.8 58.2 31.5 15.8 70.1 25.2 30.9 20.1 43.7 31.4 23.7 27.6 22.1 21.3 22.6 27.6 18.4 44.7 25.6 17.5 20.9 15.0 19.1 14.4 54.9 38.3 48.7 21.2 52.7 19.6 5.8 13.4 14.7 19.3 19.5 34.1 40.7 27.1 27.0 22.5 40.3 33.5 30.4 2.8 29.4 17.3 23.8 33.4 14.7 18.6 19.9 23.4 26.3 19.1 20.5 18.9 19.0 19.0 19.1 19.3 20.2 32.0 121.8 102.4 12.7 40.2 21.7 28.6 51.8 44.9 34.5 36.8 46.0 37.6 54.3 65.1 29.5 6.2 50.2 24.0 33.6 64.6 47.3 134.7 42.9 26.7 34.5 31.8 36.0 16.1 65.8 34.0 28.8 22.4 33.0 46.9 16.0 23.2 48.8 32.7 50.5 16.1 39.4 50.8 24.7 22.1 115.0 29.2 27.9 19.6 11.2 25.3 53.4 27.8 18.1 16.1 38.5 41.3 23.0 53.8 36.8 50.5 58.5 61.8 34.7 32.9 35.1 32.1 101.6 50.4 40.5 19.9 22.2 28.5 34.7 46.0 31.7 ENPP6 MGC33971 ENSG00000164303 "Ectonucleotide pyrophosphatase/phosphodiesterase 6" Q6UWR7 4 184088706-184221230 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4;kidney: 30.6;ovary: 12.5" "Cell type enhanced" "Detected in some" "Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9" "Cancer enriched" "Detected in some" 5 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042740, HPA069197" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 290000 "Cluster 21: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA042740: AB_10793984, HPA069197: " "unprognostic (4.81e-4)" "unprognostic (1.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.69e-3)" "unprognostic (3.07e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.60e-3)" "unprognostic (3.04e-2)" "unprognostic (1.72e-1)" "unprognostic (2.98e-2)" "unprognostic (2.82e-1)" "unprognostic (3.93e-3)" "unprognostic (2.01e-1)" 0.2 0.3 2.7 0.8 11.8 0.9 0.8 14.2 5.5 0.2 2.3 1.0 1.7 0.2 6.1 1.0 0.3 0.5 0.2 2.7 6.1 30.6 0.1 0.3 0.9 20.4 9.6 12.5 0.0 0.0 4.2 0.1 18.1 2.2 1.0 0.1 0.7 6.1 0.2 0.1 2.2 0.1 12.5 1.0 1.2 2.4 11.1 1.9 0.1 1.3 2.8 0.6 0.3 29.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.9 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 2.7 11.8 14.2 5.5 2.7 6.1 20.4 9.6 18.1 12.5 11.1 29.4 0.5 0.0 0.0 5.9 0.1 0.0 0.2 0.9 0.6 0.0 0.1 0.5 0.9 0.0 0.4 1.8 0.0 0.0 0.0 0.0 3.9 1.1 1.0 0.0 0.0 0.5 0.0 0.0 4.3 0.2 0.0 8.7 0.0 0.0 5.7 0.0 0.0 0.4 0.2 0.0 1.5 0.0 0.0 0.6 0.0 0.4 4.1 0.6 1.8 4.7 1.1 0.0 0.0 6.6 119.9 0.0 0.0 35.3 0.5 0.1 0.0 31.3 0.2 0.0 0.0 5.1 0.6 0.1 1.6 0.0 0.0 0.0 0.3 23.9 0.0 0.3 ENTPD6 "CD39L2, dJ738P15.3, IL6ST2, NTPDase-6" ENSG00000197586 "Ectonucleoside triphosphate diphosphohydrolase 6" O75354 20 25195693-25228075 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 289.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015491, HPA069555" Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 41000 "Cluster 39: Non-specific - mRNA processing" "Cluster 22: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA015491: AB_2669200, HPA069555: AB_2686152" "unprognostic (3.24e-1)" "unprognostic (1.27e-2)" "unprognostic (5.91e-2)" "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (4.44e-1)" "unprognostic (2.10e-3)" "unprognostic (7.41e-3)" "unprognostic (2.74e-3)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (8.14e-3)" "unprognostic (1.78e-2)" "unprognostic (2.74e-1)" "unprognostic (4.86e-2)" "unprognostic (4.48e-2)" 24.8 55.4 54.3 22.8 64.0 15.2 27.7 39.7 65.9 22.9 26.5 61.0 60.0 21.8 18.4 25.3 23.2 26.5 75.9 56.0 49.8 40.4 38.9 25.4 16.1 29.6 32.2 36.2 49.6 23.5 60.0 25.2 45.2 55.7 44.9 15.7 71.2 17.2 38.7 19.4 63.0 18.6 25.7 19.8 47.2 36.3 48.5 29.8 28.8 21.9 13.0 24.5 21.8 38.9 78.8 122.8 32.9 64.0 41.0 50.8 70.8 63.0 45.0 54.0 48.3 65.5 60.0 47.6 91.4 60.9 104.7 100.3 40.1 96.2 35.5 29.2 36.2 38.3 18.2 150.4 60.7 52.7 57.3 47.4 53.1 67.7 51.4 39.4 43.7 46.1 51.5 78.8 40.0 75.6 49.2 32.6 20.8 63.9 96.0 27.1 102.9 108.4 67.8 46.3 52.0 26.7 17.7 105.1 289.4 29.6 75.3 43.4 48.6 61.9 63.7 51.6 75.7 50.5 43.8 21.0 44.5 34.1 116.3 0.1 25.2 4.9 18.8 17.0 25.6 8.7 16.5 15.0 26.4 11.0 16.9 15.5 1.1 14.1 7.6 18.5 17.2 22.1 54.3 64.0 39.7 65.9 56.0 49.8 29.6 32.2 45.2 25.7 48.5 38.9 6.4 19.2 28.5 12.4 9.9 9.8 16.2 23.6 6.2 19.2 25.8 21.8 5.8 25.8 14.8 18.4 10.4 63.2 11.0 81.4 9.8 42.5 22.1 10.5 7.6 7.6 34.0 4.2 18.6 40.1 21.7 12.8 52.5 15.4 3.8 65.2 14.3 15.0 26.7 25.2 19.4 57.5 26.4 17.7 17.4 65.2 20.5 17.6 10.6 11.2 16.0 4.2 10.3 13.0 9.2 33.8 59.8 42.2 16.5 27.9 68.4 13.5 10.7 9.1 6.6 6.3 9.6 3.0 8.8 8.6 6.0 59.8 12.0 25.8 72.6 12.1 EPS8 ENSG00000151491 "Epidermal growth factor receptor pathway substrate 8" Q12929 12 15620134-15882329 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 317.0;Sertoli cells: 401.0;Smooth muscle cells: 313.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 22.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 253.0;HHSteC: 218.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003897 Approved Approved "Golgi apparatus" NA NA 17000 "Cluster 51: Monocytes - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA003897: AB_1848224" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-2)" "unprognostic (5.43e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (5.81e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (3.33e-7)" "unprognostic (2.68e-1)" "prognostic favorable (1.45e-7)" "unprognostic (7.47e-3)" "unprognostic (7.20e-2)" "prognostic favorable (5.11e-4)" "unprognostic (1.79e-2)" 62.3 13.0 12.9 16.1 17.4 0.6 33.7 15.3 14.0 53.9 14.1 49.7 37.6 46.2 47.1 20.5 20.1 56.0 26.4 11.1 17.2 55.8 37.8 29.0 9.4 18.5 20.1 49.2 15.1 21.6 3.5 53.1 19.7 16.4 53.7 39.8 13.4 39.8 13.8 11.9 42.7 53.7 15.5 11.9 32.0 15.6 16.1 4.8 22.8 24.3 5.2 51.7 21.4 20.8 65.0 38.8 37.7 1.4 253.0 177.6 53.1 73.6 59.8 34.5 46.1 33.3 97.3 0.0 2.4 140.4 114.4 16.4 11.3 9.5 52.4 0.2 12.6 5.7 11.2 34.7 218.1 4.4 0.2 159.8 42.8 91.7 115.7 44.6 17.7 0.2 0.1 0.2 169.0 17.5 0.2 2.8 5.2 50.3 30.8 0.0 109.5 0.8 97.7 92.5 3.1 4.9 21.4 12.4 91.5 6.2 34.2 4.3 28.7 54.7 14.3 32.4 30.7 3.6 0.4 0.1 32.1 10.7 160.0 0.0 2.7 0.2 0.2 10.8 0.1 1.3 0.9 0.4 5.5 0.3 1.1 0.5 4.4 1.0 22.2 0.4 0.1 1.7 12.9 17.4 15.3 14.0 11.1 17.2 18.5 20.1 19.7 15.5 16.1 20.8 121.4 12.8 175.9 91.1 11.6 17.0 39.6 32.0 13.6 9.7 28.7 42.8 27.6 87.2 58.3 23.9 66.7 33.0 15.2 317.0 60.7 69.4 67.6 87.4 72.0 61.4 38.3 0.4 2.2 68.9 7.3 73.4 81.1 152.2 6.3 139.4 36.0 36.0 65.8 6.7 31.1 54.5 67.1 54.1 35.6 49.4 134.8 46.2 35.6 148.0 8.6 15.4 0.0 121.2 96.9 97.0 217.8 43.6 5.2 26.9 69.0 114.6 104.8 153.7 401.0 18.1 313.1 10.9 4.2 22.8 13.1 21.1 11.8 40.0 80.0 97.6 ERAP2 "L-RAP, LRAP" ENSG00000164308 "Endoplasmic reticulum aminopeptidase 2" Q6P179 5 96875986-96919703 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 176.1;GAMG: 105.0;hTEC/SVTERT24-B: 83.2;MOLT-4: 98.8;TIME: 188.7" "Low region specificity" "Detected in all" "CAB025618, HPA034498, HPA064360" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 11000000 "Cluster 15: NK-cells - Transcription" "Cluster 3: T-cells - Adaptive immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "CAB025618: , HPA034498: AB_2674191, HPA064360: " "unprognostic (4.62e-2)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (8.71e-2)" "unprognostic (2.60e-2)" "unprognostic (1.17e-2)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.01e-1)" "unprognostic (9.54e-3)" "unprognostic (6.59e-2)" "unprognostic (8.48e-2)" "unprognostic (4.65e-2)" "unprognostic (3.05e-1)" 7.8 7.1 3.0 31.5 3.0 7.5 11.9 2.3 4.3 12.2 3.0 16.2 32.6 8.4 17.5 10.5 7.0 11.0 7.5 2.9 2.5 11.3 14.5 18.1 46.4 4.3 3.3 8.5 2.9 3.7 3.6 11.0 3.5 10.3 6.2 2.3 6.6 7.0 8.9 10.1 21.5 3.4 2.7 36.7 19.0 1.7 3.8 49.9 5.6 9.9 29.7 14.7 6.8 3.5 2.1 2.4 1.7 0.9 1.9 3.8 0.6 8.1 13.8 7.3 12.3 7.9 176.1 12.2 35.1 11.5 105.0 2.9 0.9 65.4 5.8 4.3 7.9 0.6 3.0 8.5 2.7 43.2 19.2 25.3 12.8 83.2 0.6 1.2 4.9 27.4 0.2 25.8 20.8 1.4 98.8 22.5 0.2 0.0 3.7 45.7 16.2 29.3 55.2 15.4 3.5 0.2 1.1 0.9 16.5 0.4 6.5 1.7 188.7 3.9 1.1 10.0 24.6 26.2 23.2 4.2 50.8 5.8 0.9 23.0 12.1 15.4 24.8 27.5 31.3 28.5 34.6 30.6 19.8 17.7 37.4 28.9 4.2 45.4 28.5 6.9 34.6 27.6 3.0 3.0 2.3 4.3 2.9 2.5 4.3 3.3 3.5 2.7 3.8 3.5 46.7 32.1 20.0 11.8 62.6 5.7 11.2 24.4 12.0 1.5 3.1 5.8 4.4 8.6 15.9 44.1 0.0 11.5 35.6 48.1 0.0 5.3 0.3 7.0 10.6 34.1 1.8 15.8 2.5 25.5 17.0 23.4 17.3 7.4 7.0 33.4 31.4 16.3 12.3 0.0 2.1 23.3 8.2 29.4 14.2 0.7 10.5 33.0 7.2 21.5 19.4 6.5 20.6 7.1 4.9 22.1 27.6 7.9 56.0 4.3 52.4 6.2 15.7 2.8 0.0 12.2 12.2 0.9 0.8 10.0 3.0 6.7 54.2 9.3 34.2 10.5 EXT2 SOTV ENSG00000151348 "Exostosin glycosyltransferase 2" Q93063 11 44095673-44251962 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease variant, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078409 Supported "Golgi apparatus" NA NA 39000000 "Cluster 27: Non-specific - Gene expression" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA078409: AB_2686884" "unprognostic (5.87e-2)" "unprognostic (3.05e-3)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.77e-3)" "unprognostic (2.22e-2)" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.36e-6)" "unprognostic (7.07e-3)" "unprognostic (2.97e-1)" "unprognostic (3.85e-1)" "unprognostic (1.36e-2)" 33.5 22.8 14.4 22.1 15.4 11.2 29.3 15.4 16.3 36.1 17.5 29.1 26.5 43.1 33.3 20.1 33.7 28.1 27.3 15.6 18.1 26.5 26.9 27.9 16.0 15.5 16.0 33.5 26.5 28.9 20.1 61.9 15.5 29.8 28.7 20.9 26.7 30.2 16.2 25.8 31.0 49.3 14.7 21.6 23.8 21.6 19.4 15.2 27.6 18.4 17.3 29.7 28.5 16.1 57.9 71.6 38.3 121.5 170.4 124.2 60.8 181.1 198.0 93.1 125.1 51.2 36.5 40.4 82.1 188.8 98.5 90.0 41.0 114.0 110.0 83.2 71.5 38.4 33.7 39.7 67.5 37.5 76.6 97.7 73.4 56.3 86.6 108.8 132.7 34.8 50.0 63.9 68.4 40.3 25.9 22.3 43.8 67.1 70.9 32.3 116.1 21.1 53.9 49.1 30.9 35.5 118.1 41.4 28.1 67.0 69.8 37.2 137.8 127.4 90.6 133.1 111.4 33.4 46.0 30.4 84.7 27.9 140.0 15.2 17.5 19.4 20.9 17.7 23.5 9.0 16.5 19.3 21.3 8.8 15.4 15.2 3.4 26.3 12.8 7.4 14.2 15.5 14.4 15.4 15.4 16.3 15.6 18.1 15.5 16.0 15.5 14.7 19.4 16.1 24.5 16.0 10.6 41.4 8.7 15.2 17.3 22.0 10.8 11.5 11.0 11.4 10.2 8.6 13.5 12.9 14.6 34.3 10.6 21.1 5.9 33.5 43.2 7.9 17.1 19.2 1.8 6.7 64.3 23.7 37.0 32.3 7.7 11.5 6.3 22.7 22.9 18.3 18.3 13.5 63.3 12.9 12.2 10.8 7.2 23.0 27.4 10.4 5.4 28.1 10.2 17.4 7.2 50.3 51.8 24.0 14.9 28.6 7.0 23.6 31.6 8.2 8.1 15.0 19.7 15.8 20.7 51.2 24.4 10.2 12.6 35.3 9.2 12.2 15.0 15.3 F5 ENSG00000198734 "Coagulation factor V" P12259 1 169511951-169586588 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "choroid plexus: 142.8;liver: 176.2;placenta: 46.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5" "Cancer enriched" "Detected in many" 7 "liver cancer: 69.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2" "Group enriched" "Detected in many" 13 "granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2" "Group enriched" "Detected in some" 23 "Hep G2: 32.8;OE19: 125.5" "Group enriched" "Detected in many" 5 "basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4" "Group enriched" "Detected in all" 7 "amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6" HPA002036 Approved "Golgi apparatus" "Secreted to blood" NA NA 7670000000 13000000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA002036: AB_1078787" "unprognostic (3.67e-2)" "unprognostic (2.77e-4)" "unprognostic (5.42e-2)" "unprognostic (2.56e-4)" "unprognostic (2.03e-1)" "unprognostic (2.39e-4)" "unprognostic (3.46e-3)" "unprognostic (9.25e-3)" "unprognostic (2.02e-1)" "unprognostic (8.99e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.15e-2)" "unprognostic (3.41e-1)" "unprognostic (4.31e-1)" 1.1 0.0 0.3 3.2 1.4 3.7 0.6 4.4 1.3 0.1 142.8 0.3 0.9 0.1 0.2 0.2 3.5 17.6 2.7 4.4 1.6 1.5 176.2 0.9 2.2 1.9 2.2 0.0 0.8 0.0 1.6 46.9 2.4 1.3 0.6 1.0 6.2 0.0 0.2 1.3 0.3 1.1 0.8 1.8 4.9 0.5 2.2 0.5 0.4 0.2 2.3 3.8 0.1 4.2 0.0 0.6 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 32.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 125.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.1 8.1 0.0 0.2 0.0 0.0 1.4 0.2 0.4 0.0 0.3 0.0 7.0 0.0 0.0 0.0 6.2 1.1 0.3 1.4 4.4 1.3 4.4 1.6 1.9 2.2 2.4 0.8 2.2 4.2 0.0 3.2 0.6 1.6 0.7 0.1 6.1 0.0 0.0 0.3 0.7 0.3 9.4 74.4 1.9 0.0 2.1 82.7 0.1 0.3 0.0 2.4 2.4 0.9 0.0 2.4 25.2 0.0 5.4 0.2 2.3 5.3 4.1 0.2 0.0 2.8 3.6 253.4 5.3 0.0 2.6 0.1 0.0 12.3 0.4 0.3 0.0 7.1 3.6 0.0 18.2 1.0 2.1 0.5 1.0 1.9 0.0 0.0 0.1 1.8 0.0 0.2 3.1 0.1 0.0 2.4 0.2 0.5 0.5 0.0 0.0 59.5 2.5 0.0 0.0 11.8 FAM149A "DKFZP564J102, MST119, MSTP119" ENSG00000109794 "Family with sequence similarity 149 member A" A5PLN7 4 186104419-186172667 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Microglial cells: 41.2;Muller glia cells: 29.1;Rod photoreceptor cells: 35.5" "Cancer enhanced" "Detected in many" "renal cancer: 9.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 11.1;JURKAT: 8.3;MOLT-4: 8.5;RT4: 9.6;SCLC-21H: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044019, HPA055004" Uncertain Approved "Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA044019: AB_2732513, HPA055004: AB_2682667" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (4.64e-2)" "prognostic favorable (2.67e-6)" "unprognostic (7.08e-2)" "unprognostic (9.12e-2)" "unprognostic (1.41e-3)" "unprognostic (1.06e-1)" "unprognostic (2.52e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.81e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-1)" "unprognostic (2.36e-1)" 11.8 5.1 22.7 1.6 25.5 0.1 6.0 20.1 26.5 7.4 25.9 13.0 5.7 7.4 11.9 11.2 13.7 14.8 7.2 28.7 22.0 35.7 50.4 5.4 1.4 23.4 22.7 7.5 25.7 9.4 5.7 2.2 23.2 9.5 7.6 26.6 9.9 16.0 10.0 2.7 5.2 7.2 23.0 2.3 14.8 5.2 24.7 2.1 3.4 11.4 1.7 11.1 5.4 23.2 0.0 3.3 2.9 0.1 11.1 4.5 0.1 0.0 0.0 0.3 0.3 0.0 1.9 0.0 1.6 1.5 2.9 0.0 5.3 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.7 0.1 0.2 2.0 0.3 0.2 0.0 1.1 0.0 8.3 0.0 2.5 1.3 1.7 8.5 0.4 5.1 0.0 0.0 0.3 0.0 2.1 1.7 9.6 14.2 3.9 0.1 0.0 4.7 0.9 1.0 0.0 0.9 0.2 1.6 0.0 1.7 0.0 0.1 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.2 0.0 22.7 25.5 20.1 26.5 28.7 22.0 23.4 22.7 23.2 23.0 24.7 23.2 1.8 0.0 1.5 8.1 0.5 0.5 2.4 0.4 1.2 11.8 0.6 1.0 8.5 22.8 4.4 5.5 45.9 0.7 0.0 1.6 5.9 9.5 15.3 17.4 3.7 1.8 9.5 2.7 8.8 5.4 0.9 5.0 4.1 16.7 0.0 0.4 1.4 13.8 0.2 1.7 12.4 3.7 2.0 1.3 1.8 5.6 3.4 2.6 3.6 41.2 0.0 29.1 0.0 7.5 0.5 5.0 4.0 4.1 2.9 2.3 0.8 8.5 11.1 35.5 6.6 2.5 3.3 1.0 4.7 1.6 0.3 0.8 1.1 0.1 3.3 2.8 FAM228B ENSG00000219626 "Family with sequence similarity 228 member B" P0C875 2 24076526-24169640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 116.9;Late spermatids: 100.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052598, HPA063357" Uncertain Approved "Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus" "HPA052598: AB_2681880, HPA063357: AB_2684994" "unprognostic (2.48e-1)" "unprognostic (1.98e-1)" "unprognostic (1.15e-2)" "unprognostic (2.66e-1)" "unprognostic (3.81e-1)" "unprognostic (5.05e-2)" "unprognostic (1.85e-2)" "unprognostic (9.14e-2)" "unprognostic (3.32e-1)" "unprognostic (1.32e-1)" "unprognostic (3.39e-5)" "unprognostic (5.62e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (5.15e-1)" "unprognostic (6.93e-2)" 21.8 15.0 44.4 2.9 48.1 7.9 17.1 53.2 63.6 21.1 33.8 20.7 1.7 12.2 19.2 6.8 18.4 9.2 26.0 40.4 47.3 17.0 4.9 11.0 5.5 45.3 43.8 21.4 8.3 14.9 30.6 6.5 45.5 21.6 4.3 8.9 7.5 12.4 13.2 8.2 10.4 7.8 45.6 12.7 11.4 33.4 45.1 6.2 14.0 9.7 5.0 16.9 14.5 54.9 2.6 1.9 3.7 13.9 9.6 12.5 0.4 6.3 5.9 2.3 1.5 0.2 1.6 3.3 3.1 4.8 4.6 0.2 0.9 0.7 2.2 5.0 6.1 4.0 0.6 0.7 18.6 2.0 1.0 11.7 6.5 1.0 9.3 15.5 5.0 3.0 0.4 4.0 3.1 4.1 0.6 9.4 1.2 0.3 5.4 3.2 1.7 1.5 6.8 2.7 1.3 10.0 2.0 0.0 11.3 5.9 3.8 9.3 5.2 4.2 0.4 0.8 2.1 6.7 2.2 3.9 9.2 7.1 2.9 9.4 5.0 10.1 5.2 3.5 2.6 7.4 3.7 4.2 6.0 4.8 5.5 5.7 4.1 4.5 3.3 9.9 3.8 3.1 44.4 48.1 53.2 63.6 40.4 47.3 45.3 43.8 45.5 45.6 45.1 54.9 19.1 51.3 35.3 49.9 10.7 6.4 9.5 8.8 5.2 24.7 11.5 18.7 24.7 10.0 34.9 14.7 8.4 9.7 17.2 1.6 31.3 5.4 116.9 13.2 11.8 17.4 9.6 6.9 52.1 5.5 4.2 20.1 2.6 5.5 25.9 22.3 20.7 3.5 10.4 37.0 52.1 3.2 10.2 12.8 21.7 100.5 42.3 13.2 10.6 39.4 14.7 39.0 21.6 41.7 78.3 3.8 1.1 38.4 4.6 4.3 2.4 12.3 41.9 27.7 52.6 24.3 21.6 39.4 11.4 2.6 7.4 3.3 13.2 17.4 3.1 5.4 FAM241A "C4orf32, FLJ39370" ENSG00000174749 "Family with sequence similarity 241 member A" Q8N8J7 4 112145454-112195256 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 41.3;HUVEC TERT2: 28.0" "Low region specificity" "Detected in all" "HPA062443, HPA069294" Approved Enhanced "Golgi apparatus" No No "Cluster 17: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA062443: AB_2684765, HPA069294: AB_2686111" "unprognostic (3.07e-1)" "unprognostic (1.11e-2)" "unprognostic (2.42e-2)" "unprognostic (5.58e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (1.61e-2)" "unprognostic (3.16e-1)" "unprognostic (1.21e-1)" "unprognostic (5.05e-2)" "unprognostic (4.81e-2)" "unprognostic (5.25e-2)" "unprognostic (9.20e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (4.08e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-2)" 16.7 4.1 7.7 5.3 8.6 7.2 11.2 16.6 15.5 2.8 0.5 2.8 2.9 3.8 3.8 4.3 2.3 5.1 7.2 6.7 1.7 4.5 4.6 5.1 5.2 1.6 2.3 2.8 2.2 3.9 1.5 10.8 2.9 3.8 2.8 10.5 8.8 2.9 6.0 6.3 3.4 5.1 0.4 5.0 7.3 6.0 3.9 3.2 4.2 5.0 4.1 5.1 2.5 13.7 6.3 2.4 2.5 2.1 12.5 7.1 3.7 5.3 1.2 1.0 1.6 1.9 7.9 41.3 4.9 2.9 3.5 3.1 3.9 5.5 1.8 19.7 6.6 4.4 6.4 3.4 7.4 10.3 2.7 7.8 8.7 1.5 9.1 2.0 28.0 5.8 8.4 19.6 3.1 6.5 3.8 7.4 3.2 10.3 5.9 8.6 4.2 8.5 4.2 6.1 4.6 3.8 5.0 9.0 2.7 3.6 6.5 4.4 17.9 3.2 9.7 2.1 1.9 8.2 11.3 19.1 7.3 5.1 4.1 2.8 0.6 0.6 0.5 0.5 0.4 0.6 0.5 0.4 0.3 0.9 0.5 0.6 1.5 0.6 0.6 1.0 0.6 0.3 7.7 8.6 16.6 15.5 6.7 1.7 1.6 2.3 2.9 0.4 3.9 13.7 272.0 60.9 69.9 0.0 4.9 0.0 0.0 0.0 0.0 0.0 87.0 42.2 0.0 0.0 36.5 33.1 0.0 1.6 9.2 0.0 7.9 12.0 0.0 4.6 3.9 44.0 0.0 0.0 0.0 17.3 2.8 13.8 0.0 12.0 32.8 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 28.2 0.0 0.0 4.0 0.0 0.0 3.5 42.3 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 2.5 9.8 1.3 0.0 0.0 FAM3C "GS3876, ILEI" ENSG00000196937 "FAM3 metabolism regulating signaling molecule C" Q92520 7 121348878-121396364 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 415.8;Urothelial cells: 425.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "memory B-cell: 22.5;naive B-cell: 19.9" "Lineage enriched" "Detected in many" 7 "B-cells: 22.5" "Cell line enhanced" "Detected in all" "CAPAN-2: 1257.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043376, HPA050548" Enhanced Enhanced "Golgi apparatus" "Secreted in other tissues" NA NA 48000000 "Cluster 37: B-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus" "HPA043376: AB_2678452, HPA050548: AB_2681169" "unprognostic (9.44e-2)" "unprognostic (3.91e-1)" "unprognostic (1.75e-1)" "unprognostic (8.11e-3)" "unprognostic (1.26e-2)" "unprognostic (3.09e-3)" "unprognostic (3.38e-3)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (1.22e-2)" "unprognostic (2.15e-3)" "unprognostic (1.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.48e-1)" "unprognostic (9.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" 40.4 45.9 23.8 38.5 26.8 9.6 42.1 20.4 46.5 96.5 15.9 46.5 177.0 51.4 57.5 32.0 34.5 35.3 64.0 33.8 22.6 62.9 49.5 34.5 44.6 29.3 20.7 36.7 74.0 57.3 29.6 44.5 30.4 31.7 54.0 47.8 38.1 32.3 19.0 32.2 158.2 44.3 19.1 47.4 61.8 24.5 21.8 17.1 111.1 24.5 44.8 56.6 31.3 25.4 133.1 33.2 60.7 64.9 100.3 164.2 55.6 139.7 61.5 41.2 52.1 26.4 1257.1 125.4 65.4 72.5 116.7 85.2 35.1 77.7 87.3 15.3 72.5 35.6 19.3 27.4 73.5 59.0 65.3 165.7 52.1 58.9 57.1 110.4 74.8 24.6 23.3 152.3 326.6 22.3 24.6 45.2 108.1 45.4 45.3 34.2 63.8 51.1 256.7 75.1 38.6 38.1 41.4 167.4 80.6 126.2 24.0 32.5 178.8 105.1 37.7 236.1 96.9 148.0 71.3 48.7 114.0 60.6 192.5 0.0 1.1 0.8 2.1 1.2 2.0 22.5 0.9 1.7 1.0 19.9 1.3 0.9 0.2 3.0 0.9 1.5 0.7 0.8 23.8 26.8 20.4 46.5 33.8 22.6 29.3 20.7 30.4 19.1 21.8 25.4 49.8 9.6 33.3 17.3 103.0 71.8 257.1 183.0 61.5 137.3 47.5 28.8 65.7 71.4 134.4 55.2 22.9 88.1 44.8 66.8 60.7 182.2 3.5 76.0 81.8 58.9 52.3 10.3 64.6 191.0 188.6 104.3 46.4 170.1 19.7 33.3 50.0 37.0 43.6 45.4 64.3 49.1 101.7 29.6 88.4 6.7 96.0 30.9 99.6 24.4 31.7 49.4 58.7 42.3 24.7 415.8 71.9 95.9 129.8 325.0 327.0 66.8 63.9 67.1 72.3 93.6 68.7 23.8 22.4 61.7 66.3 120.4 44.3 35.6 86.7 425.8 FAM8A1 AHCP ENSG00000137414 "Family with sequence similarity 8 member A1" Q9UBU6 6 17600302-17611715 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 759.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044698, HPA073675" Approved Approved "Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA044698: AB_2679051, HPA073675: AB_2732236" "unprognostic (4.06e-1)" "unprognostic (2.32e-1)" "unprognostic (9.11e-2)" "unprognostic (6.90e-2)" "unprognostic (1.99e-2)" "unprognostic (5.17e-3)" "unprognostic (6.13e-2)" "unprognostic (1.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.09e-3)" "unprognostic (4.44e-2)" "unprognostic (3.50e-1)" "unprognostic (1.56e-2)" "unprognostic (3.85e-2)" "unprognostic (3.71e-1)" "unprognostic (7.59e-2)" "unprognostic (2.98e-1)" 18.6 16.1 16.3 10.7 17.3 31.6 19.1 19.0 19.5 20.4 16.6 19.9 16.9 27.3 18.9 13.9 20.6 21.1 14.8 17.4 20.3 24.0 77.9 18.9 10.4 18.2 17.2 27.8 15.0 22.3 13.0 14.9 18.2 20.9 22.8 27.1 23.0 22.3 18.9 14.0 16.7 24.8 20.2 14.3 12.7 17.2 21.1 17.1 23.2 21.7 8.2 14.5 12.6 20.6 9.5 3.7 13.5 32.3 45.6 42.6 11.1 15.0 20.4 7.6 13.1 21.4 3.1 8.1 35.2 25.6 8.3 7.6 20.5 13.0 9.9 6.9 29.1 9.8 12.5 46.2 20.1 6.2 9.6 22.6 20.7 8.7 6.0 24.2 17.0 8.9 20.2 16.2 12.0 11.7 4.6 19.2 5.6 11.6 5.6 12.1 13.0 25.0 25.6 7.5 4.1 21.4 11.7 25.0 23.7 23.1 29.0 9.5 13.3 9.7 3.4 14.9 5.5 13.4 12.0 8.0 8.8 7.1 13.4 2.6 0.3 1.0 1.1 0.4 1.2 0.0 0.5 1.0 0.2 0.1 0.7 1.1 5.5 1.5 0.2 0.2 0.4 0.3 16.3 17.3 19.0 19.5 17.4 20.3 18.2 17.2 18.2 20.2 21.1 20.6 16.8 19.2 27.1 8.8 7.0 13.4 9.7 6.6 14.2 27.6 15.1 13.5 15.3 21.5 12.1 29.5 14.6 10.0 15.7 63.4 5.9 9.2 759.2 26.4 24.0 14.1 12.0 4.2 17.1 7.9 12.0 23.0 10.7 20.6 1.3 8.6 25.4 77.5 6.2 15.2 17.9 10.8 8.2 24.4 6.4 187.8 36.7 8.6 5.4 3.7 8.7 19.3 14.4 8.0 13.8 7.5 25.7 30.9 12.8 7.5 30.4 12.4 20.5 16.7 32.9 20.3 18.7 46.6 18.0 14.3 15.9 12.2 14.0 9.7 16.7 7.8 FBXL8 Fbl8 ENSG00000135722 "F-box and leucine rich repeat protein 8" Q96CD0 16 67159932-67164570 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 43.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035587, HPA035588" Uncertain Approved "Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 6: T47d - Mammary gland" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA035587: AB_2674690, HPA035588: AB_10670023" "unprognostic (1.31e-1)" "unprognostic (1.95e-1)" "unprognostic (3.57e-2)" "prognostic favorable (5.39e-4)" "unprognostic (3.79e-1)" "unprognostic (3.27e-2)" "unprognostic (2.94e-2)" "unprognostic (9.14e-2)" "unprognostic (1.21e-1)" "unprognostic (4.67e-1)" "unprognostic (1.06e-2)" "unprognostic (2.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.68e-1)" "unprognostic (3.88e-2)" "unprognostic (1.47e-1)" "unprognostic (7.17e-3)" 12.2 24.0 3.1 5.4 4.2 3.4 18.4 5.3 5.7 17.7 1.7 16.6 9.8 17.0 2.5 15.6 20.3 2.3 10.9 3.7 1.7 14.6 16.7 14.6 4.3 5.2 3.2 16.2 53.5 4.9 24.9 5.7 4.3 35.5 6.4 2.2 35.8 2.6 11.2 30.1 12.2 2.5 2.2 13.5 22.6 4.3 3.9 2.0 20.9 1.2 2.7 12.7 14.9 8.6 5.9 7.2 1.1 9.7 5.2 9.2 25.0 4.9 4.0 4.0 4.0 6.8 16.0 4.6 7.4 4.6 4.0 19.9 2.9 4.8 1.1 11.9 11.7 4.7 17.2 7.5 3.7 2.7 18.1 6.9 5.2 4.2 3.4 11.6 2.6 12.6 9.3 10.1 2.8 16.8 3.9 10.4 0.6 5.4 17.6 12.7 3.3 22.4 6.1 8.1 10.2 9.5 12.4 6.4 3.3 2.9 31.7 6.2 6.3 10.0 11.5 23.4 4.4 43.4 10.4 6.0 11.0 8.7 6.1 5.1 4.7 4.9 3.8 2.2 3.4 1.6 10.7 5.0 2.4 1.7 2.3 2.4 6.4 5.8 2.0 4.3 4.0 3.1 3.1 4.2 5.3 5.7 3.7 1.7 5.2 3.2 4.3 2.2 3.9 8.6 3.4 0.0 3.1 0.0 2.8 3.2 4.4 3.4 17.1 1.7 5.0 4.3 0.9 7.2 5.1 5.5 8.4 2.8 6.0 7.6 1.9 6.9 0.1 3.3 3.4 3.2 6.7 0.4 0.2 8.0 3.1 4.6 18.8 3.7 0.0 4.7 1.8 4.4 2.8 5.0 0.1 10.4 2.0 1.9 2.9 0.5 9.3 2.9 10.6 0.0 7.7 1.9 8.2 0.0 1.1 9.3 5.2 5.7 4.6 5.4 10.6 6.2 4.1 4.7 6.6 2.4 4.2 0.1 1.0 7.2 4.4 1.5 4.2 8.4 9.0 5.6 FBXW4 "dactylin, Fbw4, SHFM3" ENSG00000107829 "F-box and WD repeat domain containing 4" P57775 10 101610664-101695295 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043496 Approved Approved "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA043496: AB_2678514" "unprognostic (4.31e-2)" "unprognostic (5.43e-3)" "unprognostic (8.40e-3)" "prognostic favorable (4.91e-4)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-1)" "unprognostic (9.96e-3)" "unprognostic (1.87e-1)" "unprognostic (3.96e-1)" "prognostic favorable (4.67e-4)" "unprognostic (1.13e-2)" "prognostic favorable (3.41e-5)" "unprognostic (2.94e-3)" "unprognostic (1.81e-1)" "unprognostic (4.99e-2)" "unprognostic (1.85e-2)" 38.4 30.4 89.9 10.4 96.6 16.0 34.8 83.5 96.3 33.2 71.3 59.9 16.5 26.7 29.6 38.7 28.9 12.9 62.4 80.9 81.1 36.4 34.9 35.8 18.0 92.3 92.1 30.2 44.2 47.0 46.7 16.4 87.8 49.1 16.5 14.2 41.4 26.8 80.0 49.7 31.5 14.7 94.8 30.1 40.8 22.8 94.2 18.1 40.2 44.4 17.9 49.0 32.9 98.0 22.1 25.7 4.0 28.9 20.1 16.5 18.9 11.3 31.1 12.8 10.0 12.0 22.9 25.1 17.5 23.4 13.1 13.4 11.0 16.7 4.3 26.8 15.2 6.0 9.1 26.1 35.7 10.0 7.6 15.2 52.0 6.9 42.8 29.8 11.0 17.6 6.2 15.3 14.2 45.9 11.4 14.2 11.3 11.4 12.3 9.4 29.6 10.7 25.1 14.7 12.3 21.6 21.8 8.1 20.7 6.0 33.6 17.8 11.8 13.8 1.8 5.8 11.5 31.9 15.4 11.1 11.3 12.7 8.1 1.3 1.4 2.2 4.3 0.8 2.6 3.8 4.3 4.2 1.1 4.8 4.5 3.7 0.2 4.2 1.4 4.1 1.4 1.2 89.9 96.6 83.5 96.3 80.9 81.1 92.3 92.1 87.8 94.8 94.2 98.0 13.6 3.2 36.9 45.4 14.0 11.2 16.4 11.9 6.8 28.5 25.7 21.8 35.8 12.8 11.1 11.0 18.8 17.0 24.4 29.1 3.9 15.2 50.2 15.3 16.3 10.0 20.4 7.0 57.5 26.1 9.2 11.3 17.3 27.2 5.1 32.3 8.9 24.7 8.8 37.0 55.7 27.8 14.2 8.6 7.4 28.9 14.3 8.7 14.2 55.3 10.7 29.9 15.5 54.8 70.3 19.4 24.4 17.0 14.1 22.2 21.1 13.3 7.5 22.7 13.1 15.4 14.7 4.9 6.0 11.3 12.5 15.6 16.9 10.9 21.7 18.7 FO681492.1 ENSG00000277758 Synaptotagmin-15 10 47749758-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.3;lung: 12.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 11.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 68.9" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 2.7 0.7 2.1 1.2 2.4 0.1 2.2 0.0 11.3 2.3 0.0 0.8 0.3 1.3 0.5 2.5 2.1 1.1 1.3 5.0 0.0 0.5 0.4 12.2 3.7 0.0 0.0 0.7 4.1 0.8 0.3 2.5 0.0 1.1 0.6 0.5 1.8 1.3 0.6 3.2 0.8 0.9 0.2 0.9 0.6 0.3 0.2 0.8 1.1 0.6 1.9 1.1 2.0 1.0 0.4 4.1 0.4 0.5 0.2 0.3 0.2 2.8 0.4 0.3 0.3 4.5 4.0 0.1 0.3 2.2 1.3 0.5 0.0 0.1 0.4 0.1 1.6 0.0 0.8 0.4 3.9 0.3 0.8 0.4 0.2 0.3 0.7 0.4 0.3 1.9 0.1 0.4 0.2 7.6 0.2 0.6 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.2 0.6 0.2 5.2 68.9 0.2 0.2 5.4 0.3 0.5 0.3 0.7 0.3 0.2 0.3 0.3 0.2 0.4 0.1 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 11.3 5.0 0.0 0.0 0.0 0.0 0.2 0.2 1.0 0.1 3.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FUT6 "FCT3A, FLJ40754, FT1A, FucT-VI" ENSG00000156413 "Fucosyltransferase 6" P51993 19 5830408-5839722 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 79.4;kidney: 36.1;salivary gland: 45.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 9.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "Hep G2: 10.5;RPMI-8226: 4.0" "HPA043707, HPA046966" Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 51000 "Cluster 10: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA043707: AB_2678628, HPA046966: AB_2679879" "unprognostic (3.65e-2)" "unprognostic (3.00e-3)" "unprognostic (2.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.02e-2)" "unprognostic (6.68e-3)" "unprognostic (4.01e-2)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (4.94e-2)" "prognostic favorable (3.17e-8)" "unprognostic (1.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" 0.1 0.0 0.1 2.6 0.1 0.4 1.7 0.2 0.1 17.3 0.4 17.3 28.6 0.3 0.0 79.4 0.6 9.3 0.0 0.1 0.1 36.1 12.4 0.2 0.1 0.1 0.1 0.0 3.7 0.0 0.0 0.0 0.1 0.2 11.6 2.0 45.7 2.5 0.0 0.1 27.0 0.4 0.1 0.1 4.8 0.2 0.1 0.0 0.0 0.0 6.7 0.0 26.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.2 10.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.7 4.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.5 0.0 0.7 0.0 0.4 3.5 0.0 0.4 3.7 1.9 0.3 18.6 15.7 1.8 0.0 0.2 0.3 35.6 3.9 6.8 0.3 0.6 0.7 0.3 4.9 0.0 0.1 0.4 0.1 0.3 0.0 0.7 0.0 0.2 0.7 5.1 0.1 0.0 0.1 39.4 8.2 0.0 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.9 0.0 0.5 0.1 2.7 21.5 0.0 0.0 0.2 101.4 45.3 6.4 11.5 0.0 0.3 0.7 1.0 0.6 3.6 0.1 0.0 0.5 0.1 29.0 1.7 FUT7 ENSG00000180549 "Fucosyltransferase 7" Q11130 9 137030174-137032088 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 3.9;brain: 2.5;lymphoid tissue: 6.1" "Group enriched" "Detected in some" 8 "dendritic cells: 66.9;Langerhans cells: 38.7;monocytes: 20.7;NK-cells: 28.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 210.0" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "NB-4: 23.7;THP-1: 24.0;U-937: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA042780 Approved "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 2: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA042780: AB_2678162" "unprognostic (1.33e-2)" "unprognostic (4.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (5.42e-2)" "unprognostic (5.01e-6)" "unprognostic (2.50e-1)" "unprognostic (2.35e-2)" "unprognostic (6.75e-4)" "unprognostic (4.68e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (6.69e-6)" "unprognostic (3.99e-2)" "unprognostic (4.14e-2)" "unprognostic (1.03e-1)" "unprognostic (8.75e-2)" 0.3 0.1 0.6 1.7 1.7 3.9 0.1 1.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.7 1.2 0.1 0.1 0.9 4.6 1.9 1.2 0.0 0.0 0.0 0.2 0.1 1.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.1 0.7 6.1 0.3 0.2 1.2 1.0 0.2 0.4 3.2 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 23.7 0.0 0.2 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 2.0 7.5 1.5 10.4 1.6 52.5 20.1 52.1 28.9 21.7 5.5 0.9 4.3 91.6 127.1 0.2 210.0 90.2 15.4 0.6 1.7 1.0 1.3 0.7 1.2 1.9 1.2 1.1 0.7 1.2 2.5 0.1 0.0 0.0 0.0 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.2 0.0 3.7 38.7 0.0 0.0 2.7 0.0 0.0 20.7 0.0 28.8 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.7 0.0 GALNT2 GalNAc-T2 ENSG00000143641 "Polypeptide N-acetylgalactosaminyltransferase 2" Q10471 1 230057990-230282122 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 133.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 429.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011222 Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 13000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA011222: AB_1849446" "unprognostic (1.26e-1)" "prognostic unfavorable (1.22e-6)" "unprognostic (1.15e-2)" "unprognostic (1.35e-2)" "unprognostic (8.70e-3)" "unprognostic (7.77e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.48e-8)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (1.70e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.79e-13)" "unprognostic (3.79e-3)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" 32.9 49.6 17.0 34.8 19.9 13.9 21.9 15.2 16.7 24.7 22.0 28.9 19.5 27.1 6.9 21.0 22.4 21.2 27.4 15.8 18.6 18.5 100.1 27.1 14.0 23.0 19.5 39.2 68.1 9.9 13.6 27.6 18.3 21.4 12.4 19.8 22.1 14.3 67.4 14.7 23.6 25.0 15.3 17.4 33.1 19.7 25.1 42.8 19.0 27.4 11.2 33.4 19.5 15.5 79.5 103.7 59.9 71.4 112.4 95.3 122.8 146.3 90.0 58.4 55.6 45.2 146.5 20.0 106.2 77.7 135.9 150.7 39.9 123.0 48.6 200.1 52.0 60.7 217.2 50.9 60.9 23.4 114.8 136.9 59.8 78.0 30.9 127.3 69.2 110.1 77.0 29.6 65.6 21.8 122.3 23.9 82.1 52.8 97.7 134.3 85.5 61.7 57.4 92.9 18.9 70.1 148.4 7.9 91.0 31.7 46.5 43.5 165.3 56.7 107.9 129.5 118.0 97.9 60.3 44.4 146.1 46.3 429.7 1.5 10.7 3.6 4.4 9.3 3.2 3.4 2.6 4.5 7.8 5.8 2.5 5.0 3.2 2.8 10.2 13.2 3.3 7.7 17.0 19.9 15.2 16.7 15.8 18.6 23.0 19.5 18.3 15.3 25.1 15.5 18.6 16.0 21.3 71.5 32.1 15.3 20.0 52.8 20.5 30.8 13.8 10.7 13.6 18.6 30.1 23.9 33.3 7.3 21.7 24.1 5.9 49.7 47.2 18.7 15.4 17.9 16.8 27.6 67.3 133.0 123.4 36.1 21.4 24.5 13.3 20.5 19.6 98.8 24.9 28.6 82.0 18.9 4.1 42.4 9.7 24.6 35.8 28.9 24.9 106.8 44.0 10.9 18.6 72.9 44.6 88.5 21.6 29.3 109.0 23.5 17.9 19.2 23.5 73.5 13.1 33.1 25.4 3.4 14.0 16.6 8.0 16.6 21.2 32.8 17.6 29.9 GALNT3 "GalNAc-T3, HFTC, HHS" ENSG00000115339 "Polypeptide N-acetylgalactosaminyltransferase 3" Q14435 2 165747588-165794659 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 77.3" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 152.8;Pancreatic endocrine cells: 188.1;Prostatic glandular cells: 155.7;Urothelial cells: 274.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 50.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.4;HaCaT: 108.3;HBEC3-KT: 69.2;hTCEpi: 88.2;OE19: 201.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA007613 Enhanced Supported "Golgi apparatus" NA NA 440000 "Cluster 46: Basophils - DNA binding" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA007613: AB_1078941" "unprognostic (1.95e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.16e-3)" "unprognostic (2.78e-1)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (4.13e-2)" "unprognostic (4.47e-2)" "unprognostic (2.74e-1)" "unprognostic (6.44e-2)" "unprognostic (3.62e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.57e-1)" 1.5 1.7 1.7 8.4 2.1 54.0 26.0 2.7 1.8 29.3 4.3 48.9 43.5 5.2 9.3 27.4 38.8 32.2 0.6 1.8 3.4 10.9 2.4 14.0 3.7 4.5 5.2 6.8 26.2 6.9 9.8 6.4 3.3 25.2 53.2 3.7 55.3 8.2 0.3 15.3 39.5 2.5 7.0 20.1 77.3 25.8 1.9 3.3 25.4 0.4 12.3 17.3 12.6 5.4 61.5 0.0 0.6 0.2 0.1 2.6 43.0 18.3 7.7 6.6 16.0 32.0 85.4 0.4 0.1 0.0 0.1 108.3 0.0 69.2 13.5 1.3 13.0 0.0 14.9 0.3 0.3 14.5 0.4 0.5 88.2 0.0 30.3 2.1 0.1 2.9 0.0 55.0 5.0 42.7 0.5 5.6 0.1 201.1 7.8 0.2 0.0 1.7 17.8 42.0 6.5 0.1 0.3 49.6 16.8 1.9 21.7 0.9 0.5 0.1 1.0 0.1 0.3 34.4 16.3 1.3 0.2 14.0 0.6 50.5 6.8 32.2 10.2 9.0 7.5 6.6 3.1 5.8 11.4 6.0 1.0 3.4 25.2 10.6 13.8 17.3 5.6 6.2 1.7 2.1 2.7 1.8 1.8 3.4 4.5 5.2 3.3 7.0 1.9 5.4 1.0 12.8 34.4 7.8 13.6 38.0 107.9 36.5 29.6 0.6 45.0 26.8 0.4 35.8 45.9 66.2 0.0 8.5 37.7 68.6 3.9 70.2 127.5 91.8 5.2 2.9 23.4 1.3 10.5 113.2 22.5 2.3 102.4 70.5 45.7 0.7 1.1 0.6 8.2 0.0 5.1 152.8 28.5 1.9 12.4 14.1 2.5 8.3 16.0 1.0 7.5 16.1 15.5 27.6 1.4 188.1 46.5 0.4 29.7 155.7 32.6 3.1 89.3 1.0 6.6 0.6 4.3 71.5 1.1 42.4 41.3 11.2 14.4 1.2 61.8 274.4 GALNT4 GalNAc-T4 ENSG00000257594 "Polypeptide N-acetylgalactosaminyltransferase 4" Q8N4A0 12 89519412-89524796 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 31.6" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 11.2;Glandular and luminal cells: 3.4;Paneth cells: 3.4;Respiratory ciliated cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 22.2" HPA076116 Approved "Golgi apparatus" NA NA 520000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus" "HPA076116: AB_2686778" "unprognostic (2.96e-2)" "unprognostic (7.65e-3)" "unprognostic (8.76e-2)" "unprognostic (3.94e-5)" "unprognostic (3.50e-1)" "unprognostic (4.87e-2)" "unprognostic (2.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.24e-1)" "unprognostic (5.81e-6)" "unprognostic (2.34e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-2)" "unprognostic (2.52e-1)" 3.1 2.2 1.2 6.1 1.7 7.7 4.0 1.3 1.7 16.1 1.1 18.6 17.3 13.5 2.6 3.3 11.9 11.8 1.9 1.3 1.7 5.6 4.8 3.7 3.4 1.9 1.4 2.8 5.0 1.9 1.2 3.0 1.8 3.8 17.3 3.9 16.1 2.2 0.3 1.9 18.4 3.1 1.7 5.9 31.6 0.8 1.5 1.2 3.2 1.7 3.5 4.9 1.5 1.7 3.2 9.4 3.3 18.2 6.3 9.1 2.3 7.6 3.6 3.1 3.3 3.5 5.8 0.0 1.9 5.7 1.3 4.8 0.9 4.9 5.2 8.4 2.1 3.9 1.6 3.2 3.3 3.8 8.3 4.1 2.2 6.3 2.7 7.1 9.9 0.7 2.5 1.7 4.8 2.6 0.3 7.2 2.2 7.1 22.2 1.0 0.6 1.6 9.2 9.6 0.2 1.7 1.0 5.0 7.0 3.1 10.0 3.7 9.1 6.2 2.2 3.9 2.7 1.7 2.9 1.6 3.2 2.0 3.8 3.9 3.3 1.6 2.0 4.9 3.5 1.3 1.1 1.5 2.2 1.9 1.5 1.3 3.2 4.9 5.3 0.8 1.3 2.0 1.2 1.7 1.3 1.7 1.3 1.7 1.9 1.4 1.8 1.7 1.5 1.7 0.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 1.2 0.3 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.0 0.6 0.1 0.0 1.3 0.0 0.2 0.0 0.7 11.2 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.4 0.0 2.9 0.9 0.0 0.1 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.1 0.1 0.1 GBF1 "ARF1GEF, KIAA0248" ENSG00000107862 "Golgi brefeldin A resistant guanine nucleotide exchange factor 1" Q92538 10 102245371-102382899 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 28.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037759, HPA037760" Uncertain Supported "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA037759: AB_10671884, HPA037760: AB_2675651" "unprognostic (5.97e-2)" "unprognostic (3.33e-1)" "unprognostic (2.74e-3)" "unprognostic (7.02e-2)" "unprognostic (2.03e-1)" "unprognostic (6.72e-2)" "unprognostic (3.78e-2)" "unprognostic (8.28e-2)" "unprognostic (1.12e-2)" "unprognostic (5.34e-3)" "unprognostic (2.04e-2)" "unprognostic (6.06e-2)" "unprognostic (1.87e-1)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (3.02e-1)" "unprognostic (3.09e-2)" 19.4 21.1 31.5 16.0 31.7 25.0 19.3 28.7 47.2 21.7 34.9 24.6 20.6 23.5 12.7 21.9 19.7 9.8 30.0 32.2 27.7 21.7 23.2 20.5 14.6 28.5 37.3 21.6 25.6 24.4 31.5 11.5 30.6 24.2 13.9 19.2 24.5 15.2 48.1 24.9 25.8 16.4 27.1 21.7 21.2 20.5 29.8 11.8 25.4 30.1 13.8 21.7 20.5 29.1 19.4 49.7 23.3 25.1 62.9 40.7 28.1 37.7 56.0 45.3 48.1 52.7 35.1 21.7 29.7 59.6 33.8 38.6 45.9 52.8 33.8 35.4 36.9 33.3 38.1 44.6 26.4 35.2 46.8 37.3 28.0 60.7 57.5 77.2 45.2 22.5 20.7 53.7 41.8 36.9 24.2 38.9 15.4 29.5 35.6 33.6 72.1 18.8 39.3 30.9 15.0 16.3 30.2 22.3 26.5 33.1 50.4 30.8 60.5 29.1 29.6 37.7 55.6 32.4 36.3 26.5 30.0 36.3 22.1 28.6 4.5 4.3 4.9 5.0 5.9 6.5 3.6 6.5 5.0 3.9 5.7 5.3 4.6 4.6 4.1 4.2 7.4 3.9 31.5 31.7 28.7 47.2 32.2 27.7 28.5 37.3 30.6 27.1 29.8 29.1 12.5 12.8 10.1 56.5 15.5 9.8 5.5 10.6 17.6 24.7 15.7 12.8 17.0 15.7 10.9 12.9 56.3 12.2 15.1 31.4 3.9 12.5 4.9 14.3 18.1 12.3 12.0 13.9 72.1 16.7 16.3 14.6 31.1 15.6 7.6 10.3 8.2 17.6 12.2 52.2 73.0 21.9 12.2 11.0 5.0 4.7 10.2 13.4 12.4 66.5 9.5 11.1 9.2 80.9 71.1 18.6 20.7 11.3 46.0 7.7 27.1 9.0 12.3 41.0 6.6 21.7 12.3 36.0 25.4 20.7 13.1 17.6 16.0 19.1 19.4 6.7 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814008 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "kidney: 50.0;liver: 169.6" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 74.6" "Cancer enriched" "Detected in many" 4 "liver cancer: 10.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.0;MCF7: 1.4;SK-BR-3: 1.2;U-87 MG: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071228 Uncertain "Golgi apparatus" NA NA "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA071228: AB_2686368" "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 2.5 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.2 0.0 0.8 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 50.0 169.6 0.0 0.1 0.3 0.1 0.0 1.4 6.3 0.2 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.0 1.5 0.6 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.9 0.0 0.6 0.0 0.5 0.0 0.3 0.6 0.0 0.3 3.7 2.1 0.0 0.0 0.1 3.9 0.2 0.1 0.4 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.4 74.6 0.1 0.0 0.5 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.6 0.4 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.0 0.2 0.0 0.1 0.0 GCNT2 "bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3" ENSG00000111846 "Glucosaminyl (N-acetyl) transferase 2 (I blood group)" Q8N0V5 6 10492223-10629368 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 13.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4" "Region enriched" "Detected in all" 4 "basal ganglia: 61.1" "Low region specificity" "Detected in all" HPA026776 Approved Approved "Golgi apparatus" No No 750000 "Cluster 41: Basophils - Cellular respiration" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA026776: AB_1849573" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (3.12e-1)" "unprognostic (1.42e-2)" "unprognostic (9.31e-2)" "unprognostic (2.51e-1)" "unprognostic (4.11e-2)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (6.28e-4)" "unprognostic (3.96e-2)" "unprognostic (1.58e-3)" "unprognostic (6.54e-2)" "unprognostic (6.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" 0.6 0.3 0.7 1.0 0.6 0.3 10.1 2.5 1.1 4.2 4.5 3.6 5.2 1.4 0.2 1.4 0.8 1.5 6.6 0.8 1.1 5.7 5.1 3.9 1.8 1.2 1.0 0.3 1.3 0.4 1.4 2.6 1.4 13.5 2.0 0.3 4.2 0.3 0.7 1.4 5.8 1.6 0.9 1.5 5.9 2.5 0.9 0.5 1.2 1.8 2.4 1.0 0.7 1.0 6.3 4.9 1.5 4.8 0.0 0.0 9.6 0.0 4.1 1.1 0.5 11.0 5.2 3.5 44.2 0.0 3.2 0.3 0.4 5.1 2.9 3.1 1.8 0.5 2.6 19.7 0.0 1.7 4.7 0.0 0.0 0.5 0.0 2.4 9.1 0.0 0.4 0.0 0.4 0.0 0.0 4.0 4.4 0.0 3.6 0.2 3.8 6.0 16.0 2.9 4.0 1.2 0.0 14.4 17.1 21.4 0.3 0.8 6.4 0.8 0.5 0.0 5.0 0.1 0.0 2.4 0.8 0.3 2.3 1.9 1.1 0.5 0.1 0.8 0.0 0.7 0.1 0.1 0.8 0.4 0.1 0.2 0.1 0.2 0.2 0.2 0.0 0.3 0.7 0.6 2.5 1.1 0.8 1.1 1.2 1.0 1.4 0.9 0.9 1.0 1.4 76.9 32.4 1.0 9.5 4.6 6.6 15.5 9.6 5.1 30.5 16.1 18.4 2.8 28.6 7.3 0.0 27.9 6.4 15.5 11.7 2.9 4.3 79.1 5.5 11.0 2.4 25.9 0.7 24.7 2.1 2.0 16.8 105.5 2.5 0.0 12.8 32.0 15.8 3.3 11.8 5.6 6.1 7.7 9.4 8.2 0.3 7.8 49.8 52.5 11.1 2.4 0.0 18.6 1.1 12.0 11.9 0.0 1.0 16.6 44.3 13.4 27.9 0.6 0.0 0.7 2.2 6.2 27.6 11.2 1.7 10.9 3.1 0.0 16.3 8.1 GDF15 "MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB" ENSG00000130513 "Growth differentiation factor 15" Q99988 19 18374731-18389176 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 371.8;urinary bladder: 175.4" "Cell type enhanced" "Detected in many" "Club cells: 1160.8;Syncytiotrophoblasts: 4304.7;Urothelial cells: 3294.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.7" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;monocytes: 1.2" "Cell line enhanced" "Detected in many" "BEWO: 416.5;Hep G2: 225.5;HHSteC: 564.9;TIME: 213.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011191, CAB062554, HPA070957" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1260000 960000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168" "unprognostic (1.04e-1)" "unprognostic (1.89e-2)" "unprognostic (3.45e-2)" "unprognostic (3.36e-2)" "unprognostic (2.04e-2)" "unprognostic (2.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.30e-2)" "unprognostic (2.80e-1)" "unprognostic (2.89e-1)" "unprognostic (5.09e-2)" "unprognostic (1.46e-1)" "unprognostic (6.55e-3)" "unprognostic (3.81e-2)" "unprognostic (8.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.04e-3)" 34.8 11.7 1.3 1.5 1.4 0.4 24.9 1.0 2.3 18.9 40.9 29.2 4.5 13.6 2.2 4.8 5.5 19.9 4.5 4.3 1.3 371.8 88.6 46.9 0.6 2.0 1.7 4.7 112.3 25.9 12.3 86.9 1.5 105.3 24.4 1.2 12.5 4.6 5.5 6.4 12.3 1.9 1.2 11.4 75.5 1.6 2.5 0.3 11.2 0.5 1.7 175.4 19.2 1.6 1.8 95.6 9.4 3.5 22.3 18.5 416.5 33.1 17.9 1.2 18.8 4.2 29.6 0.4 58.8 3.0 97.0 0.7 0.0 12.2 4.7 0.2 2.2 0.9 9.2 225.5 564.9 0.1 35.7 48.8 140.1 90.7 58.6 0.7 99.5 0.0 152.4 0.7 22.9 23.5 0.1 0.8 5.4 34.4 52.5 0.2 3.7 0.2 69.9 94.6 0.9 1.0 0.4 5.5 127.9 35.1 2.6 0.4 213.1 0.0 7.4 1.8 1.5 1.5 4.0 0.4 51.9 0.1 27.8 0.0 0.7 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 1.2 0.0 0.0 0.1 1.3 1.4 1.0 2.3 4.3 1.3 2.0 1.7 1.5 1.2 2.5 1.6 6.6 35.3 62.4 0.0 1.8 1.3 350.6 366.1 0.0 0.1 54.2 15.5 0.7 47.1 1160.8 259.3 0.0 60.6 0.4 176.0 33.2 316.9 0.0 166.8 35.4 31.9 84.8 0.0 0.1 381.9 263.4 52.9 224.8 261.8 29.2 0.2 2.5 7.0 33.8 0.0 0.1 357.6 453.7 1.6 3.7 0.0 0.9 14.1 3.6 0.0 9.9 0.5 1.0 0.0 0.0 440.4 146.6 1.5 1.3 780.2 22.9 85.7 681.4 0.6 0.0 9.5 46.7 0.7 0.5 1.3 1.7 4304.7 5.5 3.4 291.0 3294.2 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525941 "Enzymes, Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 116.6;retina: 83.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 60.9;Cone photoreceptor cells: 148.0;Early spermatids: 52.1;Late spermatids: 178.0;Rod photoreceptor cells: 88.4;Syncytiotrophoblasts: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.7" "Group enriched" "Detected in many" 6 "granulocytes: 7.7;T-cells: 2.0" "Cell line enhanced" "Detected in many" "EFO-21: 32.8;fHDF/TERT166: 32.4;HDLM-2: 66.9;U-2 OS: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" No No "Cluster 38: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 31.0 8.7 19.5 4.8 22.1 12.8 24.6 17.4 12.9 12.4 6.0 7.3 2.7 17.9 1.8 3.3 10.3 4.3 9.5 10.5 14.5 7.8 8.1 15.2 6.7 14.2 27.0 7.3 38.1 0.8 19.1 14.0 10.2 11.5 1.6 83.5 21.3 5.3 13.1 7.4 10.0 6.5 7.4 116.6 4.8 38.9 42.1 3.1 7.7 8.7 4.7 12.6 9.9 12.4 2.1 7.5 3.2 3.7 2.2 1.1 11.1 2.3 3.1 1.1 0.7 10.0 4.4 14.2 32.8 32.4 8.1 4.7 4.0 3.8 0.6 66.9 3.1 2.6 11.7 21.2 3.2 1.6 10.7 2.4 2.0 0.8 1.6 3.2 26.7 12.7 4.7 6.3 1.5 4.5 3.9 7.1 5.7 3.7 10.6 4.5 0.9 3.9 0.9 3.6 1.7 1.2 4.8 18.3 9.3 4.1 2.7 6.3 7.9 7.5 30.4 5.8 2.6 1.6 0.3 2.8 1.7 8.5 0.8 7.7 0.8 0.5 1.2 0.3 1.7 0.6 1.3 0.9 0.2 0.2 0.7 0.9 0.1 0.0 0.0 0.7 2.0 0.5 19.5 22.1 17.4 12.9 10.5 14.5 14.2 27.0 10.2 7.4 42.1 12.4 4.2 6.4 0.0 1.6 5.4 1.0 0.3 0.7 0.6 60.9 3.6 3.4 3.0 1.5 1.3 0.0 148.0 3.2 9.1 0.5 0.0 4.2 52.1 1.0 10.4 7.0 0.0 8.2 5.0 9.3 1.5 6.6 1.1 1.5 4.5 1.6 20.7 2.4 1.9 5.0 15.8 0.7 0.0 2.8 3.7 178.0 5.9 3.1 5.4 8.4 4.9 8.9 1.0 1.0 0.8 4.7 0.3 2.6 5.0 0.8 0.3 0.1 0.8 88.4 0.0 4.6 1.9 12.9 8.2 0.1 1.1 46.0 7.0 0.9 2.0 0.6 GGA2 "KIAA1080, VEAR" ENSG00000103365 "Golgi associated, gamma adaptin ear containing, ARF binding protein 2" Q9UJY4 16 23463542-23521995 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 153.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 159.9;U-698: 170.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034422, HPA043313, HPA063634" Approved Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "CAB034422: AB_2110748, HPA043313: AB_2678421, HPA063634: AB_2685067" "unprognostic (1.27e-1)" "prognostic favorable (1.71e-5)" "unprognostic (8.53e-2)" "unprognostic (2.22e-2)" "unprognostic (4.91e-2)" "prognostic favorable (9.70e-5)" "unprognostic (1.68e-1)" "prognostic favorable (1.68e-4)" "unprognostic (7.82e-3)" "unprognostic (3.88e-2)" "unprognostic (2.15e-3)" "unprognostic (8.55e-2)" "prognostic favorable (3.91e-5)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (3.89e-2)" "unprognostic (2.08e-1)" 15.1 36.3 13.0 32.0 13.1 37.6 19.9 18.6 14.8 20.7 25.2 16.5 10.0 16.1 19.6 17.9 18.4 13.4 18.5 13.8 15.3 26.9 16.4 34.1 72.9 11.7 12.9 34.0 54.3 29.2 26.0 17.6 11.9 27.4 15.8 79.3 37.6 21.3 25.5 21.1 33.6 14.9 10.8 44.2 25.7 12.4 17.8 37.2 36.2 19.0 87.3 16.3 18.7 12.3 18.8 22.9 29.6 26.1 16.5 17.9 25.3 19.7 20.0 15.2 19.3 32.1 18.9 159.9 31.4 21.1 4.3 28.7 49.1 25.8 19.4 25.1 45.6 28.8 29.5 51.2 16.2 48.0 18.2 18.7 22.7 20.8 9.7 22.1 22.0 12.8 50.3 23.0 19.8 29.8 17.0 31.9 39.6 18.3 20.2 108.3 38.4 41.2 24.8 25.6 21.1 25.3 18.3 27.0 27.1 31.5 23.7 59.7 24.5 18.1 19.6 20.3 18.5 42.0 41.8 170.8 16.5 32.2 20.6 0.2 4.2 7.0 3.1 4.3 3.2 16.2 3.9 3.7 4.9 21.6 4.0 4.0 0.5 3.1 4.0 15.9 4.5 3.1 13.0 13.1 18.6 14.8 13.8 15.3 11.7 12.9 11.9 10.8 17.8 12.3 11.7 48.1 41.4 28.7 102.3 34.2 33.6 16.5 39.3 73.2 25.0 26.0 27.3 21.5 17.6 22.0 114.7 23.0 80.6 7.3 25.4 19.3 22.0 25.4 17.6 19.0 17.6 9.9 44.2 18.9 40.7 17.3 15.3 37.3 9.5 88.5 12.5 16.1 69.1 6.7 61.5 12.6 12.2 26.1 19.7 30.8 24.5 37.7 26.6 36.5 87.9 23.8 23.7 26.2 8.3 16.2 6.1 26.4 36.1 20.7 8.7 21.5 16.2 153.3 19.7 16.0 16.3 30.5 60.5 25.4 14.6 22.7 34.8 56.8 11.9 18.6 GGA3 KIAA0154 ENSG00000125447 "Golgi associated, gamma adaptin ear containing, ARF binding protein 3" Q9NZ52 17 75236599-75262363 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022945, HPA024645" Approved Supported "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA022945: AB_1849639, HPA024645: AB_2671629" "unprognostic (9.16e-2)" "unprognostic (8.89e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.26e-4)" "unprognostic (1.20e-1)" "unprognostic (4.60e-3)" "prognostic unfavorable (2.77e-6)" "unprognostic (6.33e-2)" "unprognostic (1.42e-1)" "unprognostic (9.30e-2)" "unprognostic (4.63e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (3.41e-4)" "unprognostic (1.27e-1)" "unprognostic (2.99e-3)" "unprognostic (1.28e-2)" "unprognostic (9.68e-3)" 11.7 9.8 9.0 13.0 8.4 15.7 10.8 7.7 11.4 12.3 4.3 12.4 11.5 10.8 9.8 17.0 10.2 11.4 12.8 8.4 6.7 11.1 11.6 13.0 17.5 8.9 7.6 15.3 12.3 9.1 9.0 14.6 7.6 10.1 11.7 6.7 12.3 7.8 22.7 15.7 15.0 11.8 6.8 19.6 13.0 11.5 7.8 12.8 9.9 10.5 19.0 11.6 12.2 9.4 16.9 21.1 19.5 11.9 21.5 17.9 22.8 18.5 13.3 24.9 21.2 24.8 18.4 21.4 8.2 16.4 19.9 10.6 13.8 8.0 25.7 15.1 21.4 34.3 19.2 19.6 10.3 32.5 24.3 14.1 19.7 13.6 23.5 13.2 26.5 16.1 37.8 19.1 17.7 17.4 42.5 9.6 13.8 19.6 14.9 16.9 28.0 14.3 17.1 18.4 14.0 23.9 18.5 33.2 14.9 27.3 25.3 17.4 29.6 25.7 18.7 17.4 19.9 19.8 15.1 27.5 20.8 23.0 17.2 5.1 6.8 2.9 5.5 5.9 5.1 3.9 4.9 4.2 6.4 4.7 4.3 4.6 7.3 8.4 5.8 6.6 5.4 6.0 9.0 8.4 7.7 11.4 8.4 6.7 8.9 7.6 7.6 6.8 7.8 9.4 9.5 35.3 21.0 13.4 15.5 2.5 4.9 5.2 8.0 8.1 8.8 7.6 12.6 4.3 9.6 0.0 10.4 10.3 21.2 14.3 5.9 5.2 27.6 10.5 13.6 10.2 0.0 4.6 20.6 7.0 11.0 7.7 21.9 14.7 10.1 12.4 9.7 10.4 12.5 6.7 20.2 10.0 6.1 19.2 7.1 30.1 9.3 19.4 12.4 16.9 20.3 5.9 10.3 18.1 21.2 11.6 9.1 10.1 11.0 8.2 9.5 3.5 10.2 8.9 0.0 7.7 6.1 8.1 6.9 7.8 5.3 13.0 12.2 7.0 12.8 8.5 GLG1 "CFR-1, ESL-1, MG-160" ENSG00000090863 "Golgi glycoprotein 1" Q92896 16 74447427-74607144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010815 Supported Supported "Golgi apparatus" NA NA 2100000 "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA010815: AB_2232486" "unprognostic (3.70e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (7.42e-2)" "unprognostic (3.30e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-3)" "unprognostic (5.13e-3)" "unprognostic (9.45e-3)" "unprognostic (8.46e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (8.85e-2)" "prognostic favorable (1.56e-7)" "unprognostic (3.54e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.97e-4)" 42.7 36.8 25.0 17.4 26.3 9.0 40.3 24.0 25.7 53.3 17.3 44.5 17.3 57.8 22.4 30.9 46.7 20.4 50.5 24.7 27.5 42.6 25.6 38.2 16.3 27.0 29.0 69.0 58.1 34.3 38.9 24.9 25.2 37.5 18.7 20.3 36.1 24.9 53.8 35.2 36.4 29.9 25.0 35.1 36.3 40.6 29.5 20.0 43.1 16.4 18.9 42.3 40.8 30.0 38.4 52.2 44.7 43.3 113.7 113.2 42.8 45.0 64.2 48.6 68.3 34.4 116.0 22.8 59.8 102.9 35.8 71.1 30.1 62.1 80.1 10.3 26.1 17.9 37.8 54.3 70.5 29.3 12.6 68.0 32.8 63.6 66.3 91.3 100.8 54.8 19.0 24.9 44.2 70.0 14.1 26.0 34.7 81.2 20.6 33.9 32.6 59.5 31.6 17.1 15.8 23.3 87.3 24.9 25.0 47.7 28.2 36.5 79.1 46.1 40.9 48.2 30.3 47.4 51.2 41.1 86.3 22.5 46.6 3.2 16.7 13.3 19.1 15.7 19.2 11.6 23.8 20.9 18.5 10.1 28.2 22.6 7.3 15.4 19.9 18.4 21.0 19.0 25.0 26.3 24.0 25.7 24.7 27.5 27.0 29.0 25.2 25.0 29.5 30.0 52.8 64.1 50.7 114.3 46.4 27.1 27.2 33.0 55.8 68.5 35.6 35.6 79.5 77.2 39.7 51.5 146.0 78.0 75.6 33.5 7.9 39.9 39.7 49.2 79.3 62.0 38.6 25.0 133.4 42.5 43.6 101.4 38.7 58.0 3.8 91.0 75.3 40.7 50.1 70.7 155.3 31.9 24.4 68.8 42.1 28.1 96.9 44.4 42.7 62.8 64.8 59.6 111.2 97.5 137.3 40.8 28.8 114.3 100.2 33.6 47.8 44.2 44.3 57.9 92.1 84.6 59.9 89.2 87.9 30.5 21.6 75.2 72.4 72.4 32.9 26.4 GNPTAB "GNPTA, KIAA1208, MGC4170" ENSG00000111670 "N-acetylglucosamine-1-phosphate transferase subunits alpha and beta" Q3T906 12 101745499-101830959 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cancer-related genes, Disease variant, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 192.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014558, HPA042343" Approved Supported "Golgi apparatus" NA NA 160000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA014558: AB_2732409, HPA042343: " "unprognostic (6.72e-2)" "unprognostic (1.66e-1)" "unprognostic (8.71e-3)" "prognostic favorable (8.48e-4)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (2.73e-1)" "unprognostic (8.57e-2)" "unprognostic (3.73e-2)" "unprognostic (1.09e-2)" "unprognostic (2.28e-2)" "unprognostic (2.00e-1)" "unprognostic (6.86e-2)" "unprognostic (3.44e-1)" "unprognostic (1.02e-1)" "unprognostic (5.44e-2)" "unprognostic (4.98e-2)" 11.9 7.9 18.8 16.2 22.2 23.9 16.4 14.4 20.0 17.4 2.7 29.6 14.2 11.8 6.2 15.6 8.8 14.8 21.5 22.7 10.8 14.5 9.4 27.0 20.6 8.5 11.1 7.2 11.3 23.0 8.4 14.8 9.7 20.1 30.3 13.0 54.3 13.0 16.4 25.1 16.2 15.9 8.9 19.0 21.3 10.4 12.4 34.1 13.9 25.9 17.8 19.3 12.0 13.3 18.2 17.5 6.4 10.9 52.3 24.8 19.6 25.4 52.3 24.7 32.2 13.5 12.4 38.1 17.9 35.1 20.1 23.2 29.8 32.8 38.4 18.1 15.6 16.3 15.4 19.3 9.7 15.0 31.7 19.3 17.7 23.5 13.8 61.4 44.0 30.0 25.9 11.0 23.4 27.8 45.6 21.0 22.0 22.6 12.5 10.6 32.6 51.2 39.5 46.8 13.6 11.2 42.3 29.7 60.7 23.5 30.6 9.8 43.6 23.1 12.5 19.6 14.4 30.0 32.9 21.5 26.4 21.8 14.6 8.6 3.8 4.4 18.8 3.6 6.2 3.0 4.0 10.3 7.1 4.9 5.1 7.9 1.4 17.0 4.6 6.9 3.3 3.7 18.8 22.2 14.4 20.0 22.7 10.8 8.5 11.1 9.7 8.9 12.4 13.3 25.3 60.9 65.0 35.9 42.1 16.8 32.9 16.2 17.1 23.6 25.2 18.9 43.5 18.6 27.8 22.0 25.0 25.7 107.3 68.3 7.9 10.3 0.6 25.3 23.7 21.1 18.0 19.5 84.5 15.1 15.0 18.9 33.1 61.6 122.8 24.6 10.4 9.7 46.7 8.4 83.8 29.6 24.4 46.7 17.6 3.8 17.1 41.2 42.7 30.0 43.5 26.9 192.6 135.2 19.8 15.7 129.3 12.8 63.9 28.1 17.7 13.8 10.0 37.0 0.0 18.6 14.9 12.4 33.0 26.7 14.3 8.8 63.4 30.6 49.7 46.5 GOLGA1 "golgin-97, MGC33154" ENSG00000136935 "Golgin A1" Q92805 9 124878275-124948492 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013065, HPA044329, HPA050555" Supported Enhanced "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174" "unprognostic (5.44e-2)" "unprognostic (9.35e-2)" "unprognostic (6.92e-2)" "prognostic favorable (2.21e-4)" "unprognostic (9.34e-2)" "unprognostic (4.43e-1)" "unprognostic (4.40e-2)" "unprognostic (6.03e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-3)" "unprognostic (3.06e-1)" "unprognostic (6.28e-3)" "unprognostic (4.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.24e-3)" "unprognostic (2.52e-2)" 8.7 9.4 5.4 8.7 7.0 5.9 7.8 5.8 6.3 8.0 7.1 10.8 10.1 8.8 5.9 9.9 7.7 7.6 10.2 5.1 5.9 6.8 9.5 7.5 7.6 6.1 6.4 8.0 10.8 9.1 8.0 5.6 6.9 8.3 9.3 37.7 8.4 8.3 13.2 10.8 9.6 8.6 6.1 8.5 8.7 15.2 6.8 5.3 8.2 9.6 7.4 10.4 8.1 9.0 8.4 14.7 8.6 9.1 14.7 13.0 11.0 13.5 14.3 14.0 10.2 9.7 9.6 5.6 6.5 15.0 10.8 21.2 7.1 11.4 10.2 8.0 7.0 5.9 20.5 12.9 16.9 7.1 13.7 8.8 8.1 13.5 16.3 9.9 12.7 7.0 9.8 9.4 10.0 17.5 5.1 8.0 3.2 19.7 13.5 3.2 12.7 12.3 7.0 11.3 5.0 9.5 16.2 13.0 8.5 7.6 25.1 5.0 14.8 13.0 7.2 16.8 12.6 11.4 19.6 6.5 16.3 7.4 13.8 8.1 3.4 4.3 4.2 3.5 3.4 3.0 2.6 4.5 3.3 3.5 2.7 2.5 7.6 3.2 2.8 4.6 2.7 1.3 5.4 7.0 5.8 6.3 5.1 5.9 6.1 6.4 6.9 6.1 6.8 9.0 11.8 6.4 14.4 32.3 8.1 2.0 4.2 5.8 6.2 16.3 10.2 10.2 21.0 7.2 10.8 5.5 64.6 6.8 11.5 11.7 3.9 9.5 16.2 10.4 13.6 10.0 5.4 5.0 31.7 8.9 4.9 7.8 10.7 8.8 15.8 14.6 10.8 14.8 6.6 18.5 31.4 9.7 12.2 7.3 4.2 9.8 5.9 9.3 8.8 20.6 10.1 15.2 9.2 27.2 34.3 9.0 2.7 9.1 11.1 4.5 7.8 6.1 17.8 38.0 6.6 15.4 12.3 50.1 21.4 11.0 4.3 8.6 9.1 10.9 8.8 4.0 GOLGA2 "GM130, golgin-95" ENSG00000167110 "Golgin A2" Q08379 9 128255829-128275995 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015421, HPA021178, HPA021230, HPA021799" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB015421: AB_831377, HPA021178: AB_1849837, HPA021230: AB_1849839, HPA021799: AB_1849841" "unprognostic (2.88e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (3.70e-2)" "unprognostic (4.34e-2)" "unprognostic (1.84e-1)" "unprognostic (3.20e-1)" "unprognostic (2.83e-1)" "unprognostic (1.58e-1)" "unprognostic (3.50e-1)" "unprognostic (4.07e-1)" "unprognostic (2.21e-2)" "prognostic favorable (9.77e-5)" "unprognostic (3.92e-2)" "unprognostic (6.44e-2)" "unprognostic (4.84e-2)" "unprognostic (4.27e-2)" 51.8 44.2 31.5 31.3 31.8 33.4 49.6 30.4 31.5 73.5 44.1 48.2 28.9 57.0 59.7 75.0 49.9 42.2 63.9 30.9 36.2 42.3 50.3 47.3 24.5 34.0 36.3 57.4 65.3 77.4 122.4 56.9 36.7 54.4 44.5 31.4 65.1 54.9 57.2 73.4 38.0 58.1 28.7 33.4 51.7 35.8 33.0 23.3 53.3 51.1 32.1 48.6 66.3 31.8 49.1 48.1 52.8 54.9 130.4 148.3 46.3 93.6 129.2 79.4 71.1 60.7 44.7 23.1 34.4 154.3 84.4 94.4 30.3 47.4 74.2 34.1 28.9 25.5 114.0 48.3 85.2 38.2 71.4 95.4 74.0 79.1 81.9 124.9 64.3 55.1 83.8 58.6 77.6 99.8 33.0 33.9 16.2 92.0 86.2 32.9 58.1 40.0 63.4 42.5 29.3 34.9 62.5 52.1 43.2 53.3 117.0 32.2 86.3 102.9 51.8 66.9 50.8 40.7 51.1 29.7 89.8 20.0 65.6 32.4 6.6 12.2 6.2 5.3 3.8 6.0 4.1 3.4 2.7 7.3 4.4 6.1 30.2 7.4 8.2 13.2 3.6 2.9 31.5 31.8 30.4 31.5 30.9 36.2 34.0 36.3 36.7 28.7 33.0 31.8 33.9 44.8 66.8 20.9 27.0 31.7 27.7 45.1 41.5 68.0 53.8 34.8 88.1 45.8 57.8 42.3 41.7 37.9 32.6 69.6 43.0 47.6 41.5 62.9 82.2 35.5 46.1 18.7 15.1 60.8 35.6 67.1 59.7 94.3 65.9 33.6 44.6 72.3 28.3 25.2 20.4 90.9 40.7 24.9 23.1 7.7 68.3 34.2 24.9 10.3 19.5 33.4 28.8 15.6 15.5 57.7 45.1 64.7 55.6 43.7 42.6 35.4 73.2 51.7 13.1 59.6 43.3 99.5 51.1 71.4 45.5 102.3 28.1 29.5 42.6 44.2 GOLGA5 "golgin-84, GOLIM5, ret-II, rfg5" ENSG00000066455 "Golgin A5" Q8TBA6 14 92794305-92839947 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000992, HPA063876" Enhanced Supported Supported "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA000992: AB_1079009, HPA063876: AB_2685140" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (2.77e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-1)" "unprognostic (1.78e-1)" "unprognostic (5.02e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (7.67e-2)" "unprognostic (6.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.06e-2)" "unprognostic (2.49e-2)" 26.0 23.3 21.4 18.2 23.7 10.4 33.1 22.4 26.4 32.2 23.9 26.4 23.3 21.9 54.2 25.0 19.2 24.0 21.5 20.8 22.3 25.5 54.3 22.4 18.8 22.6 22.4 20.6 32.2 33.6 23.5 28.2 23.1 31.2 32.5 15.8 32.4 25.8 26.9 23.3 22.9 26.0 22.6 19.1 32.9 34.3 22.1 16.9 33.2 20.0 23.3 24.1 19.6 25.9 32.4 29.4 25.9 23.7 53.1 71.4 44.3 43.9 80.4 41.9 49.2 21.8 43.4 21.0 35.1 70.2 29.2 33.4 23.1 35.9 56.6 25.8 11.2 19.9 14.0 29.3 61.5 23.3 31.8 55.1 63.7 29.5 60.6 46.2 42.0 21.8 17.7 27.3 46.5 60.1 18.1 19.6 16.1 70.2 31.0 13.9 37.9 21.1 42.8 38.9 18.4 26.0 40.0 29.6 45.7 35.7 51.0 25.6 35.0 23.9 15.6 31.3 22.2 33.3 27.6 18.2 54.9 18.2 40.8 10.4 10.0 23.6 10.3 13.0 11.8 9.5 10.4 10.6 9.9 9.5 9.2 8.1 8.8 8.7 11.9 9.1 12.9 6.7 21.4 23.7 22.4 26.4 20.8 22.3 22.6 22.4 23.1 22.6 22.1 25.9 18.7 28.9 26.3 8.8 15.7 7.8 11.2 17.9 16.5 7.5 16.2 11.9 26.8 8.6 19.6 14.7 12.5 23.7 17.2 23.8 29.4 25.3 31.6 17.6 24.6 16.7 22.3 15.8 17.6 32.7 32.0 21.7 33.1 25.7 9.5 29.7 13.9 33.5 15.4 25.2 15.6 31.6 4.1 14.7 10.3 18.5 23.0 14.6 12.4 15.0 18.2 15.6 16.5 14.6 21.9 28.9 12.0 25.2 29.2 19.4 19.9 24.2 18.7 10.7 26.3 18.0 19.3 34.1 37.0 16.5 11.4 50.3 15.9 15.6 16.5 16.5 GOLGB1 "GCP, GCP372, giantin, GOLIM1" ENSG00000173230 "Golgin B1" Q14789 3 121663199-121749767 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011008, HPA011555" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA011008: AB_1079011, HPA011555: AB_1079010" "unprognostic (2.56e-2)" "unprognostic (7.69e-2)" "unprognostic (1.46e-1)" "unprognostic (6.57e-2)" "unprognostic (5.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (6.58e-2)" "unprognostic (7.49e-2)" "unprognostic (3.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-1)" "unprognostic (9.90e-3)" "unprognostic (9.05e-2)" 19.9 25.2 11.0 7.1 12.7 14.1 24.1 15.0 12.9 21.9 26.5 18.8 12.2 17.4 32.1 15.1 15.8 13.3 18.5 13.2 10.5 18.6 17.9 15.3 8.4 8.5 9.9 21.9 27.1 20.7 25.0 13.4 9.0 25.8 17.1 31.0 25.2 19.9 14.2 20.2 19.0 10.0 9.6 16.6 19.7 14.6 9.3 11.3 21.0 11.1 9.8 16.3 15.7 11.5 19.9 15.7 15.3 9.9 28.8 31.0 9.6 12.6 27.5 11.9 13.4 13.8 7.1 4.3 10.4 23.6 11.9 9.0 9.2 13.7 14.1 6.3 17.5 12.2 20.1 19.2 17.2 13.7 16.0 25.4 31.9 7.5 18.7 25.8 15.3 7.3 5.8 9.6 12.7 14.3 4.1 9.9 9.9 19.1 16.4 5.4 12.0 10.3 17.7 20.2 10.8 12.0 15.5 11.0 16.7 17.3 13.6 15.2 21.5 11.4 6.9 4.9 9.2 17.8 11.4 7.2 15.3 6.6 4.3 1.6 4.1 4.3 4.3 2.2 3.5 3.4 3.5 3.3 2.6 2.8 3.3 3.6 15.4 3.9 1.7 5.5 3.9 1.6 11.0 12.7 15.0 12.9 13.2 10.5 8.5 9.9 9.0 9.6 9.3 11.5 118.9 291.7 233.9 101.2 97.3 51.6 89.1 62.1 96.8 101.4 110.2 130.3 274.8 74.4 179.2 53.3 123.0 78.7 134.7 148.6 11.7 104.3 56.0 247.9 186.4 102.7 91.9 36.8 72.9 111.0 53.0 135.5 144.8 284.0 115.6 220.7 74.3 68.9 34.5 69.0 80.2 176.8 65.1 47.2 48.3 23.8 198.5 82.1 33.8 68.4 76.8 82.1 54.6 50.3 72.8 100.2 95.7 199.0 176.0 74.9 79.9 29.3 165.7 193.6 85.5 165.9 120.5 155.0 66.8 70.2 45.7 150.8 102.6 197.7 101.7 88.3 GOLIM4 "GIMPC, GOLPH4, GPP130, P138" ENSG00000173905 "Golgi integral membrane protein 4" O00461 3 168008689-168095924 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 370.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001677, HPA002315" Enhanced Enhanced "Golgi apparatus" NA NA 1000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA001677: AB_1079017, HPA002315: AB_1079018" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (6.27e-2)" "unprognostic (2.11e-1)" "unprognostic (4.76e-2)" "unprognostic (2.44e-1)" "unprognostic (5.17e-2)" "unprognostic (1.39e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.84e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (9.62e-3)" 24.8 12.6 25.4 21.4 23.0 9.0 12.9 24.7 32.1 16.8 13.9 53.4 65.8 21.9 8.9 15.7 15.7 28.5 54.6 27.7 34.8 31.3 59.2 29.1 11.3 39.5 29.5 19.9 11.9 12.8 9.6 22.4 40.1 15.2 51.1 53.0 17.3 13.6 32.4 9.3 85.2 26.6 35.1 23.0 24.3 9.0 27.5 6.5 19.0 30.7 9.5 16.8 10.7 33.6 23.7 34.5 47.8 30.4 79.7 58.6 14.5 135.8 72.4 36.3 33.2 38.7 28.4 51.6 159.1 82.4 58.4 42.5 44.4 39.9 54.9 81.3 57.0 83.8 100.2 48.1 32.1 80.5 45.8 61.5 20.9 33.4 32.8 32.2 42.1 0.0 43.7 146.2 41.9 39.2 0.1 21.8 46.9 44.2 36.6 0.1 48.1 72.2 20.6 8.5 42.9 55.5 83.5 25.1 28.4 31.7 30.9 36.1 79.0 114.9 44.2 81.3 110.1 56.4 43.4 109.4 57.1 47.4 52.4 3.2 2.5 10.8 0.6 2.8 0.2 1.2 0.1 0.5 3.3 2.0 0.0 0.2 0.0 5.5 2.3 4.0 0.0 0.7 25.4 23.0 24.7 32.1 27.7 34.8 39.5 29.5 40.1 35.1 27.5 33.6 74.9 48.1 124.8 141.0 11.1 41.4 24.4 18.3 41.5 16.2 21.3 20.6 157.3 67.2 23.3 36.8 37.5 11.4 33.5 184.5 17.6 21.8 1.7 20.6 51.5 70.9 63.3 33.9 18.1 29.6 17.2 119.2 34.1 30.9 58.3 23.3 45.3 178.8 39.1 16.8 84.2 136.5 12.2 50.7 57.5 3.3 39.7 42.2 37.4 38.4 22.0 370.3 14.4 145.8 44.7 23.6 181.2 51.1 28.9 26.0 195.2 31.6 9.2 62.8 46.0 108.2 82.5 5.5 37.6 20.1 35.9 5.5 16.5 20.4 167.6 8.4 GOLM1 "bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73" ENSG00000135052 "Golgi membrane protein 1" Q8NBJ4 9 86026146-86100173 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 396.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 362.8;Early spermatids: 339.0;Gastric mucus-secreting cells: 245.6;Ionocytes: 325.5;Late spermatids: 391.6;Pancreatic endocrine cells: 282.9;Paneth cells: 265.2;Undifferentiated cells: 245.6" "Cancer enhanced" "Detected in all" "prostate cancer: 343.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 1.9;classical monocyte: 3.6;gdT-cell: 3.5;intermediate monocyte: 2.6;neutrophil: 4.2;non-classical monocyte: 4.2;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 372.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010638, HPA011929, CAB015341" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 81000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" "unprognostic (1.10e-1)" "prognostic favorable (8.14e-5)" "unprognostic (1.97e-1)" "unprognostic (4.40e-3)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.89e-3)" "unprognostic (2.81e-1)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "unprognostic (1.34e-2)" "unprognostic (5.59e-3)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (2.87e-3)" "unprognostic (1.23e-1)" 22.2 159.8 72.5 33.8 78.8 6.6 39.5 69.2 84.5 70.0 99.0 195.7 235.1 40.1 15.7 13.6 38.1 131.0 12.7 72.1 93.8 74.7 19.0 14.7 9.7 73.4 76.1 36.9 41.6 37.6 36.4 17.2 69.9 143.2 163.9 25.5 173.4 10.5 9.4 14.9 61.3 28.4 80.1 41.7 396.2 17.4 108.0 45.4 68.1 4.8 5.6 38.3 14.9 79.2 146.0 139.5 102.4 116.7 129.3 74.3 108.0 64.8 46.6 99.9 80.5 69.4 282.9 2.7 62.6 126.2 96.6 109.4 63.7 64.1 71.9 5.0 101.2 45.3 89.1 3.4 76.8 67.3 34.9 113.4 34.2 94.1 34.0 124.9 172.9 21.2 28.7 4.2 57.3 68.4 8.3 49.6 161.9 188.9 99.6 42.9 116.9 21.8 166.0 61.2 115.1 72.0 88.2 189.0 73.8 66.1 106.7 68.1 110.5 25.9 72.6 79.3 78.3 372.3 37.4 0.9 112.2 29.8 57.8 1.9 3.6 0.4 3.5 2.6 0.4 0.6 0.2 0.5 0.4 0.6 0.4 0.7 4.2 0.7 4.2 1.5 0.1 1.8 72.5 78.8 69.2 84.5 72.1 93.8 73.4 76.1 69.9 80.1 108.0 79.2 13.8 9.6 15.3 30.3 1.7 2.3 10.8 11.3 4.6 20.1 41.4 21.1 4.9 80.1 80.9 35.0 8.4 8.4 10.7 362.8 25.4 168.4 339.0 78.0 49.8 20.5 73.1 11.2 47.0 222.2 35.0 30.4 245.6 56.8 1.3 65.9 8.6 11.1 11.8 67.3 43.2 95.5 325.5 5.0 2.6 391.6 18.3 6.6 23.2 6.5 6.9 16.9 12.3 82.0 19.3 282.9 265.2 13.2 3.2 72.6 71.8 16.0 78.6 6.7 0.0 13.5 19.5 10.3 38.7 2.9 1.0 6.4 5.2 60.7 245.6 29.1 GOLM2 "CASC4, DKFZp459F1927, H63" ENSG00000166734 "Golgi membrane protein 2" Q6P4E1 15 44288719-44415758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 19.9;Cardiomyocytes: 24.0;Cytotrophoblasts: 16.3;dendritic cells: 16.1;Extravillous trophoblasts: 19.4;Fibroblasts: 18.2;Hofbauer cells: 27.3;Syncytiotrophoblasts: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043015, HPA049488" Enhanced Enhanced "Golgi apparatus" NA NA 1200000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA043015: AB_2678271, HPA049488: AB_2680790" "unprognostic (2.64e-2)" "unprognostic (2.63e-1)" "unprognostic (3.38e-1)" "unprognostic (1.81e-2)" "unprognostic (8.08e-2)" "unprognostic (1.35e-1)" "unprognostic (1.20e-2)" "unprognostic (2.20e-1)" "unprognostic (2.40e-1)" "unprognostic (1.68e-2)" "unprognostic (4.99e-2)" "unprognostic (2.60e-2)" "prognostic favorable (1.45e-5)" "unprognostic (2.15e-1)" "unprognostic (3.56e-2)" "unprognostic (9.65e-2)" "unprognostic (1.12e-1)" 39.5 84.5 48.5 32.4 47.0 16.5 43.2 43.1 59.2 57.9 62.4 45.7 28.8 50.4 53.5 23.7 53.8 50.5 33.1 42.8 52.6 54.0 60.9 40.9 30.8 49.6 51.5 55.3 37.4 82.0 38.7 34.4 46.9 67.5 43.8 33.7 47.8 56.1 22.3 13.2 29.8 44.4 46.7 35.4 49.4 34.6 52.9 28.9 84.6 26.3 29.5 39.2 24.3 52.7 45.0 38.7 51.9 92.6 141.4 121.8 32.0 78.6 125.2 44.9 57.1 19.3 80.0 13.5 106.4 119.3 47.8 53.8 34.4 25.5 48.2 64.6 19.5 21.4 41.8 35.9 65.1 42.5 68.1 72.1 28.3 49.8 38.4 126.8 53.4 34.2 33.0 103.4 56.2 23.2 36.7 33.2 14.8 60.8 27.5 30.5 29.3 43.3 58.8 54.4 23.3 53.2 60.7 57.0 26.6 28.1 64.1 49.2 76.4 78.1 39.8 112.5 69.5 79.0 145.1 27.9 92.6 58.5 51.7 20.9 14.7 20.8 15.2 9.8 16.3 11.9 12.4 15.2 12.0 10.7 9.5 9.9 37.8 10.5 18.2 10.6 13.2 13.6 48.5 47.0 43.1 59.2 42.8 52.6 49.6 51.5 46.9 46.7 52.9 52.7 19.9 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 16.3 16.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 19.4 18.2 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 12.7 2.9 0.0 0.0 0.0 GOPC "CAL, dJ94G16.2, FIG, GOPC1, PIST" ENSG00000047932 "Golgi associated PDZ and coiled-coil motif containing" Q9HD26 6 117560269-117602542 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019477, HPA024018" Approved Enhanced "Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA019477: AB_1849890, HPA024018: AB_1849891" "unprognostic (2.48e-2)" "unprognostic (1.63e-3)" "unprognostic (1.71e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (3.12e-2)" "unprognostic (9.21e-2)" "unprognostic (6.22e-2)" "unprognostic (6.77e-2)" "unprognostic (8.23e-2)" "unprognostic (9.46e-2)" "unprognostic (1.40e-2)" "unprognostic (2.67e-2)" "unprognostic (1.38e-1)" "unprognostic (9.55e-2)" "unprognostic (3.01e-2)" 15.5 14.2 14.6 15.8 14.9 7.1 20.2 15.6 18.0 23.4 11.0 18.7 12.2 23.5 18.0 12.1 17.4 16.3 22.1 15.9 13.3 14.5 16.4 13.6 19.9 12.5 12.5 25.6 12.7 22.1 16.1 19.9 13.1 16.2 20.3 13.5 14.3 17.3 15.8 18.7 15.0 18.4 13.6 16.9 14.9 17.7 12.6 21.0 23.9 17.4 17.2 15.1 14.7 16.8 14.1 15.0 19.1 25.6 40.1 47.9 30.3 57.1 41.7 30.6 31.5 23.1 15.5 42.2 24.3 32.4 60.4 31.2 37.2 27.6 42.8 21.2 20.8 38.7 39.9 37.5 42.4 52.2 24.8 57.4 74.9 22.8 65.7 60.6 26.5 29.0 36.7 16.8 62.2 12.9 21.8 40.3 16.5 24.0 16.0 33.0 37.0 30.8 23.3 12.9 26.7 21.0 57.6 19.7 15.8 36.3 14.3 49.7 31.8 2.2 27.9 28.5 62.6 29.9 28.8 35.4 37.9 43.4 23.9 10.5 4.2 3.2 6.7 3.9 9.3 7.9 7.1 7.1 5.5 7.7 8.2 8.5 2.9 9.2 4.7 9.2 7.7 4.1 14.6 14.9 15.6 18.0 15.9 13.3 12.5 12.5 13.1 13.6 12.6 16.8 43.2 22.4 22.7 46.4 33.4 46.7 25.1 63.9 46.7 59.2 47.0 67.3 46.2 34.3 32.2 20.2 22.9 77.0 28.6 40.4 27.4 27.9 35.1 30.4 77.4 38.1 33.6 26.5 52.9 25.6 62.4 48.3 30.1 30.6 31.1 50.4 35.0 38.7 38.5 74.0 46.2 65.2 24.4 24.2 22.9 13.7 42.3 27.0 28.4 32.8 24.1 39.3 35.0 73.9 64.5 21.1 40.9 42.2 38.7 40.3 20.9 27.1 35.3 35.9 32.9 50.0 44.3 115.6 51.4 36.7 59.8 52.3 38.7 43.3 37.7 27.3 GORASP1 "FLJ23443, GOLPH5, GRASP65, P65" ENSG00000114745 "Golgi reassembly stacking protein 1" Q9BQQ3 3 39096599-39107863 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 98.9;Late spermatids: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056283 Supported Supported "Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA056283: AB_2683085" "unprognostic (1.06e-1)" "unprognostic (8.31e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.92e-6)" "unprognostic (2.77e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.13e-2)" "unprognostic (8.79e-3)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.73e-3)" "prognostic favorable (1.91e-6)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.44e-1)" "unprognostic (3.24e-3)" 16.9 13.5 35.4 12.8 36.4 11.5 18.6 38.7 35.7 25.2 30.3 23.6 13.6 18.8 16.6 20.0 22.2 15.6 21.3 34.1 35.9 26.9 26.3 19.6 13.4 41.7 36.9 13.3 24.5 22.5 15.4 21.0 38.0 22.1 26.0 20.6 26.2 30.7 16.3 16.4 18.5 24.0 42.0 21.5 19.1 10.5 38.8 11.8 18.4 19.0 17.4 17.9 14.8 46.6 15.6 19.0 18.0 17.8 42.8 28.1 16.6 27.1 31.1 27.5 24.6 11.3 18.4 16.8 15.7 41.4 17.2 24.7 20.7 32.2 19.3 22.4 14.3 23.8 18.7 16.0 19.3 20.0 25.8 22.0 43.8 28.5 28.0 30.6 38.2 6.0 19.8 20.3 26.3 22.6 5.6 18.9 13.1 35.7 23.1 6.0 10.7 23.8 27.4 28.1 7.1 14.0 25.7 51.4 16.1 24.4 33.2 20.7 29.0 15.4 14.3 37.0 15.0 14.1 14.8 4.1 18.3 16.7 23.0 6.5 12.0 7.0 3.3 12.7 4.5 11.7 4.1 3.1 12.8 9.3 4.7 3.4 6.9 2.8 17.2 7.2 6.7 8.0 35.4 36.4 38.7 35.7 34.1 35.9 41.7 36.9 38.0 42.0 38.8 46.6 21.1 3.2 9.8 23.2 8.7 4.1 10.6 6.5 8.0 8.5 12.9 9.7 8.7 12.8 7.2 12.9 0.0 14.0 3.4 21.4 11.7 10.7 98.9 15.5 11.4 13.4 11.4 5.5 7.7 8.7 11.1 8.9 24.5 16.3 1.3 8.8 8.9 11.4 9.5 8.4 9.2 15.3 8.2 7.2 9.8 56.1 7.2 9.5 12.4 9.4 7.0 7.3 0.0 9.0 9.6 11.0 8.0 6.4 5.7 11.4 14.2 6.0 10.7 11.1 0.0 8.8 10.0 10.1 6.8 8.0 5.8 19.8 4.4 6.5 15.1 12.6 GORASP2 "GOLPH6, GRASP55, GRS2" ENSG00000115806 "Golgi reassembly stacking protein 2" Q9H8Y8 2 170928464-170967130 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 380.7;Syncytiotrophoblasts: 229.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035274, HPA035275, CAB075758" Enhanced Enhanced "Golgi apparatus" NA NA 830000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600" "unprognostic (2.04e-2)" "unprognostic (4.37e-3)" "unprognostic (4.61e-1)" "unprognostic (1.64e-1)" "unprognostic (9.94e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (3.13e-2)" "unprognostic (3.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.58e-1)" "unprognostic (4.56e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.38e-8)" "unprognostic (1.26e-1)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (3.13e-1)" 32.1 43.1 32.6 32.0 34.6 33.7 40.5 35.8 36.7 62.6 34.1 43.5 38.3 43.2 60.4 46.8 34.3 37.2 57.6 32.5 35.9 33.6 45.6 34.3 39.9 34.2 34.5 37.3 67.1 47.3 40.0 55.5 34.8 40.7 43.6 37.0 68.4 52.6 39.7 38.6 36.7 46.1 34.6 31.1 42.0 32.0 34.4 41.8 50.8 38.1 44.2 53.3 24.0 37.0 66.1 51.7 72.2 54.9 137.5 103.2 83.0 101.5 113.9 89.6 113.8 132.8 84.2 97.0 59.7 143.2 61.0 75.9 82.3 96.0 102.2 57.8 81.2 107.5 41.2 198.8 138.4 90.2 62.9 79.2 102.9 90.0 148.3 95.7 98.9 64.5 92.4 72.4 80.3 103.2 85.5 87.0 74.3 109.9 49.3 68.4 64.5 115.0 112.9 91.8 59.3 54.3 58.4 91.6 95.9 59.0 60.8 73.6 93.5 82.8 56.2 79.5 55.7 81.1 56.2 112.4 86.6 58.3 95.6 48.3 38.3 27.0 53.0 40.6 81.7 44.8 59.1 63.4 48.3 40.7 58.0 48.5 9.6 64.5 46.8 63.9 57.0 62.8 32.6 34.6 35.8 36.7 32.5 35.9 34.2 34.5 34.8 34.6 34.4 37.0 28.7 41.7 36.6 15.0 46.7 37.2 39.6 83.4 38.1 30.6 33.0 22.5 40.9 27.1 64.2 20.2 31.3 114.4 49.3 39.2 56.7 69.1 196.6 16.2 34.4 32.1 31.3 35.1 20.1 78.1 112.1 48.4 48.4 32.7 20.3 25.7 38.9 45.0 46.4 42.1 23.0 63.9 48.8 22.7 29.7 380.7 58.7 23.9 48.0 22.5 46.3 39.3 35.0 27.2 31.7 69.7 41.9 49.7 171.9 62.1 31.7 43.7 23.1 34.8 59.2 27.5 40.3 39.6 39.6 47.1 36.1 229.7 43.4 44.9 48.2 67.7 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 11.4;brain: 37.3;liver: 20.9" "Group enriched" "Detected in some" 23 "Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 287 "Hep G2: 55.5" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" Yes NA "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Golgi apparatus" "HPA043768: AB_2678662, HPA063054: AB_2684932" 11.4 0.2 6.1 0.1 23.1 0.0 8.3 0.3 9.4 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.6 5.0 6.1 0.2 20.9 0.1 0.1 37.3 10.3 0.1 0.2 0.0 2.4 0.0 13.5 0.8 0.0 2.2 0.4 0.0 0.2 0.3 0.7 0.0 5.1 0.1 0.5 0.5 19.0 0.0 0.2 0.0 0.0 0.2 0.5 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 23.1 0.3 9.4 5.0 6.1 37.3 10.3 13.5 5.1 19.0 17.9 0.2 0.0 0.0 94.3 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 3.1 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 1.9 0.0 29.1 0.0 49.3 114.6 0.0 0.0 1.2 0.0 0.1 0.0 2.2 0.0 1.9 0.0 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 HGD "AKU, HGO" ENSG00000113924 "Homogentisate 1,2-dioxygenase" Q93099 3 120628172-120682269 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "kidney: 200.3;liver: 752.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5" "Cancer enriched" "Detected in many" 4 "liver cancer: 119.8" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.2" "HPA047374, HPA052359" Enhanced Approved "Golgi apparatus" NA NA 700000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA047374: AB_2680019, HPA052359: AB_2681798" "unprognostic (1.36e-1)" "unprognostic (9.89e-2)" "unprognostic (3.93e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.56e-1)" "unprognostic (2.05e-1)" "unprognostic (5.65e-3)" "unprognostic (7.20e-2)" "unprognostic (6.05e-2)" "unprognostic (2.41e-3)" "unprognostic (2.68e-2)" "unprognostic (1.16e-1)" "unprognostic (4.29e-3)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.43e-1)" 0.4 0.3 0.4 2.5 1.9 0.5 12.5 0.6 0.8 27.4 1.5 16.7 31.6 3.1 13.0 0.4 4.2 61.7 0.3 0.5 0.4 200.3 752.6 0.8 0.4 0.4 0.4 0.2 31.2 7.0 0.2 0.2 0.4 44.5 20.3 0.7 4.2 4.2 0.1 0.9 25.6 0.5 0.4 0.6 25.5 0.1 0.5 0.7 55.1 0.2 0.1 0.2 0.1 0.6 0.0 12.3 4.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 55.8 10.7 0.1 82.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.2 186.6 0.0 0.4 1.0 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.3 328.0 0.0 0.1 0.3 0.1 212.2 0.0 0.2 0.2 0.2 0.9 0.0 0.0 0.2 1.0 0.6 0.1 0.9 0.2 0.1 0.0 0.3 0.5 0.2 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.3 0.4 1.9 0.6 0.8 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.6 0.1 0.0 2.0 0.3 5.9 0.0 0.4 0.6 0.0 0.3 7.5 1.7 0.3 81.5 4.9 27.6 2.1 0.0 0.3 18.5 103.7 7.2 0.2 113.9 17.1 1.2 43.8 24.0 3.2 17.8 0.0 0.4 19.4 127.8 1.3 0.0 16.4 534.7 0.2 0.0 0.6 16.0 2.0 16.1 0.0 0.0 0.0 21.3 0.0 1.9 2.0 4.2 0.0 0.0 0.5 12.1 35.6 0.0 0.0 12.9 54.6 477.5 4.1 0.2 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 3.8 0.4 9.1 0.4 HHAT "FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn" ENSG00000054392 "Hedgehog acyltransferase" Q5VTY9 1 210328252-210676296 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 25.8;Excitatory neurons: 47.7;Microglial cells: 20.6;Oligodendrocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.8;dendritic cells: 3.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HMC-1: 13.6;LHCN-M2: 11.6;RH-30: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA016462 Approved Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA016462: AB_2669360" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (5.02e-3)" "unprognostic (8.89e-3)" "unprognostic (4.81e-2)" "unprognostic (3.32e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (1.67e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-3)" "prognostic favorable (8.47e-7)" "unprognostic (2.55e-1)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (5.67e-2)" 2.1 6.5 1.1 0.6 1.1 0.4 3.3 0.3 1.6 3.4 3.6 2.3 1.1 2.5 3.1 2.8 2.8 2.2 2.4 1.0 0.4 4.0 2.7 2.1 0.8 0.7 0.8 2.1 2.3 1.7 3.2 1.3 0.6 4.0 1.3 1.7 4.4 2.0 0.3 3.4 2.5 1.1 0.9 2.2 1.8 2.5 0.6 2.0 4.6 0.2 0.8 3.1 2.9 0.9 0.8 0.9 2.3 1.3 1.0 1.3 4.8 1.2 1.1 1.9 3.1 0.2 0.9 0.0 1.2 0.9 3.1 0.6 0.5 0.5 2.2 1.7 1.2 0.0 0.1 1.1 0.2 0.3 13.6 1.2 2.7 1.6 1.2 3.2 0.3 1.2 0.0 0.0 11.6 1.2 0.6 0.0 0.6 0.7 0.1 1.3 12.4 0.0 7.5 2.6 1.9 7.8 2.1 0.0 6.0 5.9 4.0 0.7 1.7 2.8 8.5 1.6 4.7 3.8 0.2 0.0 1.1 0.8 2.3 0.0 0.3 0.0 0.7 0.4 1.3 1.5 0.9 0.8 0.4 1.8 0.0 0.2 0.0 0.1 0.1 3.7 0.2 0.4 1.1 1.1 0.3 1.6 1.0 0.4 0.7 0.8 0.6 0.9 0.6 0.9 2.0 0.0 2.4 25.8 5.3 2.2 5.7 2.8 6.8 0.5 5.8 2.4 2.4 4.3 1.2 9.2 0.0 4.6 13.9 1.9 3.9 2.6 1.2 8.8 2.6 2.0 0.0 0.4 47.7 0.7 3.6 3.0 2.6 5.8 0.0 4.6 3.6 2.5 1.9 0.0 11.8 2.7 4.1 2.9 0.5 0.5 1.2 1.5 0.0 20.6 1.0 15.6 0.0 17.1 26.0 1.2 2.1 0.4 2.2 3.7 2.3 0.6 12.9 0.5 0.0 1.7 1.7 0.3 1.3 3.1 2.6 2.2 2.8 0.4 2.0 5.2 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;kidney: 13.9;ovary: 14.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 35.7;Excitatory neurons: 37.5;Inhibitory neurons: 44.2;Leydig cells: 62.7;Oligodendrocyte precursor cells: 54.3;Peritubular cells: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 46.2;HeLa: 28.1;RH-30: 66.1;RT4: 33.7;SH-SY5Y: 82.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034625 Uncertain Approved "Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA034625: AB_10612119" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.2 2.4 12.4 0.6 10.0 0.0 2.0 1.2 7.4 1.0 0.0 0.6 0.1 3.5 2.4 3.9 1.8 0.3 0.2 9.6 10.7 13.9 0.0 0.7 0.1 6.3 22.5 14.1 5.3 0.3 1.1 8.4 7.3 2.8 0.8 1.5 0.9 0.8 6.2 0.2 0.1 1.5 4.9 0.0 0.9 2.9 20.3 0.6 0.4 0.9 0.5 2.5 0.7 2.6 10.7 0.1 14.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 17.0 0.0 0.0 15.2 0.0 0.0 0.5 21.7 0.1 0.0 0.0 46.2 0.1 28.1 0.0 0.0 0.0 0.0 0.7 20.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 7.8 0.3 0.1 11.8 7.2 0.6 0.0 66.1 0.0 13.3 33.7 1.8 82.0 14.8 0.0 0.1 23.7 0.0 0.1 0.0 0.0 2.6 9.6 23.8 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.4 10.0 1.2 7.4 9.6 10.7 6.3 22.5 7.3 4.9 20.3 2.6 0.0 0.0 0.0 1.6 0.0 0.3 0.2 1.8 6.8 0.2 4.3 2.4 0.8 0.0 5.5 3.7 0.0 35.7 0.2 0.3 5.9 0.0 0.5 0.3 0.6 0.5 0.0 0.0 37.5 2.0 2.6 2.6 0.0 0.1 0.0 0.1 0.0 0.0 3.4 0.0 44.2 0.2 2.0 0.0 0.0 1.1 62.7 0.2 0.0 10.3 0.0 5.3 0.0 54.3 1.4 0.8 0.2 35.3 0.0 1.3 0.0 0.1 9.8 0.4 0.0 17.9 0.3 0.3 1.1 11.1 0.3 17.4 0.1 0.3 0.2 1.8 IGFBP1 "AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12" ENSG00000146678 "Insulin like growth factor binding protein 1" P08833 7 45888360-45893660 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 1198.4" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 994.8" "Cancer enriched" "Detected in many" 29 "liver cancer: 385.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004445, HPA046972, HPA050640" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 28100000 25000000 "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197" "unprognostic (8.66e-3)" "unprognostic (1.45e-1)" "unprognostic (9.41e-2)" "unprognostic (7.80e-2)" "unprognostic (7.04e-2)" "unprognostic (2.93e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.89e-2)" "unprognostic (2.09e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.90e-11)" "prognostic unfavorable (6.64e-4)" "unprognostic (7.20e-2)" "unprognostic (7.98e-2)" "unprognostic (3.43e-1)" 2.6 0.1 0.2 0.0 0.2 0.0 2.4 0.2 0.3 0.3 0.1 0.0 0.3 79.6 0.1 0.0 4.1 0.3 0.5 0.2 0.3 1.6 1198.4 0.1 0.1 0.8 0.3 46.3 0.5 0.0 0.5 204.5 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.1 0.1 0.3 1.1 0.3 0.0 0.0 0.0 0.2 0.2 0.2 6.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.3 1.4 0.1 1.6 0.3 0.0 0.0 0.7 0.0 0.0 0.3 0.5 54.7 0.3 1.1 0.1 0.1 0.7 11.3 0.1 0.6 0.3 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.3 0.0 2.2 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 84.9 0.0 0.0 0.0 0.2 145.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.8 0.3 0.9 0.2 0.3 0.2 0.4 0.0 0.5 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 5.7 1.0 35.8 0.7 0.0 0.0 0.9 0.0 0.0 0.0 11.0 0.1 4.7 94.3 0.9 3.5 10.7 0.1 0.0 1.6 1.8 0.0 15.9 0.0 2.1 6.8 994.8 1.7 0.0 0.1 0.0 0.0 14.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.7 0.1 0.5 0.0 0.0 3.4 0.8 0.0 0.0 0.0 IGFBP7 "FSTL2, IGFBP-7, MAC25, PSF" ENSG00000163453 "Insulin like growth factor binding protein 7" Q16270 4 57030773-57110385 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 21.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002196, CAB020668" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 30300000 190000000 "Cluster 52: Eosinophils - Transcription" "Cluster 7: Kidney - Transmembrane transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "CAB020668: , HPA002196: AB_1079107" "unprognostic (2.76e-1)" "unprognostic (1.39e-2)" "unprognostic (6.82e-2)" "unprognostic (5.97e-3)" "unprognostic (3.86e-1)" "unprognostic (3.18e-1)" "unprognostic (2.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.62e-1)" "unprognostic (1.01e-2)" "unprognostic (2.57e-1)" "unprognostic (6.65e-2)" "unprognostic (2.28e-1)" "unprognostic (2.62e-3)" "unprognostic (1.78e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" 833.0 374.9 99.4 151.1 124.0 44.2 583.2 112.7 149.7 640.3 1299.1 473.1 105.6 653.2 260.4 115.3 618.1 405.7 1117.2 132.7 143.8 1298.6 283.2 532.4 133.1 185.2 138.7 359.1 270.1 77.2 246.0 66.6 146.4 506.0 83.2 4.7 193.7 659.0 185.6 193.6 259.6 334.9 136.8 436.9 267.4 259.2 187.9 48.9 995.3 91.8 81.9 546.4 494.0 132.6 1.3 4.8 1.1 0.0 134.8 50.4 4.7 693.6 643.1 59.2 19.0 2.8 0.1 0.3 433.7 33.5 35.3 70.2 0.7 111.1 15.7 1.3 5.4 2.5 78.7 0.5 207.7 17.1 17.9 234.7 55.8 96.8 26.2 1471.3 138.2 0.6 0.5 0.9 142.8 0.0 0.5 74.5 5.9 0.0 1.3 13.4 0.4 2.8 682.7 0.0 1.0 1.8 130.2 9.5 0.0 276.3 1.8 64.6 1009.4 60.5 46.4 7.8 114.8 41.1 0.4 1.4 159.2 58.3 1.8 2.0 3.9 21.7 0.1 4.1 0.1 0.0 0.0 0.0 10.7 0.0 0.0 0.1 0.3 10.8 4.5 0.4 0.1 1.7 99.4 124.0 112.7 149.7 132.7 143.8 185.2 138.7 146.4 136.8 187.9 132.6 2254.8 112.2 20.2 164.9 16.2 238.5 127.2 300.5 24.5 5.9 27.7 53.5 148.2 20.0 90.6 2087.4 22.9 6.6 76.9 1.4 516.5 2455.3 75.9 1235.5 702.2 2740.1 1.2 82.7 0.7 15.1 8.3 1435.9 29.0 381.3 15.8 1205.0 3079.4 16.4 26.5 0.0 3.7 1.0 61.1 101.9 375.7 335.4 11440.4 70.4 944.5 151.8 41.8 17.1 345.0 11.6 0.8 84.6 1.5 11731.6 11.0 113.3 0.0 692.2 731.0 12.5 8184.6 155.0 4434.0 36.6 38.6 9.9 179.1 5.7 51.3 759.1 2.5 64.0 ITIH2 H2P ENSG00000151655 "Inter-alpha-trypsin inhibitor heavy chain 2" P19823 10 7703316-7749520 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 668 "liver: 2156.1" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 489.6" "Cancer enriched" "Detected in many" 279 "liver cancer: 626.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 453 "Hep G2: 1103.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059150 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 32000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA059150: AB_2683930" "unprognostic (4.82e-2)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.21e-2)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (2.28e-1)" "unprognostic (2.02e-1)" "unprognostic (2.10e-8)" "unprognostic (9.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.35e-1)" "unprognostic (4.46e-4)" 0.1 0.2 0.3 0.1 1.1 0.1 3.0 1.6 3.2 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.6 1.0 0.8 2156.1 0.6 0.1 0.6 0.5 0.0 0.2 0.0 1.7 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.8 0.4 0.0 0.0 0.9 0.3 0.5 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 1103.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 2.4 0.0 0.1 0.7 0.0 0.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.1 1.6 3.2 0.6 1.0 0.6 0.5 0.6 0.9 0.9 0.7 0.1 0.0 2.2 0.7 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.4 117.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.1 0.0 0.0 0.6 0.0 2.7 3.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 8.2 489.6 0.1 0.0 1.4 0.0 0.0 9.4 0.0 2.1 0.0 0.0 0.0 18.7 0.0 0.0 0.0 1.5 1.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 JAKMIP2 "JAMIP2, KIAA0555" ENSG00000176049 "Janus kinase and microtubule interacting protein 2" Q96AA8 5 147585438-147782775 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8" "Group enriched" "Detected in many" 6 "Astrocytes: 195.5;Excitatory neurons: 250.7;Horizontal cells: 85.8;Inhibitory neurons: 229.4;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 198.5" "Cancer enriched" "Detected in some" 6 "glioma: 4.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;MAIT T-cell: 5.3;memory CD4 T-cell: 2.8;memory CD8 T-cell: 5.5;naive CD8 T-cell: 4.6;NK-cell: 7.0" "Group enriched" "Detected in many" 6 "NK-cells: 7.0;T-cells: 7.3" "Cell line enhanced" "Detected in many" "AF22: 19.9;Karpas-707: 47.5;RH-30: 47.8;RPMI-8226: 16.0;SCLC-21H: 22.4;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046929, HPA065023" Approved Supported "Golgi apparatus" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA046929: AB_2679867, HPA065023: AB_2685407" "unprognostic (3.69e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (3.58e-2)" "unprognostic (1.63e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.21e-4)" "unprognostic (1.28e-1)" "unprognostic (5.20e-8)" "unprognostic (1.54e-3)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.2 3.3 11.4 1.0 12.5 0.5 0.1 24.8 14.3 0.5 0.1 2.2 0.4 1.0 0.2 1.3 0.1 1.4 0.4 11.4 12.1 0.3 2.6 2.0 0.9 11.7 11.8 0.1 0.8 1.0 8.3 0.1 12.4 0.6 0.5 5.3 0.2 0.4 0.0 0.3 0.6 1.5 10.4 0.8 1.8 2.9 13.0 7.0 0.1 1.6 0.9 0.7 0.2 16.6 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.1 0.0 0.0 4.8 0.1 0.0 0.0 0.0 3.1 6.9 2.0 0.0 0.0 0.3 0.0 5.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 47.5 0.0 0.1 5.1 0.0 11.4 0.1 0.1 2.0 47.8 16.0 0.0 0.1 22.4 15.4 0.0 0.3 0.1 2.5 0.0 0.0 0.0 3.5 4.0 0.0 1.1 3.3 2.0 4.6 8.9 0.0 0.0 0.0 0.0 0.4 7.3 0.0 5.3 0.7 2.8 5.5 0.1 0.3 0.7 4.6 0.5 7.0 0.2 1.1 1.3 1.5 11.4 12.5 24.8 14.3 11.4 12.1 11.7 11.8 12.4 10.4 13.0 16.6 0.2 0.0 1.5 195.5 1.5 0.0 0.0 0.0 0.0 23.2 0.0 0.1 0.7 0.0 1.3 0.0 2.1 0.0 13.3 0.0 0.0 0.8 11.3 0.2 0.5 0.3 1.2 3.0 250.7 0.0 0.0 1.2 0.5 0.1 29.1 10.3 0.7 3.1 1.3 85.8 229.4 0.8 0.0 0.9 0.0 8.4 0.0 4.2 0.0 11.2 0.4 24.4 23.7 159.3 198.5 0.2 0.0 0.0 3.1 0.0 0.1 0.1 1.5 7.9 0.0 0.4 0.7 7.8 2.0 0.1 0.1 0.3 13.8 18.9 0.0 0.3 JAM3 "JAM-C, JAMC" ENSG00000166086 "Junctional adhesion molecule 3" Q9BX67 11 134069071-134152001 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 342.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 5.3" "Group enriched" "Detected in many" 7 "B-cells: 5.3;T-cells: 2.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 99.5;RH-30: 122.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003417, HPA050434" Approved Enhanced "Golgi apparatus" "Secreted to blood" NA NA 44000 "Cluster 43: B-cells - Humoral immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA003417: AB_1851981, HPA050434: AB_2681126" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (3.24e-1)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.23e-3)" "unprognostic (2.17e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.68e-4)" 23.6 18.7 53.4 10.1 86.3 1.3 19.2 68.7 73.4 33.4 52.9 54.6 6.6 40.8 17.5 21.5 28.7 24.5 31.0 56.5 61.3 11.4 3.2 29.6 7.8 73.5 76.8 48.7 5.1 17.7 33.3 102.7 71.0 32.5 12.9 47.3 13.3 44.5 7.0 13.0 22.5 42.8 59.7 13.5 22.4 35.7 73.3 17.6 15.8 14.6 7.5 41.7 23.4 115.2 0.0 1.0 87.9 42.5 85.3 62.7 75.4 37.0 49.1 15.1 14.8 0.3 0.6 0.0 38.7 53.3 56.2 0.5 70.0 0.7 28.2 0.2 29.6 0.3 0.0 6.9 24.9 0.4 36.2 43.2 0.0 10.7 9.6 35.8 99.5 40.8 0.3 0.2 64.5 1.0 27.5 0.2 18.9 0.6 2.9 0.5 122.8 0.0 0.9 0.2 57.5 32.2 0.0 0.2 1.0 35.3 0.2 0.2 0.6 25.1 18.4 40.3 24.7 0.1 0.1 0.4 27.6 1.2 48.0 0.0 0.0 0.1 1.3 0.0 1.6 5.3 1.6 0.9 0.0 3.1 2.3 1.7 0.5 0.0 0.0 0.0 0.0 1.8 53.4 86.3 68.7 73.4 56.5 61.3 73.5 76.8 71.0 59.7 73.3 115.2 22.2 0.0 6.0 12.7 10.9 5.1 5.6 0.9 0.0 21.7 0.3 9.3 15.7 0.0 0.7 5.5 8.4 6.0 1.2 0.1 1.9 0.4 2.1 0.8 23.3 35.5 0.0 0.4 84.3 0.2 71.2 29.6 1.5 0.5 1.3 11.7 12.5 0.0 8.6 8.4 44.2 0.0 12.2 0.6 4.2 4.9 42.9 10.9 17.8 24.4 0.2 20.2 1.0 76.4 342.8 0.3 0.0 64.3 0.9 2.2 0.0 0.2 1.5 75.6 26.3 19.0 24.3 15.5 19.2 0.2 3.8 6.2 3.5 9.7 0.0 1.0 LAPTM4B LC27 ENSG00000104341 "Lysosomal protein transmembrane 4 beta" Q86VI4 8 97775057-97853013 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 380.1" "Cell type enhanced" "Detected in all" "Granulosa cells: 348.5;Rod photoreceptor cells: 575.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.3" "Group enriched" "Detected in many" 7 "granulocytes: 3.3;T-cells: 1.4" "Cell line enhanced" "Detected in many" "HEL: 611.7;RPTEC TERT1: 549.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020782, HPA068830" Uncertain Approved "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "CAB020782: , HPA068830: AB_2686044" "prognostic unfavorable (5.63e-4)" "unprognostic (1.91e-2)" "unprognostic (7.04e-2)" "unprognostic (6.83e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (2.70e-6)" "unprognostic (9.25e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-1)" "unprognostic (7.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.65e-1)" "unprognostic (3.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" 24.2 43.2 30.2 18.0 29.7 5.3 42.9 37.3 29.6 50.1 78.2 34.0 79.7 71.0 29.3 33.7 67.5 46.3 220.9 23.6 35.3 67.3 25.3 39.6 13.7 42.1 36.1 45.1 28.8 185.5 20.3 28.2 39.5 29.2 32.9 380.1 32.8 44.9 153.7 43.9 43.0 47.8 45.2 38.3 32.2 62.5 44.2 8.6 43.0 117.0 20.2 41.0 28.5 50.1 219.2 170.8 171.9 350.3 80.2 61.0 108.1 98.0 50.1 222.9 188.6 103.1 168.0 1.0 378.0 73.5 75.2 241.2 208.8 94.8 242.9 1.5 282.4 611.7 130.6 169.0 66.1 0.3 101.5 83.8 71.0 130.8 66.0 75.1 29.1 69.5 375.7 0.8 92.4 164.1 54.5 34.1 318.8 116.5 106.5 0.6 90.5 0.7 549.4 100.9 172.8 287.1 133.6 63.8 159.4 188.0 154.3 83.7 8.1 47.7 92.0 99.0 70.7 22.4 68.8 2.2 60.8 0.5 144.9 3.3 0.1 0.0 0.5 0.0 1.4 0.3 0.4 0.3 0.1 0.1 0.8 0.9 0.1 0.3 0.0 0.1 0.2 0.2 30.2 29.7 37.3 29.6 23.6 35.3 42.1 36.1 39.5 45.2 44.2 50.1 60.5 102.5 56.1 8.5 4.9 55.2 68.1 63.9 89.4 195.9 59.8 55.6 208.1 82.9 30.9 106.7 223.1 26.6 3.9 17.9 39.2 244.5 7.1 70.6 59.6 77.4 35.4 36.6 15.0 123.6 33.2 72.2 19.4 105.6 12.7 348.5 132.8 32.6 8.6 134.6 36.6 29.6 59.0 3.7 10.1 8.6 23.9 6.6 42.7 4.7 2.8 135.0 1.0 19.1 20.1 72.1 34.4 30.9 1.7 77.0 95.9 62.1 10.5 575.3 59.2 62.6 75.4 7.4 35.8 45.1 44.3 14.1 10.2 119.9 52.1 86.4 LCK ENSG00000182866 "LCK proto-oncogene, Src family tyrosine kinase" P06239 1 32251239-32286165 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 343.0" "Group enriched" "Detected in many" 9 "dendritic cells: 143.9;NK-cells: 272.9;T-cells: 255.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in all" 12 "gdT-cell: 1109.8;MAIT T-cell: 1034.8;memory CD4 T-cell: 1123.8;memory CD8 T-cell: 1201.7;naive CD4 T-cell: 1260.7;naive CD8 T-cell: 1168.7;NK-cell: 641.5;T-reg: 1682.7" "Group enriched" "Detected in all" 12 "NK-cells: 641.5;T-cells: 1682.7" "Group enriched" "Detected in some" 6 "JURKAT: 365.7;MOLT-4: 536.9;U-698: 302.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA003494, CAB003816" Enhanced Approved "Golgi apparatus" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "CAB003816: AB_562158, HPA003494: AB_1852751" "unprognostic (6.38e-3)" "unprognostic (5.45e-3)" "unprognostic (8.39e-2)" "prognostic favorable (2.96e-6)" "unprognostic (2.20e-2)" "prognostic favorable (2.91e-4)" "unprognostic (4.78e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.65e-5)" "unprognostic (3.07e-2)" "unprognostic (3.80e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (8.15e-2)" "unprognostic (4.05e-2)" "unprognostic (7.39e-2)" "unprognostic (1.17e-2)" 3.4 2.2 0.4 50.6 0.5 13.7 2.3 0.4 0.5 2.2 0.7 6.9 7.6 1.7 13.0 3.9 2.1 9.4 1.9 0.5 0.4 3.8 3.8 11.4 111.0 0.8 0.5 1.6 0.9 0.5 0.8 1.1 0.6 2.8 6.5 0.0 4.8 1.4 1.3 1.9 23.1 2.3 0.6 39.9 12.1 1.1 0.5 343.0 3.7 1.4 79.6 13.2 2.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.7 64.1 3.5 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.6 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 365.7 0.2 0.0 0.0 0.0 536.9 0.2 5.9 4.6 0.3 20.6 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.3 0.3 0.4 0.6 0.4 0.0 0.0 1.7 0.1 0.1 0.7 0.3 302.7 0.0 0.1 0.0 12.8 5.2 6.0 1109.8 4.9 1034.8 62.0 1123.8 1201.7 5.2 98.9 1260.7 1168.7 33.6 641.5 6.0 7.7 1682.7 1836.9 0.4 0.5 0.4 0.5 0.5 0.4 0.8 0.5 0.6 0.6 0.5 0.6 4.9 0.0 9.3 0.0 23.4 4.6 1.2 0.4 0.0 0.0 3.5 5.2 1.8 4.3 1.6 3.7 0.0 0.3 143.9 0.9 0.0 0.6 0.1 1.0 0.5 3.4 2.4 10.1 0.2 0.5 0.2 3.1 7.7 0.7 5.1 0.0 4.6 1.5 0.3 0.0 0.2 0.3 0.0 7.8 7.3 0.0 0.0 8.1 3.6 0.0 8.7 0.0 272.9 0.5 0.1 4.7 0.0 0.4 15.7 1.0 0.0 1.4 1.8 0.0 0.0 1.5 2.4 4.5 2.0 0.5 3.1 0.4 255.5 2.9 1.3 1.1 LGI4 ENSG00000153902 "Leucine rich repeat LGI family member 4" Q8N135 19 35124513-35142451 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 74.7;Distal enterocytes: 33.1;Muller glia cells: 95.5;Sertoli cells: 78.9;Smooth muscle cells: 104.4" "Group enriched" "Detected in many" 6 "glioma: 4.5;melanoma: 11.5;renal cancer: 13.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 27 "WM-115: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042116, HPA043556" Approved Approved "Golgi apparatus" "Secreted in brain" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA042116: AB_2677855, HPA043556: AB_2678550" "unprognostic (3.79e-1)" "unprognostic (6.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-2)" "unprognostic (3.71e-2)" "unprognostic (2.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.71e-2)" "unprognostic (4.47e-1)" "unprognostic (7.73e-2)" "unprognostic (7.13e-2)" 77.6 5.4 71.2 4.1 72.3 0.2 36.1 70.3 98.4 99.9 52.1 100.5 3.6 35.5 2.3 15.0 43.7 5.0 39.4 67.8 61.3 4.7 8.0 14.3 2.1 86.5 68.4 13.3 6.4 1.4 4.4 3.6 70.1 37.2 3.7 7.2 12.2 13.3 39.1 21.2 35.1 4.8 72.8 1.9 27.0 2.7 72.0 0.5 19.1 5.4 0.5 33.5 79.3 81.4 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 71.2 72.3 70.3 98.4 67.8 61.3 86.5 68.4 70.1 72.8 72.0 81.4 13.3 0.0 0.0 74.7 0.2 2.5 0.6 0.3 3.4 0.8 1.5 1.5 17.1 0.0 0.8 1.8 2.1 0.0 0.2 33.1 0.0 0.0 0.1 0.2 2.8 5.4 1.8 0.0 21.9 0.0 0.3 12.7 0.0 0.2 0.0 0.0 7.9 2.0 0.1 0.0 2.2 0.9 0.0 0.0 4.6 0.3 14.6 0.7 10.6 5.6 0.1 95.5 0.0 2.0 9.2 0.1 21.8 7.2 0.3 1.2 1.1 0.1 0.9 3.1 78.9 7.9 104.4 2.8 2.8 0.8 2.4 0.0 0.7 0.0 0.7 1.1 LRRC4 NAG14 ENSG00000128594 "Leucine rich repeat containing 4" Q9HBW1 7 128027071-128032107 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.5" "Cell type enhanced" "Detected in many" "Club cells: 33.2;Cone photoreceptor cells: 27.1;Horizontal cells: 55.5;Respiratory ciliated cells: 53.0;Rod photoreceptor cells: 35.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 38.5" "Immune cell enriched" "Detected in some" 5 "neutrophil: 13.1" "Lineage enriched" "Detected in single" 20 "granulocytes: 13.1" "Group enriched" "Detected in some" 6 "AF22: 15.9;NTERA-2: 35.4;REH: 33.5;SCLC-21H: 18.2;SH-SY5Y: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051100 Approved "Golgi apparatus" NA NA 2100000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA051100: AB_2797241" "unprognostic (7.98e-2)" "unprognostic (6.15e-3)" "unprognostic (2.85e-2)" "prognostic favorable (8.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.34e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (3.23e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.98e-4)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-1)" "unprognostic (5.84e-3)" 2.3 6.7 8.4 2.7 11.4 10.9 0.6 7.8 38.5 1.6 0.0 0.9 0.6 3.2 0.3 4.1 6.6 3.2 2.6 14.4 0.0 3.2 1.9 6.0 1.8 0.0 0.0 4.8 0.4 6.8 1.8 4.4 0.0 0.7 0.5 4.3 1.5 2.8 0.8 0.4 0.8 1.6 0.0 4.7 1.9 6.2 0.0 5.1 0.5 1.8 2.1 1.5 2.8 11.9 0.0 0.2 15.9 0.0 0.6 0.0 0.0 0.9 0.0 1.4 0.4 0.0 0.0 0.0 1.1 1.5 0.0 1.4 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 35.4 0.0 0.0 33.5 0.0 0.3 0.2 0.0 18.2 10.9 0.0 0.0 1.3 2.5 0.0 3.7 0.4 1.1 0.2 0.1 0.9 0.0 0.0 0.0 0.2 0.0 2.3 0.5 0.2 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.1 0.0 0.6 0.0 0.0 0.1 8.4 11.4 7.8 38.5 14.4 0.0 0.0 0.0 0.0 0.0 0.0 11.9 1.8 16.0 14.3 5.5 0.6 0.1 1.6 5.7 0.6 11.3 0.5 0.4 1.4 0.0 33.2 1.8 27.1 0.2 0.7 0.2 0.0 0.1 6.6 11.6 5.2 5.1 0.0 0.0 18.3 0.0 0.3 1.2 0.0 18.7 1.3 1.8 11.0 0.1 19.8 55.5 22.6 0.0 2.0 11.2 0.7 0.9 0.0 1.6 1.8 9.4 0.6 0.8 0.0 11.6 2.1 0.0 0.5 0.7 0.9 4.5 0.1 0.6 53.0 35.1 0.0 2.4 2.0 6.2 4.6 5.6 0.0 0.4 0.5 0.7 0.3 19.0 LRRC63 RP11-139H14.4 ENSG00000173988 "Leucine rich repeat containing 63" 13 46211940-46277366 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;testis: 3.4" "Cell type enriched" "Detected in some" 7 "Oligodendrocytes: 255.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 1.7;JURKAT: 3.0;Karpas-707: 1.6;U-87 MG: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039318, HPA039763" Uncertain Approved "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA039318: AB_10796224, HPA039763: AB_10795408" "unprognostic (3.40e-2)" "unprognostic (2.81e-1)" "unprognostic (5.33e-1)" "unprognostic (2.12e-3)" "unprognostic (1.96e-1)" "unprognostic (3.99e-1)" "unprognostic (1.06e-2)" "unprognostic (7.28e-2)" "unprognostic (3.05e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-2)" "unprognostic (7.61e-2)" "unprognostic (1.18e-6)" "unprognostic (1.27e-1)" "unprognostic (2.98e-1)" "unprognostic (4.57e-2)" "unprognostic (7.31e-2)" 0.1 0.3 1.8 0.1 5.0 0.3 0.1 4.9 2.9 0.2 0.7 0.1 0.0 0.0 2.4 0.0 1.1 0.1 0.1 1.7 2.9 0.1 0.1 0.4 0.2 6.6 4.0 0.0 0.0 0.1 0.0 0.1 6.2 0.5 0.0 2.4 0.3 0.1 0.0 0.0 0.0 0.1 4.8 0.1 0.1 3.4 4.1 1.3 0.0 0.1 0.1 0.0 0.0 10.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.4 0.7 0.6 0.0 2.1 0.0 0.2 0.0 0.1 1.7 0.5 0.7 0.0 0.0 0.1 0.4 1.1 0.4 0.0 0.2 0.0 0.0 0.0 3.0 0.0 1.6 0.0 0.0 1.0 0.3 0.1 0.0 0.2 0.2 0.0 0.2 0.3 0.0 0.5 0.6 0.0 0.0 0.7 0.8 0.0 0.5 0.3 0.2 0.1 0.0 0.3 0.6 1.3 0.1 2.0 1.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 0.1 0.1 1.8 5.0 4.9 2.9 1.7 2.9 6.6 4.0 6.2 4.8 4.1 10.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 34.1 3.1 0.1 0.1 0.0 1.3 0.9 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.0 0.0 0.5 0.0 5.2 0.0 0.0 0.8 0.3 8.4 0.0 0.2 0.0 1.9 0.0 0.1 0.0 4.0 255.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 2.8 0.0 0.0 0.2 3.8 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 LRRC8C AD158 ENSG00000171488 "Leucine rich repeat containing 8 VRAC subunit C" Q8TDW0 1 89633072-89769903 "Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 73.5;Excitatory neurons: 73.6;Inhibitory neurons: 99.2;Microglial cells: 185.5;Oligodendrocytes: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.9;monocytes: 6.6;T-cells: 11.3" "Cell line enhanced" "Detected in many" "THP-1: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029347 Uncertain Approved "Golgi apparatus" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 28: Placenta - Pregnancy" "Cluster 43: THP-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA029347: AB_10601544" "unprognostic (2.61e-2)" "unprognostic (3.09e-2)" "unprognostic (3.83e-2)" "unprognostic (1.76e-2)" "unprognostic (3.32e-2)" "unprognostic (1.65e-2)" "unprognostic (5.02e-2)" "unprognostic (3.76e-3)" "unprognostic (4.28e-2)" "unprognostic (4.90e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.78e-2)" "unprognostic (4.42e-2)" "unprognostic (1.94e-2)" "unprognostic (3.38e-2)" 14.3 7.6 3.8 9.0 4.5 8.0 7.7 4.5 5.8 3.2 11.4 3.2 3.2 7.3 1.9 2.9 2.8 6.6 6.2 4.1 4.1 2.5 3.3 7.7 12.2 4.6 5.0 5.3 1.8 2.8 2.3 6.6 5.1 2.3 3.7 1.6 2.0 2.0 2.7 6.0 3.8 15.8 4.8 9.2 2.9 4.0 4.7 5.6 3.5 8.0 7.7 6.2 2.0 6.0 0.3 3.8 3.0 2.7 9.1 10.2 1.4 19.3 21.6 8.7 8.0 0.0 1.3 6.0 5.3 8.5 14.9 13.1 10.1 29.0 20.9 14.8 6.1 5.7 2.9 0.3 7.4 26.6 1.9 4.4 5.8 18.8 10.0 5.8 35.6 9.2 3.9 7.9 7.5 0.7 3.9 26.2 3.3 0.1 7.8 26.5 1.4 2.0 1.8 3.2 2.3 10.7 7.1 0.7 16.2 4.7 0.2 41.3 29.9 15.3 7.3 5.3 14.9 2.9 2.6 3.1 4.7 19.6 2.6 0.4 6.0 0.0 3.8 5.2 3.3 0.7 6.1 5.1 8.9 0.5 4.8 4.5 0.8 2.0 6.6 0.7 11.3 3.2 3.8 4.5 4.5 5.8 4.1 4.1 4.6 5.0 5.1 4.8 4.7 6.0 73.5 3.2 3.6 31.3 7.6 45.4 3.8 5.6 3.4 2.3 1.7 2.9 6.3 2.8 2.7 0.0 0.0 0.1 24.6 0.3 0.0 1.7 36.3 0.2 1.9 47.3 1.2 4.8 73.6 2.4 1.1 8.7 2.6 0.6 0.0 58.5 28.9 0.1 13.6 1.7 99.2 0.3 2.0 29.5 36.9 21.3 0.0 27.8 26.6 185.5 21.3 0.5 13.4 22.1 85.2 12.8 1.9 0.7 20.8 2.1 0.3 0.6 2.9 1.2 0.0 2.2 24.2 3.9 2.0 1.3 44.9 0.3 27.1 3.4 0.3 2.5 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304752 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.4;salivary gland: 12.8" "Group enriched" "Detected in some" 4 "Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046607, HPA062660" Approved Approved "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA046607: , HPA062660: AB_2684824" "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.5 0.9 6.4 0.3 13.4 0.0 0.1 0.0 10.0 2.2 0.0 3.7 0.6 0.6 0.3 0.3 1.2 0.2 1.3 16.3 5.2 0.3 0.4 0.1 0.0 0.9 9.4 0.3 0.1 0.0 1.9 0.0 2.0 1.0 0.3 0.4 12.8 1.2 0.0 0.1 1.3 0.3 0.2 0.0 0.7 0.2 22.4 0.0 1.6 0.1 0.0 0.6 0.8 4.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.4 0.0 10.0 16.3 5.2 0.9 9.4 2.0 0.2 22.4 4.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 1.0 4.8 0.3 0.0 0.0 7.2 0.7 0.0 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 10.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 6.6 0.0 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 LTBR "D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3" ENSG00000111321 "Lymphotoxin beta receptor" P36941 12 6375045-6391571 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 71.3;intermediate monocyte: 66.3;myeloid DC: 49.8;neutrophil: 45.0;non-classical monocyte: 50.1" "Group enriched" "Detected in many" 36 "dendritic cells: 49.8;granulocytes: 45.0;monocytes: 71.3" "Cell line enhanced" "Detected in many" "HHSteC: 393.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026202, HPA061617" Uncertain Supported "Golgi apparatus" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Golgi apparatus" "CAB026202: , HPA061617: AB_2732666" "unprognostic (2.60e-2)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" "unprognostic (3.24e-3)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (3.66e-2)" "unprognostic (9.84e-3)" "unprognostic (6.91e-2)" "unprognostic (2.86e-1)" 67.6 64.4 13.9 36.4 14.6 11.7 60.3 14.7 15.9 65.8 18.0 72.7 48.6 68.1 20.7 81.3 49.6 48.3 37.2 13.3 15.8 55.1 135.8 66.0 14.6 19.6 17.3 46.3 78.7 54.9 26.3 48.6 18.8 61.9 34.3 1.9 61.5 44.0 26.3 75.1 51.1 62.6 17.4 44.8 67.7 13.3 18.1 11.7 57.2 23.5 18.0 65.8 65.1 17.0 98.2 130.3 0.0 41.1 245.9 183.7 89.9 67.9 153.1 98.8 101.1 62.0 148.7 0.1 39.5 145.7 0.5 112.2 0.5 140.5 38.9 0.0 0.2 58.1 53.2 36.6 393.1 4.1 94.6 270.8 255.2 70.7 197.1 102.6 91.2 0.0 55.5 0.5 115.0 93.5 0.4 29.3 1.2 155.7 74.4 0.0 6.6 0.2 149.2 112.2 0.7 0.5 63.6 122.9 143.6 5.0 20.5 105.3 58.0 34.6 39.6 129.0 72.1 0.0 0.4 0.1 14.6 35.9 129.5 5.4 71.3 0.5 0.2 66.3 0.0 0.1 0.1 0.1 49.8 0.1 0.3 0.2 45.0 1.5 50.1 11.8 0.1 27.2 13.9 14.6 14.7 15.9 13.3 15.8 19.6 17.3 18.8 17.4 18.1 17.0 47.0 60.9 68.9 2.9 3.6 39.0 87.2 46.4 72.3 4.1 33.9 35.9 15.5 45.8 60.7 31.3 0.0 31.3 12.4 78.3 9.8 52.2 0.7 23.8 48.6 49.3 52.0 15.8 0.5 99.8 43.6 50.5 89.7 45.2 29.7 30.1 50.7 66.5 48.7 0.0 0.5 57.1 34.6 77.3 34.6 5.1 52.8 50.8 23.2 14.0 43.1 9.6 11.3 5.5 1.1 69.5 82.3 39.9 3.3 110.7 136.9 30.1 42.8 1.6 26.3 33.1 42.0 1.6 0.9 78.9 61.7 37.5 4.9 28.0 63.4 97.6 LY75 "CD205, CLEC13B, DEC-205" ENSG00000054219 "Lymphocyte antigen 75" O60449 2 159803355-159904756 "CD markers, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 78.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 27.8;monocytes: 96.5;Proximal enterocytes: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 21.8;HDLM-2: 21.7;Karpas-707: 85.3;RT4: 30.1;THP-1: 22.3" "CAB001450, HPA049108, HPA054073" Enhanced Approved "Golgi apparatus" NA NA 1300000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus" "CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: AB_2682370" "unprognostic (7.29e-3)" "unprognostic (1.92e-3)" "unprognostic (3.15e-1)" "unprognostic (1.52e-2)" "unprognostic (4.60e-3)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.80e-1)" "unprognostic (2.36e-1)" "unprognostic (8.74e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (2.66e-1)" "unprognostic (4.89e-2)" "unprognostic (1.94e-2)" "prognostic favorable (3.86e-4)" 2.0 1.9 1.1 18.7 1.0 9.6 9.4 1.1 1.2 7.3 0.7 12.4 18.0 2.6 0.7 5.0 8.5 7.7 1.0 0.9 1.3 3.7 2.0 7.7 30.3 1.7 1.1 1.0 1.4 1.1 0.6 1.3 1.6 1.8 11.9 0.7 7.8 2.6 0.3 7.4 17.6 2.3 1.8 18.4 7.1 0.4 1.2 78.4 17.3 0.9 22.1 10.3 2.2 1.8 3.5 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 9.1 21.8 15.7 0.7 0.0 0.0 0.4 0.0 0.1 0.0 21.7 0.0 4.4 0.2 0.1 0.4 3.3 0.1 0.3 0.1 0.6 0.2 0.0 11.1 0.0 0.0 85.3 0.0 0.0 0.0 5.8 0.5 0.5 0.0 6.0 0.0 3.8 6.4 30.1 0.0 0.0 7.0 5.0 0.0 0.2 0.0 22.3 16.7 0.0 0.0 0.0 0.0 13.2 2.4 3.0 0.0 7.7 0.0 2.6 1.2 2.4 4.2 1.7 4.6 3.7 3.8 4.8 2.9 2.7 4.3 5.1 3.7 5.2 0.7 1.0 3.0 1.4 1.1 1.0 1.1 1.2 0.9 1.3 1.7 1.1 1.6 1.8 1.2 1.8 1.7 0.0 3.4 0.0 15.4 7.5 2.2 5.6 7.4 0.2 9.9 12.1 0.5 4.3 6.3 23.9 2.1 0.1 10.6 27.8 0.0 0.8 0.6 15.4 1.3 3.3 1.8 6.9 0.0 5.5 0.1 1.8 8.6 9.4 11.4 1.7 2.2 0.2 3.9 0.0 0.0 9.8 4.1 10.1 11.3 0.3 2.5 11.5 5.4 0.0 96.5 0.2 13.4 0.0 0.0 4.9 10.9 0.4 8.1 1.3 33.5 2.0 20.7 0.2 0.0 3.7 1.3 0.0 0.7 4.5 6.7 0.3 14.2 0.9 12.3 5.6 MALRD1 "bA265G8.2, C10orf112, Diet1" ENSG00000204740 "MAM and LDL receptor class A domain containing 1" Q5VYJ5 10 19048801-19790401 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "intestine: 31.1" "Group enriched" "Detected in some" 4 "Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3" "Cancer enhanced" "Detected in some" "breast cancer: 0.9;stomach cancer: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Karpas-707: 44.2" "Not detected" "Not detected" "HPA035732, HPA038106, HPA046848" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837" "unprognostic (9.03e-3)" "unprognostic (1.38e-1)" "unprognostic (2.40e-2)" "unprognostic (4.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (2.74e-2)" "unprognostic (5.57e-2)" "unprognostic (5.01e-1)" "unprognostic (1.00e-1)" "unprognostic (3.55e-1)" "unprognostic (7.69e-2)" "unprognostic (3.16e-2)" "unprognostic (9.80e-2)" "unprognostic (8.90e-2)" "unprognostic (3.13e-2)" "unprognostic (3.78e-4)" 0.5 0.7 1.9 0.2 1.9 0.4 0.6 1.0 1.6 0.7 1.3 0.5 30.6 0.6 2.2 0.2 0.2 0.4 1.4 1.8 2.1 1.5 0.1 0.9 0.1 1.5 1.7 1.2 0.1 0.0 1.5 0.4 1.5 0.6 0.1 0.3 0.1 0.3 0.6 0.2 31.1 0.4 1.7 0.2 0.3 2.1 1.9 1.9 0.5 0.1 0.0 0.6 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.8 0.0 2.6 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 44.2 0.0 4.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.9 1.9 1.0 1.6 1.8 2.1 1.5 1.7 1.5 1.7 1.9 1.5 0.0 0.0 1.8 37.9 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.6 1.6 0.0 0.0 0.0 0.0 0.8 1.3 0.0 1.9 0.1 7.9 0.1 0.3 0.1 0.0 4.2 11.6 0.0 0.8 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 11.0 9.5 0.0 0.0 0.3 1.8 0.0 0.0 0.0 5.6 0.0 1.4 0.0 76.4 4.9 0.0 13.8 0.7 0.0 0.2 69.3 0.2 0.0 0.0 0.0 0.1 0.2 9.0 4.1 0.1 0.1 0.3 0.0 1.9 9.7 0.0 MAN1A1 ENSG00000111885 "Mannosidase alpha class 1A member 1" P33908 6 119177205-119349761 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 154.6" "Cell type enhanced" "Detected in many" "Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037058, HPA053198, HPA063561" Uncertain Supported "Golgi apparatus" NA NA 460000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" "CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042" "unprognostic (1.50e-1)" "unprognostic (7.36e-3)" "unprognostic (4.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.33e-3)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" "unprognostic (5.11e-2)" "unprognostic (1.68e-3)" "unprognostic (4.62e-1)" "unprognostic (2.37e-2)" "unprognostic (3.49e-2)" "unprognostic (2.25e-1)" "unprognostic (6.89e-2)" "unprognostic (3.40e-1)" 102.2 48.5 4.2 32.8 12.3 28.9 34.3 1.2 8.9 25.9 5.1 36.1 52.7 23.8 8.8 22.7 16.0 47.1 15.3 8.0 4.6 66.6 154.6 35.8 34.8 2.9 5.0 20.1 32.7 25.8 4.6 79.4 2.5 18.1 29.3 6.2 42.7 15.0 7.6 14.3 69.8 27.2 3.3 36.5 25.9 7.0 8.4 18.9 22.6 31.0 25.9 56.0 17.1 5.9 0.2 0.0 3.4 0.0 273.1 119.9 6.6 6.9 41.4 5.1 12.5 19.8 2.6 43.2 0.3 26.5 65.7 0.4 7.6 0.1 6.4 64.5 19.4 36.3 3.9 204.0 27.2 0.1 17.7 82.4 5.3 41.6 25.3 22.1 3.4 12.6 128.1 219.6 39.7 6.1 1.7 0.3 2.3 20.0 10.0 12.1 4.2 66.6 13.4 35.4 14.1 21.0 0.1 0.6 0.0 8.3 10.4 4.8 24.8 16.9 15.4 32.0 15.8 294.5 44.6 84.8 50.2 0.7 10.4 4.3 0.3 1.1 1.1 0.5 2.3 0.7 0.6 0.6 0.3 0.4 0.3 0.9 1.9 0.9 0.5 2.8 0.7 0.3 4.2 12.3 1.2 8.9 8.0 4.6 2.9 5.0 2.5 3.3 8.4 5.9 37.1 9.6 46.1 19.9 31.0 31.7 5.7 1.2 5.2 28.1 18.8 5.8 4.4 44.3 6.9 106.7 0.0 6.8 40.6 23.3 5.9 9.4 232.5 5.9 63.9 42.1 48.0 40.4 165.0 37.8 12.4 98.4 18.8 10.7 3.8 24.0 97.5 270.5 101.1 0.0 79.4 61.1 0.0 84.6 91.2 39.3 26.4 98.0 28.4 128.4 13.5 1.7 42.2 4.5 3.7 14.8 18.9 4.1 147.5 5.3 92.2 33.5 4.6 5.0 6.6 12.9 27.8 2.8 3.9 3.4 27.8 6.2 24.3 14.6 18.9 9.7 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 236.1;Inhibitory neurons: 238.0;Syncytiotrophoblasts: 380.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" NA NA 2000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: AB_2683419" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favorable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 15.6 11.7 6.7 13.0 12.0 6.3 12.9 8.8 11.6 17.5 7.7 12.5 11.1 16.4 13.7 15.2 14.2 12.3 11.0 7.2 8.5 15.3 21.1 10.8 14.1 1.6 5.0 14.3 36.2 32.9 6.7 21.7 1.6 14.4 12.5 18.2 14.0 13.1 8.4 10.3 11.6 18.0 1.0 12.2 14.2 10.8 6.2 14.7 25.4 10.1 13.8 17.8 7.7 9.8 32.4 13.8 23.2 20.1 29.8 35.7 74.2 26.3 40.9 11.6 10.9 10.7 18.2 24.2 47.4 33.9 10.8 18.7 11.0 22.3 26.0 30.3 16.4 14.4 18.5 11.8 18.1 22.7 31.6 24.2 23.5 17.8 15.5 21.3 35.0 16.7 23.5 36.1 24.5 62.6 14.0 7.2 11.9 16.4 14.4 12.5 50.5 16.7 15.9 43.3 12.6 18.4 26.2 27.6 21.1 30.1 13.8 14.2 33.6 26.0 21.4 18.6 27.2 24.4 18.0 15.9 34.4 17.8 63.1 0.9 1.5 2.6 3.0 1.2 3.6 1.9 2.4 2.5 1.4 1.9 2.0 2.9 1.2 3.8 1.1 2.7 6.3 1.5 6.7 12.0 8.8 11.6 7.2 8.5 1.6 5.0 1.6 1.0 6.2 9.8 40.3 38.5 33.4 71.5 45.1 31.0 34.8 26.7 39.3 63.5 43.3 46.0 101.8 35.8 39.1 44.1 22.9 55.1 52.6 24.7 17.6 32.3 33.1 43.2 52.0 40.6 21.7 43.8 188.5 60.4 236.1 50.7 28.5 54.7 16.4 32.3 42.1 88.7 29.4 43.7 238.0 37.1 20.3 36.2 22.0 22.5 53.7 37.2 40.9 101.2 39.2 51.3 55.6 136.7 149.1 37.5 25.1 65.5 120.2 43.0 28.6 22.1 40.9 42.2 39.5 69.1 53.5 72.9 56.2 53.0 34.5 380.5 45.8 68.3 30.8 47.3 MAN2A1 "GOLIM7, MANA2" ENSG00000112893 "Mannosidase alpha class 2A member 1" Q16706 5 109689927-109869625 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 107.8" "Cell type enriched" "Detected in many" 9 "Oligodendrocytes: 2117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022377, HPA026896" Enhanced Supported "Golgi apparatus" NA NA 110000000 "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "CAB022377: , HPA026896: AB_1853512" "unprognostic (1.62e-2)" "unprognostic (4.06e-2)" "unprognostic (1.25e-2)" "unprognostic (6.96e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (4.20e-2)" "unprognostic (3.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.73e-2)" "unprognostic (1.23e-1)" "unprognostic (6.77e-3)" "unprognostic (2.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.11e-3)" "unprognostic (5.31e-3)" 11.2 17.0 28.0 13.9 66.1 12.7 11.3 41.4 29.6 13.8 3.8 20.7 30.1 12.0 4.2 8.5 9.0 18.1 3.7 21.7 31.5 17.4 42.4 10.1 15.8 64.5 49.9 9.8 22.2 20.7 0.9 15.3 62.1 9.1 20.8 1.7 6.5 10.2 6.0 7.4 25.7 18.3 39.4 14.1 15.7 9.5 42.8 22.7 14.7 11.5 14.7 16.1 2.7 107.8 23.1 18.6 26.5 11.0 56.2 42.2 97.5 49.3 78.0 26.1 46.7 23.2 37.0 17.4 30.7 63.3 18.5 26.5 14.5 56.0 59.7 16.3 9.7 32.6 13.5 30.7 34.6 15.9 15.5 39.7 25.0 43.4 61.4 37.3 54.5 16.9 8.8 87.0 70.5 13.8 27.6 9.1 20.4 17.9 7.3 10.8 40.0 78.5 34.1 32.8 3.7 3.3 22.6 24.9 16.1 29.1 20.5 17.1 56.4 53.7 21.3 30.1 32.9 48.7 58.7 13.6 41.8 22.4 30.3 4.1 2.0 0.6 1.6 2.8 1.3 1.9 2.8 2.8 1.8 1.6 3.3 2.7 1.6 0.5 4.4 2.0 2.8 1.1 28.0 66.1 41.4 29.6 21.7 31.5 64.5 49.9 62.1 39.4 42.8 107.8 20.9 6.4 8.4 100.9 41.1 17.8 15.8 12.7 29.6 0.6 20.0 9.5 7.6 34.3 14.7 31.3 0.0 19.4 28.9 65.8 1.9 27.1 13.7 10.2 35.8 21.6 24.7 29.2 220.8 35.3 98.0 32.3 45.3 33.3 15.2 19.2 36.8 130.3 18.0 0.0 115.2 35.2 22.4 74.8 24.6 8.3 9.9 47.4 26.6 102.1 39.6 5.9 13.4 46.8 2117.7 28.8 28.4 6.8 84.0 39.8 60.6 24.7 12.1 0.2 19.7 52.6 16.5 16.5 19.9 33.6 23.7 23.7 34.7 14.2 49.6 24.2 MANEA "FLJ12838, mandaselin" ENSG00000172469 "Mannosidase endo-alpha" Q5SRI9 6 95577535-95609452 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 59.8;Plasma cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011046, HPA011069" Enhanced Supported "Golgi apparatus" NA NA 140000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 1: Thyroid gland - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA011046: AB_1079303, HPA011069: AB_1079304" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "prognostic favorable (3.04e-4)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (5.03e-2)" "unprognostic (2.98e-3)" "unprognostic (2.74e-1)" "unprognostic (5.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (9.07e-2)" "unprognostic (2.86e-3)" "unprognostic (5.18e-2)" "unprognostic (3.08e-1)" "unprognostic (9.68e-2)" "unprognostic (7.47e-2)" 11.9 6.9 3.1 7.9 3.6 3.3 8.9 3.7 3.7 8.4 4.2 8.1 8.8 6.8 6.3 8.0 6.4 7.9 5.6 2.5 3.7 12.0 24.0 7.3 9.2 4.3 3.3 9.7 8.4 11.1 2.1 6.3 4.4 7.0 8.7 6.1 5.6 7.9 1.4 6.8 8.8 6.7 3.6 9.6 12.1 6.1 3.7 9.1 11.6 3.4 11.2 9.0 3.5 5.6 6.5 5.3 20.4 16.6 33.1 38.5 7.7 17.7 16.2 10.1 14.8 6.1 16.0 12.3 21.7 11.7 14.9 10.4 14.1 12.0 23.2 20.9 12.6 16.6 4.7 10.2 11.5 22.3 14.4 38.4 13.7 12.0 8.5 14.6 24.3 12.1 26.2 28.1 22.0 4.5 13.1 9.5 3.0 17.1 5.5 15.4 19.9 18.8 15.5 11.2 16.3 8.8 10.0 7.2 6.5 14.3 11.4 20.7 22.0 10.1 7.1 18.4 17.8 20.9 12.9 15.2 18.2 19.1 23.6 8.5 2.3 1.3 3.2 4.1 4.6 4.5 3.9 3.8 2.5 2.3 4.5 3.1 0.5 2.9 3.7 1.0 7.7 2.4 3.1 3.6 3.7 3.7 2.5 3.7 4.3 3.3 4.4 3.6 3.7 5.6 11.6 12.8 8.4 7.8 15.5 7.4 4.4 6.4 8.6 8.1 8.4 7.4 4.5 10.0 7.4 12.9 4.2 5.4 5.4 1.8 5.9 4.1 16.7 7.3 14.4 10.7 1.8 8.2 6.0 7.3 5.6 12.0 8.2 8.1 2.5 17.8 28.2 59.8 11.0 11.8 7.3 4.6 0.0 12.0 5.8 11.7 5.9 7.9 8.8 8.4 6.8 10.5 3.1 16.1 18.7 3.4 2.8 15.8 113.4 3.4 4.8 8.5 8.5 5.3 13.1 9.8 17.1 7.1 12.1 11.8 7.0 1.4 9.2 13.5 5.0 3.5 MANEAL FLJ31434 ENSG00000185090 "Mannosidase endo-alpha like" Q5VSG8 1 37793847-37801137 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 16.5;Enteroendocrine cells: 30.5;Horizontal cells: 26.9;Inhibitory neurons: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063423 Approved "Golgi apparatus" "Intracellular and membrane" NA NA 47000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" "HPA063423: AB_2685011" "unprognostic (8.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (7.92e-2)" "prognostic favorable (5.28e-4)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.02e-1)" "unprognostic (1.03e-2)" "unprognostic (7.67e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.17e-3)" "unprognostic (8.29e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (2.26e-1)" 1.1 7.1 16.3 2.1 16.7 0.2 5.0 12.3 18.2 2.9 4.6 6.1 3.5 1.9 6.5 4.7 2.8 1.3 1.3 16.6 21.4 3.6 9.1 3.0 1.2 16.1 17.0 1.2 10.1 5.9 19.3 0.9 20.0 4.2 6.3 13.3 3.6 2.7 4.0 4.1 3.5 2.3 11.9 1.9 4.6 2.7 20.1 1.3 5.6 2.6 1.9 2.3 2.4 13.6 24.0 30.1 5.4 57.1 7.3 2.7 51.7 4.4 26.0 22.1 9.6 50.3 55.0 40.0 18.8 3.1 26.1 5.4 11.1 5.9 7.9 47.5 23.7 29.4 25.5 41.0 0.5 42.3 23.4 0.9 30.6 1.2 1.1 30.7 0.6 7.1 17.5 30.4 3.5 47.8 11.9 0.1 18.1 57.0 31.8 18.2 39.0 46.2 13.1 62.8 139.8 42.4 63.0 2.0 23.6 1.0 27.3 4.4 3.5 31.0 19.0 30.2 41.0 43.6 45.0 13.1 5.1 13.7 23.2 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 16.3 16.7 12.3 18.2 16.6 21.4 16.1 17.0 20.0 11.9 20.1 13.6 1.1 3.2 2.7 0.3 1.0 0.5 1.1 0.3 2.2 16.5 4.3 4.3 1.1 1.5 0.6 3.7 4.2 0.2 1.1 2.3 0.0 1.6 0.2 1.1 0.7 0.8 30.5 0.0 9.0 6.0 2.0 1.0 1.1 2.5 0.0 1.8 0.0 5.0 0.9 26.9 12.1 3.7 0.0 0.8 0.4 0.0 0.3 0.5 3.6 3.7 0.0 5.0 0.0 9.5 2.7 2.4 2.3 0.0 2.4 1.7 1.1 0.4 0.2 9.5 0.0 0.7 0.4 0.0 1.5 1.5 0.0 0.1 0.7 0.5 4.1 1.3 MASP2 MASP1P1 ENSG00000009724 "Mannan binding lectin serine peptidase 2" O00187 1 11026523-11047239 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 64 "liver: 476.5" "Cell type enriched" "Detected in some" 52 "Hepatocytes: 658.6" "Cancer enriched" "Detected in some" 71 "liver cancer: 41.9" "Region enriched" "Detected in single" 9 "cerebellum: 6.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 16.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029313, HPA029314" Uncertain Supported "Golgi apparatus" "Secreted to blood" NA NA 340000000 820000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA029313: AB_10669654, HPA029314: AB_10670029" "unprognostic (7.00e-2)" "unprognostic (8.37e-2)" "unprognostic (2.75e-2)" "unprognostic (2.89e-1)" "unprognostic (1.86e-1)" "unprognostic (3.26e-3)" "prognostic favorable (1.60e-4)" "unprognostic (2.92e-3)" "unprognostic (3.13e-2)" "unprognostic (4.04e-2)" "unprognostic (6.90e-3)" "unprognostic (8.30e-4)" "unprognostic (7.14e-2)" "unprognostic (3.91e-1)" "unprognostic (2.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-4)" 2.1 1.2 0.0 1.7 0.0 7.4 2.2 6.4 0.7 2.4 0.0 2.7 1.6 2.8 0.0 1.2 2.7 1.2 1.3 0.1 0.0 1.0 476.5 1.8 2.7 0.0 0.0 2.9 2.9 0.0 2.3 0.6 0.2 1.6 0.0 6.9 2.5 0.0 5.1 5.3 3.4 0.0 0.0 2.5 2.4 1.5 0.0 0.0 1.9 0.0 0.0 2.1 1.6 0.4 0.5 0.3 2.6 1.6 0.0 0.1 0.4 0.7 0.0 0.0 0.0 1.2 1.0 2.3 0.6 0.0 0.5 0.7 0.0 0.0 0.0 0.6 2.3 1.3 2.7 16.4 0.0 2.0 1.5 0.0 0.0 0.1 0.0 1.8 0.0 1.7 0.7 0.5 0.0 0.5 0.6 1.1 0.3 0.2 0.7 1.6 0.9 0.6 0.0 1.3 1.7 0.7 0.9 0.4 0.4 1.6 0.6 1.2 1.2 0.9 0.5 0.8 0.5 0.5 0.9 1.5 0.5 1.7 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 4.6 1.1 0.9 0.2 0.0 0.6 0.2 0.2 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.0 5.3 9.5 0.0 0.0 0.1 0.0 0.1 1.3 0.0 8.2 658.6 0.1 0.0 8.3 0.0 0.0 12.6 0.3 0.0 0.0 0.0 1.8 1.9 0.0 0.1 0.0 8.0 10.4 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.7 0.4 0.0 0.7 0.2 0.0 0.0 0.4 0.6 0.0 0.8 0.1 0.0 0.1 MBOAT4 "FKSG89, GOAT, OACT4" ENSG00000177669 "Membrane bound O-acyltransferase domain containing 4" Q96T53 8 30131671-30144665 "Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 3.6;stomach 1: 3.7" "Cell type enhanced" "Detected in some" "Astrocytes: 3.6;Cholangiocytes: 12.8;Ductal cells: 3.1;Enteroendocrine cells: 3.5;Excitatory neurons: 2.4;Inhibitory neurons: 3.1;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 3.1;OE19: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044509 Supported "Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 25: Pancreas - Digestion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA044509: AB_2678966" "unprognostic (4.35e-3)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (3.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.76e-2)" "unprognostic (1.85e-3)" "unprognostic (4.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (6.30e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-6)" "unprognostic (9.87e-3)" "unprognostic (1.58e-1)" "unprognostic (2.18e-1)" "unprognostic (3.66e-2)" 0.1 0.5 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 1.7 0.9 0.2 0.1 0.1 0.1 0.4 0.3 0.4 0.1 0.1 0.1 3.6 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.4 3.7 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.1 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 0.1 0.1 0.6 0.1 0.4 0.7 0.0 0.4 0.6 0.2 1.0 0.7 1.2 0.8 0.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.1 1.1 0.0 0.0 0.0 3.5 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.0 3.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 METTL26 "C16orf13, MGC13114" ENSG00000130731 "Methyltransferase like 26" Q96S19 16 634427-636366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 172.6;Distal tubular cells: 168.3;Extravillous trophoblasts: 187.2;Proximal tubular cells: 289.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044004, HPA067414" Uncertain Approved "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA044004: AB_10964777, HPA067414: " "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (3.35e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (6.27e-2)" "unprognostic (6.93e-2)" "unprognostic (6.21e-2)" "unprognostic (1.20e-1)" "unprognostic (4.71e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.73e-6)" "unprognostic (2.59e-1)" "unprognostic (1.37e-1)" "unprognostic (2.53e-1)" "unprognostic (2.72e-2)" 55.7 71.7 97.8 14.5 100.4 23.6 49.9 90.3 158.9 55.2 90.2 65.7 18.6 57.0 23.8 47.4 50.3 10.6 82.3 102.3 95.8 68.8 75.5 44.9 12.0 92.5 92.7 65.5 50.3 30.2 54.3 13.7 93.0 59.0 10.5 5.2 49.1 22.3 91.3 54.0 39.7 13.6 91.4 47.3 56.0 55.1 97.2 25.8 46.3 35.1 11.8 55.2 47.9 97.7 59.6 60.7 20.0 48.6 28.7 47.2 72.5 46.5 39.2 40.1 30.3 55.6 50.2 71.8 77.7 38.2 47.9 74.5 28.7 73.8 12.5 54.1 140.1 45.9 86.6 83.0 68.5 68.6 41.5 43.1 41.3 53.5 39.9 47.0 48.8 87.7 55.5 29.2 23.3 94.0 75.8 120.4 61.7 83.5 174.9 105.2 23.1 147.6 64.2 25.4 86.9 60.1 43.0 77.9 57.5 14.3 57.4 67.7 35.1 40.4 52.9 67.1 46.5 69.8 47.2 52.7 41.2 43.6 35.7 102.9 119.8 68.3 110.1 145.3 121.6 145.4 114.9 109.2 150.7 124.1 108.6 105.2 26.2 123.0 167.7 162.7 160.0 120.9 97.8 100.4 90.3 158.9 102.3 95.8 92.5 92.7 93.0 91.4 97.2 97.7 70.2 32.1 61.3 0.0 20.9 0.0 0.0 0.0 0.0 0.0 119.6 172.6 0.0 0.0 19.2 49.7 0.0 113.3 52.9 0.0 168.3 118.6 0.0 72.7 73.3 29.2 0.0 0.0 0.0 94.1 187.2 42.7 0.0 59.0 25.2 119.7 0.0 0.0 106.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 41.3 0.0 0.0 0.0 0.0 91.8 0.0 0.0 8.4 0.0 0.0 289.7 28.4 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 57.9 30.9 125.9 0.0 0.0 MGAT2 GNT-II ENSG00000168282 "Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase" Q10469 14 49620799-49623481 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043721, HPA056824" Approved Supported "Golgi apparatus" NA Yes 5100000 "Cluster 44: Non-specific - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA043721: AB_2678636, HPA056824: AB_2683248" "unprognostic (1.20e-2)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.84e-1)" "unprognostic (5.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (3.77e-1)" "unprognostic (1.92e-2)" "unprognostic (1.14e-1)" "unprognostic (7.44e-2)" "unprognostic (7.12e-2)" "unprognostic (5.63e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-2)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" 16.8 17.6 5.9 24.3 5.8 10.3 13.3 6.9 6.8 17.4 9.0 23.6 23.1 12.7 21.7 11.8 11.9 15.2 11.7 5.6 6.7 14.2 40.7 13.8 25.3 6.4 6.3 13.1 23.8 8.2 7.9 22.0 6.6 14.1 21.9 8.2 15.8 13.7 5.0 9.3 22.5 16.0 6.9 20.2 21.0 24.3 7.2 16.4 13.3 5.6 25.1 20.9 8.8 7.3 63.5 30.7 23.2 39.2 53.6 51.7 15.1 68.6 67.7 62.2 55.8 37.5 47.1 63.7 56.9 62.9 36.0 49.5 32.9 39.7 66.7 65.5 29.1 40.7 21.7 37.2 42.3 94.5 91.2 39.8 31.2 36.8 51.8 45.5 75.5 31.4 31.7 170.4 66.3 24.2 32.9 60.1 23.8 22.2 49.1 36.7 67.1 55.6 49.3 36.2 24.0 25.6 49.3 12.9 39.8 22.2 39.1 63.6 78.9 56.1 60.8 41.1 49.6 182.8 94.6 56.7 27.3 46.5 38.6 49.4 38.6 39.3 36.6 34.1 39.3 25.1 33.3 33.1 39.9 15.9 19.3 26.8 11.6 22.3 39.8 47.2 31.6 44.8 5.9 5.8 6.9 6.8 5.6 6.7 6.4 6.3 6.6 6.9 7.2 7.3 17.4 12.8 8.6 2.0 31.7 15.7 25.7 28.8 14.2 13.7 15.5 8.9 0.1 24.3 18.0 11.0 4.2 26.4 46.9 34.6 9.8 31.0 7.9 12.5 20.7 20.8 12.1 19.0 3.0 34.4 40.3 24.3 13.7 11.7 17.1 27.7 27.1 63.0 37.2 18.5 4.3 20.5 40.7 34.5 28.8 6.0 17.4 26.3 21.4 2.8 40.6 16.7 63.8 6.0 4.5 36.5 25.1 22.2 77.1 27.0 26.7 15.2 23.5 15.8 6.6 15.8 34.6 56.4 13.0 15.2 14.1 5.3 31.5 23.2 20.0 25.5 MGAT4A "GnT-4a, GnT-Iva" ENSG00000071073 "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A" Q9UM21 2 98619106-98731132 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 96.0" "Cell type enhanced" "Detected in many" "Microglial cells: 175.2;Proximal enterocytes: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 127.2;HUVEC TERT2: 48.3;JURKAT: 86.5;TIME: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007608 Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 28: BEWO - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA007608: AB_10602008" "prognostic unfavorable (4.30e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.48e-8)" "unprognostic (1.35e-1)" "unprognostic (2.28e-2)" "unprognostic (3.82e-3)" "unprognostic (1.89e-1)" "unprognostic (3.76e-1)" "unprognostic (3.58e-1)" "unprognostic (2.80e-2)" "unprognostic (2.32e-2)" "unprognostic (4.17e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.04e-2)" "unprognostic (2.04e-1)" 11.2 7.8 13.2 20.8 17.8 96.0 12.5 26.1 15.6 8.9 15.1 24.4 29.5 5.8 3.7 6.3 7.0 12.7 7.6 13.1 15.2 27.5 9.7 16.9 21.1 16.4 15.8 3.2 38.8 28.0 9.8 19.6 15.5 7.5 25.5 5.4 25.9 6.4 3.8 4.1 43.8 11.5 18.1 8.1 11.3 6.3 15.5 20.5 8.7 4.7 18.2 13.1 4.7 22.9 8.8 1.7 3.4 7.3 0.0 0.0 127.2 0.0 0.1 0.9 0.0 21.0 10.6 0.0 18.9 0.0 2.4 0.4 7.2 1.0 0.2 10.6 7.9 0.5 0.0 36.7 0.2 17.8 6.4 0.0 4.7 0.0 0.7 0.3 48.3 86.5 1.6 9.2 0.0 17.3 39.3 30.9 1.1 7.6 1.4 9.8 0.0 10.5 24.8 17.6 10.4 3.3 2.5 32.2 4.8 9.2 7.6 23.8 78.8 0.0 4.0 0.1 2.6 3.2 7.6 2.2 0.0 26.7 0.6 7.0 5.1 12.7 20.8 1.0 27.5 3.6 25.2 23.7 3.8 2.5 32.6 27.2 14.0 15.3 2.5 17.1 16.0 12.5 13.2 17.8 26.1 15.6 13.1 15.2 16.4 15.8 15.5 18.1 15.5 22.9 80.8 54.5 25.7 19.2 22.7 9.9 21.1 6.1 11.4 19.8 28.2 15.6 13.4 11.5 17.6 22.0 4.2 6.2 116.9 92.4 21.5 20.8 12.7 14.2 3.8 39.8 53.0 6.3 58.0 29.8 77.9 7.2 19.4 35.1 13.3 5.1 18.9 10.4 57.2 48.8 48.6 41.3 34.6 33.9 18.3 17.5 2.5 54.5 10.6 175.2 21.0 13.4 89.6 36.7 42.0 21.6 58.2 2.2 31.4 17.8 132.4 27.3 7.1 4.8 6.6 6.8 4.9 2.5 7.7 8.6 10.5 14.9 112.2 0.7 40.9 30.2 MINAR1 "KIAA1024, UBTOR" ENSG00000169330 "Membrane integral NOTCH2 associated receptor 1" Q9UPX6 15 79432336-79472304 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 10.3;brain: 4.7;retina: 6.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "melanoma: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 10: BJ & FHDF - ECM organization" "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 10.3 1.0 0.1 0.8 0.4 0.3 4.7 0.7 0.3 0.2 0.2 0.0 0.2 0.3 0.2 0.1 0.3 0.1 0.6 1.6 0.1 0.0 0.1 0.4 3.2 3.5 0.1 2.1 0.0 0.7 0.2 3.4 0.7 0.2 6.8 2.8 0.1 0.1 0.2 0.2 0.1 1.5 0.3 0.3 0.2 1.8 0.2 0.2 0.0 0.2 0.1 0.2 1.1 0.3 0.2 0.4 0.5 1.1 0.9 0.4 0.5 0.8 0.4 0.4 0.0 0.3 0.7 0.1 0.8 0.5 0.2 0.9 0.1 0.3 0.8 1.0 1.9 0.5 0.0 0.6 2.7 0.9 0.4 0.2 0.7 0.1 0.8 0.4 0.8 0.1 0.0 0.1 0.0 0.3 1.0 0.4 0.4 0.4 0.4 0.1 0.4 0.1 0.0 1.8 1.0 0.2 1.6 1.0 0.7 0.2 1.3 0.3 8.7 0.3 0.0 1.9 1.1 1.4 0.3 0.9 1.5 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.8 4.7 0.7 0.6 1.6 3.2 3.5 3.4 1.5 1.8 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MKRN2OS "C3orf83, MKRN2-AS1" ENSG00000225526 "MKRN2 opposite strand" H3BPM6 3 12514934-12561059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 9.2;intestine: 8.0" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 6.6;Proximal enterocytes: 7.5;Respiratory ciliated cells: 4.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 4.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.9;CAPAN-2: 13.8;HBEC3-KT: 3.4;MCF7: 3.2;RT4: 5.7;T-47d: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065586, HPA065753" Uncertain Approved "Golgi apparatus" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA065586: AB_2685514, HPA065753: AB_2685553" "unprognostic (2.53e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (2.03e-3)" "unprognostic (3.81e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.29e-1)" "unprognostic (5.26e-2)" "unprognostic (3.86e-2)" "unprognostic (1.58e-2)" "unprognostic (4.29e-3)" "unprognostic (2.53e-5)" "unprognostic (1.02e-1)" "unprognostic (2.48e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-3)" 0.1 0.0 0.1 0.4 0.4 0.0 1.3 4.4 0.8 1.8 0.0 4.3 8.0 0.2 9.2 4.6 1.9 2.2 2.0 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.2 4.1 1.0 1.6 0.4 0.2 0.9 5.0 1.3 7.0 1.9 0.4 2.5 7.6 0.0 0.0 0.0 5.1 0.1 0.1 0.2 0.6 0.0 0.9 0.9 1.1 0.1 2.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 13.8 0.0 0.3 0.0 0.0 0.6 0.0 3.4 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 2.0 5.7 0.2 0.0 0.0 0.8 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.4 0.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 1.1 0.3 0.5 0.0 0.7 0.0 1.8 0.7 2.9 1.3 0.7 2.8 0.6 3.7 0.0 2.7 0.0 1.9 0.0 1.7 1.5 3.0 0.5 0.2 0.0 0.0 2.3 2.2 0.6 0.0 6.6 2.8 0.0 0.2 0.0 0.0 0.2 0.0 2.6 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.8 2.1 2.2 0.0 0.2 0.4 7.5 1.1 4.4 1.0 0.0 0.1 0.1 0.2 0.1 3.4 0.0 0.3 0.0 0.1 2.1 0.9 MPZL3 ENSG00000160588 "Myelin protein zero like 3" Q6UWV2 11 118226690-118252365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.3;skin 1: 30.4" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 43.8;Suprabasal keratinocytes: 63.9;T-cells: 44.3;Urothelial cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 6 "basophil: 44.3;eosinophil: 99.4;MAIT T-cell: 28.9;neutrophil: 87.8" "Group enriched" "Detected in all" 8 "granulocytes: 99.4;T-cells: 28.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.3;HMC-1: 29.0;MCF7: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029116 Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA029116: AB_10610142" "unprognostic (2.54e-2)" "unprognostic (1.24e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (8.74e-3)" "unprognostic (2.86e-2)" "unprognostic (9.82e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.86e-2)" "unprognostic (1.58e-2)" "unprognostic (1.89e-1)" "unprognostic (3.90e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.20e-1)" 3.3 0.5 0.7 4.7 1.0 7.3 8.2 2.8 0.7 11.5 1.7 5.6 5.4 1.5 4.9 33.3 5.4 7.6 1.6 0.7 0.8 3.1 7.5 7.9 4.8 1.0 0.7 0.5 7.2 6.7 3.8 0.8 0.9 5.6 6.1 1.3 11.7 2.7 1.7 30.4 5.3 1.5 0.7 6.0 6.8 1.1 0.8 2.8 6.1 0.9 12.6 4.4 16.8 0.7 5.0 0.6 0.0 0.7 0.0 0.0 0.7 0.6 0.1 0.1 0.1 16.7 26.3 4.9 12.5 0.0 1.9 6.8 1.2 5.6 0.1 0.3 2.0 3.0 1.4 8.1 0.2 4.1 29.0 0.3 13.6 0.0 5.4 0.0 8.8 3.3 3.8 2.7 0.1 17.1 1.9 2.2 2.4 16.5 1.2 0.0 0.0 7.4 10.0 6.2 3.4 0.3 6.6 8.6 0.5 1.3 15.4 2.2 4.3 0.1 1.3 0.1 0.1 0.4 5.1 3.1 0.1 0.1 0.3 44.3 6.0 99.4 7.0 3.7 28.9 1.7 11.3 9.6 8.1 1.9 8.4 6.9 87.8 8.2 2.6 1.1 8.4 5.3 0.7 1.0 2.8 0.7 0.7 0.8 1.0 0.7 0.9 0.7 0.8 0.7 2.4 16.0 26.9 0.0 4.9 35.6 21.7 11.8 9.6 0.3 28.2 14.7 1.7 5.7 15.9 9.2 2.1 0.6 9.6 19.6 0.0 10.5 7.4 32.7 4.1 4.9 12.0 0.4 2.2 8.8 0.7 1.6 18.3 34.0 1.3 0.1 2.2 8.2 1.3 0.0 2.3 5.1 14.2 5.1 18.7 7.7 0.0 5.5 10.6 1.9 3.8 0.3 4.1 0.5 0.3 16.7 9.1 0.4 6.6 30.6 9.3 1.1 43.8 1.7 0.0 0.4 2.3 1.7 0.8 14.3 63.9 1.6 44.3 0.2 8.1 46.4 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071115 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 93 "bone marrow: 420.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 1478 "basophil: 2686.3" "Lineage enriched" "Detected in single" 4507 "granulocytes: 2686.3" "Cell line enhanced" "Detected in some" "HEL: 48.9;K-562: 94.2;NB-4: 109.8;THP-1: 319.0;U-937: 126.2" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.1 0.0 0.0 0.3 0.0 420.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.9 0.0 0.0 0.0 17.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.2 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 319.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 126.2 0.0 2686.3 0.1 1.8 0.1 0.1 0.3 0.2 0.4 0.0 0.3 0.2 0.2 0.4 0.9 0.1 0.5 0.2 0.1 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 19.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.8 0.0 3.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 MZB1 "HSPC190, MEDA-7, MGC29506, PACAP, pERp1" ENSG00000170476 "Marginal zone B and B1 cell specific protein" Q8WU39 5 139387467-139390081 "Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 89.8;lymphoid tissue: 272.2" "Cell type enriched" "Detected in many" 6 "Plasma cells: 4000.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 160.4;plasmacytoid DC: 569.3" "Group enriched" "Detected in many" 116 "B-cells: 160.4;dendritic cells: 569.3" "Group enriched" "Detected in some" 5 "Karpas-707: 581.5;RPMI-8226: 2193.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043745, HPA052694" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 350000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA043745: AB_10960359, HPA052694: AB_2681919" "unprognostic (4.97e-3)" "unprognostic (1.75e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.27e-4)" "unprognostic (2.21e-2)" "prognostic favorable (4.60e-5)" "unprognostic (6.57e-2)" "unprognostic (1.35e-1)" "unprognostic (6.45e-3)" "unprognostic (7.10e-3)" "unprognostic (2.57e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.15e-8)" "unprognostic (7.22e-2)" "unprognostic (3.14e-1)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" 4.4 9.1 0.0 87.4 0.1 33.0 21.0 0.0 0.7 18.3 0.2 70.1 89.8 1.8 0.4 10.1 5.7 14.3 2.3 0.0 0.0 5.9 5.8 15.9 123.2 0.1 0.0 4.9 1.3 0.0 0.7 0.0 0.1 5.1 39.9 0.0 56.7 4.9 0.1 0.4 47.8 2.1 0.4 272.2 66.6 2.4 0.1 147.3 9.1 0.0 117.8 58.7 3.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 256.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 144.6 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 128.5 0.5 581.5 0.0 0.0 227.8 2.2 0.0 0.0 0.0 90.1 0.3 2193.9 0.0 0.0 0.3 0.8 0.0 11.4 0.0 0.0 3.1 0.1 0.6 0.0 1.8 0.1 0.0 262.0 16.7 223.0 0.1 0.4 0.0 0.0 0.1 0.1 1.5 0.1 3.0 160.4 0.6 1.1 0.5 75.6 0.1 0.2 3.1 2.7 0.0 569.3 0.2 26.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.3 0.4 6.4 10.1 0.0 665.7 2.5 1.3 0.1 0.0 0.0 3.7 3.2 1.1 4.3 2.0 0.0 0.0 0.1 235.0 0.9 0.0 0.1 0.1 1.8 0.4 2.0 1.2 49.3 0.0 0.0 0.1 2.0 6.1 0.4 2.5 0.1 11.4 14.0 0.1 0.0 0.0 1.1 0.0 7.1 3.4 1.1 0.0 4.7 540.7 0.0 1.0 0.0 4.1 0.0 0.0 0.1 0.4 0.0 4000.1 3.0 1.2 1.9 1.2 0.0 0.0 1.7 2.1 0.1 0.1 0.4 2.4 2.2 100.7 0.5 9.7 0.4 NECAB3 "APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51" ENSG00000125967 "N-terminal EF-hand calcium binding protein 3" Q96P71 20 33657087-33674463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044785, HPA070595, HPA071786" Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186" "unprognostic (8.95e-2)" "unprognostic (1.45e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.44e-1)" "unprognostic (4.05e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.19e-5)" "unprognostic (3.13e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (6.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-1)" 10.2 55.9 20.1 2.2 21.2 1.5 10.4 18.9 33.9 11.8 20.4 14.4 13.6 9.1 6.9 8.9 10.9 4.5 45.7 21.7 21.2 13.3 13.3 11.1 2.3 23.3 19.1 41.2 19.1 17.5 10.3 3.9 24.4 27.2 4.4 6.5 13.6 7.8 60.3 6.9 10.6 3.7 16.6 6.5 30.5 10.6 23.2 1.9 19.2 31.7 1.7 14.6 10.0 22.3 8.2 7.1 5.1 10.5 4.0 7.8 24.6 11.2 4.2 7.1 6.2 33.2 5.3 9.1 26.2 6.6 16.7 9.7 5.3 3.3 2.6 3.2 7.7 8.7 30.7 39.3 10.5 2.1 8.0 9.7 4.8 6.6 2.1 7.6 4.8 4.8 12.6 4.8 9.3 12.5 3.3 8.6 2.2 8.7 17.5 9.7 13.3 15.9 6.6 6.1 32.4 9.0 26.1 28.7 12.0 5.6 36.6 10.4 4.0 8.6 12.4 11.3 12.7 17.7 7.8 17.1 16.9 4.0 3.8 0.0 1.3 1.8 0.3 1.3 0.9 0.2 0.6 0.3 1.2 0.9 0.4 0.1 0.0 1.2 3.5 0.0 1.6 0.6 20.1 21.2 18.9 33.9 21.7 21.2 23.3 19.1 24.4 16.6 23.2 22.3 5.4 16.0 45.5 14.7 4.1 3.1 6.5 2.7 8.6 19.4 20.5 11.6 29.9 10.0 5.9 5.5 8.4 20.6 3.8 22.5 33.2 3.7 93.1 5.7 7.2 2.4 19.9 4.0 13.0 7.5 26.1 12.5 26.5 5.4 3.8 14.0 2.2 9.1 8.9 8.4 14.5 16.2 4.1 6.0 6.2 54.0 26.4 5.5 12.4 1.0 3.6 18.2 2.1 6.0 4.5 4.4 15.1 23.7 11.7 14.2 45.9 12.2 3.8 20.8 6.6 9.2 12.1 20.5 20.6 9.3 3.1 20.7 5.4 23.9 20.0 10.0 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 21.9;retina: 34.6" "Group enriched" "Detected in some" 14 "Bipolar cells: 206.4;Excitatory neurons: 307.1;Inhibitory neurons: 345.9;Oligodendrocyte precursor cells: 172.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Group enriched" "Detected in many" 41 "amygdala: 6.6;basal ganglia: 12.4;cerebral cortex: 21.9;hippocampal formation: 17.5;white matter: 16.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 21.9;REH: 20.6;RPMI-8226: 32.7;RT4: 24.7;SCLC-21H: 26.9;U-2 OS: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064630 Approved "Golgi apparatus" "Secreted in brain" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 58: Brain - Synaptic function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA064630: AB_2685305" "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 1.2 0.0 6.6 0.3 12.4 0.1 1.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 17.5 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.1 34.6 0.2 0.0 0.0 0.3 0.5 0.0 0.0 3.1 0.2 0.8 0.2 0.4 0.6 0.0 1.2 0.1 0.0 16.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 8.7 0.0 0.0 20.6 0.0 32.7 4.0 24.7 26.9 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 12.4 0.0 21.9 17.5 0.0 0.3 0.0 0.3 0.0 0.2 16.3 2.0 0.0 0.0 16.6 6.1 0.0 0.0 0.0 0.0 206.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 307.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 17.8 0.0 2.2 0.0 172.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NETO2 "FLJ10430, NEOT2" ENSG00000171208 "Neuropilin and tolloid like 2" Q8NC67 16 47077703-47143945 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;lymphoid tissue: 22.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 96.5;Inhibitory neurons: 176.6;Oligodendrocyte precursor cells: 79.4;Theca cells: 98.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013180 Uncertain Approved "Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA013180: AB_1854383" "unprognostic (2.67e-2)" "unprognostic (3.46e-2)" "unprognostic (3.90e-1)" "unprognostic (1.51e-3)" "unprognostic (2.25e-1)" "unprognostic (5.26e-3)" "unprognostic (1.10e-2)" "unprognostic (5.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (5.53e-6)" "unprognostic (3.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.79e-2)" "unprognostic (1.32e-1)" 2.7 7.2 6.1 6.4 19.8 2.4 2.8 3.6 9.3 1.6 1.0 8.5 1.6 2.2 0.6 6.1 0.8 4.8 2.6 4.1 8.3 2.7 0.7 5.9 6.3 6.9 0.8 1.6 2.5 10.7 1.2 3.4 6.4 1.1 2.4 7.5 2.7 1.2 4.4 1.8 2.8 1.6 1.7 22.7 2.2 8.0 3.5 5.4 8.8 2.2 6.2 4.9 2.9 4.2 86.8 94.4 133.9 0.3 19.3 111.6 22.2 84.0 13.2 72.9 39.3 19.9 54.0 21.3 50.4 18.0 70.2 37.9 86.4 83.6 89.0 0.3 55.7 17.2 32.8 21.3 23.9 55.8 43.7 67.9 54.7 29.5 41.2 70.5 49.2 50.5 25.9 25.7 47.4 23.5 31.9 30.4 64.7 25.8 68.8 0.1 26.2 43.0 51.4 18.3 87.8 63.5 110.9 8.6 12.5 21.8 1.7 40.3 24.1 0.1 0.3 0.1 0.5 27.5 24.7 47.6 58.9 38.9 59.6 0.3 0.9 0.0 0.0 0.5 0.3 0.2 0.3 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.1 6.1 19.8 3.6 9.3 4.1 8.3 6.9 0.8 6.4 1.7 3.5 4.2 4.9 0.0 4.5 4.6 6.5 7.8 0.6 10.4 13.1 2.2 5.2 8.9 1.3 0.0 3.6 0.0 0.0 1.4 2.1 15.9 0.0 0.4 3.1 2.1 4.0 10.6 10.8 0.4 96.5 3.1 0.5 4.9 1.5 0.9 2.5 18.0 2.9 0.4 6.6 0.0 176.6 2.6 6.1 11.4 14.6 5.7 0.6 16.6 3.6 8.4 7.3 39.9 1.0 79.4 3.1 1.3 1.5 0.0 13.7 4.9 2.9 0.1 2.4 1.6 6.6 5.3 3.6 17.9 22.2 18.8 3.3 0.8 5.2 98.7 2.8 1.4 NHLH1 "bHLHa35, HEN1, NSCL, NSCL1" ENSG00000171786 "Nescient helix-loop-helix 1" Q02575 1 160367071-160372846 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.9" "Cell type enhanced" "Detected in some" "Astrocytes: 8.5;Excitatory neurons: 22.5;Inhibitory neurons: 18.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 48.6" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 26.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.0" "Region enriched" "Detected in some" 12 "cerebellum: 19.1" HPA017943 Approved "Golgi apparatus" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA017943: AB_2732421" "unprognostic (6.95e-2)" "unprognostic (3.02e-1)" "unprognostic (3.81e-1)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-2)" "unprognostic (7.06e-2)" "unprognostic (1.96e-2)" "unprognostic (4.21e-8)" "unprognostic (4.09e-2)" "unprognostic (2.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.36e-1)" 0.2 0.1 1.2 0.1 1.9 0.0 0.1 1.5 1.9 0.0 0.9 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 1.5 1.3 0.1 0.2 0.2 0.0 2.2 1.6 0.1 0.1 0.0 0.3 0.0 1.5 0.1 0.0 0.7 0.2 0.0 0.3 0.6 0.2 0.0 2.9 0.6 0.1 0.3 1.4 0.6 0.1 0.0 0.0 0.1 0.1 1.5 0.0 0.1 2.6 0.0 0.6 0.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 1.2 0.5 0.2 0.6 0.0 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.4 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.0 26.3 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.1 0.1 0.2 0.3 0.0 1.9 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.9 1.5 1.9 1.5 1.3 2.2 1.6 1.5 2.9 1.4 1.5 0.5 0.0 0.0 8.5 0.5 0.3 0.0 0.1 0.6 0.9 0.5 0.8 0.7 0.0 0.1 0.0 2.1 0.1 0.3 0.2 0.0 0.2 0.0 0.2 0.3 0.3 1.8 0.0 22.5 0.2 0.1 0.2 0.0 0.5 0.0 0.2 0.4 0.0 0.2 3.3 18.6 0.6 0.0 1.9 0.6 0.0 0.3 1.1 0.0 9.4 0.4 0.2 0.0 16.6 48.6 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 1.4 0.0 0.5 0.1 1.1 0.6 0.3 0.0 0.3 0.2 0.2 0.0 0.1 NIPA2 SLC57A2 ENSG00000140157 "NIPA magnesium transporter 2" Q8N8Q9 15 22838644-22869362 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067160, HPA071342" Approved Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "HPA067160: AB_2685794, HPA071342: AB_2686391" "unprognostic (2.88e-3)" "unprognostic (1.82e-1)" "unprognostic (9.34e-3)" "unprognostic (1.17e-1)" "unprognostic (4.49e-1)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.22e-2)" "unprognostic (2.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (2.94e-1)" "unprognostic (7.75e-3)" "unprognostic (3.53e-2)" "unprognostic (1.59e-1)" "unprognostic (3.22e-2)" "unprognostic (2.93e-2)" 24.0 26.9 15.5 35.0 15.4 30.6 20.7 14.8 16.3 21.2 19.1 40.5 39.7 21.1 18.5 25.5 17.1 24.7 18.9 15.5 17.3 31.0 27.3 23.0 36.3 15.3 17.4 15.0 24.2 25.5 18.5 28.7 17.1 26.4 38.9 15.9 26.6 17.1 27.5 15.3 35.7 24.4 16.3 27.1 28.5 16.9 16.5 28.7 26.8 27.2 42.9 34.8 15.3 16.6 103.6 103.7 51.7 61.7 55.9 58.1 57.3 117.3 99.1 78.4 90.4 76.5 64.3 101.0 70.6 71.7 88.6 82.6 99.9 58.3 77.3 109.7 61.0 89.9 66.4 61.2 72.3 127.0 81.8 54.9 61.2 64.2 65.5 51.6 87.7 79.2 137.4 117.1 99.8 39.2 40.1 56.0 60.2 109.9 99.9 88.3 87.0 74.9 71.6 120.9 69.4 71.7 95.6 84.8 98.9 48.4 74.4 114.3 91.4 104.0 65.6 73.2 237.5 90.0 153.3 107.4 76.3 129.9 88.2 72.1 44.5 38.9 41.1 55.4 46.9 76.3 36.9 45.4 54.9 67.1 34.2 34.6 32.7 48.6 55.7 82.0 52.8 49.2 15.5 15.4 14.8 16.3 15.5 17.3 15.3 17.4 17.1 16.3 16.5 16.6 26.0 16.0 23.1 10.7 62.9 45.0 41.3 26.1 20.5 9.4 25.2 16.5 3.8 22.8 25.0 12.9 12.5 39.9 45.0 53.7 21.5 39.6 10.7 21.7 24.5 28.5 24.4 29.2 14.7 43.8 65.4 23.4 26.0 27.6 10.1 26.2 22.9 22.1 48.3 21.9 15.4 30.2 38.7 30.3 41.3 3.3 13.4 35.5 23.2 14.0 31.4 27.3 35.0 9.5 13.3 57.8 31.1 21.1 60.8 56.5 31.8 23.3 20.6 13.0 13.1 17.6 28.6 32.8 35.2 28.8 57.8 84.4 37.3 38.7 38.1 89.7 NIPAL1 "DKFZp686A06115, NPAL1" ENSG00000163293 "NIPA like domain containing 1" Q6NVV3 4 47914142-48040173 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.8;skin 1: 25.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 42.0;Collecting duct cells: 42.3;Distal enterocytes: 56.2;Squamous epithelial cells: 44.4;Undifferentiated cells: 38.6;Urothelial cells: 55.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 13.3;CAPAN-2: 11.6;HaCaT: 15.3;HBEC3-KT: 11.1;RT4: 17.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA036765 Uncertain Approved "Golgi apparatus" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA036765: AB_10672366" "unprognostic (3.03e-1)" "unprognostic (4.55e-2)" "unprognostic (2.34e-3)" "unprognostic (2.18e-2)" "unprognostic (1.12e-2)" "unprognostic (3.57e-1)" "unprognostic (9.55e-2)" "unprognostic (4.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (3.71e-3)" "unprognostic (1.34e-1)" "unprognostic (9.03e-7)" "unprognostic (2.55e-1)" "unprognostic (3.73e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" 0.3 0.1 0.1 1.7 0.3 0.2 3.6 0.3 0.3 2.0 0.3 14.1 5.4 0.3 7.3 21.8 2.1 1.4 0.1 0.1 0.4 3.3 16.2 0.4 0.1 0.2 0.2 0.0 1.9 3.7 0.6 1.8 0.2 2.1 13.3 1.8 5.1 1.2 1.6 25.7 7.1 0.5 0.1 0.2 7.1 0.6 1.0 0.3 1.6 0.1 3.0 7.7 4.8 0.1 13.3 0.2 0.0 0.0 0.0 0.0 2.1 2.4 2.3 1.8 3.2 7.8 11.6 0.0 1.7 0.0 3.3 15.3 2.2 11.1 4.7 0.1 2.8 0.0 0.1 0.5 0.0 0.1 0.1 0.1 4.0 0.2 2.6 3.1 0.6 0.8 0.1 0.0 2.6 5.1 0.1 0.1 1.9 9.1 3.4 0.0 0.0 0.0 6.4 17.9 1.1 0.3 1.2 4.3 1.9 1.0 2.7 0.0 5.0 0.1 4.5 0.0 0.3 0.1 0.2 0.0 0.2 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.3 0.1 0.4 0.2 0.2 0.2 0.1 1.0 0.1 0.3 9.6 6.1 0.0 0.4 14.4 42.0 6.4 4.6 0.2 9.9 5.0 2.8 4.3 12.6 42.3 0.0 2.1 0.2 56.2 0.0 15.7 0.7 7.3 1.1 1.1 11.5 0.0 0.9 6.7 1.4 1.5 11.2 14.2 0.0 0.3 0.4 18.5 0.4 0.0 1.0 27.5 4.1 1.2 2.1 0.3 0.0 0.6 1.8 1.0 0.6 0.7 0.0 0.5 0.1 16.1 31.2 0.0 1.4 27.4 31.8 1.0 3.2 5.1 0.0 1.9 2.8 1.3 2.8 44.4 33.0 3.6 1.0 0.1 38.6 55.2 NLRP7 "CLR19.4, NALP7, NOD12, PAN7, PYPAF3" ENSG00000167634 "NLR family pyrin domain containing 7" Q8WX94 19 54923509-54966312 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.9" "Cell type enhanced" "Detected in some" "dendritic cells: 8.2;Early spermatids: 8.3;Extravillous trophoblasts: 5.7;Late spermatids: 14.8;Plasma cells: 5.2;Spermatocytes: 6.4;Spermatogonia: 5.6" "Cancer enriched" "Detected in many" 30 "testis cancer: 146.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.9" "Cell line enhanced" "Detected in some" "BEWO: 1.9;RT4: 1.0;SuSa: 1.5;U-266/84: 5.0" HPA051382 Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 83: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA051382: AB_2681461" "unprognostic (2.15e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-3)" "unprognostic (1.24e-2)" "unprognostic (5.29e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-1)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.34e-1)" "unprognostic (3.25e-8)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (7.31e-3)" "unprognostic (4.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 8.2 0.0 0.0 0.0 8.3 0.3 0.0 0.0 0.0 0.0 0.9 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 5.6 0.0 0.0 1.9 0.3 0.0 0.0 0.6 NPY PYY4 ENSG00000122585 "Neuropeptide Y" P01303 7 24284188-24291862 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Neuropeptide "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 122.6;brain: 423.9;prostate: 332.8" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 56.7;Prostatic glandular cells: 100.6" "Cancer enriched" "Detected in many" 187 "prostate cancer: 1214.9" "Region enriched" "Detected in all" 7 "hypothalamus: 423.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 34 "SH-SY5Y: 700.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016733, CAB034368, HPA036636, HPA044572, HPA056798" Supported Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 30700000 21000 "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 35: Glandular cells - Unknown function" "Golgi apparatus" "CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371" "unprognostic (2.00e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (4.15e-1)" "unprognostic (3.76e-2)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "unprognostic (6.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.78e-1)" "unprognostic (2.52e-1)" 1.8 122.6 32.8 12.8 59.0 5.6 2.2 11.0 39.1 1.3 11.3 2.9 9.7 0.3 0.3 2.3 0.5 1.1 0.8 31.7 423.9 0.5 0.2 0.3 0.0 24.2 25.1 0.5 8.8 0.1 4.7 0.0 15.2 332.8 1.9 4.4 0.3 3.9 0.2 0.2 13.1 1.2 18.8 0.0 8.8 1.1 29.2 0.2 0.9 0.2 0.0 1.4 23.8 33.1 0.0 0.0 2.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 2.0 0.0 0.2 20.5 0.0 0.6 0.0 0.0 0.8 700.2 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 59.0 11.0 39.1 31.7 423.9 24.2 25.1 15.2 18.8 29.2 33.1 0.0 0.0 0.0 2.0 0.5 0.1 1.3 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 56.7 0.0 0.0 0.0 0.0 16.1 0.3 0.7 1.8 1.0 0.0 0.8 0.0 2.0 1.9 0.3 0.0 0.4 0.0 100.6 0.0 0.0 0.0 0.7 0.0 15.6 0.3 2.4 2.8 0.0 0.0 5.1 0.3 0.0 0.0 2.0 NRTN NTN ENSG00000171119 Neurturin Q99748 19 5823802-5828324 "Disease related genes, Predicted secreted proteins" "Growth factor" "Disease variant, Hirschsprung disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 25.6;pancreas: 16.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.2;Cone photoreceptor cells: 12.5;Endometrial ciliated cells: 14.9;Hepatocytes: 12.3;Rod photoreceptor cells: 50.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 8.2;K-562: 8.1;REH: 21.0;SH-SY5Y: 10.8;U-266/70: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA065260 Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 14: REH - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA065260: AB_2685448" "unprognostic (4.85e-2)" "unprognostic (1.66e-2)" "unprognostic (2.96e-2)" "prognostic favorable (3.86e-4)" "unprognostic (1.60e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.21e-3)" "unprognostic (5.60e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.38e-1)" "unprognostic (2.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.78e-3)" "unprognostic (3.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.32e-2)" 0.3 8.2 0.1 0.4 0.2 0.0 0.8 0.4 0.5 1.5 0.4 9.6 1.2 0.4 0.6 4.4 1.1 0.5 25.6 0.2 0.2 2.8 14.4 0.8 0.0 0.5 0.5 0.1 16.9 1.5 1.1 0.2 0.6 2.8 0.2 9.7 5.3 0.9 0.0 6.1 3.1 0.9 0.1 0.2 9.4 1.3 0.4 0.4 0.4 0.0 0.2 4.6 3.0 0.4 0.6 0.8 0.9 3.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.9 0.0 0.5 0.1 3.2 0.0 0.0 8.2 5.7 0.0 0.0 2.6 0.9 0.1 2.1 0.1 0.8 0.0 0.0 0.0 0.0 2.7 8.1 0.0 0.0 1.7 0.7 0.9 2.6 1.2 2.0 21.0 2.6 4.9 0.3 0.0 0.5 10.8 0.2 1.0 1.2 0.3 0.4 0.7 0.0 0.0 1.6 0.0 0.0 11.5 2.6 0.7 0.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.2 0.4 0.5 0.2 0.2 0.5 0.5 0.6 0.1 0.4 0.4 0.3 0.0 1.8 0.3 0.4 1.9 1.4 0.4 1.8 4.6 3.0 6.9 17.2 1.5 0.1 3.7 12.5 0.1 0.4 1.0 3.9 0.3 0.1 14.9 4.3 0.6 1.2 0.0 0.5 0.7 0.0 1.3 2.0 2.6 0.0 1.1 3.6 12.3 0.3 0.0 0.7 1.8 0.0 0.3 0.2 0.6 0.9 0.3 5.4 0.0 0.1 6.0 1.0 0.5 1.0 0.7 0.1 0.0 2.5 1.0 0.2 0.7 0.2 50.0 0.0 0.0 0.9 0.4 3.4 1.4 4.5 0.1 0.6 0.5 1.4 1.1 NSG2 "CALY3, HMP19" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045706-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 198.5" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "SCLC-21H: 39.5;SH-SY5Y: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA046531: AB_2732528, HPA056191: AB_2683062" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 0.5 33.3 115.8 2.6 198.5 0.0 0.1 43.8 152.8 0.0 1.7 6.9 2.3 0.0 0.4 0.1 0.0 0.3 1.0 125.2 171.9 0.7 0.4 0.3 0.0 54.5 82.1 0.1 0.9 0.0 7.0 0.0 101.1 0.2 3.9 39.2 0.1 0.1 0.3 0.1 3.8 1.8 52.4 0.2 3.0 14.7 100.3 0.0 0.6 0.0 0.0 0.1 1.2 47.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 64.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.8 198.5 43.8 152.8 125.2 171.9 54.5 82.1 101.1 52.4 100.3 47.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NSUN6 "ARL5B-AS1, FLJ23743, NOPD1" ENSG00000241058 "NOP2/Sun RNA methyltransferase 6" Q8TEA1 10 18545561-18659285 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 61.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045902 Approved Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA045902: AB_10962354" "unprognostic (7.34e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-3)" "unprognostic (9.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.33e-3)" "unprognostic (1.63e-2)" "prognostic favorable (8.42e-4)" "unprognostic (1.60e-1)" "unprognostic (2.45e-1)" "unprognostic (9.96e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (2.23e-1)" "unprognostic (7.53e-3)" "unprognostic (3.18e-2)" "unprognostic (2.00e-3)" 6.4 12.2 13.6 7.5 14.3 12.4 9.3 16.0 15.9 9.0 13.5 6.1 8.6 9.6 12.2 5.7 8.7 6.0 8.6 14.0 14.1 10.6 61.1 6.5 11.3 13.8 14.8 12.7 12.0 7.8 17.2 6.5 14.7 10.5 8.4 12.9 8.4 5.6 4.5 9.1 8.7 6.1 13.9 9.8 8.5 17.5 13.8 11.8 12.0 4.8 10.9 9.1 7.6 17.6 7.5 6.3 16.6 12.3 8.1 11.1 7.2 10.3 2.5 8.4 11.3 12.0 11.2 17.0 4.3 4.0 5.9 11.0 17.1 10.8 10.8 16.6 13.9 17.8 8.8 14.5 8.3 8.1 11.6 8.6 10.3 8.0 5.5 8.3 3.9 20.0 25.1 16.1 8.2 4.2 18.6 9.3 8.5 14.8 4.8 13.1 8.6 17.4 6.3 9.1 8.9 11.0 8.7 9.0 7.3 11.3 5.8 6.4 6.7 7.0 8.1 12.8 7.6 9.9 11.0 18.8 5.0 14.5 4.3 1.5 3.5 2.8 4.4 4.7 7.0 8.0 6.3 5.6 2.9 6.1 7.8 6.7 1.6 5.3 8.2 4.0 10.5 2.5 13.6 14.3 16.0 15.9 14.0 14.1 13.8 14.8 14.7 13.9 13.8 17.6 75.4 9.6 15.1 57.8 34.9 28.7 17.1 11.0 30.1 33.2 32.4 34.7 8.1 18.6 13.6 9.2 22.9 10.1 39.6 19.5 5.9 10.0 19.7 23.6 38.9 37.5 14.5 20.8 43.5 12.7 8.0 19.2 40.2 49.0 17.7 32.0 26.7 86.6 7.4 25.2 45.0 24.5 18.3 24.2 52.4 12.7 25.7 28.5 12.4 23.4 15.3 15.3 17.5 43.7 57.6 11.1 20.0 17.0 31.0 10.1 40.2 10.9 14.5 28.9 13.1 20.1 19.1 49.5 21.8 21.3 26.7 6.7 31.0 26.7 18.7 14.2 NTF4 "GLC1O, NT-4/5, NTF5" ENSG00000225950 "Neurotrophin 4" P34130 19 49061066-49065054 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 20.1;skeletal muscle: 17.1;skin 1: 31.1" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 35.6;Basal respiratory cells: 24.0;Basal squamous epithelial cells: 15.4;Breast myoepithelial cells: 24.3;Club cells: 9.5;Cytotrophoblasts: 13.6;Urothelial cells: 11.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.8;HaCaT: 31.1;HBEC3-KT: 11.7;hTCEpi: 50.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049376 Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA049376: AB_2680735" "unprognostic (4.15e-2)" "unprognostic (1.07e-1)" "unprognostic (9.27e-4)" "unprognostic (1.76e-4)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.73e-2)" "unprognostic (4.87e-3)" "unprognostic (3.90e-4)" "unprognostic (2.97e-1)" "unprognostic (1.40e-3)" "unprognostic (3.71e-2)" "unprognostic (2.49e-1)" "unprognostic (1.89e-2)" "unprognostic (2.46e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 4.3 0.7 0.0 0.0 0.1 3.7 10.8 2.5 0.0 1.0 0.1 0.0 0.1 0.0 3.5 0.0 0.1 0.2 0.2 0.0 0.0 1.6 3.2 0.1 20.1 0.0 0.0 8.2 7.1 17.1 31.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.9 1.5 2.5 1.1 6.5 9.6 0.1 3.9 0.2 0.3 2.1 0.0 0.0 9.3 0.0 0.0 0.1 0.0 3.4 13.8 0.0 3.5 0.0 0.5 31.1 0.1 11.7 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 50.4 0.0 1.6 3.1 0.0 0.1 0.0 0.2 0.4 1.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 8.8 0.0 0.1 0.7 0.1 0.0 4.3 8.0 0.1 0.2 1.8 3.5 0.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 3.2 0.0 0.0 0.0 7.0 35.6 24.0 15.4 0.0 3.4 24.3 0.4 0.0 9.5 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.3 1.7 3.1 2.7 0.3 0.1 0.0 11.9 NUCB2 NEFA ENSG00000070081 "Nucleobindin 2" P80303 11 17208153-17349980 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 758.3;salivary gland: 771.4" "Cell type enhanced" "Detected in all" "Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 1867.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008395, CAB015931, CAB079781" Enhanced Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1250000 690000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Golgi apparatus" "CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683" "unprognostic (2.49e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.27e-6)" "unprognostic (5.24e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-3)" "unprognostic (3.66e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.46e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" 56.2 75.7 23.9 62.1 27.8 619.9 141.1 28.8 32.1 137.2 58.0 68.3 57.3 60.8 458.2 146.3 107.2 60.8 95.7 22.8 34.7 43.2 102.2 49.8 60.2 25.7 28.2 56.0 758.3 479.1 113.0 90.9 26.8 70.9 68.4 64.5 771.4 190.9 38.5 21.1 40.7 78.5 26.2 42.2 92.9 119.2 28.4 334.2 153.9 30.4 78.5 61.8 44.9 26.6 119.9 49.0 53.7 163.4 118.9 162.3 65.0 260.5 381.0 115.1 203.0 48.7 26.8 182.9 63.5 250.7 107.1 50.1 34.4 66.8 178.7 126.7 76.3 135.8 57.8 85.2 340.5 1867.0 238.6 71.1 86.8 82.9 200.9 284.9 143.3 672.1 120.1 361.1 114.9 105.9 656.2 670.3 12.9 194.0 50.5 239.8 130.4 15.1 51.9 37.5 63.5 35.4 114.6 114.2 61.4 78.0 93.5 498.1 128.1 120.9 110.9 369.1 112.1 70.3 41.3 101.1 140.5 646.1 106.4 210.5 43.5 168.2 94.1 30.5 122.9 22.7 88.5 173.7 40.6 14.5 246.7 271.2 39.3 277.9 25.6 426.0 42.7 119.8 23.9 27.8 28.8 32.1 22.8 34.7 25.7 28.2 26.8 26.2 28.4 26.6 118.7 44.8 70.4 16.3 54.8 27.5 60.2 156.3 14.8 71.0 152.8 87.0 193.8 55.8 176.5 42.3 54.2 127.1 136.5 17.6 27.4 91.1 690.6 112.4 92.9 94.7 42.4 137.8 21.9 132.6 319.1 148.8 40.2 97.0 67.6 80.0 108.5 141.8 70.7 35.3 23.5 189.0 189.2 29.4 40.0 508.5 149.8 37.6 69.4 18.7 24.1 111.2 95.8 13.6 10.8 75.2 13.2 114.3 256.5 108.7 3.9 28.5 618.8 99.3 46.0 50.8 75.4 174.9 61.3 87.7 30.1 1158.2 92.3 88.3 45.3 61.2 OAZ2 ENSG00000180304 "Ornithine decarboxylase antizyme 2" O95190 15 64687573-64703281 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 324.9;Sertoli cells: 374.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 418.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047694 Uncertain Approved "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA047694: AB_2680121" "unprognostic (2.67e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (9.05e-4)" "unprognostic (2.09e-2)" "unprognostic (4.44e-2)" "unprognostic (2.32e-3)" "unprognostic (3.46e-2)" "unprognostic (7.94e-2)" "unprognostic (3.11e-2)" "unprognostic (5.24e-2)" "unprognostic (1.76e-3)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.54e-1)" "unprognostic (1.45e-1)" 65.1 68.5 110.1 49.5 111.8 32.9 55.1 112.2 112.5 61.1 108.0 72.4 28.4 64.7 57.2 44.4 59.8 46.9 79.3 110.1 114.5 68.4 89.3 55.8 50.7 112.6 114.6 56.5 35.9 96.8 75.0 75.1 112.4 53.3 35.8 123.4 45.3 49.1 207.9 45.9 40.9 72.3 114.3 89.8 47.7 80.8 114.4 41.7 65.8 152.5 45.4 56.3 48.3 116.4 71.2 63.5 130.6 43.5 91.8 79.4 24.6 80.5 120.6 113.4 98.5 43.5 62.2 61.6 72.7 113.4 84.5 37.5 126.7 71.6 99.2 82.4 48.3 40.3 48.3 32.5 52.2 35.7 125.7 104.4 49.6 57.0 40.1 147.4 109.2 42.9 30.1 29.6 123.4 45.3 24.5 43.8 223.1 39.1 50.7 57.5 74.5 54.0 102.0 55.7 68.4 125.1 30.4 45.0 80.3 161.6 75.6 52.7 66.0 76.4 102.2 38.0 87.0 65.1 104.6 58.2 87.4 75.2 69.8 22.1 145.3 268.4 29.3 247.8 24.2 30.2 24.6 24.0 91.1 29.1 27.9 25.3 418.0 39.5 209.6 49.4 30.7 115.5 110.1 111.8 112.2 112.5 110.1 114.5 112.6 114.6 112.4 114.3 114.4 116.4 67.5 25.6 43.5 15.3 36.1 121.7 99.5 67.7 47.8 93.8 57.9 40.4 61.9 44.3 41.0 42.3 104.3 114.1 33.4 19.2 168.3 109.5 324.9 35.2 30.0 109.3 81.9 33.3 14.6 66.0 70.9 61.3 14.3 20.5 103.3 36.9 134.6 83.6 133.9 74.0 13.6 26.0 91.6 115.4 238.1 80.9 114.3 86.6 103.2 20.6 114.2 268.2 49.4 12.1 26.9 81.8 25.7 68.1 19.1 88.9 29.2 94.2 51.1 180.8 374.7 68.1 160.9 166.2 83.9 28.0 121.2 68.5 31.7 44.3 27.4 72.4 OCEL1 FLJ22709 ENSG00000099330 "Occludin/ELL domain containing 1" Q9H607 19 17226213-17229219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 75.5" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 137.0;Proximal tubular cells: 150.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042070, HPA043223" Uncertain Approved "Golgi apparatus" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA042070: AB_2677830, HPA043223: " "unprognostic (6.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.13e-1)" "unprognostic (3.00e-3)" "unprognostic (6.40e-2)" "unprognostic (2.06e-2)" "unprognostic (4.33e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (4.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.52e-1)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "unprognostic (1.18e-3)" 18.3 21.6 14.9 4.7 15.8 5.6 16.4 15.9 24.9 14.8 15.5 20.9 19.0 13.5 18.9 9.4 18.1 5.8 17.4 14.6 15.6 37.4 75.5 14.6 7.3 17.4 16.0 11.2 22.7 7.2 9.2 6.7 17.0 21.1 12.3 8.9 14.9 9.0 14.0 8.8 20.0 7.2 16.4 17.3 22.1 6.7 16.5 6.7 20.5 13.5 9.5 13.9 12.3 15.8 8.2 6.4 3.3 2.9 34.9 13.8 8.5 5.3 14.5 4.1 7.2 4.6 9.8 7.2 19.5 7.8 3.6 3.9 4.5 5.4 3.8 6.0 5.3 6.7 6.8 22.6 11.7 1.4 10.5 11.1 5.6 4.8 8.1 14.2 5.9 8.9 5.8 6.8 7.5 6.7 3.7 4.0 5.6 12.3 11.3 2.7 2.8 18.2 17.7 11.2 1.1 5.6 3.3 10.8 9.4 6.9 16.4 6.8 3.9 2.6 3.0 5.1 2.6 18.5 15.3 5.8 7.7 6.3 1.2 27.7 30.8 15.2 9.9 20.9 9.5 15.7 15.1 11.4 23.3 17.0 16.5 10.8 9.7 16.0 17.1 10.0 19.1 13.4 14.9 15.8 15.9 24.9 14.6 15.6 17.4 16.0 17.0 16.4 16.5 15.8 14.6 12.8 8.2 3.9 16.4 6.4 26.7 18.8 17.1 11.4 21.4 23.7 7.3 27.1 21.9 20.2 2.1 38.6 23.9 66.8 60.7 21.4 6.3 59.3 12.5 15.6 17.4 9.7 4.7 27.1 46.0 17.2 25.5 20.4 15.9 8.0 25.0 93.5 25.8 25.2 5.2 40.5 10.2 26.1 7.5 14.6 28.3 22.3 16.0 3.7 19.2 29.6 24.7 1.0 4.6 21.0 67.4 23.3 23.2 20.7 137.0 150.5 71.8 9.7 32.9 12.5 25.8 7.8 13.8 8.8 6.7 103.2 16.4 19.9 28.1 21.9 PANK3 FLJ12899 ENSG00000120137 "Pantothenate kinase 3" Q9H999 5 168548495-168579368 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078669 Approved Approved "Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA078669: " "unprognostic (1.24e-2)" "unprognostic (5.71e-2)" "prognostic favorable (3.94e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-2)" "unprognostic (2.42e-2)" "unprognostic (1.20e-2)" "unprognostic (8.43e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-1)" "unprognostic (9.48e-2)" "unprognostic (2.30e-1)" "unprognostic (3.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (1.97e-3)" "unprognostic (2.01e-1)" 12.5 20.1 6.8 13.5 8.3 17.9 25.5 20.4 10.0 10.5 2.6 27.0 41.5 13.2 9.3 13.1 7.9 10.0 10.3 8.5 7.9 15.0 43.2 10.3 13.1 8.8 8.7 11.3 10.5 21.8 6.3 14.1 8.5 12.8 25.7 18.0 10.5 7.8 7.7 14.9 30.5 11.7 7.6 12.7 16.1 12.5 9.4 14.2 15.2 12.1 12.5 11.5 11.2 10.4 29.0 16.1 65.2 34.9 23.8 27.5 27.5 17.1 18.0 22.3 32.5 26.9 26.1 44.9 27.3 24.3 35.6 20.3 44.2 34.2 40.1 42.1 21.6 23.4 15.2 20.1 27.7 31.1 29.4 22.1 45.4 28.1 31.4 15.8 26.5 33.1 21.5 43.4 31.0 16.0 31.3 14.1 27.7 22.2 12.1 22.3 44.8 18.2 28.1 42.2 30.2 64.4 19.6 31.5 48.9 32.6 41.2 38.8 27.8 29.9 41.3 17.9 36.8 30.0 45.1 32.5 17.8 31.3 23.8 1.1 1.0 0.5 0.5 1.2 0.7 1.4 0.6 0.6 0.6 0.5 0.4 0.7 0.4 0.3 1.7 0.9 0.7 0.3 6.8 8.3 20.4 10.0 8.5 7.9 8.8 8.7 8.5 7.6 9.4 10.4 26.3 25.6 19.3 6.2 18.3 34.3 23.6 27.4 4.6 28.7 59.1 29.0 16.4 17.2 26.4 25.8 27.1 17.6 29.9 114.8 9.8 17.9 12.8 20.4 28.7 24.8 34.2 36.4 23.3 20.1 14.2 22.0 36.7 32.4 15.2 31.4 14.3 94.2 23.0 28.6 22.6 37.5 26.4 33.6 30.5 17.0 16.8 25.0 23.2 10.3 23.1 12.6 14.4 12.5 17.5 23.0 40.4 17.7 17.0 40.1 98.3 27.2 22.7 26.4 26.3 30.7 28.0 42.1 25.1 26.7 56.1 41.9 18.0 42.4 50.6 52.3 PCSK5 "PC5, PC6, SPC6" ENSG00000099139 "Proprotein convertase subtilisin/kexin type 5" Q92824 9 75890644-76362975 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Pregnancy "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 189.7;Inhibitory neurons: 81.9;NK-cells: 82.4;Oligodendrocyte precursor cells: 149.3;Proximal enterocytes: 99.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 2447.1;neutrophil: 626.3" "Lineage enriched" "Detected in all" 18 "granulocytes: 2447.1" "Cell line enhanced" "Detected in many" "BEWO: 32.6;HaCaT: 46.9;RH-30: 30.4;RPTEC TERT1: 42.5;U-2 OS: 66.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031072 Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 290000 "Cluster 41: Basophils - Cellular respiration" "Cluster 45: Intestine - Brush border" "Cluster 9: U-2 OS - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA031072: AB_10602190" "unprognostic (3.28e-2)" "unprognostic (1.44e-1)" "unprognostic (4.13e-4)" "unprognostic (4.08e-2)" "unprognostic (7.43e-3)" "unprognostic (3.17e-1)" "unprognostic (2.07e-3)" "unprognostic (9.39e-2)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (2.81e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (2.99e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-2)" "unprognostic (1.77e-5)" 17.6 4.2 6.6 5.9 6.6 2.3 6.9 22.2 23.8 9.0 0.0 10.2 25.0 7.1 9.6 8.5 6.9 8.6 5.3 7.4 7.8 3.8 1.7 6.1 2.7 21.7 17.3 13.5 3.0 5.9 2.3 9.4 20.0 3.3 8.4 6.0 3.5 3.0 3.0 3.6 26.4 6.6 23.0 3.3 3.3 6.3 5.3 9.1 4.8 5.4 2.5 5.3 8.8 2.4 2.5 1.8 5.1 3.4 3.2 1.0 32.6 4.7 0.4 0.3 0.0 18.7 2.0 0.8 1.3 0.6 0.1 46.9 2.4 1.4 0.3 0.6 4.1 6.3 4.5 1.6 0.8 1.9 2.8 6.0 0.4 1.0 0.5 0.3 9.6 3.1 7.5 2.4 3.3 11.5 7.4 11.1 22.8 4.3 1.9 1.3 30.4 1.9 42.5 2.9 0.7 0.5 7.1 1.5 0.5 9.5 2.6 8.0 7.6 1.5 66.5 3.8 2.0 0.7 0.3 1.0 5.1 2.7 25.7 2447.1 43.1 192.4 100.0 25.9 85.2 92.3 100.8 93.7 21.8 116.5 98.2 125.2 626.3 135.5 51.6 135.0 96.9 10.1 6.6 6.6 22.2 23.8 7.4 7.8 21.7 17.3 20.0 23.0 5.3 2.4 41.1 6.4 7.2 189.7 0.1 6.5 3.5 8.6 13.6 4.8 0.7 2.0 5.8 11.5 14.3 5.5 0.0 2.1 9.6 47.3 0.0 8.2 19.0 6.0 35.1 19.5 1.2 0.0 33.5 6.1 34.3 26.6 9.7 10.6 0.0 32.1 15.0 0.9 2.9 55.5 81.9 10.2 6.1 4.1 3.9 39.4 20.5 7.5 1.8 70.3 11.4 30.3 82.4 149.3 5.8 10.1 18.5 25.2 0.4 2.9 99.2 4.2 23.4 1.4 19.7 9.1 11.4 1.0 1.9 6.2 3.0 2.5 6.2 5.6 23.9 0.9 PDE4DIP "CMYA2, KIAA0454, KIAA0477, MMGL" ENSG00000178104 "Phosphodiesterase 4D interacting protein" Q5VU43 1 148808181-149048286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "heart muscle: 729.5;skeletal muscle: 2164.0;tongue: 1379.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 702.6;Rod photoreceptor cells: 272.3;Syncytiotrophoblasts: 309.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 289.6;ASC TERT1: 233.8;K-562: 222.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012678 Supported "Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" "HPA012678: AB_1855123" "unprognostic (2.14e-1)" "unprognostic (3.27e-1)" "unprognostic (5.31e-2)" "unprognostic (6.73e-2)" "unprognostic (7.82e-2)" "unprognostic (1.16e-2)" "unprognostic (2.17e-1)" "unprognostic (9.72e-2)" "unprognostic (7.65e-2)" "unprognostic (1.67e-1)" "unprognostic (2.23e-2)" "unprognostic (5.08e-2)" "unprognostic (1.70e-3)" "unprognostic (1.82e-1)" "unprognostic (4.14e-2)" "unprognostic (9.13e-2)" "unprognostic (2.28e-1)" 32.9 16.9 103.0 20.9 82.9 15.8 22.3 142.7 106.1 28.0 32.4 22.5 24.2 17.4 73.5 37.9 19.8 19.5 729.5 115.5 118.5 42.0 63.5 36.1 21.7 102.2 95.6 8.6 21.4 84.6 53.1 68.5 109.7 29.2 25.4 173.3 34.9 22.9 2164.0 26.1 29.4 18.8 96.8 17.2 29.7 9.2 139.9 12.1 16.9 1379.7 23.2 24.0 17.1 114.9 39.2 7.5 10.6 11.6 289.6 233.8 60.7 45.2 42.3 42.7 55.7 35.5 24.1 19.8 13.7 64.5 121.3 19.8 25.7 31.5 72.1 14.7 36.8 10.0 16.2 14.2 76.2 8.8 10.2 167.5 61.9 181.7 97.8 96.9 17.1 16.3 222.1 45.0 76.8 66.2 6.9 5.4 37.1 32.3 15.9 14.6 26.5 7.7 25.4 39.9 50.1 4.7 44.1 123.4 36.1 44.7 37.5 11.7 22.9 49.3 11.2 124.7 100.9 19.9 29.6 29.1 200.6 8.0 30.2 10.6 5.7 4.5 5.3 6.1 5.5 12.0 10.6 7.1 7.0 11.0 8.1 4.5 1.3 4.9 2.1 3.0 14.4 4.8 103.0 82.9 142.7 106.1 115.5 118.5 102.2 95.6 109.7 96.8 139.9 114.9 5.7 51.3 45.1 81.3 24.0 28.8 9.9 19.8 23.3 71.0 16.1 11.3 702.6 24.3 45.4 69.9 114.7 184.6 9.5 24.0 62.6 13.1 38.9 41.1 14.2 15.7 43.2 7.4 85.8 7.1 148.3 54.2 20.4 27.0 13.9 6.1 5.3 80.8 45.0 33.7 81.1 32.0 20.3 46.1 90.4 50.0 10.5 68.7 55.2 6.5 21.5 45.7 14.4 65.9 41.5 4.5 25.1 9.8 37.5 4.1 48.8 20.7 88.0 272.3 32.9 131.2 40.1 8.7 15.9 14.6 16.3 309.2 24.0 4.2 24.2 4.3 PDE8A HsT19550 ENSG00000073417 "Phosphodiesterase 8A" O60658 15 84980440-85139145 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Oligodendrocytes: 968.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RT4: 89.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007722 Approved Approved "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 45: Intestine - Brush border" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA007722: AB_1855130" "unprognostic (1.68e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (4.97e-2)" "unprognostic (6.25e-2)" "unprognostic (3.47e-2)" "unprognostic (2.97e-2)" "unprognostic (3.94e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (8.99e-3)" "unprognostic (2.75e-2)" "unprognostic (3.42e-1)" "unprognostic (3.72e-1)" "unprognostic (4.26e-1)" "unprognostic (1.31e-1)" "unprognostic (1.94e-2)" 16.7 16.6 20.9 8.5 32.3 3.3 10.5 21.9 22.4 11.6 15.2 24.0 15.3 9.1 7.3 6.4 9.0 15.8 8.0 17.3 20.1 24.3 30.0 10.8 5.6 23.8 28.5 12.7 14.5 16.9 6.7 11.4 23.6 6.9 21.9 14.5 6.4 9.6 5.8 6.3 13.6 10.6 19.5 6.3 11.0 11.0 26.9 4.6 12.3 6.5 5.1 17.7 7.0 45.2 29.0 48.4 7.9 5.4 32.7 17.2 9.6 19.4 21.1 16.6 18.9 10.9 16.9 5.8 14.6 25.9 19.7 20.2 33.8 14.9 22.0 10.8 20.2 7.7 30.3 15.6 23.5 4.5 11.3 17.4 9.1 19.6 18.6 14.3 21.6 6.4 15.6 18.3 15.2 24.5 2.6 4.5 3.8 9.5 8.6 3.6 6.5 8.1 13.2 89.0 18.3 14.1 18.9 20.3 55.5 8.7 6.7 8.7 17.1 38.4 13.6 13.9 31.6 8.9 16.7 6.2 26.1 18.1 11.0 0.0 0.9 0.6 0.3 0.7 0.6 0.2 0.5 0.6 0.5 0.3 0.7 0.3 0.0 0.2 1.6 0.0 1.1 0.2 20.9 32.3 21.9 22.4 17.3 20.1 23.8 28.5 23.6 19.5 26.9 45.2 30.7 6.4 26.5 83.9 14.8 11.3 11.1 13.9 18.2 13.0 6.6 5.2 6.8 41.5 15.4 7.3 12.5 8.0 5.5 58.7 7.9 11.3 6.4 12.5 21.6 24.3 14.5 0.8 60.8 9.6 7.1 16.2 26.5 20.6 22.1 17.9 14.3 23.3 10.8 10.1 126.2 19.0 4.1 12.3 18.9 5.6 10.8 19.2 10.6 85.3 9.0 2.6 10.3 119.1 968.6 11.5 31.8 11.3 7.2 25.4 22.1 21.1 10.5 31.2 39.5 17.8 24.5 25.6 17.3 7.5 10.4 4.5 10.8 25.3 28.5 26.4 PDGFA "PDGF-A, PDGF1" ENSG00000197461 "Platelet derived growth factor subunit A" P04085 7 497258-520296 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 89.8;Breast myoepithelial cells: 154.9;Paneth cells: 97.0;Smooth muscle cells: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 11.3" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "WM-115: 311.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005579, HPA065024" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 580000 "Cluster 42: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "CAB005579: AB_2161916, HPA065024: " "unprognostic (2.22e-1)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.63e-3)" "unprognostic (4.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.85e-1)" "unprognostic (8.26e-2)" "unprognostic (1.07e-2)" "unprognostic (5.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (8.67e-4)" 15.4 8.5 29.3 7.9 36.8 1.7 17.0 36.6 32.4 18.1 20.5 29.2 20.2 26.1 11.2 9.6 21.2 11.4 21.1 27.0 27.5 22.2 8.5 24.9 3.5 46.4 37.5 7.7 71.6 6.6 10.2 26.8 40.7 23.3 14.8 5.2 20.3 11.2 95.2 12.5 25.9 10.2 35.8 16.3 32.1 4.5 36.5 6.6 10.0 15.1 2.4 17.8 15.9 58.8 22.9 15.3 1.5 21.6 4.1 0.7 50.7 5.0 2.9 6.4 4.4 23.8 25.3 0.6 8.7 4.3 2.9 56.6 1.5 69.0 3.4 12.9 2.3 0.3 13.3 8.7 26.9 2.4 2.2 3.0 26.8 3.3 21.3 8.5 12.5 1.3 2.3 3.1 15.8 28.7 3.5 5.0 40.1 8.9 3.3 11.6 1.5 2.5 9.0 5.3 2.1 1.8 76.5 4.2 13.3 47.5 10.7 2.6 37.3 13.6 37.8 8.0 31.0 0.9 1.4 0.8 12.3 7.1 311.4 11.3 1.6 2.4 1.6 1.9 2.2 1.9 1.6 1.5 1.5 1.8 1.9 2.0 4.9 3.4 3.3 2.1 1.8 2.1 29.3 36.8 36.6 32.4 27.0 27.5 46.4 37.5 40.7 35.8 36.5 58.8 15.2 89.8 11.9 11.1 1.5 28.0 20.2 12.1 59.7 15.7 12.7 154.9 29.9 15.7 11.0 14.7 8.4 8.8 1.7 76.9 5.9 15.8 0.3 49.0 4.2 19.4 13.1 0.0 7.7 53.3 5.4 12.3 41.8 35.7 10.8 18.1 21.0 1.0 2.0 32.0 5.9 40.5 2.0 1.3 10.4 0.1 2.1 14.8 14.2 6.5 1.5 0.7 1.0 5.0 27.5 72.6 97.0 6.4 4.4 29.4 47.2 8.5 4.5 2.1 39.5 48.9 110.3 0.5 1.8 9.4 9.8 2.9 3.9 0.2 32.1 18.2 PGPEP1 "Pcp, PGP, PGP-I, PGPI" ENSG00000130517 "Pyroglutamyl-peptidase I" Q9NXJ5 19 18340598-18369950 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 73.9;Proximal enterocytes: 88.2;Proximal tubular cells: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 28.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.4" "Cell line enhanced" "Detected in many" "HMC-1: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035368, HPA055277" Approved Approved "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA035368: AB_10601388, HPA055277: AB_2682770" "unprognostic (9.52e-3)" "unprognostic (1.37e-2)" "unprognostic (6.95e-2)" "unprognostic (5.74e-3)" "unprognostic (5.29e-2)" "unprognostic (6.60e-2)" "unprognostic (1.96e-2)" "unprognostic (2.11e-3)" "prognostic favorable (6.80e-4)" "unprognostic (2.79e-2)" "prognostic favorable (1.71e-4)" "unprognostic (4.81e-3)" "prognostic favorable (3.71e-8)" "unprognostic (1.12e-2)" "unprognostic (1.66e-1)" "unprognostic (1.51e-1)" "unprognostic (1.20e-3)" 10.1 27.8 30.1 6.9 30.2 13.1 10.3 27.0 36.7 14.9 38.3 23.5 22.4 11.1 12.8 5.5 12.7 7.9 25.1 31.0 30.6 40.8 48.4 14.3 6.5 35.6 28.9 16.5 34.2 13.9 24.4 5.2 36.2 20.3 15.6 4.2 20.4 12.9 27.1 4.9 30.3 6.4 36.2 23.5 23.6 3.8 30.2 8.2 14.6 14.4 6.3 15.9 8.3 35.5 8.7 13.6 11.1 11.2 13.7 10.8 13.5 10.2 15.9 6.9 10.2 9.7 18.4 13.4 16.7 16.8 12.3 2.3 4.4 2.3 3.8 15.9 4.8 14.7 15.0 27.9 19.4 8.7 58.5 10.9 4.9 5.3 1.0 24.6 10.4 22.8 27.5 19.7 5.8 13.9 8.9 7.0 11.3 6.0 4.2 0.1 4.1 12.1 7.5 13.5 3.9 6.1 1.9 1.1 18.4 7.2 5.1 17.3 16.1 7.9 5.3 10.4 4.4 24.3 12.6 8.2 21.0 24.0 7.4 28.4 5.5 8.1 4.8 5.8 2.9 1.9 3.4 4.5 3.5 5.5 4.2 3.8 3.1 4.8 6.8 2.3 4.2 3.9 30.1 30.2 27.0 36.7 31.0 30.6 35.6 28.9 36.2 36.2 30.2 35.5 7.5 9.6 15.0 10.4 12.2 2.3 10.2 9.5 8.6 4.7 14.3 9.8 20.9 37.1 13.2 31.3 10.4 18.6 21.2 73.9 7.9 20.7 0.8 15.2 8.6 10.0 38.9 10.7 11.3 45.4 26.6 9.6 27.5 14.7 35.4 7.9 13.6 72.5 24.1 5.0 7.9 21.0 8.2 29.0 5.4 1.7 7.8 19.3 16.0 8.4 13.1 8.9 24.7 3.5 4.3 44.4 36.5 20.3 25.8 9.2 88.2 85.7 12.3 7.0 6.6 10.3 9.0 2.9 4.7 1.8 1.1 18.7 15.2 9.4 33.4 16.9 PHKB ENSG00000102893 "Phosphorylase kinase regulatory subunit beta" Q93100 16 47461123-47701523 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" Calmodulin-binding "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 159.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073380 Approved "Golgi apparatus" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA073380: AB_2686598" "unprognostic (2.87e-3)" "unprognostic (2.41e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.98e-2)" "unprognostic (3.98e-2)" "unprognostic (1.28e-2)" "unprognostic (6.73e-2)" "unprognostic (2.99e-2)" "unprognostic (2.35e-3)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "unprognostic (3.01e-2)" "prognostic favorable (3.89e-9)" "unprognostic (3.56e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (2.53e-2)" 29.7 42.4 15.8 21.9 16.2 28.2 36.1 18.3 19.5 33.8 34.1 39.0 37.8 26.8 32.8 34.5 25.6 30.6 32.7 14.3 21.3 47.2 30.1 30.0 26.2 15.8 16.0 24.2 26.6 56.7 21.6 37.1 18.6 36.2 41.5 18.9 46.1 32.2 159.0 18.9 38.0 32.1 13.8 29.0 40.4 30.6 18.9 31.0 54.1 80.7 29.0 26.5 21.2 16.6 36.7 53.3 60.3 39.1 41.2 38.8 74.9 42.8 41.2 30.1 15.0 29.4 62.2 44.5 63.5 62.7 23.7 50.6 57.0 66.9 42.3 13.8 29.8 42.1 45.4 98.3 37.0 46.2 47.7 35.1 33.4 20.3 38.2 65.4 59.8 53.5 58.8 27.4 43.7 26.3 45.2 44.1 25.5 61.1 39.8 75.7 73.3 74.3 59.2 31.1 31.5 35.8 70.9 92.4 12.0 66.1 36.0 37.7 66.5 54.4 25.4 28.0 22.9 31.1 24.6 57.2 34.5 30.2 22.7 11.1 21.0 18.4 11.8 18.9 15.3 30.6 12.2 9.7 20.6 34.7 11.8 11.7 10.4 18.5 23.7 13.9 15.8 12.6 15.8 16.2 18.3 19.5 14.3 21.3 15.8 16.0 18.6 13.8 18.9 16.6 49.3 19.2 38.0 66.9 46.8 8.9 17.5 28.8 18.8 34.9 28.7 23.4 61.2 32.9 39.9 42.3 100.1 48.5 29.3 43.1 23.5 19.6 64.7 33.5 31.1 42.9 30.5 40.1 109.8 15.6 26.3 28.8 47.9 38.3 18.3 52.6 39.3 30.9 28.4 23.5 149.0 37.8 20.3 58.7 17.0 89.8 25.4 45.1 8.8 104.0 72.2 25.8 32.0 133.2 118.4 27.2 26.4 35.7 28.1 30.2 48.9 35.9 26.7 71.8 26.3 33.3 30.6 53.9 19.5 47.2 7.2 33.8 24.7 74.9 38.6 26.7 PI4KB "PI4K-BETA, pi4K92, PIK4CB" ENSG00000143393 "Phosphatidylinositol 4-kinase beta" Q9UBF8 1 151291797-151327715 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006280, HPA006281, CAB022071" Approved Supported "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614" "unprognostic (1.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.42e-3)" "unprognostic (5.23e-3)" "unprognostic (7.32e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.25e-5)" "unprognostic (8.51e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.53e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (7.08e-2)" 45.6 45.0 57.3 33.1 61.4 78.0 47.6 64.4 63.2 62.6 53.2 50.9 35.8 58.8 54.8 48.0 58.6 40.2 45.8 59.2 62.3 50.4 40.5 47.2 46.8 57.9 60.7 60.2 46.1 56.0 56.5 39.6 60.4 57.6 44.0 46.4 45.8 42.6 68.5 60.5 47.0 62.2 54.4 59.8 48.0 46.0 61.0 45.7 67.8 58.6 47.5 48.9 51.3 68.2 49.2 40.1 34.2 53.9 92.8 68.1 28.9 50.9 88.3 65.3 53.8 51.7 43.4 46.1 57.1 78.5 41.1 44.9 57.3 52.5 50.1 63.0 50.9 33.0 48.8 26.6 64.8 38.5 60.9 71.7 62.4 72.3 51.3 56.3 63.7 46.3 57.5 67.9 56.0 91.2 41.0 30.9 27.6 69.5 60.3 36.2 28.8 54.4 45.2 61.2 41.3 35.4 35.5 71.1 46.7 53.9 60.1 71.9 50.3 46.5 36.3 37.3 55.1 71.6 50.4 89.8 52.9 39.7 82.3 41.3 22.7 36.0 17.8 24.7 19.9 20.4 18.5 23.6 24.3 16.7 15.1 14.3 21.0 19.3 26.3 13.9 20.0 23.9 57.3 61.4 64.4 63.2 59.2 62.3 57.9 60.7 60.4 54.4 61.0 68.2 16.8 16.0 24.3 19.2 26.4 22.3 18.2 17.7 28.5 33.5 24.3 24.6 7.0 21.5 17.7 12.9 20.9 30.1 16.0 28.7 19.6 20.9 12.2 21.5 19.9 19.3 18.5 26.9 17.8 24.9 20.5 25.9 23.0 24.6 19.0 30.0 15.4 12.4 29.2 35.3 19.0 16.4 10.2 20.1 20.5 15.5 23.3 21.3 14.2 15.9 29.3 23.1 21.6 18.1 25.8 23.5 17.3 24.8 24.4 17.7 25.7 15.2 17.1 28.4 13.1 24.2 23.2 28.9 25.1 24.8 31.1 48.7 23.8 44.7 20.2 28.1 PLCXD3 ENSG00000182836 "Phosphatidylinositol specific phospholipase C X domain containing 3" Q63HM9 5 41306952-41510628 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;heart muscle: 33.2;ovary: 22.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 138.2;Endometrial stromal cells: 58.7;Enteroendocrine cells: 42.4;Inhibitory neurons: 163.5;Microglial cells: 52.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.5;PC-3: 7.5;SH-SY5Y: 34.3;TIME: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046849 Uncertain Approved "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA046849: AB_2679838" "unprognostic (1.71e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (7.04e-3)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (4.90e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-2)" "unprognostic (3.12e-1)" "unprognostic (6.38e-3)" "unprognostic (2.57e-1)" "unprognostic (2.73e-2)" "unprognostic (2.15e-3)" "unprognostic (5.91e-5)" "unprognostic (5.11e-2)" "unprognostic (6.75e-2)" 3.9 12.7 4.5 0.5 4.1 0.0 2.4 17.8 4.2 2.9 1.1 0.9 0.5 1.1 0.9 0.6 3.4 2.4 33.2 3.4 9.5 5.9 1.6 1.8 1.6 8.2 10.4 22.5 3.6 0.3 5.3 0.1 16.0 1.0 0.6 0.7 0.4 1.0 0.5 0.7 1.2 1.2 7.7 0.2 5.0 0.4 12.1 0.5 1.5 0.7 0.2 1.4 4.0 6.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.4 34.3 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 4.1 17.8 4.2 3.4 9.5 8.2 10.4 16.0 7.7 12.1 6.3 8.7 0.0 0.0 7.5 0.1 0.1 0.1 0.0 0.0 0.7 0.1 0.0 138.2 5.7 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.3 0.9 1.7 58.7 13.6 42.4 5.3 27.8 0.0 2.0 10.3 0.0 1.1 0.0 33.4 33.2 0.4 0.1 1.7 163.5 2.2 0.0 0.6 0.3 4.4 7.8 0.2 0.0 52.5 0.0 0.4 0.0 7.5 1.3 0.9 0.0 0.4 0.0 0.3 0.1 10.4 0.0 0.2 6.6 0.2 2.9 0.2 0.0 0.2 0.0 0.1 0.3 9.7 0.1 0.1 PLEKHA3 FAPP1 ENSG00000116095 "Pleckstrin homology domain containing A3" Q9HB20 2 178480457-178516463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 196.2;Late spermatids: 413.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034496, HPA034497" Approved Enhanced "Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA034496: AB_2674189, HPA034497: AB_10603126" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" "unprognostic (5.93e-2)" "unprognostic (3.74e-2)" "unprognostic (1.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.22e-3)" "unprognostic (8.83e-2)" "unprognostic (4.02e-2)" "unprognostic (8.23e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.79e-2)" "unprognostic (2.29e-1)" "unprognostic (3.51e-2)" "unprognostic (8.52e-2)" 3.6 6.6 4.1 3.9 4.7 5.4 3.0 7.1 5.9 3.4 5.9 4.0 4.6 3.5 6.2 3.2 3.5 3.0 6.3 4.2 4.2 4.7 4.1 3.2 3.6 3.8 4.2 3.8 2.7 4.6 4.2 2.7 4.1 3.6 2.6 8.0 2.7 4.3 2.7 1.7 3.4 3.4 4.0 3.4 3.9 10.0 4.3 1.3 3.7 3.2 2.8 3.7 2.5 5.1 4.1 2.7 3.1 4.0 6.0 3.2 5.9 6.6 5.0 3.2 3.5 1.1 2.7 3.5 8.3 4.7 9.0 2.8 2.9 1.7 6.0 10.8 2.8 5.5 2.7 3.2 4.2 3.5 6.0 2.9 5.6 5.9 3.7 5.7 2.9 3.1 2.6 5.4 4.3 1.3 4.7 5.1 5.2 2.9 3.9 2.5 4.6 6.1 4.1 2.4 3.2 4.5 3.3 2.4 10.4 4.3 2.8 6.1 3.3 6.3 6.1 8.0 7.4 6.7 14.2 3.5 8.2 2.9 3.7 0.5 0.2 0.3 0.4 0.2 0.4 0.5 0.7 0.5 0.2 1.5 0.4 0.5 0.6 0.8 0.4 0.6 0.3 0.1 4.1 4.7 7.1 5.9 4.2 4.2 3.8 4.2 4.1 4.0 4.3 5.1 56.7 16.0 14.6 9.8 32.7 43.2 48.4 12.6 50.7 90.3 39.6 35.2 56.1 32.9 13.4 27.6 41.7 29.2 53.6 15.3 78.2 36.9 196.2 44.9 39.5 44.9 25.8 35.3 15.8 47.3 18.6 43.0 21.4 38.0 10.8 23.7 39.3 42.8 15.8 132.9 20.4 23.3 12.2 28.3 44.9 413.6 34.8 33.1 30.2 18.7 28.6 56.7 40.2 11.6 18.5 45.0 11.3 52.3 39.9 91.7 20.0 67.9 17.9 64.0 78.9 54.2 54.4 66.0 41.5 28.6 30.4 30.5 44.0 44.8 19.0 79.7 PLEKHH3 FLJ21019 ENSG00000068137 "Pleckstrin homology, MyTH4 and FERM domain containing H3" Q7Z736 17 42667914-42676994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 45.5;T-47d: 48.7;U-266/84: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046234 Uncertain Approved "Golgi apparatus" NA NA "Cluster 50: Non-specific - Ribosome" "Cluster 16: U-266 - Nucleosome" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA046234: AB_2679597" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.75e-2)" "unprognostic (5.72e-3)" "unprognostic (1.25e-1)" "unprognostic (3.42e-3)" "unprognostic (5.05e-3)" "unprognostic (5.95e-2)" "unprognostic (6.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.51e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (9.62e-5)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (9.30e-3)" "unprognostic (1.44e-3)" 10.3 11.1 1.3 1.9 1.6 5.2 10.6 3.7 2.4 16.9 0.3 10.6 3.8 15.3 1.6 17.7 16.8 2.8 9.5 0.6 1.3 5.5 7.8 10.1 1.2 2.2 2.4 15.1 41.3 5.2 9.3 3.5 2.0 11.2 1.1 1.3 9.8 6.5 25.8 11.9 4.8 3.6 1.1 4.4 15.6 7.3 2.5 2.5 8.5 4.9 1.2 12.0 14.4 1.2 13.7 12.2 5.7 9.3 7.0 2.9 10.3 5.2 4.7 3.9 3.7 5.7 7.4 2.0 6.1 5.9 6.6 25.1 4.1 6.7 1.2 12.8 9.0 0.9 26.6 4.9 7.6 0.2 8.7 4.8 11.0 5.1 0.8 3.9 2.7 0.8 15.5 30.1 1.7 24.6 0.7 11.0 2.1 6.9 10.8 2.1 5.6 45.5 1.4 15.1 20.4 22.1 8.1 11.1 12.0 1.3 48.7 11.2 4.0 12.2 11.3 14.2 9.3 36.0 42.9 10.5 8.9 3.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.6 3.7 2.4 0.6 1.3 2.2 2.4 2.0 1.1 2.5 1.2 13.4 12.8 13.1 16.3 1.7 15.6 22.9 10.3 41.5 63.2 32.4 29.7 11.3 12.8 9.4 9.2 22.9 11.3 2.1 7.6 0.0 2.7 9.8 15.5 18.4 11.2 7.7 24.4 7.0 7.6 4.4 17.0 30.5 18.3 2.5 2.9 12.8 11.8 2.2 33.7 11.3 5.8 12.2 3.5 11.3 2.7 17.7 2.4 16.0 4.7 1.0 18.0 0.0 6.6 3.9 5.6 1.7 22.6 10.5 12.4 0.7 3.2 7.0 23.1 26.3 16.0 38.0 5.1 16.6 49.4 18.6 6.2 1.8 7.7 6.4 20.0 PLPP3 "LPP3, PAP-2b, PPAP2B" ENSG00000162407 "Phospholipid phosphatase 3" O14495 1 56494761-56645301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 168.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.4;naive B-cell: 2.3" "Lineage enriched" "Detected in single" 6 "B-cells: 2.4" "Cell line enhanced" "Detected in many" "ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4" "Low region specificity" "Detected in all" HPA072751 Approved Supported "Golgi apparatus" NA Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA072751: AB_2686555" "unprognostic (2.50e-2)" "unprognostic (3.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.65e-1)" "unprognostic (2.71e-1)" "unprognostic (2.22e-3)" "unprognostic (5.86e-3)" "unprognostic (7.25e-2)" "unprognostic (1.59e-1)" "unprognostic (3.75e-2)" "unprognostic (3.91e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.59e-4)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (3.54e-2)" "unprognostic (2.09e-1)" 168.4 53.0 93.9 33.6 94.2 13.1 139.8 87.3 105.9 294.6 50.7 56.7 24.0 107.2 56.2 51.3 122.5 66.3 84.6 88.3 90.6 91.4 182.0 87.0 22.4 107.5 108.1 81.9 36.8 130.2 23.1 225.5 87.7 102.8 41.8 19.0 76.2 169.7 50.9 82.1 45.8 65.6 86.8 23.3 66.0 37.3 113.2 29.8 327.6 63.0 19.9 139.2 142.8 88.6 3.3 10.8 14.1 1.5 710.0 351.8 34.5 39.3 39.7 35.5 17.4 31.8 6.2 5.2 4.6 59.3 39.4 5.9 2.1 0.8 7.4 0.0 9.4 1.3 4.4 44.5 17.3 0.1 0.0 438.1 3.0 34.2 28.6 25.1 34.1 0.4 2.9 0.1 39.0 3.2 0.1 0.5 43.3 9.2 42.6 0.1 0.1 1.7 6.1 32.6 0.4 28.1 12.4 16.1 4.2 42.6 5.2 0.0 21.6 176.2 14.4 660.4 1.8 0.0 0.0 0.0 31.0 1.7 12.7 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 93.9 94.2 87.3 105.9 88.3 90.6 107.5 108.1 87.7 86.8 113.2 88.6 148.5 25.6 18.9 0.0 7.2 0.0 19.8 0.0 35.3 3.9 12.2 31.2 0.0 44.3 13.0 22.0 0.0 127.0 1.1 8.1 21.5 21.5 7.9 13.9 139.4 148.3 2.4 8.0 0.0 9.2 9.8 392.7 5.6 16.3 3.8 8.1 779.6 132.6 38.8 0.0 0.0 8.5 0.0 35.2 0.0 28.3 1092.6 14.9 0.0 0.0 0.9 136.0 0.0 0.0 0.0 7.9 5.9 398.7 7.1 20.8 15.5 21.3 4.4 4.1 138.1 179.7 107.2 4.5 3.4 16.4 0.0 214.9 5.0 22.4 7.2 20.1 POC1B-GALNT4 ENSG00000259075 "POC1B-GALNT4 readthrough" 12 89519408-89526262 "Metabolic proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "B-cells: 2.5;Basal squamous epithelial cells: 3.4;Club cells: 3.1;Erythroid cells: 3.0;Gastric mucus-secreting cells: 2.6;Glandular and luminal cells: 2.5;Respiratory ciliated cells: 2.9;Squamous epithelial cells: 1.8;T-cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 10.2" HPA076116 Approved "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA076116: AB_2686778" "unprognostic (4.91e-2)" "unprognostic (5.00e-2)" "unprognostic (1.26e-1)" "unprognostic (2.77e-6)" "unprognostic (7.99e-2)" "unprognostic (1.55e-2)" "unprognostic (2.26e-1)" "unprognostic (2.64e-1)" "unprognostic (7.67e-2)" "unprognostic (2.44e-1)" "unprognostic (7.72e-3)" "unprognostic (1.95e-1)" "unprognostic (1.61e-4)" "unprognostic (7.65e-3)" "unprognostic (1.05e-1)" "unprognostic (2.15e-2)" "unprognostic (5.16e-2)" 0.9 0.3 0.2 1.6 0.5 2.8 0.4 0.7 0.5 0.5 0.0 0.8 1.7 1.1 0.0 0.5 1.1 1.3 0.4 0.4 0.6 0.5 0.4 0.5 0.8 0.5 0.4 0.8 0.4 0.5 0.4 0.5 0.5 0.5 1.0 1.3 1.4 0.1 0.8 0.5 0.9 0.4 0.2 0.7 2.0 0.9 0.6 0.4 0.7 0.2 0.5 0.6 0.5 0.6 1.1 1.0 2.2 10.2 0.3 0.2 0.6 0.4 0.9 1.4 1.0 0.9 0.8 0.9 0.2 1.1 0.9 0.8 2.1 0.7 1.5 2.2 1.3 1.6 1.3 1.8 0.0 1.3 1.8 0.0 0.6 1.5 0.8 1.4 1.2 1.6 1.1 0.6 0.4 0.6 1.3 1.5 0.7 2.1 3.9 1.5 1.4 2.6 0.8 1.5 0.9 1.1 1.2 1.0 0.5 0.7 2.0 1.5 1.4 1.5 0.8 0.7 1.2 0.9 1.7 1.2 1.1 1.1 1.4 1.1 0.8 0.8 0.9 0.9 1.5 0.3 0.6 0.7 0.6 0.7 0.7 0.8 1.7 0.8 1.1 0.4 0.7 0.6 0.2 0.5 0.7 0.5 0.4 0.6 0.5 0.4 0.5 0.2 0.6 0.6 0.3 0.0 0.6 0.0 2.5 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.1 0.0 3.0 0.0 0.0 0.0 0.3 2.6 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 1.8 0.1 0.2 0.1 POMT1 LGMD2K ENSG00000130714 "Protein O-mannosyltransferase 1" Q9Y6A1 9 131502789-131523806 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 64.5;Spermatocytes: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065252 Uncertain "Golgi apparatus" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA065252: AB_2685445" "unprognostic (2.00e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (5.09e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (5.35e-3)" "unprognostic (1.14e-1)" "unprognostic (9.76e-3)" "unprognostic (2.84e-1)" "prognostic favorable (3.90e-5)" "unprognostic (8.36e-2)" "prognostic favorable (4.68e-5)" "unprognostic (2.41e-2)" "unprognostic (1.61e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-1)" 15.7 20.9 16.6 7.6 16.7 6.6 16.2 18.4 21.0 21.1 15.0 24.8 9.0 17.1 7.2 15.2 18.4 9.3 24.5 25.5 16.0 25.5 24.4 15.6 8.3 16.0 16.2 25.6 25.9 15.5 31.3 9.7 16.5 28.4 6.5 8.1 20.1 8.7 32.9 17.5 19.9 7.1 14.2 22.2 20.4 63.7 16.9 7.1 19.0 13.4 5.4 16.5 17.1 15.5 9.8 17.4 10.5 26.4 19.3 13.5 24.5 12.1 17.0 21.3 14.1 15.8 14.7 2.5 16.9 26.4 8.6 24.1 17.3 16.6 5.9 16.2 21.6 4.2 28.5 7.8 23.1 13.1 10.5 10.8 10.0 12.3 5.0 17.6 15.1 16.4 13.4 15.6 23.2 27.6 15.8 25.2 6.7 9.6 21.1 15.7 13.8 24.6 18.1 1.5 15.0 14.1 25.1 26.8 13.0 5.8 31.4 17.7 20.9 13.8 2.2 28.6 10.3 7.3 7.0 5.2 8.7 29.1 13.0 0.0 2.8 3.4 5.2 3.0 7.7 1.9 5.0 5.3 4.0 2.6 4.8 3.6 0.6 3.2 2.9 2.4 5.2 4.0 16.6 16.7 18.4 21.0 25.5 16.0 16.0 16.2 16.5 14.2 16.9 15.5 5.9 9.6 16.0 18.6 7.1 4.5 4.9 7.2 5.7 13.2 7.8 8.6 9.7 10.0 8.7 12.9 8.4 20.8 6.5 12.9 1.9 10.7 64.5 9.6 7.3 8.0 7.8 1.3 21.5 6.7 12.9 9.0 9.2 9.9 2.5 15.1 11.0 10.1 10.8 21.9 25.9 8.4 10.2 5.4 5.9 33.0 8.7 5.6 5.4 15.9 7.5 12.3 5.2 18.6 11.1 8.1 6.0 10.1 6.8 4.9 14.2 7.5 6.8 16.6 6.6 7.5 7.2 71.6 9.6 5.7 3.0 17.5 9.0 6.2 9.1 2.6 PPP1R15B FLJ14744 ENSG00000158615 "Protein phosphatase 1 regulatory subunit 15B" Q5SWA1 1 204403381-204411817 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" "Diabetes mellitus, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 125.7" "Cell type enhanced" "Detected in all" "Langerhans cells: 171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061088 Approved "Golgi apparatus" No No "Cluster 18: Basophils - Vesicular transport" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA061088: AB_2684426" "unprognostic (2.91e-3)" "unprognostic (8.61e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-3)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (5.31e-2)" "unprognostic (2.66e-2)" "unprognostic (7.37e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.74e-5)" "unprognostic (9.52e-3)" "unprognostic (2.47e-1)" "unprognostic (2.99e-2)" "unprognostic (7.50e-2)" 40.7 23.1 12.9 31.0 15.3 125.7 23.0 17.8 13.9 19.6 16.4 23.4 22.4 21.4 13.1 25.9 21.5 30.8 13.0 11.7 13.2 21.0 48.1 24.2 29.1 14.4 15.2 24.5 36.8 18.7 10.5 32.6 14.6 22.5 24.1 16.0 22.1 15.9 13.2 18.1 24.3 29.9 14.6 23.8 27.0 11.7 15.2 33.3 28.2 18.2 24.7 53.2 14.7 19.7 29.3 23.0 26.9 22.8 34.1 23.2 108.7 23.6 28.3 31.9 28.7 27.6 40.3 48.2 16.0 28.9 22.2 36.3 40.2 23.9 29.5 37.3 28.7 28.5 55.7 17.8 41.5 49.1 49.0 29.3 30.4 31.4 34.5 22.9 35.1 40.4 44.4 92.8 21.8 29.1 47.1 30.6 46.2 26.8 32.9 33.2 48.9 49.8 32.0 35.4 25.7 39.3 42.6 59.8 49.3 36.0 39.4 50.2 19.8 22.2 31.3 28.6 40.3 62.5 30.0 47.3 20.0 33.1 23.4 13.1 5.5 5.7 3.2 5.1 3.4 2.0 3.2 3.0 5.0 2.1 4.9 3.5 11.8 3.2 6.2 2.0 4.4 2.9 12.9 15.3 17.8 13.9 11.7 13.2 14.4 15.2 14.6 14.6 15.2 19.7 72.2 48.1 37.9 15.3 40.8 73.7 43.0 23.1 48.3 18.5 43.7 24.6 15.6 32.9 25.9 18.4 20.9 22.9 40.3 70.4 3.9 15.9 9.0 72.0 90.8 50.9 44.7 27.3 12.3 24.0 42.7 54.7 76.5 146.7 49.4 31.0 28.9 48.6 31.8 8.4 13.0 43.3 22.4 42.0 171.9 4.6 13.1 97.9 49.8 10.3 36.8 14.4 11.3 18.1 23.2 30.3 40.5 12.8 50.9 55.0 39.5 11.0 43.0 18.5 6.6 72.7 48.6 17.2 13.2 39.8 64.2 49.3 46.8 31.2 35.6 104.5 PPP2R3A "PPP2R3, PR130, PR72" ENSG00000073711 "Protein phosphatase 2 regulatory subunit B''alpha" Q06190 3 135965728-136147894 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 51.2;skeletal muscle: 180.5;tongue: 117.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.3;Oligodendrocytes: 201.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 37.4;BJ hTERT+: 35.3;RPTEC TERT1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035829, HPA035830, HPA065338" Uncertain Approved "Golgi apparatus" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" "HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475" "unprognostic (3.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.71e-1)" "unprognostic (4.04e-1)" "unprognostic (1.44e-4)" "unprognostic (9.43e-2)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (8.92e-2)" "prognostic favorable (1.15e-5)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.91e-4)" 3.1 3.4 3.3 2.3 7.2 0.2 7.1 4.3 5.0 5.2 3.9 8.0 2.0 7.7 5.1 8.3 4.1 5.0 51.2 4.2 4.9 22.0 1.1 3.9 0.6 5.7 5.5 5.6 3.4 11.7 1.8 2.8 5.3 5.9 5.4 2.6 8.9 6.5 180.5 18.9 2.3 9.6 4.3 1.1 7.4 7.2 6.0 0.6 3.1 117.6 1.2 4.5 4.0 13.7 37.4 2.0 10.3 5.0 8.1 10.2 11.9 28.5 35.3 13.2 16.3 2.4 2.4 0.1 10.7 29.3 9.5 4.7 4.3 10.0 28.3 0.1 1.4 1.6 1.0 0.1 5.8 0.0 1.4 9.3 8.5 16.8 7.8 13.3 12.8 1.0 1.0 0.1 19.2 6.2 0.3 0.2 7.2 0.4 6.9 0.1 15.1 0.1 46.2 1.4 0.7 5.7 4.7 5.7 10.9 9.2 9.1 0.5 8.4 13.7 7.5 18.8 12.7 0.4 1.0 0.1 10.1 0.8 4.9 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 3.3 7.2 4.3 5.0 4.2 4.9 5.7 5.5 5.3 4.3 6.0 13.7 7.9 28.9 27.6 51.6 2.8 26.4 19.5 7.1 19.4 5.7 19.9 15.5 115.3 8.6 10.0 55.2 0.0 10.9 6.7 25.3 21.5 20.6 8.4 9.9 19.0 11.4 13.1 0.4 35.2 9.9 15.4 14.8 21.9 16.1 3.8 15.7 8.6 2.9 2.5 3.3 47.2 6.9 6.1 2.4 9.8 10.7 24.5 3.2 28.4 13.1 9.6 8.9 2.1 72.4 201.1 17.2 10.6 18.4 1.5 17.8 21.7 40.1 8.1 2.6 6.6 29.0 14.0 10.1 18.6 15.3 33.2 10.4 3.4 6.7 8.9 15.6 PRAM1 PML-RAR ENSG00000133246 "PML-RARA regulated adaptor molecule 1" Q96QH2 19 8490056-8502640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 97.0" "Group enriched" "Detected in many" 4 "Hofbauer cells: 30.0;Kupffer cells: 71.5;Macrophages: 49.0;monocytes: 70.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 95.4;intermediate monocyte: 101.3;myeloid DC: 58.6;neutrophil: 54.0;non-classical monocyte: 121.4" "Group enriched" "Detected in many" 7 "dendritic cells: 58.6;granulocytes: 54.0;monocytes: 121.4" "Cell line enhanced" "Detected in some" "HL-60: 23.3;NB-4: 19.4;THP-1: 39.4;U-937: 127.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045236, HPA050161" Approved Approved "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "HPA045236: AB_2679267, HPA050161: AB_2681036" "unprognostic (1.68e-2)" "unprognostic (3.79e-3)" "unprognostic (1.15e-2)" "unprognostic (3.91e-3)" "unprognostic (1.25e-1)" "unprognostic (6.54e-3)" "unprognostic (3.36e-1)" "unprognostic (1.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.28e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.73e-1)" "unprognostic (2.15e-3)" "unprognostic (2.72e-1)" "unprognostic (6.12e-3)" 1.8 1.4 2.8 10.9 3.5 97.0 1.2 3.5 3.9 2.2 1.3 0.9 2.7 1.4 0.2 0.8 2.0 2.0 0.8 2.7 7.2 1.0 2.6 9.8 1.3 11.1 5.8 1.4 1.2 0.3 1.6 1.0 7.4 3.3 0.5 0.8 1.4 0.4 0.6 1.5 2.9 2.2 4.8 12.8 1.1 1.0 7.0 1.0 1.7 0.3 0.4 1.2 1.2 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.1 23.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.1 19.4 0.2 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.4 0.3 0.0 0.1 0.1 0.1 0.7 0.8 0.3 0.0 127.6 0.0 2.8 95.4 3.3 0.2 101.3 0.3 0.1 0.1 0.2 58.6 0.0 0.0 0.4 54.0 11.5 121.4 3.0 0.1 41.9 2.8 3.5 3.5 3.9 2.7 7.2 11.1 5.8 7.4 4.8 7.0 6.3 0.3 6.4 5.0 1.3 0.9 0.4 1.1 0.3 0.0 3.2 0.4 1.0 0.8 4.3 3.2 0.0 0.0 0.3 3.1 0.1 0.0 0.0 0.0 0.3 0.4 1.3 0.0 3.8 0.9 0.0 0.4 0.5 0.0 0.3 2.5 0.6 2.9 0.2 30.0 1.7 1.1 0.2 2.0 71.5 2.0 0.4 0.6 49.0 0.0 12.2 70.1 0.4 3.1 0.0 1.6 0.0 0.0 1.5 0.3 0.3 0.0 0.2 0.2 1.3 0.0 0.5 0.2 0.2 1.8 0.4 0.1 0.3 1.9 1.1 0.0 0.8 PROSER3 "C19orf55, FLJ30657" ENSG00000167595 "Proline and serine rich 3" Q2NL68 19 35758143-35771028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 89.6;Rod photoreceptor cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 10.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058492 Approved Approved "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA058492: AB_2683733" "unprognostic (1.35e-2)" "unprognostic (1.29e-2)" "unprognostic (6.74e-3)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (9.29e-3)" "unprognostic (1.25e-3)" "unprognostic (5.13e-2)" "unprognostic (2.52e-1)" "unprognostic (1.28e-1)" "unprognostic (2.52e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (3.74e-7)" "unprognostic (8.60e-2)" "unprognostic (2.41e-1)" "unprognostic (2.87e-2)" "unprognostic (9.54e-2)" 2.3 2.4 3.4 4.3 3.7 5.2 2.3 2.3 5.2 3.4 6.7 2.9 1.8 3.8 2.8 2.5 4.3 3.3 2.5 2.8 0.6 1.9 1.3 2.7 3.0 3.6 2.7 4.1 5.1 3.1 3.8 2.8 1.6 2.4 1.9 3.6 2.6 3.1 1.7 5.8 2.6 3.3 0.0 2.9 4.0 8.8 2.6 4.6 3.8 1.4 2.6 3.1 2.9 2.5 9.3 26.7 9.4 9.3 3.7 3.8 3.1 6.7 7.6 7.3 7.7 8.2 6.3 5.2 7.3 6.4 3.5 5.5 4.0 11.8 4.9 12.5 6.8 7.5 12.2 3.4 3.2 6.0 15.6 4.6 6.5 10.2 9.0 5.7 3.2 6.7 6.6 9.3 6.4 4.6 10.7 2.5 2.6 5.4 3.9 8.2 2.3 3.9 4.7 9.8 9.2 8.1 7.4 5.4 1.0 3.5 8.7 5.1 8.2 7.7 8.1 8.0 7.2 11.9 8.6 4.2 8.0 3.8 6.1 5.7 1.7 4.0 1.1 1.0 1.9 2.4 1.7 1.0 0.4 2.6 1.4 0.5 10.3 0.8 1.0 1.5 1.6 0.2 3.4 3.7 2.3 5.2 2.8 0.6 3.6 2.7 1.6 0.0 2.6 2.5 2.6 9.6 1.5 1.6 7.4 0.0 12.8 0.0 6.2 10.8 3.1 2.9 1.4 8.6 1.8 11.0 89.6 8.2 9.4 5.3 0.0 5.9 30.0 8.9 6.3 3.4 9.5 9.5 3.7 1.9 5.4 5.6 10.2 3.6 2.5 4.4 7.5 2.6 2.8 6.7 2.1 3.9 0.0 2.8 0.0 21.2 14.3 3.3 0.0 1.0 7.0 6.0 13.4 1.0 2.1 5.3 3.4 4.1 3.4 9.2 5.3 1.8 14.6 39.5 6.6 7.9 5.0 27.2 6.5 4.0 0.0 7.3 6.6 15.4 4.7 5.7 PRRG4 TMG4 ENSG00000135378 "Proline rich and Gla domain 4" Q9BZD6 11 32829927-32858120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 124.3;Basal squamous epithelial cells: 145.1;Prostatic glandular cells: 153.9;Squamous epithelial cells: 141.8;Suprabasal keratinocytes: 141.5;Urothelial cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "neutrophil: 11.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.9" "Cell line enhanced" "Detected in many" "HaCaT: 52.7;hTCEpi: 28.0;SK-BR-3: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009040, HPA024566" Uncertain Approved "Golgi apparatus" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA009040: AB_1079694, HPA024566: AB_2237712" "unprognostic (3.30e-1)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (6.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.06e-1)" "unprognostic (4.13e-1)" "unprognostic (3.24e-2)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (2.26e-3)" "unprognostic (3.16e-2)" "unprognostic (1.99e-1)" "unprognostic (2.41e-1)" "unprognostic (1.26e-2)" 1.1 1.6 0.7 2.0 0.9 4.6 7.2 0.7 0.8 7.5 2.1 6.9 7.5 1.4 6.1 23.4 5.4 3.4 1.3 0.7 1.5 13.3 22.6 6.4 1.1 1.1 0.9 0.3 3.9 2.9 2.8 5.8 1.1 6.3 6.3 0.2 10.0 6.0 1.1 20.8 7.4 0.9 0.7 3.0 5.4 0.5 1.0 3.6 5.5 1.4 6.6 6.8 13.7 1.3 13.2 0.4 0.1 0.1 0.3 0.0 5.4 0.1 6.5 1.5 2.6 6.2 12.7 0.1 0.4 0.0 3.3 52.7 1.3 3.2 0.4 0.4 8.7 2.7 1.8 0.4 0.0 0.9 2.4 0.4 28.0 0.5 0.1 2.2 0.0 0.0 0.0 0.7 0.5 5.9 1.1 6.0 0.6 10.7 1.5 0.1 0.0 1.6 9.6 16.5 1.8 0.1 8.8 22.0 2.8 1.6 16.0 12.8 0.1 0.6 0.8 2.9 1.3 5.8 4.3 0.1 1.6 7.5 2.5 0.8 2.3 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 11.9 0.2 0.8 0.2 0.1 0.5 0.7 0.9 0.7 0.8 0.7 1.5 1.1 0.9 1.1 0.7 1.0 1.3 4.2 28.9 23.0 1.0 2.8 124.3 92.5 53.6 145.1 0.1 43.0 21.1 1.0 95.8 33.9 47.8 0.0 24.4 1.7 46.8 7.9 31.5 0.7 75.5 7.4 10.2 13.8 2.5 0.3 36.3 16.8 3.6 25.0 81.9 0.0 6.0 8.9 57.1 8.1 1.7 0.3 34.7 24.4 50.0 15.4 0.3 0.3 12.6 12.4 4.7 40.2 0.1 0.0 1.0 0.1 26.4 19.5 1.5 6.9 153.9 48.3 21.4 51.1 0.2 6.6 2.5 8.8 2.4 4.1 141.8 141.5 82.0 2.6 0.2 47.0 167.4 PTCH1 "BCNS, NBCCS, PTCH" ENSG00000185920 "Patched 1" Q13635 9 95442980-95517057 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, Disease variant, Holoprosencephaly, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 26.7" "Cell type enhanced" "Detected in many" "Late spermatids: 237.5;Leydig cells: 191.0;Peritubular cells: 444.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 6.1" "Lineage enriched" "Detected in single" 9 "T-cells: 6.1" "Cell line enhanced" "Detected in many" "NTERA-2: 29.6;WM-115: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013717, HPA075072" Uncertain Approved "Golgi apparatus" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "CAB013717: , HPA075072: AB_2686733" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (3.16e-1)" "unprognostic (1.79e-2)" "unprognostic (3.22e-2)" "unprognostic (9.01e-2)" "unprognostic (2.13e-1)" "unprognostic (3.54e-3)" "unprognostic (2.63e-1)" "unprognostic (8.66e-3)" "unprognostic (1.52e-2)" "unprognostic (2.82e-1)" "unprognostic (1.13e-6)" "unprognostic (8.63e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-1)" "unprognostic (2.82e-1)" 3.0 3.5 9.5 4.0 11.6 0.7 2.8 24.6 5.6 26.7 2.7 11.3 8.1 15.6 2.7 2.9 7.1 8.1 2.9 4.7 17.8 4.6 2.2 5.5 2.2 16.0 12.7 5.0 6.4 2.5 2.1 3.8 8.0 6.8 12.3 8.3 7.5 4.0 3.0 3.2 11.6 2.4 7.0 3.3 12.5 14.5 24.0 2.1 4.7 4.8 3.0 7.2 2.9 4.5 10.1 4.7 20.3 12.9 3.0 5.0 11.4 1.9 1.7 2.2 1.4 4.9 4.8 8.0 3.3 3.8 4.4 22.3 11.7 1.6 1.4 7.9 7.8 0.0 4.8 2.3 2.7 0.2 4.2 4.7 2.4 2.2 1.4 4.3 4.2 3.5 7.3 9.1 1.0 1.9 0.1 3.2 29.6 7.2 1.8 0.0 15.5 4.2 1.6 1.5 13.8 7.0 7.1 6.8 2.9 18.8 1.8 2.1 1.1 2.6 12.9 13.6 1.5 18.0 16.8 5.3 3.8 3.9 71.0 0.0 0.0 0.0 6.1 0.0 3.3 0.7 1.1 2.5 0.0 0.2 1.9 2.2 0.0 0.3 0.0 0.0 1.2 1.7 9.5 11.6 24.6 5.6 4.7 17.8 16.0 12.7 8.0 7.0 24.0 4.5 6.0 0.0 6.4 49.0 3.0 4.0 2.7 3.0 4.6 20.3 3.5 4.6 5.9 25.8 2.7 0.0 41.7 3.0 11.8 2.0 5.9 3.5 88.4 12.2 89.8 5.4 21.7 0.4 15.2 4.2 1.9 27.2 1.1 11.0 1.3 2.6 6.4 2.9 0.8 20.2 10.7 11.0 4.1 0.9 1.2 237.5 191.0 1.4 12.4 4.7 0.8 55.6 54.6 39.7 20.5 2.4 3.1 444.5 3.1 4.9 3.1 1.6 5.5 13.4 39.5 4.8 9.4 4.4 35.5 3.0 4.4 1.4 6.5 71.7 4.7 1.4 PTPRF LAR ENSG00000142949 "Protein tyrosine phosphatase receptor type F" P10586 1 43525187-43623666 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 259.9;Extravillous trophoblasts: 290.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 314.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012710 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA 160000000 "Cluster 37: Intestine - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA012710: AB_1855933" "unprognostic (8.20e-2)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (9.17e-2)" "unprognostic (8.34e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.59e-1)" "unprognostic (1.51e-1)" "unprognostic (4.97e-2)" "unprognostic (4.68e-2)" "unprognostic (7.07e-2)" "unprognostic (1.99e-2)" "prognostic favorable (7.03e-4)" "unprognostic (2.33e-1)" "unprognostic (3.19e-2)" "unprognostic (2.58e-1)" 91.7 11.9 47.1 14.0 48.4 1.8 57.4 22.3 45.6 36.3 4.7 79.5 70.5 28.0 71.9 101.7 70.5 30.4 7.6 45.3 39.9 27.7 107.2 35.4 4.7 33.1 43.6 22.1 56.8 31.1 23.5 55.7 33.1 67.3 51.4 24.7 101.7 43.1 2.7 107.9 78.5 35.0 30.4 4.0 49.7 9.4 45.6 29.6 23.8 3.4 26.2 40.0 51.2 37.4 165.6 76.5 49.0 58.0 11.2 0.6 274.3 92.1 36.1 73.9 62.6 82.0 214.9 0.4 25.6 40.2 59.2 124.7 57.5 200.7 89.1 2.0 72.1 1.0 48.7 75.3 33.8 1.2 1.3 11.3 113.2 106.4 174.9 92.6 111.5 7.7 25.4 7.1 27.5 94.0 1.2 1.3 75.9 89.8 21.0 57.2 86.9 3.7 28.3 241.5 73.3 28.0 90.8 314.0 11.8 128.8 91.5 17.3 88.2 1.6 116.5 7.5 126.1 3.1 2.7 0.4 7.4 3.9 233.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 48.4 22.3 45.6 45.3 39.9 33.1 43.6 33.1 30.4 45.6 37.4 2.3 157.0 101.1 39.2 2.3 62.8 51.3 67.4 52.9 33.5 146.3 102.9 7.6 130.1 74.9 86.5 43.8 64.3 1.4 259.9 0.0 147.4 4.9 80.6 17.2 7.7 100.9 8.0 40.6 120.8 290.1 19.8 93.8 70.6 5.1 72.8 10.4 159.6 14.1 185.1 16.1 171.7 50.8 4.9 5.8 8.5 6.8 3.4 12.4 7.5 2.9 27.2 2.1 16.6 68.1 165.0 124.7 7.2 1.8 68.0 208.1 13.9 128.3 31.0 0.0 15.8 18.5 9.0 37.5 107.5 91.4 66.2 3.9 9.6 142.5 78.7 QPCTL FLJ20084 ENSG00000011478 "Glutaminyl-peptide cyclotransferase like" Q9NXS2 19 45692403-45703989 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 5.5;granulocytes: 5.7;Inhibitory neurons: 6.5;Plasma cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040797 Approved Supported "Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA040797: AB_10794148" "unprognostic (6.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.09e-1)" "unprognostic (7.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.26e-1)" "unprognostic (8.41e-3)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (3.14e-2)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.15e-8)" "unprognostic (1.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.02e-2)" "unprognostic (5.71e-2)" 4.1 7.8 3.9 3.1 3.9 4.1 4.9 3.6 4.8 4.9 4.1 5.9 4.7 4.8 3.7 4.7 4.8 2.5 3.4 4.2 4.0 5.3 9.2 6.2 4.7 4.5 3.8 6.6 7.5 4.4 7.0 3.7 4.5 6.5 3.9 2.1 6.7 3.4 1.5 5.2 5.5 2.5 3.2 8.5 6.1 4.4 4.2 2.4 6.7 0.8 3.5 4.6 4.4 3.9 16.7 10.8 8.5 36.9 8.6 4.1 6.4 10.3 15.7 15.0 24.7 11.2 12.3 19.7 11.1 11.5 15.4 9.5 10.0 11.9 8.9 5.0 12.7 6.7 10.9 24.6 14.6 7.5 12.0 7.6 14.9 12.6 17.3 10.7 13.6 10.8 9.7 32.1 9.5 13.0 7.0 7.7 5.5 14.2 5.4 7.8 6.4 16.5 16.2 8.0 7.6 4.7 10.6 8.8 18.2 3.7 6.4 10.6 8.4 7.4 12.4 7.3 10.4 28.6 20.2 18.2 26.0 17.2 5.8 1.4 0.3 0.2 1.4 0.5 0.9 0.9 0.6 0.3 0.8 0.6 0.5 0.7 1.3 1.4 0.3 1.0 0.3 0.2 3.9 3.9 3.6 4.8 4.2 4.0 4.5 3.8 4.5 3.2 4.2 3.9 0.5 0.0 1.5 2.3 3.3 1.3 1.2 1.1 0.6 1.1 0.7 0.6 0.8 1.5 1.2 0.0 0.0 0.8 2.1 1.2 0.0 0.6 5.4 0.9 1.4 0.7 0.0 1.3 5.5 0.4 1.4 0.7 1.5 1.4 5.7 0.7 0.0 1.3 0.9 1.7 6.5 0.4 0.0 0.6 1.8 1.3 0.0 1.6 1.8 0.0 0.7 0.3 1.0 3.5 1.6 0.6 0.1 0.0 9.8 1.2 0.7 0.1 2.2 2.4 0.0 0.6 1.1 1.0 0.3 1.4 1.1 0.8 2.4 1.5 1.0 0.5 RAB6A RAB6 ENSG00000175582 "RAB6A, member RAS oncogene family" P20340 11 73675638-73761137 "Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009936, HPA059131" Approved Approved "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "CAB009936: AB_2175466, HPA059131: AB_2683916" "unprognostic (2.84e-1)" "unprognostic (7.18e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (8.18e-5)" "unprognostic (1.79e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (8.67e-3)" "unprognostic (1.16e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (2.24e-4)" "unprognostic (9.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-1)" "unprognostic (4.93e-2)" "unprognostic (2.36e-1)" 71.2 69.8 87.7 53.0 96.5 38.4 50.6 85.4 112.8 64.4 79.3 66.2 71.6 66.9 53.0 100.2 54.0 55.6 99.5 101.8 100.9 75.1 85.3 68.5 45.7 106.0 90.1 64.5 49.0 67.5 36.4 91.4 112.9 64.0 70.6 56.1 47.8 64.9 107.5 55.0 83.4 79.8 80.0 56.9 54.9 36.1 97.4 54.2 98.7 101.7 60.8 78.9 62.4 93.4 86.2 66.3 105.8 68.5 135.9 154.3 141.7 130.4 124.6 111.1 100.8 131.5 146.4 73.2 136.6 174.0 94.9 94.6 68.4 135.3 142.5 84.6 25.6 118.2 68.6 110.9 114.2 78.1 113.1 114.7 246.8 113.5 165.0 124.4 135.9 75.7 71.3 111.5 133.3 99.6 85.7 54.7 42.2 192.0 62.3 64.8 193.9 132.5 135.2 146.6 83.0 70.5 136.1 136.7 290.9 104.7 107.2 71.0 165.0 113.3 56.9 193.5 56.6 71.9 89.5 149.5 46.3 63.2 104.6 227.9 81.8 133.2 84.2 87.6 76.2 56.1 70.3 75.5 62.9 50.7 52.0 61.8 61.9 78.6 88.6 33.7 86.3 111.1 87.7 96.5 85.4 112.8 101.8 100.9 106.0 90.1 112.9 80.0 97.4 93.4 66.3 32.1 51.0 79.7 59.2 83.5 49.4 57.2 88.2 53.9 45.8 30.4 64.2 35.8 42.7 68.0 87.6 109.9 55.3 85.2 43.0 66.0 8.8 51.5 41.3 78.7 52.0 47.5 133.6 49.5 162.3 60.5 52.5 51.2 48.8 83.7 72.5 63.7 65.7 40.4 119.0 61.8 75.3 58.4 85.7 9.5 52.8 58.3 72.9 49.6 74.2 47.7 52.5 130.7 109.4 79.0 61.7 61.7 86.3 57.8 102.7 54.1 47.2 54.2 26.3 47.4 65.5 74.2 53.4 106.5 112.7 173.6 63.8 45.0 50.8 69.8 RAB6B ENSG00000154917 "RAB6B, member RAS oncogene family" Q9NRW1 3 133824235-133895882 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 30.8;Erythroid cells: 79.2;Excitatory neurons: 60.5;Horizontal cells: 67.3;Inhibitory neurons: 54.1" "Cancer enhanced" "Detected in all" "glioma: 18.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 47 "T-cells: 7.3" "Cell line enriched" "Detected in many" 4 "HEL: 226.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017713, HPA059131" Uncertain Approved "Golgi apparatus" NA NA 2200000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus" "CAB017713: , HPA059131: AB_2683916" "unprognostic (2.87e-2)" "unprognostic (6.33e-3)" "unprognostic (4.53e-3)" "prognostic unfavorable (9.01e-4)" "unprognostic (3.61e-1)" "unprognostic (5.14e-2)" "unprognostic (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.97e-6)" "unprognostic (9.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (8.10e-2)" "unprognostic (9.53e-2)" "unprognostic (6.05e-3)" 6.8 11.1 45.7 2.8 72.6 12.0 4.4 0.4 138.0 2.9 0.0 6.8 2.4 3.0 2.1 4.2 16.2 3.2 20.8 71.8 31.3 7.1 0.9 3.1 3.3 74.6 43.1 2.1 4.4 24.9 12.0 1.7 55.7 2.7 2.1 29.4 10.1 5.9 2.7 1.5 2.9 8.4 3.7 5.9 5.5 4.0 21.5 1.4 5.2 2.8 2.0 1.6 2.2 63.1 0.1 3.0 5.8 14.9 10.1 10.3 0.5 3.0 6.3 7.2 0.8 1.6 1.5 0.2 6.3 2.4 21.2 0.4 13.8 0.4 3.6 0.2 8.6 226.6 3.5 0.5 1.2 1.4 8.5 3.1 2.9 1.1 0.2 0.1 2.9 8.3 53.4 0.6 1.1 5.5 0.7 21.3 18.0 10.8 2.2 0.2 0.4 2.3 4.0 1.3 47.2 10.1 4.4 4.2 26.7 22.5 16.8 9.7 3.7 6.5 15.5 3.2 5.4 5.6 1.5 0.5 0.7 0.5 5.6 0.0 0.0 0.0 0.6 0.0 7.3 0.1 0.1 1.7 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.8 45.7 72.6 0.4 138.0 71.8 31.3 74.6 43.1 55.7 3.7 21.5 63.1 2.0 0.0 0.0 25.8 0.2 1.3 2.2 0.5 0.6 10.5 2.0 2.3 30.8 1.5 2.8 1.8 2.1 0.3 0.6 2.2 3.9 3.6 0.1 2.3 0.9 3.5 0.0 79.2 60.5 1.3 0.7 3.7 2.0 1.3 0.0 12.4 7.9 0.1 0.2 67.3 54.1 0.2 0.0 0.6 1.1 0.2 1.8 0.4 1.8 16.9 0.1 10.2 0.0 17.1 9.6 2.5 1.1 6.8 0.1 2.0 0.0 1.5 9.3 21.3 0.0 4.1 13.8 0.9 12.7 0.8 1.4 0.3 1.1 2.2 0.0 0.6 RAB6C WTH3 ENSG00000222014 "RAB6C, member RAS oncogene family" Q9H0N0 2 129979666-129982738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.6;breast: 2.5;parathyroid gland: 3.6" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 10.3;Oligodendrocytes: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 0.7;prostate cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.5;HMC-1: 2.2;REH: 5.4;T-47d: 3.2;U-266/70: 2.1" HPA059131 Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 6: T47d - Mammary gland" "Cluster 43: Cardiomyocytes - Nuclear processes" "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (3.84e-2)" "unprognostic (5.77e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (8.62e-2)" "unprognostic (1.83e-1)" "unprognostic (1.98e-1)" "unprognostic (1.38e-2)" "unprognostic (1.50e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (4.48e-2)" "unprognostic (6.04e-2)" "unprognostic (1.24e-1)" "unprognostic (4.78e-1)" 0.1 0.6 1.4 0.1 2.2 0.0 2.5 0.7 1.9 1.9 0.7 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 1.3 1.6 0.1 0.0 0.0 0.0 1.2 1.2 0.1 0.0 3.6 0.2 0.3 1.3 1.7 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.7 0.5 0.0 0.9 1.6 0.0 0.1 0.0 0.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.4 0.1 0.5 3.2 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.7 1.9 1.3 1.6 1.2 1.2 1.3 0.7 1.6 3.6 0.1 0.0 0.0 0.3 0.1 0.8 0.3 0.3 0.0 0.0 0.9 0.1 10.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.1 1.7 1.0 0.0 0.0 0.7 0.0 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.4 0.0 0.3 0.4 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.7 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.6 1.4 1.4 1.3 0.0 1.1 0.5 0.1 0.1 0.1 0.3 RAB6D "RAB6CL, WTH3DI" ENSG00000233087 "RAB6D, member RAS oncogene family" Q53S08 2 131361111-131364142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "parathyroid gland: 7.4" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 1.5" "Cancer enhanced" "Detected in some" "prostate cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 2.2" HPA059131 Uncertain Approved "Golgi apparatus" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (4.19e-2)" "unprognostic (8.54e-2)" "unprognostic (1.16e-1)" "unprognostic (3.03e-2)" "unprognostic (4.08e-1)" "unprognostic (4.79e-2)" "unprognostic (4.41e-2)" "unprognostic (1.01e-1)" "unprognostic (1.87e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-1)" "unprognostic (2.55e-2)" "unprognostic (2.61e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.12e-1)" 0.0 0.2 0.6 0.1 0.5 0.0 0.0 0.0 0.8 0.1 0.0 0.9 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.6 0.9 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 7.4 0.0 0.0 0.5 1.4 0.8 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 1.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.3 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.8 0.6 0.9 0.3 0.2 0.5 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RASGEF1A "CG4853, FLJ37817" ENSG00000198915 "RasGEF domain family member 1A" Q8N9B8 10 43194535-43267065 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.6;brain: 19.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 22.1;Inhibitory neurons: 16.3;NK-cells: 8.2;Spermatogonia: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 17.2;SCLC-21H: 15.6;SK-BR-3: 14.1;T-47d: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035593 Enhanced Approved "Golgi apparatus" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA035593: AB_10602083" "prognostic favorable (1.86e-5)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.86e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (5.73e-2)" "unprognostic (8.53e-2)" "unprognostic (9.00e-2)" "unprognostic (2.86e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.11e-7)" "unprognostic (2.88e-2)" "unprognostic (2.32e-1)" "unprognostic (1.89e-2)" "unprognostic (3.83e-2)" 0.8 1.6 18.8 1.3 17.0 14.6 3.3 11.6 19.3 1.7 5.2 0.8 0.9 1.2 0.4 1.1 2.5 2.3 1.5 19.2 14.6 2.6 0.4 1.6 5.3 15.0 15.2 1.2 3.7 4.3 4.4 0.7 13.6 1.4 0.4 1.3 3.4 1.7 0.8 0.8 1.3 1.2 13.1 3.8 0.7 2.3 18.4 1.0 0.8 0.7 3.7 1.2 2.6 17.0 9.7 8.2 0.0 0.1 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.2 5.2 8.4 8.6 0.8 0.0 0.1 1.3 7.7 0.0 0.0 6.3 0.0 0.1 0.4 3.7 0.0 3.0 2.0 8.7 0.7 0.0 0.0 0.0 0.4 17.2 0.0 0.0 1.9 0.0 0.2 0.8 4.3 0.0 0.0 0.0 0.2 0.6 4.5 15.6 0.0 0.0 14.1 0.1 7.1 15.6 0.1 0.1 0.0 3.5 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 6.1 2.9 0.5 1.1 0.2 0.7 2.2 2.9 2.6 0.2 1.4 9.4 6.3 0.4 5.1 0.0 1.2 18.8 17.0 11.6 19.3 19.2 14.6 15.0 15.2 13.6 13.1 18.4 17.0 0.2 0.0 0.0 3.6 1.1 0.5 0.3 2.4 0.6 2.0 4.3 4.1 2.2 0.0 0.2 3.7 0.0 0.4 6.7 0.2 0.0 0.3 1.3 1.8 0.5 1.0 0.0 0.0 22.1 1.3 1.1 1.0 0.5 2.3 0.0 1.9 1.1 0.1 0.9 1.7 16.3 0.3 0.0 0.9 1.7 0.7 0.0 1.4 0.0 1.0 1.4 0.3 8.2 1.5 1.0 2.1 0.1 0.0 0.7 1.2 0.2 0.6 0.6 0.3 0.0 0.9 0.4 0.7 7.7 0.5 0.3 0.3 5.0 0.5 0.6 0.1 RASGRF1 "CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187" ENSG00000058335 "Ras protein specific guanine nucleotide releasing factor 1" Q13972 15 78959906-79090780 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 26.5;lung: 7.5;retina: 7.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010413, HPA041965" Approved Supported "Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "CAB010413: AB_2238127, HPA041965: AB_10793939" "unprognostic (2.57e-3)" "unprognostic (3.08e-2)" "unprognostic (3.14e-2)" "prognostic favorable (6.14e-6)" "unprognostic (1.90e-1)" "unprognostic (1.15e-3)" "unprognostic (5.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.03e-1)" "unprognostic (4.02e-6)" "unprognostic (2.35e-1)" "unprognostic (8.02e-2)" "unprognostic (3.81e-2)" "unprognostic (8.81e-2)" 0.1 0.1 4.2 1.0 4.1 0.0 0.1 24.4 24.4 0.6 0.0 0.2 0.2 0.4 0.1 0.1 0.4 0.1 0.0 12.2 6.4 0.7 0.0 7.5 1.3 13.9 10.2 0.8 2.3 0.6 1.1 0.2 16.4 0.5 0.2 7.4 0.1 0.2 0.0 0.0 1.4 0.1 8.7 0.6 0.2 0.3 14.9 0.5 0.0 0.0 1.4 0.3 0.1 26.5 8.5 0.1 0.1 0.0 0.0 0.0 7.7 0.0 0.4 0.5 1.2 0.0 1.5 0.4 0.2 0.0 0.6 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 10.4 1.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.9 13.0 0.1 0.3 0.8 0.0 0.0 0.1 1.6 0.7 0.0 1.7 0.0 0.0 15.1 0.0 0.3 0.0 3.8 2.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.1 24.4 24.4 12.2 6.4 13.9 10.2 16.4 8.7 14.9 26.5 0.2 3.2 80.6 8.5 4.5 0.6 0.6 0.2 0.0 13.7 0.2 0.1 1.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.6 0.4 0.5 0.0 0.0 80.9 0.0 2.7 0.3 0.0 1.8 0.0 0.0 0.0 0.0 2.0 25.2 91.2 0.0 0.0 0.3 16.1 0.0 0.0 1.8 3.6 5.6 0.6 1.1 0.0 1.5 121.5 0.3 0.0 0.4 2.1 0.2 0.0 6.8 2.0 2.5 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.8 0.1 1.6 0.0 0.4 RBP2 "CRABP-II, CRBP2, CRBPII, RBPC2" ENSG00000114113 "Retinol binding protein 2" P50120 3 139452884-139480747 "Metabolic proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 294 "intestine: 2713.5" "Cell type enriched" "Detected in some" 26 "Proximal enterocytes: 6095.4" "Group enriched" "Detected in many" 4 "colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CACO-2: 78.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA035866 Enhanced Approved "Golgi apparatus" NA NA 140000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA035866: AB_10672232" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (3.34e-2)" "unprognostic (6.72e-6)" "unprognostic (2.33e-1)" "unprognostic (4.10e-2)" "unprognostic (1.56e-2)" "unprognostic (2.24e-1)" "unprognostic (8.51e-3)" "unprognostic (3.92e-2)" "unprognostic (7.35e-2)" "unprognostic (1.24e-3)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (9.23e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" 0.4 1.1 4.6 1.1 3.2 0.7 0.5 0.3 3.2 0.2 0.0 4.0 2713.5 2.0 0.0 0.2 0.3 1.8 0.2 3.3 5.0 2.6 0.0 7.6 2.2 8.1 9.2 0.3 3.0 0.0 0.1 0.1 3.4 0.4 2.4 2.2 0.1 0.0 0.2 1.1 1886.7 1.0 3.4 0.1 3.6 1.0 9.0 0.0 0.5 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.2 0.2 0.0 0.0 7.1 0.0 0.0 0.0 0.0 78.8 0.1 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.1 0.2 0.1 0.1 0.0 11.7 0.0 0.0 4.0 10.1 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 3.2 0.3 3.2 3.3 5.0 8.1 9.2 3.4 3.4 9.0 5.3 0.0 9.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 12.9 8.4 0.0 0.0 14.0 0.0 0.6 0.0 0.0 0.0 0.2 1.2 0.0 1.0 6.1 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 185.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.5 0.9 6.1 226.3 0.0 0.0 0.0 6095.4 0.0 0.7 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 142.6 0.1 RER1 ENSG00000157916 "Retention in endoplasmic reticulum sorting receptor 1" O15258 1 2391775-2405442 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037240, HPA051400" Supported Supported "Golgi apparatus" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "CAB037240: AB_2179604, HPA051400: AB_2681469" "unprognostic (2.90e-2)" "unprognostic (3.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.23e-8)" "unprognostic (1.01e-1)" "unprognostic (5.41e-2)" "unprognostic (1.06e-1)" "unprognostic (3.27e-2)" 100.4 154.2 60.0 89.3 67.6 81.6 97.1 67.0 62.8 93.6 78.3 137.4 114.8 74.4 122.7 176.4 86.1 86.9 75.7 61.1 64.1 106.3 224.8 79.6 94.6 67.0 65.1 92.9 122.3 100.9 82.9 99.0 66.9 94.3 151.4 73.8 101.1 104.2 105.2 101.7 120.0 104.6 65.6 102.2 118.6 107.1 68.5 94.5 85.9 85.1 143.5 101.0 106.5 76.1 203.1 111.0 131.1 146.8 233.7 275.7 100.9 297.1 261.1 254.3 253.2 157.6 299.3 143.9 242.7 297.7 205.1 213.3 152.2 176.7 322.2 180.8 156.1 163.9 247.2 153.0 252.5 181.3 188.6 225.0 176.1 264.3 233.1 175.4 235.8 160.3 197.8 232.6 299.8 141.5 127.2 127.3 87.5 314.1 279.0 146.0 131.9 183.7 227.5 94.3 109.9 126.2 167.9 376.9 242.9 143.7 149.6 127.4 171.8 197.3 114.1 355.9 219.5 223.0 270.2 255.3 209.6 254.8 102.8 239.1 235.5 284.5 195.9 268.2 180.0 169.0 169.8 210.0 221.2 151.7 127.0 155.9 351.3 164.8 275.9 256.1 244.5 309.0 60.0 67.6 67.0 62.8 61.1 64.1 67.0 65.1 66.9 65.6 68.5 76.1 88.7 64.1 50.0 23.5 73.1 53.2 84.4 214.2 50.1 33.6 111.9 123.6 41.6 118.7 131.4 104.8 33.3 233.8 97.5 218.9 66.5 213.4 475.6 89.5 93.5 68.2 36.5 57.2 16.7 258.4 321.8 94.3 71.9 118.8 44.3 76.5 82.1 233.5 217.9 37.0 16.8 158.6 122.1 104.3 73.2 464.0 82.6 99.9 62.2 15.9 126.1 97.0 114.4 19.1 25.8 256.4 195.4 76.0 145.1 142.5 238.7 119.6 136.3 62.6 111.7 60.9 141.6 291.4 145.2 103.4 67.1 467.9 74.3 159.0 162.0 141.0 RFK "FLJ11149, RIFK" ENSG00000135002 "Riboflavin kinase" Q969G6 9 76385526-76394517 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 352.0;Pancreatic endocrine cells: 220.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023259, CAB033887, HPA057163" Approved Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 45: Intestine - Brush border" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357" "unprognostic (1.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-3)" "unprognostic (8.61e-3)" "unprognostic (3.11e-1)" "unprognostic (1.39e-1)" "unprognostic (2.88e-1)" "unprognostic (1.02e-1)" "unprognostic (4.61e-2)" "unprognostic (1.22e-3)" "unprognostic (3.22e-2)" "unprognostic (1.83e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" 11.6 20.6 18.0 14.6 18.4 25.0 11.7 12.6 21.1 11.7 12.5 30.8 33.1 12.8 18.2 12.9 13.6 19.9 16.3 20.6 27.2 27.0 29.2 12.4 11.6 16.9 18.4 11.7 16.4 23.8 12.0 13.2 27.0 13.0 22.9 14.7 11.0 9.9 14.9 5.1 28.2 11.9 14.2 10.2 29.0 16.7 21.6 12.0 19.7 18.7 11.2 13.9 5.9 13.5 21.9 23.2 13.9 18.1 20.5 20.3 41.8 25.2 18.6 17.8 13.9 8.2 13.3 35.3 28.7 18.2 32.3 22.9 19.3 16.5 35.3 10.4 18.0 11.2 30.4 26.2 36.7 37.9 25.6 13.5 29.3 21.4 23.2 19.9 58.3 30.4 30.6 28.7 36.1 20.8 49.3 13.3 18.1 51.2 22.7 26.7 18.3 8.9 82.0 10.6 35.0 12.7 26.9 37.2 22.9 18.1 9.4 20.2 35.9 18.5 33.3 40.1 35.6 30.7 32.3 12.4 30.7 33.3 25.9 5.2 9.8 3.6 5.0 19.9 7.5 5.8 7.3 6.0 11.8 4.4 7.0 6.7 1.4 8.5 21.1 4.3 7.4 9.8 18.0 18.4 12.6 21.1 20.6 27.2 16.9 18.4 27.0 14.2 21.6 13.5 27.3 16.0 9.2 5.9 22.9 45.4 23.8 15.3 22.2 50.4 24.5 20.6 37.9 34.3 20.1 42.3 20.9 54.1 18.4 158.8 60.7 64.9 191.7 37.8 18.5 46.2 28.2 48.8 18.0 189.3 352.0 33.5 33.1 42.3 12.0 18.0 124.2 40.9 33.2 11.8 19.3 23.1 40.7 57.6 26.6 118.1 22.1 29.9 30.2 10.3 25.2 44.7 9.2 7.1 6.5 220.6 68.3 65.1 12.7 33.6 79.9 142.8 27.7 28.7 0.0 23.0 21.7 91.8 64.1 18.8 40.5 123.5 23.1 18.8 33.7 22.6 RGS18 RGS13 ENSG00000150681 "Regulator of G protein signaling 18" Q9NS28 1 192158462-192185815 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.2;lymphoid tissue: 25.4" "Cell type enriched" "Detected in some" 4 "Macrophages: 527.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 353.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 353.1" "Group enriched" "Detected in some" 5 "HEL: 60.2;HL-60: 46.7;NB-4: 43.6;U-937: 39.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA028727, HPA045780" Uncertain Approved "Golgi apparatus" NA NA 340000 "Cluster 2: Granulocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus" "HPA028727: AB_2797219, HPA045780: AB_10962728" "unprognostic (3.09e-2)" "unprognostic (4.32e-2)" "unprognostic (8.66e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.48e-1)" "unprognostic (2.18e-2)" "unprognostic (2.58e-1)" "unprognostic (1.87e-1)" "unprognostic (3.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.30e-3)" "unprognostic (8.21e-3)" "unprognostic (2.81e-4)" "unprognostic (1.73e-2)" "unprognostic (9.91e-2)" 4.3 2.3 0.7 14.1 0.6 13.2 2.3 0.9 0.7 2.4 0.9 2.4 2.9 1.0 0.5 1.9 1.3 5.3 0.8 0.6 1.2 1.0 5.3 4.1 8.4 1.5 1.0 0.8 0.8 0.4 0.3 2.2 1.5 1.1 2.9 0.6 0.7 1.0 0.9 0.4 5.8 2.9 1.3 25.4 1.9 0.4 0.8 4.2 0.8 3.1 4.4 4.8 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 39.9 0.0 195.5 50.7 353.1 0.8 66.7 6.8 0.1 0.8 1.3 51.0 0.2 0.1 0.2 164.8 0.6 82.1 12.0 0.0 94.4 0.7 0.6 0.9 0.7 0.6 1.2 1.5 1.0 1.5 1.3 0.8 1.6 0.3 6.4 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.4 0.0 1.8 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 16.0 0.0 0.0 0.0 0.8 0.0 0.0 24.7 0.0 5.7 1.1 7.3 0.0 0.0 0.0 0.0 124.9 27.3 0.8 0.3 527.4 0.0 15.9 128.3 0.1 28.8 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.3 1.5 0.3 13.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 7.6 0.0 0.1 0.0 RHBDD2 "NPD007, RHBDL7" ENSG00000005486 "Rhomboid domain containing 2" Q6NTF9 7 75842602-75888926 "Enzymes, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 380.1" "Cell type enhanced" "Detected in all" "Late spermatids: 300.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 398.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045074, HPA051960" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA045074: AB_10965705, HPA051960: AB_2681673" "unprognostic (2.75e-1)" "unprognostic (3.89e-2)" "prognostic unfavorable (3.31e-5)" "unprognostic (9.79e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.05e-2)" "unprognostic (1.18e-2)" "unprognostic (2.37e-3)" "unprognostic (1.55e-1)" "unprognostic (2.75e-1)" "unprognostic (5.11e-2)" "unprognostic (1.87e-2)" "prognostic favorable (8.68e-6)" "unprognostic (3.73e-1)" "unprognostic (6.53e-2)" "unprognostic (1.89e-1)" "unprognostic (1.03e-1)" 43.9 232.5 247.5 20.0 248.6 26.9 47.7 169.0 313.0 46.7 224.2 39.4 35.7 36.4 59.3 48.5 47.0 23.2 54.7 255.0 380.1 97.7 99.8 72.0 16.2 216.3 252.8 61.2 56.8 182.8 299.6 16.5 274.5 79.0 16.0 39.1 53.3 94.8 35.0 49.4 44.9 11.8 187.5 50.2 57.6 87.2 321.2 19.9 91.1 11.6 12.5 45.3 43.6 208.3 24.0 80.2 34.5 57.9 16.3 11.5 12.8 12.8 50.6 26.6 27.2 43.6 59.7 7.5 13.0 26.3 59.4 33.7 22.4 17.6 10.3 25.9 46.3 9.0 48.0 41.4 45.0 13.8 61.5 25.0 35.7 31.1 12.3 43.9 20.4 51.2 19.0 51.6 26.9 165.3 26.1 74.9 31.7 41.0 45.1 19.4 22.7 66.8 47.2 42.9 43.3 88.7 59.3 107.8 47.9 23.2 66.3 23.2 20.4 43.5 39.6 29.2 27.9 48.4 18.5 12.9 50.4 20.4 59.9 398.8 62.8 79.0 80.0 66.1 68.9 51.7 89.1 71.7 63.0 50.8 72.5 65.3 104.7 63.6 35.1 49.7 126.8 61.2 247.5 248.6 169.0 313.0 255.0 380.1 216.3 252.8 274.5 187.5 321.2 208.3 20.5 41.7 31.9 16.6 23.7 23.2 46.5 127.6 18.2 34.9 42.3 22.4 8.8 55.8 76.8 86.5 33.3 54.8 20.7 48.3 19.6 94.1 171.2 30.2 12.8 26.9 89.8 10.3 27.0 102.1 41.3 34.7 39.8 16.2 192.7 72.4 57.8 43.1 45.5 18.5 31.9 35.1 128.1 35.9 32.7 300.8 42.6 47.8 60.5 5.6 21.4 68.8 29.9 13.0 11.0 78.1 37.6 52.6 27.9 47.8 52.8 52.5 89.3 35.7 6.6 19.0 26.4 57.3 29.7 27.9 23.7 52.0 61.2 198.1 30.2 50.1 RINT1 "FLJ11785, RINT-1" ENSG00000135249 "RAD50 interactor 1" Q6NUQ1 7 105532169-105567677 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019875, HPA031646" Approved Approved "Golgi apparatus" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA019875: AB_1856283, HPA031646: AB_2673975" "unprognostic (1.58e-2)" "unprognostic (3.94e-2)" "unprognostic (9.00e-2)" "unprognostic (1.80e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-2)" "unprognostic (4.68e-3)" "unprognostic (1.33e-2)" "unprognostic (4.96e-3)" "unprognostic (2.41e-1)" "unprognostic (8.72e-2)" "unprognostic (5.35e-2)" "unprognostic (8.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (1.76e-1)" 7.3 6.1 2.8 9.0 3.1 15.2 10.0 6.9 3.7 8.2 5.6 8.1 9.4 8.6 7.2 11.3 8.0 6.7 8.2 3.1 3.1 9.3 10.5 6.7 13.4 2.8 2.7 8.0 11.6 9.7 5.4 8.8 3.1 7.8 9.3 10.3 11.3 6.1 16.7 8.7 7.1 6.4 3.2 8.8 9.7 11.1 2.7 9.9 8.8 13.3 13.7 8.4 5.7 4.1 28.8 23.5 12.1 27.8 18.8 24.9 15.9 27.2 19.2 26.4 29.6 27.4 18.4 31.6 31.3 24.1 29.4 19.0 22.5 21.0 34.7 17.0 25.9 18.3 26.1 18.5 14.5 38.9 17.8 17.9 16.4 28.1 16.3 20.3 29.1 16.3 39.5 23.2 30.3 46.9 29.3 28.6 26.1 23.8 23.1 17.5 20.5 45.4 14.2 23.6 20.5 22.4 28.9 47.7 20.6 20.9 19.4 12.5 20.3 30.2 24.0 83.1 34.8 46.6 59.7 61.4 20.0 31.8 34.6 4.4 3.9 4.4 6.7 5.8 11.6 9.0 9.8 9.2 6.0 7.8 8.6 9.4 0.7 9.1 4.8 4.0 10.5 6.2 2.8 3.1 6.9 3.7 3.1 3.1 2.8 2.7 3.1 3.2 2.7 4.1 6.7 3.2 9.8 10.4 12.4 6.6 9.6 7.7 8.6 5.8 5.9 5.3 10.5 1.5 9.4 3.7 8.4 11.2 13.4 6.0 9.8 8.1 10.8 9.0 6.4 6.8 5.4 4.6 25.6 6.3 10.3 9.4 12.2 5.5 10.1 7.5 4.2 5.1 7.3 6.7 26.0 5.8 10.2 5.6 3.4 6.2 8.7 5.2 5.4 9.4 5.7 7.8 7.2 9.0 18.2 6.7 4.0 9.8 17.9 6.5 5.5 6.8 18.1 8.9 6.6 8.3 8.0 29.2 12.4 8.3 7.7 12.0 10.8 7.5 6.4 8.3 RNF24 G1L ENSG00000101236 "Ring finger protein 24" Q9Y225 20 3927309-4015558 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 112.5;Inhibitory neurons: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 238.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 238.2" "Cell line enhanced" "Detected in all" "ASC TERT1: 81.7" "Low region specificity" "Detected in all" HPA011900 Approved Supported "Golgi apparatus" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA011900: AB_10671089" "unprognostic (6.61e-2)" "unprognostic (6.56e-2)" "unprognostic (1.72e-1)" "unprognostic (1.17e-2)" "unprognostic (8.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (2.65e-1)" "unprognostic (5.87e-2)" "unprognostic (2.66e-2)" "unprognostic (5.19e-3)" "unprognostic (3.42e-1)" "prognostic unfavorable (2.67e-7)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (1.24e-1)" 9.0 7.8 9.5 8.0 9.7 51.8 7.0 4.9 10.9 6.6 0.0 5.7 2.5 5.7 14.9 7.5 5.3 5.9 6.5 10.7 9.5 11.3 2.7 13.9 2.3 7.4 7.6 5.1 4.8 2.5 6.2 3.4 7.6 8.7 3.5 4.7 6.9 6.9 2.1 8.8 4.5 5.3 6.6 12.5 5.7 4.1 8.9 5.4 7.3 3.7 3.8 7.9 5.9 7.2 19.8 9.0 12.9 11.2 48.8 81.7 4.6 16.4 35.4 16.5 23.6 6.0 19.3 4.1 3.5 33.7 25.3 12.9 5.2 18.7 27.4 2.8 3.9 36.4 16.2 4.7 42.1 73.8 13.8 27.6 5.7 43.8 36.8 18.3 15.5 12.6 47.1 9.6 26.9 5.2 11.8 15.1 19.5 18.2 12.6 14.0 10.9 3.3 9.3 10.5 12.1 9.8 44.4 26.3 11.6 18.8 9.6 25.3 23.3 39.8 12.9 27.1 19.7 7.5 7.9 1.4 20.2 24.7 12.7 108.9 23.5 51.3 3.7 8.5 3.0 1.4 7.0 5.4 19.3 4.6 4.2 5.4 238.2 7.5 12.7 0.5 3.4 11.5 9.5 9.7 4.9 10.9 10.7 9.5 7.4 7.6 7.6 6.6 8.9 7.2 6.2 3.2 19.1 34.0 7.8 48.8 36.9 24.1 26.2 18.1 26.9 19.3 2.7 4.3 18.6 49.7 16.7 1.9 9.1 5.7 7.9 33.6 16.3 17.2 37.4 13.9 13.1 43.3 112.5 25.6 6.7 42.4 9.7 31.4 4.5 12.6 17.2 1.2 5.7 38.7 127.2 6.6 10.2 24.7 71.6 22.6 36.7 30.9 39.2 16.9 25.2 10.4 7.2 74.4 21.1 29.2 5.8 60.2 5.9 73.8 2.2 1.8 6.8 9.6 19.7 12.4 32.3 21.4 22.4 12.8 54.4 2.9 17.0 7.4 4.8 75.1 RNPEP APB ENSG00000176393 "Arginyl aminopeptidase" Q9H4A4 1 201982372-202006147 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 201.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 19.8;granulocytes: 22.9;monocytes: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036074, HPA036075, HPA061487" Approved Approved "Golgi apparatus" "Secreted - unknown location" NA NA 7800000 "Cluster 52: Eosinophils - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537" "unprognostic (8.57e-2)" "unprognostic (3.43e-2)" "unprognostic (2.81e-1)" "unprognostic (5.45e-2)" "unprognostic (2.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-3)" "unprognostic (1.80e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-1)" "unprognostic (3.50e-3)" "unprognostic (1.91e-1)" "unprognostic (6.00e-2)" "unprognostic (1.97e-2)" "unprognostic (1.68e-1)" 25.2 31.1 8.0 22.8 8.3 25.2 25.8 8.1 8.5 26.7 16.1 53.6 68.5 25.6 39.0 53.8 40.6 22.3 14.7 8.5 8.7 25.9 32.4 30.5 22.1 9.9 9.1 23.4 34.1 25.4 13.3 27.5 9.1 25.9 57.0 4.2 38.3 27.6 18.8 37.0 58.1 28.1 9.1 33.4 28.5 17.9 10.6 21.7 33.2 12.7 26.5 23.3 28.8 11.8 66.2 71.0 40.8 62.7 65.1 61.3 102.1 49.5 95.6 60.9 67.6 51.8 83.1 14.3 61.8 87.8 38.0 117.4 52.5 97.2 42.4 39.1 67.6 35.5 32.5 48.7 55.1 92.3 121.3 55.9 97.9 54.1 62.0 74.7 110.6 34.8 82.5 21.6 62.1 61.0 12.8 40.2 58.4 105.4 34.4 48.3 57.5 101.6 128.7 61.2 46.9 39.9 122.2 155.9 52.1 78.9 116.6 52.4 79.9 28.9 38.0 28.7 61.3 45.3 39.6 12.9 27.8 77.3 58.1 22.9 14.9 22.1 3.0 25.9 4.1 2.5 3.2 3.4 19.8 4.6 2.8 3.2 11.0 2.9 29.9 7.2 5.4 4.0 8.0 8.3 8.1 8.5 8.5 8.7 9.9 9.1 9.1 9.1 10.6 11.8 26.7 9.6 21.5 8.5 19.7 28.8 40.5 31.2 40.5 15.5 32.8 33.1 12.2 38.6 26.7 25.8 10.4 116.6 21.4 136.6 19.6 71.1 5.4 35.9 17.7 26.1 44.9 19.0 12.7 51.2 91.1 26.1 45.3 21.5 15.2 23.2 27.1 51.4 103.7 11.8 11.1 71.9 14.2 81.0 39.4 4.9 25.4 72.9 24.9 15.0 86.7 12.6 17.5 5.5 8.1 47.8 83.4 23.0 23.6 25.0 201.7 65.8 39.1 8.0 26.3 11.4 28.2 22.7 9.5 53.6 21.6 87.6 17.7 33.2 86.6 34.8 RPGR "COD1, CORDX1, CRD, RP15, RP3" ENSG00000156313 "Retinitis pigmentosa GTPase regulator" Q92834 X 38269163-38327544 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Guanine-nucleotide releasing factor" "Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 146.1;Hepatic stellate cells: 121.7;Respiratory ciliated cells: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 14.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 14.6" "Cell line enhanced" "Detected in many" "HL-60: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001593, HPA073455" Approved Supported "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA001593: AB_1079835, HPA073455: AB_2686603" "unprognostic (3.22e-2)" "unprognostic (1.16e-2)" "unprognostic (5.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.20e-1)" "unprognostic (9.94e-2)" "unprognostic (3.46e-2)" "unprognostic (6.32e-2)" "unprognostic (2.04e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-6)" "unprognostic (1.93e-1)" "unprognostic (7.59e-2)" "unprognostic (8.96e-3)" "unprognostic (1.61e-3)" 19.2 5.7 4.7 4.4 4.6 12.2 16.8 5.2 5.5 10.2 15.5 9.1 3.0 11.6 2.5 5.5 15.0 5.5 9.8 4.6 6.3 6.2 3.7 14.8 3.7 7.6 7.0 6.2 7.5 2.6 32.9 3.7 5.8 6.9 3.6 12.1 5.2 2.6 12.1 6.0 9.4 4.5 6.6 5.1 6.8 8.1 5.3 4.7 9.7 3.7 3.2 8.7 8.2 5.4 4.7 6.0 3.4 3.2 3.6 5.2 2.7 5.8 6.5 4.1 4.8 2.7 2.6 7.1 1.8 3.9 3.4 4.4 4.1 1.8 5.6 7.5 7.9 2.5 2.7 5.5 3.3 31.8 5.8 8.0 2.4 8.7 9.2 1.6 18.9 7.5 3.3 0.0 5.7 1.5 9.1 17.7 8.7 2.9 7.5 6.8 11.7 6.4 3.6 3.0 2.7 5.2 6.4 2.6 7.2 5.1 1.7 5.4 22.4 4.5 8.0 10.7 7.2 1.9 3.9 6.0 10.6 6.1 6.2 1.3 2.6 5.9 1.3 2.4 2.9 1.9 1.5 1.8 2.6 1.5 2.2 1.8 14.6 1.7 2.0 1.8 1.9 1.8 4.7 4.6 5.2 5.5 4.6 6.3 7.6 7.0 5.8 6.6 5.3 5.4 75.2 16.0 32.6 21.2 21.8 7.9 13.5 6.6 7.4 29.5 8.8 8.8 8.0 8.6 18.0 1.8 62.6 5.8 14.0 12.6 3.9 15.3 51.4 146.1 30.4 61.3 17.4 5.5 21.8 8.6 9.5 11.8 9.2 21.0 20.3 73.5 121.7 9.7 7.8 35.3 20.0 13.5 10.2 16.2 8.4 9.1 7.8 14.5 5.4 18.7 15.5 9.4 14.4 9.0 17.1 9.9 8.9 4.5 11.0 10.2 5.0 3.1 119.2 85.7 0.0 23.1 12.9 24.9 25.3 4.8 5.8 8.2 17.2 6.6 8.9 11.2 RPL12 L12 ENSG00000197958 "Ribosomal protein L12" P30050 9 127447674-127451406 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast myoepithelial cells: 16277.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003403 Approved Approved "Golgi apparatus" NA NA 710000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "HPA003403: AB_1856432" "unprognostic (5.89e-3)" "unprognostic (3.27e-1)" "unprognostic (1.08e-1)" "unprognostic (5.75e-3)" "unprognostic (4.93e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (4.98e-2)" "unprognostic (3.05e-1)" "unprognostic (6.82e-2)" "unprognostic (3.22e-3)" "unprognostic (1.03e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (7.42e-7)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-3)" "unprognostic (4.80e-2)" 1951.8 1231.3 835.3 1038.0 851.8 2761.0 2915.7 839.5 1071.0 1971.7 849.8 1701.0 1014.9 1367.8 2197.8 1898.6 2181.0 1058.6 1075.1 814.9 877.7 1217.9 1183.9 1195.7 2118.1 883.8 861.1 3020.6 2703.8 700.7 888.2 879.2 891.8 1637.0 1384.7 360.7 1784.8 997.7 2166.7 2609.6 1237.2 1202.9 884.9 1349.8 1401.3 339.2 851.4 1696.8 1423.5 1318.1 2422.7 1851.7 1787.9 901.5 1511.6 1359.5 1474.8 2976.3 2773.6 6171.2 2266.6 1317.9 3562.5 2315.3 1802.2 2949.5 1529.4 2855.4 1745.3 2256.0 1161.2 1774.7 1887.1 3068.4 1578.4 1451.5 1731.1 1678.1 1705.9 2724.4 5881.5 2596.8 1735.1 6766.3 6013.6 1628.4 6142.1 4589.1 3178.6 1755.1 2307.8 2371.9 2920.2 5170.1 2464.7 3988.0 2166.2 4448.6 2519.6 2073.6 2828.6 3141.2 3458.6 1497.1 1295.6 1882.9 989.8 3291.6 4287.8 1727.6 2707.1 3536.1 1796.2 866.3 1546.2 1504.9 2645.1 1223.5 1630.1 2951.4 901.8 2447.8 1351.3 354.9 961.6 274.4 997.8 982.9 1845.3 2714.4 1857.1 1366.2 1536.6 2602.0 2177.6 1891.8 114.3 1265.6 973.6 1398.4 1772.9 3151.7 835.3 851.8 839.5 1071.0 814.9 877.7 883.8 861.1 891.8 884.9 851.4 901.5 2021.8 695.5 1593.2 9.1 5219.3 6047.5 4680.5 5696.6 6688.2 186.4 9458.0 16277.6 445.0 2522.1 2427.5 1272.7 85.5 3455.7 2702.3 1424.3 4073.5 2502.6 320.6 1210.9 3910.1 2415.0 2095.3 2939.8 7.4 7126.9 5794.1 2409.3 2320.1 1688.1 1876.4 1940.1 3301.1 2861.4 3348.2 95.9 7.5 4283.6 1810.7 5716.7 5579.1 839.4 5405.5 2945.4 3601.9 13.1 4509.5 782.7 2582.9 5.5 13.4 4166.6 2911.7 2389.9 2741.9 4582.4 3159.4 6003.0 879.7 309.3 986.1 3458.1 2319.6 334.8 584.2 7183.3 6963.2 3724.4 3677.5 3289.4 4446.0 4896.3 SCARF1 "KIAA0149, SREC, SREC1" ENSG00000074660 "Scavenger receptor class F member 1" Q14162 17 1633858-1645744 "Predicted intracellular proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6" "Cell type enhanced" "Detected in many" "Adipocytes: 65.9;Endothelial cells: 51.3;Hepatic stellate cells: 62.4;Langerhans cells: 37.7;Microglial cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 12.1;REH: 11.5;TIME: 37.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035108, HPA072936" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 2000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "HPA035108: AB_10670289, HPA072936: AB_2686559" "unprognostic (1.94e-1)" "unprognostic (2.84e-1)" "unprognostic (2.53e-3)" "unprognostic (2.88e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.62e-2)" "unprognostic (3.76e-1)" "unprognostic (1.32e-1)" "unprognostic (2.13e-2)" "unprognostic (3.22e-2)" "unprognostic (1.38e-1)" "unprognostic (6.39e-2)" 15.2 5.0 1.5 3.1 1.8 0.4 12.7 1.4 3.4 5.6 1.4 5.2 0.0 6.0 0.9 2.7 6.5 2.2 11.8 1.6 1.8 7.5 7.5 16.3 2.1 2.7 1.7 2.6 3.1 0.1 3.8 4.3 2.2 4.6 1.2 0.2 4.2 0.0 5.3 3.1 5.4 1.2 1.7 25.6 4.2 1.6 1.7 0.5 18.8 1.9 1.0 5.6 4.6 2.8 0.0 0.1 0.3 0.3 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.3 12.1 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 11.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.3 37.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 1.5 1.8 1.4 3.4 1.6 1.8 2.7 1.7 2.2 1.7 1.7 2.8 65.9 22.4 17.6 6.5 0.6 3.4 0.4 0.7 1.2 1.2 0.8 0.9 3.5 0.0 2.9 3.7 4.2 0.4 2.0 4.9 1.9 0.4 0.3 0.5 0.9 51.3 0.0 3.4 5.4 0.2 0.2 2.5 4.1 1.1 3.8 0.3 62.4 2.3 9.0 0.0 3.5 4.4 0.0 15.7 37.7 0.4 1.2 10.1 3.6 26.2 4.8 0.7 0.0 0.5 1.1 0.3 1.2 1.2 0.0 0.7 3.0 0.2 3.0 2.0 0.0 2.1 3.0 0.5 0.6 0.3 2.7 1.2 1.0 1.3 2.2 0.8 SCLY SCL ENSG00000132330 "Selenocysteine lyase" Q96I15 2 238060924-238099413 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 39.1" "Group enriched" "Detected in many" 13 "Early spermatids: 90.6;Late spermatids: 156.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020190, HPA055760" Uncertain Enhanced "Golgi apparatus" NA NA 300000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA020190: , HPA055760: AB_2682910" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (8.65e-5)" "unprognostic (8.96e-2)" "unprognostic (9.85e-3)" "unprognostic (1.14e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-2)" "unprognostic (8.38e-2)" "unprognostic (3.98e-3)" "unprognostic (1.03e-2)" "unprognostic (1.02e-3)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "unprognostic (2.50e-3)" "unprognostic (1.98e-1)" 5.1 4.3 7.2 5.3 9.4 5.0 4.9 9.4 9.3 6.8 6.4 7.3 8.5 8.1 5.6 5.9 6.3 3.8 8.1 6.8 8.2 12.9 39.1 4.7 5.7 9.2 8.8 6.3 22.8 6.1 5.0 2.0 9.4 5.9 3.2 4.6 4.4 4.1 6.4 3.5 8.6 3.9 7.3 7.2 5.8 16.8 8.3 5.9 7.2 3.5 4.3 7.8 5.1 10.4 11.1 19.1 11.9 31.1 9.0 6.4 23.2 11.2 5.6 11.3 14.3 11.6 8.0 18.9 3.3 5.9 35.4 16.4 44.1 21.5 10.9 21.2 41.8 21.1 24.0 37.6 16.7 17.6 18.2 7.1 11.6 21.3 22.0 5.1 21.0 26.1 38.0 5.1 11.7 16.9 17.9 33.0 36.4 16.0 15.6 22.0 23.3 18.2 11.3 3.6 13.1 28.9 12.0 19.4 20.6 8.2 6.3 26.5 8.5 16.3 11.8 24.2 23.7 14.2 13.3 9.3 11.3 37.0 14.4 1.1 3.2 4.0 2.6 2.3 2.0 2.6 3.1 4.4 3.3 1.6 2.3 2.6 0.5 2.9 3.5 0.6 3.2 2.8 7.2 9.4 9.4 9.3 6.8 8.2 9.2 8.8 9.4 7.3 8.3 10.4 2.2 0.0 0.0 0.0 4.6 1.7 2.4 1.9 5.7 5.4 1.7 1.9 2.6 1.5 1.2 0.0 8.4 1.4 3.4 1.9 3.9 5.3 90.6 1.7 3.4 2.4 2.4 9.4 0.0 3.7 2.1 1.9 5.1 2.6 0.0 3.5 1.8 3.3 4.0 6.7 0.0 3.3 8.2 0.9 3.2 156.3 3.1 2.1 1.8 0.0 2.7 2.6 2.1 0.0 0.0 3.0 5.0 0.0 4.9 1.9 3.9 2.7 1.9 6.9 0.0 1.9 3.2 6.2 5.6 3.4 1.6 0.7 4.4 2.2 4.8 1.8 SCPEP1 RISC ENSG00000121064 "Serine carboxypeptidase 1" Q9HB40 17 56978129-57006768 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 300.9" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 456.2;Club cells: 304.9;Respiratory ciliated cells: 397.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 319.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 389.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039102, HPA057200" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA039102: AB_10673605, HPA057200: AB_2683365" "unprognostic (5.83e-3)" "unprognostic (7.43e-3)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (9.26e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.00e-3)" "unprognostic (1.68e-1)" "unprognostic (1.70e-1)" "unprognostic (3.56e-3)" "unprognostic (1.40e-1)" "unprognostic (3.25e-1)" "unprognostic (7.28e-2)" "unprognostic (8.89e-2)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" 64.1 121.5 25.7 32.6 26.4 75.8 91.0 27.3 42.9 69.8 34.5 46.9 31.4 37.5 73.1 54.8 48.5 71.2 60.1 27.2 30.9 88.6 32.0 95.1 48.7 30.1 29.5 53.6 17.0 300.9 28.7 20.8 30.6 61.6 33.7 8.1 90.0 102.9 15.8 46.3 40.3 60.9 28.7 44.8 54.2 14.3 28.4 14.6 135.1 32.5 60.6 71.1 51.1 33.6 48.3 20.9 49.4 41.4 389.3 85.6 26.0 23.3 119.6 41.9 77.8 13.7 33.3 63.3 126.4 55.9 65.8 44.0 22.0 105.4 46.8 82.0 36.1 19.8 28.2 8.7 89.1 39.1 190.1 103.7 45.0 52.0 43.0 37.5 72.3 24.3 5.1 257.9 59.1 20.3 19.9 100.4 20.4 15.2 39.3 24.2 53.8 41.4 9.3 143.7 13.8 33.8 56.3 45.6 33.3 57.1 19.1 104.1 34.1 118.3 29.9 68.8 26.5 250.5 187.2 35.9 88.1 28.5 34.4 2.1 228.5 319.0 11.8 137.1 8.0 56.0 8.2 8.3 105.7 55.1 11.3 12.3 34.8 23.7 141.0 18.0 10.2 118.7 25.7 26.4 27.3 42.9 27.2 30.9 30.1 29.5 30.6 28.7 28.4 33.6 48.8 44.8 61.8 25.1 52.7 23.7 208.6 456.2 37.5 12.7 52.4 110.7 32.5 10.0 304.9 95.6 16.7 9.9 20.5 2.0 19.6 22.2 1.0 51.5 24.5 27.1 24.4 21.2 37.2 6.8 19.4 115.4 4.6 13.6 8.2 4.3 62.8 15.7 160.5 10.1 24.9 5.0 126.1 135.0 33.7 3.4 64.3 110.2 24.9 20.6 142.2 18.9 25.7 21.1 20.7 4.8 1.6 68.1 39.0 74.1 62.4 29.7 397.8 17.0 52.6 28.1 63.2 4.4 12.3 38.1 19.9 11.1 18.8 67.1 8.0 122.6 SDF4 Cab45 ENSG00000078808 "Stromal cell derived factor 4" Q9BRK5 1 1216909-1232067 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 406.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011249, HPA011895, CAB015227" Supported Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 2600000 "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "CAB015227: , HPA011249: AB_2668468, HPA011895: " "unprognostic (1.98e-1)" "prognostic unfavorable (5.89e-4)" "unprognostic (3.63e-1)" "unprognostic (2.38e-3)" "unprognostic (5.88e-2)" "unprognostic (7.95e-3)" "unprognostic (3.73e-3)" "unprognostic (1.06e-1)" "unprognostic (2.01e-1)" "unprognostic (8.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.07e-1)" "unprognostic (8.39e-3)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.04e-2)" 86.5 91.8 44.2 78.8 47.8 56.2 80.2 47.2 65.3 84.4 72.5 95.9 117.1 91.8 43.9 66.3 74.6 66.2 134.6 45.5 44.8 89.6 160.7 82.0 53.4 53.2 46.1 85.4 104.6 61.5 78.5 73.3 47.0 76.9 60.4 25.7 83.5 52.2 78.9 72.9 116.8 58.2 43.5 78.0 93.6 71.7 50.5 34.6 81.8 47.7 39.6 82.2 71.6 45.9 139.7 123.7 67.1 214.0 320.0 160.4 80.5 266.1 241.4 191.2 159.4 147.0 236.2 87.8 201.8 258.0 137.4 140.4 77.5 117.1 58.2 147.9 133.0 153.6 185.7 207.8 147.4 156.7 199.2 199.0 59.5 144.6 81.2 186.5 155.9 57.3 129.2 225.0 95.7 101.1 77.8 158.9 61.7 158.0 167.1 85.8 86.5 234.4 127.2 66.4 243.3 86.7 177.2 208.2 182.8 59.0 108.0 176.7 198.8 196.2 107.0 149.5 154.2 138.9 141.2 144.6 222.9 289.7 87.1 14.4 21.5 30.8 19.3 14.6 14.6 13.5 27.6 28.4 21.9 16.8 16.0 14.1 16.9 26.8 23.2 14.0 25.1 11.8 44.2 47.8 47.2 65.3 45.5 44.8 53.2 46.1 47.0 43.5 50.5 45.9 92.9 22.4 19.2 18.6 62.5 119.8 74.0 24.6 46.7 34.5 51.2 47.6 35.7 68.6 28.9 49.7 18.8 124.1 68.4 240.0 11.7 79.0 39.1 49.0 76.2 77.8 65.5 32.8 21.1 71.4 284.4 117.1 81.1 60.8 36.2 61.4 76.4 117.1 122.4 38.7 23.5 174.9 30.5 73.7 154.8 36.8 95.4 62.8 167.2 13.1 50.8 64.9 111.2 13.6 17.5 73.0 213.5 76.0 202.5 101.5 406.2 57.7 18.4 40.0 59.2 69.8 75.1 101.7 63.5 53.2 114.2 168.0 73.4 88.7 181.0 71.1 SERPINE2 "GDN, nexin, PI7, PN1, PNI" ENSG00000135919 "Serpin family E member 2" P07093 2 223975045-224039318 "Plasma proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "placenta: 1091.9" "Cell type enriched" "Detected in many" 8 "Granulosa cells: 4466.0" "Cancer enriched" "Detected in all" 9 "melanoma: 271.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 12.9;naive CD8 T-cell: 6.8;NK-cell: 23.2" "Group enriched" "Detected in many" 15 "NK-cells: 23.2;T-cells: 12.9" "Cell line enhanced" "Detected in many" "BJ: 1492.9;fHDF/TERT166: 6425.1;SK-MEL-30: 2966.9;WM-115: 2183.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000277 Approved "Golgi apparatus" "Secreted in female reproductive system" NA NA 910000 "Cluster 48: NK-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "HPA000277: " "unprognostic (1.73e-1)" "unprognostic (7.08e-3)" "unprognostic (8.49e-2)" "unprognostic (7.78e-3)" "unprognostic (2.57e-3)" "unprognostic (5.57e-2)" "unprognostic (1.49e-2)" "unprognostic (7.43e-3)" "unprognostic (4.41e-1)" "unprognostic (7.12e-2)" "unprognostic (7.56e-3)" "unprognostic (2.40e-1)" "unprognostic (1.97e-3)" "unprognostic (1.23e-2)" "unprognostic (1.31e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.48e-5)" 28.0 19.8 120.3 75.7 125.9 6.5 14.3 128.6 158.7 28.1 71.1 22.7 28.2 17.4 5.6 36.2 20.8 46.0 100.0 115.9 145.9 39.3 10.8 14.5 30.9 158.1 152.6 145.6 8.5 3.4 8.7 1091.9 134.4 26.4 21.8 5.4 12.6 7.5 6.6 11.2 27.0 119.6 141.1 30.9 8.9 57.6 146.4 17.0 26.1 10.8 44.0 146.9 27.6 132.0 3.1 83.8 29.4 32.6 1172.5 438.7 4.4 1492.9 851.5 118.1 112.7 4.8 7.0 0.4 32.5 6425.1 188.0 5.0 3.5 102.5 101.0 0.6 26.8 16.6 49.9 22.7 57.7 12.8 1.5 128.3 68.5 342.0 505.6 304.6 9.0 5.4 0.5 1.9 412.1 4.5 2.3 3.9 56.2 31.8 92.3 10.3 25.2 64.5 1100.2 97.5 43.0 7.1 284.4 0.5 2966.9 385.2 1.2 6.4 1056.5 692.5 96.6 214.4 72.7 6.3 13.3 0.8 443.5 11.1 2183.6 0.0 0.0 0.0 0.7 0.0 0.5 0.8 0.6 0.6 0.0 1.2 12.9 6.8 0.5 23.2 0.0 0.2 0.7 2.7 120.3 125.9 128.6 158.7 115.9 145.9 158.1 152.6 134.4 141.1 146.4 132.0 13.5 0.0 1.1 233.1 3.1 23.3 16.0 132.2 351.7 5.3 7.9 8.5 5.3 0.0 4.6 7.3 0.0 106.1 11.3 19.5 11.7 13.0 2.6 5.3 17.7 20.9 24.0 23.1 86.1 33.2 524.3 556.7 5.6 5.9 2.5 4466.0 23.2 0.0 45.5 0.0 11.4 4.7 0.0 0.8 26.9 9.9 401.4 9.7 142.3 23.4 3.5 2.5 2.1 199.6 13.5 22.1 14.9 98.9 5.6 27.2 2.0 146.2 1.7 3.5 13.1 5.2 146.6 4.2 70.9 34.8 14.5 133.9 10.7 18.9 3.1 7.2 SGSM3 "DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3" ENSG00000100359 "Small G protein signaling modulator 3" Q96HU1 22 40370591-40410289 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Gastric mucus-secreting cells: 176.4;Intestinal goblet cells: 135.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048980 Approved Supported "Golgi apparatus" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA048980: AB_2680585" "unprognostic (4.63e-2)" "unprognostic (7.51e-3)" "unprognostic (3.02e-2)" "prognostic favorable (4.47e-5)" "unprognostic (1.81e-1)" "unprognostic (6.83e-3)" "unprognostic (5.70e-3)" "unprognostic (7.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.67e-2)" "unprognostic (1.71e-3)" "unprognostic (1.93e-1)" "unprognostic (2.97e-1)" "unprognostic (4.08e-3)" "unprognostic (2.10e-1)" "unprognostic (1.63e-1)" "unprognostic (5.98e-3)" 24.8 42.6 34.6 26.1 34.8 19.3 29.4 27.3 43.6 37.3 32.6 46.6 32.8 31.9 14.5 49.2 37.1 28.7 37.0 33.2 33.3 36.4 37.3 33.8 32.9 36.5 34.3 30.8 107.7 24.7 55.0 21.9 34.8 62.6 24.3 11.0 70.1 25.9 34.2 36.7 46.1 17.4 27.6 51.5 91.4 39.8 33.6 27.5 48.7 23.4 28.3 33.1 35.6 31.9 37.8 21.1 30.6 34.1 33.2 18.1 43.4 35.0 22.9 26.0 33.7 12.0 30.9 23.3 23.7 37.9 15.6 30.0 29.2 42.9 10.4 58.4 68.8 15.9 56.9 11.3 31.6 23.1 33.1 30.2 29.5 29.1 17.4 29.2 46.0 48.6 19.8 31.4 19.4 60.5 32.1 23.5 20.5 75.8 14.0 59.3 19.3 51.1 26.8 33.0 18.8 24.2 38.6 55.4 27.5 24.2 46.3 38.9 40.2 8.8 31.8 23.4 20.6 47.1 23.2 31.0 37.4 19.0 22.9 1.1 14.6 16.3 18.7 15.7 15.6 17.7 11.5 14.9 18.9 22.3 13.8 11.3 3.3 35.4 11.9 31.6 11.7 15.8 34.6 34.8 27.3 43.6 33.2 33.3 36.5 34.3 34.8 27.6 33.6 31.9 5.3 3.2 10.3 14.0 32.8 11.5 32.4 33.1 14.8 57.0 12.1 7.1 8.3 27.1 42.1 7.3 18.8 42.8 23.9 46.4 1.9 20.2 17.5 5.1 3.8 14.3 31.3 18.1 27.1 45.3 54.3 14.0 176.4 6.7 15.9 3.1 21.8 24.0 24.2 26.9 34.6 135.3 50.8 17.2 8.3 31.7 22.7 11.8 16.0 13.1 21.6 13.4 30.9 15.6 15.1 21.3 40.6 19.2 30.5 46.1 36.2 4.4 60.2 34.0 39.5 14.4 13.8 83.5 44.4 19.8 10.4 45.6 16.7 3.3 47.7 60.0 SH3BP2 "CRBM, RES4-23" ENSG00000087266 "SH3 domain binding protein 2" P78314 4 2793071-2841098 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036789, HPA036790" Approved Approved "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA036789: , HPA036790: AB_10671712" "unprognostic (7.86e-2)" "unprognostic (3.45e-1)" "unprognostic (9.83e-2)" "prognostic unfavorable (5.42e-6)" "prognostic unfavorable (9.52e-4)" "prognostic favorable (1.57e-5)" "unprognostic (6.58e-2)" "unprognostic (3.16e-2)" "unprognostic (3.17e-2)" "unprognostic (6.41e-3)" "unprognostic (3.35e-2)" "unprognostic (3.30e-2)" "unprognostic (3.24e-3)" "unprognostic (1.78e-2)" "unprognostic (5.32e-1)" "unprognostic (1.78e-1)" "prognostic favorable (2.67e-4)" 15.3 6.8 17.2 30.0 20.6 48.2 7.9 20.1 16.6 7.0 6.8 12.3 11.4 6.8 9.8 7.1 8.9 8.7 6.7 14.4 22.3 13.1 12.1 17.0 23.2 34.0 30.5 5.8 9.6 4.8 5.0 12.8 25.2 5.3 9.1 5.2 10.4 8.3 16.9 39.7 16.0 10.5 21.5 43.9 16.7 5.2 36.1 8.4 4.7 4.8 13.3 12.3 9.7 14.8 11.2 5.2 7.4 8.7 4.6 14.6 7.2 16.8 13.0 11.1 10.9 6.9 31.6 18.0 20.5 14.2 9.7 5.6 0.3 10.5 7.5 12.2 6.8 41.4 15.2 6.1 17.1 15.4 29.1 27.7 10.5 7.1 5.9 11.8 25.7 13.7 2.5 37.2 15.0 9.6 2.7 24.3 13.3 21.6 13.3 0.6 7.4 9.9 20.1 16.1 25.4 16.4 12.8 10.7 10.3 6.8 15.7 30.8 35.4 12.1 8.9 4.2 13.8 19.5 10.6 4.3 14.1 40.2 14.4 4.1 21.0 13.6 13.8 36.5 8.2 3.0 3.8 8.8 15.9 6.9 1.9 5.0 33.8 8.3 44.6 6.7 6.9 12.1 17.2 20.6 20.1 16.6 14.4 22.3 34.0 30.5 25.2 21.5 36.1 14.8 27.6 3.2 5.8 40.5 19.5 38.1 10.0 35.3 8.6 0.8 19.8 10.0 8.3 7.2 25.3 40.5 0.0 1.3 43.7 42.5 3.9 6.3 8.5 9.7 11.0 31.3 10.2 14.9 0.4 22.0 1.2 11.3 18.3 22.0 9.5 11.6 33.9 59.0 49.3 0.0 2.7 14.2 30.5 81.5 63.3 10.8 13.7 71.9 19.6 18.7 48.9 23.7 57.7 2.5 0.5 25.3 27.1 10.1 18.1 16.1 23.7 43.7 12.3 6.4 39.5 5.2 16.0 1.9 3.7 18.6 83.4 4.2 22.0 25.5 15.4 20.1 SLC17A1 "NAPI-1, NPT1" ENSG00000124568 "Solute carrier family 17 member 1" Q14916 6 25782915-25832052 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 49 "kidney: 169.3;liver: 49.4" "Cell type enhanced" "Detected in some" "Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2" "Group enriched" "Detected in some" 150 "liver cancer: 7.6;renal cancer: 19.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 647 "RPTEC TERT1: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050513 Approved "Golgi apparatus" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA050513: AB_2681152" "unprognostic (6.98e-2)" "unprognostic (2.99e-1)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.32e-1)" "unprognostic (2.37e-1)" "unprognostic (4.74e-1)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 169.3 49.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 SLC20A1 "Glvr-1, GLVR1, PiT-1" ENSG00000144136 "Solute carrier family 20 member 1" Q8WUM9 2 112645939-112663825 "Metabolic proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Phosphate transport, Symport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 353.3;Paneth cells: 261.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 522.4;U-87 MG: 507.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019279, HPA035834" Approved Approved "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB019279: , HPA035834: AB_2674809" "unprognostic (1.81e-1)" "unprognostic (2.18e-1)" "unprognostic (5.38e-2)" "unprognostic (4.03e-3)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.50e-2)" "unprognostic (3.38e-2)" "unprognostic (2.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.43e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.44e-5)" "unprognostic (6.85e-2)" "unprognostic (1.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-3)" 36.1 11.7 16.2 33.2 24.3 74.6 15.6 27.8 26.3 11.8 25.0 53.6 14.4 13.7 8.4 15.0 14.5 26.4 21.8 20.7 19.8 22.1 49.0 29.2 37.1 25.5 20.7 9.2 30.7 10.4 15.9 29.7 25.2 13.3 21.9 52.3 12.8 9.3 19.7 14.5 28.4 15.0 18.6 29.5 20.2 15.7 24.5 27.2 15.9 7.5 27.5 40.8 13.3 21.2 69.0 55.5 71.1 57.8 52.9 128.8 54.4 181.6 215.3 79.1 102.2 85.0 164.9 124.0 97.5 67.7 305.0 70.5 78.8 138.0 114.8 68.5 80.4 105.5 57.1 81.3 78.2 61.2 178.9 66.0 53.8 279.1 193.9 522.4 102.2 52.9 199.5 126.3 346.7 26.8 83.9 235.9 119.3 31.8 147.6 77.8 63.5 34.9 114.5 312.8 64.4 60.8 91.7 54.9 127.9 31.4 56.0 42.9 223.6 143.5 94.7 50.8 142.4 52.1 143.7 102.2 507.2 57.9 178.3 13.4 33.5 30.1 52.8 59.8 59.4 8.3 22.2 38.4 25.4 5.0 17.5 27.6 14.7 50.2 37.2 41.8 14.6 33.9 16.2 24.3 27.8 26.3 20.7 19.8 25.5 20.7 25.2 18.6 24.5 21.2 61.7 12.8 25.9 42.4 40.3 112.8 59.1 38.7 104.7 60.0 41.9 31.6 49.6 32.9 35.3 9.2 210.6 44.7 119.1 353.3 13.7 18.1 1.5 86.0 34.3 48.2 35.7 53.2 47.3 14.0 13.5 61.5 96.4 167.8 25.3 20.6 41.0 58.1 28.2 20.2 27.2 85.8 32.6 58.5 86.2 3.3 3.7 80.5 26.6 19.7 42.8 31.8 66.9 18.6 26.1 26.9 261.6 4.9 59.8 34.0 156.3 5.2 59.6 84.6 0.0 36.9 25.9 8.5 18.7 119.5 61.8 74.3 70.4 19.0 96.5 90.3 SLC30A6 "FLJ31101, ZNT6" ENSG00000152683 "Solute carrier family 30 member 6" Q6NXT4 2 32165841-32224379 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055032, HPA057328" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 1: Thyroid gland - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA055032: AB_2682677, HPA057328: AB_2683411" "unprognostic (5.61e-2)" "unprognostic (9.11e-3)" "unprognostic (1.05e-3)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.58e-6)" "unprognostic (2.98e-1)" "unprognostic (9.47e-2)" "unprognostic (1.88e-1)" "unprognostic (3.30e-3)" "unprognostic (7.05e-2)" "unprognostic (3.06e-2)" "unprognostic (3.51e-1)" "unprognostic (3.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" 10.3 8.9 4.0 8.5 4.8 4.2 10.1 5.2 4.8 10.1 5.1 10.0 8.6 9.2 7.5 8.8 8.0 9.0 7.6 4.0 4.5 11.7 11.2 8.4 9.8 5.0 4.4 9.0 10.4 11.3 4.3 12.1 4.9 8.8 10.0 6.0 7.7 7.8 7.8 8.0 8.4 9.4 4.8 7.8 9.2 6.2 4.4 9.4 11.8 7.6 10.3 9.9 5.6 6.2 27.7 20.3 20.5 18.0 25.4 22.6 22.7 25.3 25.0 20.4 18.5 15.8 25.4 13.1 16.4 20.4 23.4 17.0 24.7 17.4 25.8 26.6 13.7 28.6 10.9 20.3 16.3 30.4 16.9 17.0 26.7 27.4 21.8 20.7 16.6 9.2 24.6 17.2 23.6 10.2 16.1 13.9 31.0 30.8 10.6 14.2 24.7 19.3 22.5 23.9 15.3 23.3 19.9 21.2 20.4 19.0 11.7 13.6 14.3 25.9 14.3 17.2 30.3 23.1 43.5 19.2 23.0 23.4 26.6 12.8 2.4 1.9 2.5 2.0 3.5 3.0 2.3 2.8 2.9 2.7 3.4 3.2 2.4 7.0 2.3 2.0 4.6 2.0 4.0 4.8 5.2 4.8 4.0 4.5 5.0 4.4 4.9 4.8 4.4 6.2 8.6 9.6 9.9 19.9 14.9 9.1 5.3 14.9 13.6 4.5 9.0 5.7 4.1 8.6 8.3 7.3 6.2 19.8 8.4 9.5 5.9 7.5 2.8 7.4 10.1 10.9 3.6 13.2 29.2 8.7 14.7 9.5 11.7 10.5 3.8 12.9 11.4 15.3 10.7 1.7 31.0 7.9 14.2 8.8 9.3 1.0 6.5 6.6 8.8 10.3 7.7 7.5 12.3 27.2 37.2 9.8 7.0 7.9 20.0 8.7 9.1 8.3 10.0 7.1 13.1 7.3 7.3 12.3 9.4 13.6 6.3 27.5 9.5 9.0 9.0 5.2 SLC30A7 "ZNT7, ZnTL2" ENSG00000162695 "Solute carrier family 30 member 7" Q8NEW0 1 100896076-100981757 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018034 Uncertain Supported "Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA018034: AB_1857089" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (8.05e-3)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "unprognostic (3.18e-1)" "unprognostic (2.89e-3)" "unprognostic (1.24e-1)" "unprognostic (1.61e-1)" "unprognostic (1.11e-3)" "unprognostic (2.78e-2)" "unprognostic (1.95e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" "unprognostic (3.37e-1)" 6.8 6.8 2.5 7.2 3.0 6.7 6.5 3.7 3.5 7.2 6.6 5.9 6.6 4.7 7.8 5.0 4.6 6.7 4.2 2.5 3.0 5.3 10.2 9.3 7.5 2.9 3.1 4.5 8.0 6.8 5.7 8.7 3.0 5.9 7.1 4.7 8.6 3.6 2.6 6.1 6.1 4.4 2.7 7.1 7.6 3.0 3.2 7.0 6.9 2.1 7.0 7.8 5.3 3.9 11.3 5.2 6.1 12.5 16.5 14.9 16.2 8.5 17.0 7.3 9.4 5.3 7.7 5.0 17.2 14.1 4.9 10.7 6.5 11.1 12.7 6.4 4.7 8.5 8.4 11.4 19.5 11.7 7.6 17.3 8.4 12.9 18.9 10.9 15.3 8.4 4.9 15.9 12.5 4.4 9.4 8.1 7.7 5.6 5.5 4.2 10.8 5.8 10.6 10.0 3.3 7.4 11.4 15.8 12.2 5.3 6.7 8.1 17.9 18.2 6.3 19.9 13.7 14.0 5.7 4.6 23.1 11.1 5.7 8.3 5.8 4.2 5.2 6.6 4.9 2.7 5.3 4.8 3.9 2.5 5.5 5.7 2.7 3.5 8.7 3.9 4.3 3.1 2.5 3.0 3.7 3.5 2.5 3.0 2.9 3.1 3.0 2.7 3.2 3.9 28.3 32.1 21.6 32.3 26.3 57.4 19.7 22.8 21.1 10.1 25.8 13.2 6.1 20.0 22.1 23.9 6.2 32.6 24.5 24.1 1.9 24.1 0.9 14.9 27.0 34.5 22.8 11.6 44.8 26.4 24.3 29.1 29.0 29.4 37.4 16.3 33.5 44.6 22.1 5.0 39.6 38.3 14.2 37.0 39.1 1.1 17.1 28.5 32.0 34.7 29.6 6.5 28.8 52.8 59.2 36.0 27.9 16.6 48.1 46.0 20.7 15.7 23.5 13.7 6.6 30.2 20.9 11.4 9.2 19.3 63.9 41.7 28.8 34.8 24.3 32.7 SLC35A2 "UGALT, UGAT, UGT, UGT1, UGT2, UGTL" ENSG00000102100 "Solute carrier family 35 member A2" P78381 X 48903180-48911958 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036087 Approved Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "HPA036087: AB_10604093" "prognostic unfavorable (3.16e-4)" "unprognostic (3.34e-1)" "unprognostic (4.88e-3)" "unprognostic (1.11e-1)" "unprognostic (8.15e-3)" "unprognostic (4.25e-3)" "prognostic unfavorable (9.64e-5)" "unprognostic (3.47e-1)" "unprognostic (2.50e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-3)" "unprognostic (9.58e-2)" "unprognostic (3.16e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" 15.8 20.5 13.7 12.7 14.3 15.9 14.9 14.3 14.8 18.7 19.4 29.3 17.3 13.1 28.4 24.7 32.6 15.2 15.0 14.5 15.8 19.8 31.8 18.2 11.4 14.6 15.0 9.3 30.0 24.7 21.3 19.9 15.4 17.1 28.2 3.1 23.8 14.8 14.0 21.9 18.0 11.7 14.4 14.7 25.0 7.1 15.9 11.8 15.4 7.2 14.7 19.8 15.4 15.9 48.8 55.2 18.8 27.3 36.5 31.6 29.7 49.7 54.1 51.3 59.9 64.0 84.5 18.8 22.2 54.2 64.4 67.0 51.7 40.0 39.7 27.9 34.0 20.5 33.1 49.6 47.8 38.7 40.9 35.7 69.9 48.6 39.8 28.9 30.6 25.9 38.7 29.8 37.6 47.1 20.5 35.0 39.7 55.3 67.7 22.3 35.5 61.1 44.4 39.1 21.8 36.1 52.9 54.5 28.7 35.1 80.8 30.7 28.2 30.3 30.6 55.4 27.5 45.1 32.8 19.6 38.4 34.1 40.3 18.1 22.3 40.0 15.3 23.4 15.8 10.7 12.6 13.9 27.7 9.9 8.3 14.6 24.2 13.8 17.5 27.7 13.1 11.9 13.7 14.3 14.3 14.8 14.5 15.8 14.6 15.0 15.4 14.4 15.9 15.9 16.2 9.6 17.0 3.3 13.1 14.1 11.7 29.0 2.8 4.5 26.5 10.9 5.2 10.0 23.5 16.5 0.0 31.0 15.6 24.1 3.9 27.4 3.3 24.2 12.0 13.5 12.7 19.0 2.6 32.3 30.6 14.0 18.8 16.8 2.5 8.0 11.0 15.6 23.4 6.7 2.5 31.5 28.5 10.1 14.5 1.3 9.9 12.3 10.6 4.7 21.9 9.4 8.2 4.5 4.4 27.1 19.7 10.9 19.3 18.7 17.8 10.5 50.5 5.7 6.6 9.7 19.4 10.3 6.8 10.9 17.5 48.0 13.8 12.2 21.7 23.4 SLC35A5 FLJ20730 ENSG00000138459 "Solute carrier family 35 member A5" Q9BS91 3 112561709-112585579 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035519, HPA057964" Uncertain Approved "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA035519: AB_10601487, HPA057964: AB_2683566" "unprognostic (7.89e-2)" "unprognostic (2.33e-1)" "unprognostic (7.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (7.09e-2)" "unprognostic (1.45e-1)" "unprognostic (4.78e-2)" "unprognostic (8.60e-3)" "unprognostic (2.60e-1)" "unprognostic (8.21e-2)" "unprognostic (3.51e-1)" "prognostic favorable (4.10e-5)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (8.05e-2)" "unprognostic (3.42e-1)" 15.5 19.3 18.2 13.4 23.9 5.7 14.8 22.4 26.9 15.5 18.4 15.6 16.7 15.6 16.0 14.3 14.6 15.4 9.7 18.1 21.4 20.2 21.0 14.7 15.7 24.0 21.7 17.9 9.5 17.2 9.1 18.4 24.3 16.0 16.1 21.7 11.4 13.9 6.1 9.2 18.3 15.9 23.2 14.2 14.5 18.8 21.2 12.7 26.1 10.2 15.3 12.6 8.3 30.0 20.4 18.4 31.2 18.8 39.3 37.4 18.0 33.2 23.7 27.5 31.5 13.6 22.8 18.1 27.4 28.8 31.3 25.3 22.4 15.6 34.6 14.2 11.1 23.2 15.9 11.4 33.6 20.7 21.5 31.8 30.9 24.3 14.9 34.8 25.1 13.8 13.5 22.1 38.7 7.2 16.2 13.1 20.8 24.0 19.2 14.4 11.4 19.7 34.2 14.9 18.3 24.1 21.3 10.4 38.0 20.9 14.2 13.9 28.3 40.3 21.8 8.6 15.7 15.7 24.4 32.2 29.9 17.2 30.8 14.8 16.4 21.0 10.9 25.9 10.3 14.7 10.2 8.6 19.7 13.6 13.6 11.2 14.6 7.3 27.4 9.4 11.2 10.8 18.2 23.9 22.4 26.9 18.1 21.4 24.0 21.7 24.3 23.2 21.2 30.0 9.9 3.2 10.1 13.1 12.5 6.4 8.3 9.9 11.4 12.8 8.5 6.5 5.5 7.2 12.6 14.7 0.0 36.1 12.5 16.4 9.8 7.8 156.8 9.2 9.1 12.9 7.7 9.2 15.0 7.7 25.6 14.0 10.7 10.0 14.0 9.0 19.6 13.1 17.9 37.0 15.2 11.8 20.3 23.2 9.2 23.5 17.1 13.0 26.6 5.6 14.0 20.3 9.2 23.1 36.6 8.1 13.1 17.3 14.3 8.5 25.8 14.8 10.4 16.9 26.3 9.6 10.6 14.9 15.7 8.9 6.7 29.8 10.7 14.6 10.0 6.5 SLC35C1 "FLJ11320, FUCT1" ENSG00000181830 "Solute carrier family 35 member C1" Q96A29 11 45804072-45813016 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 84.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064001 Enhanced Supported "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA064001: AB_2685171" "unprognostic (2.62e-2)" "unprognostic (5.16e-2)" "unprognostic (7.82e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (8.22e-2)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "unprognostic (4.09e-2)" "unprognostic (2.73e-1)" "unprognostic (7.68e-2)" "unprognostic (1.83e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.64e-4)" "unprognostic (2.30e-2)" 28.2 7.3 6.6 10.7 6.3 2.4 19.8 7.0 7.0 9.6 6.1 19.8 24.4 8.8 2.3 41.5 7.3 12.2 9.0 6.2 7.2 7.0 84.5 10.2 6.6 8.2 7.9 6.3 13.4 5.6 10.4 15.0 7.7 9.9 14.3 1.6 26.1 5.9 6.8 5.1 24.1 9.9 6.5 8.4 18.5 5.2 8.8 4.5 6.6 6.9 10.0 13.8 14.9 6.3 10.3 25.8 6.3 16.3 19.9 19.8 19.5 22.1 20.1 13.3 14.4 10.7 15.2 10.4 9.9 27.3 19.4 26.0 13.4 13.6 6.5 24.8 14.5 5.9 20.4 20.6 42.6 11.4 16.2 23.8 16.3 9.2 11.1 16.2 17.6 10.3 13.3 13.8 14.4 21.8 5.9 9.0 27.5 39.9 34.6 7.2 10.5 21.5 15.1 25.4 6.0 8.6 16.6 16.3 9.5 6.6 13.7 6.0 25.7 25.0 14.7 46.1 15.6 9.8 26.9 4.9 18.5 14.4 14.2 9.7 11.6 12.5 11.0 11.9 12.3 5.0 18.0 14.7 9.6 3.7 9.3 8.0 1.8 5.6 8.7 8.2 13.0 10.1 6.6 6.3 7.0 7.0 6.2 7.2 8.2 7.9 7.7 6.5 8.8 6.3 5.5 0.0 11.2 2.6 6.2 3.6 8.9 12.7 3.4 1.9 11.1 3.0 50.6 22.8 26.7 5.5 2.1 13.8 6.4 54.6 0.0 18.4 4.9 7.3 6.7 10.6 9.6 3.6 2.0 41.9 14.0 10.5 23.4 11.4 2.5 5.2 6.8 42.2 14.7 3.3 2.1 40.6 4.1 9.3 4.8 6.0 6.5 6.3 1.8 2.8 9.5 2.8 7.2 1.0 2.1 50.6 54.0 5.7 13.6 11.8 58.0 4.7 11.4 1.1 0.0 3.6 9.7 4.0 4.3 12.7 2.4 15.3 6.5 5.7 26.4 20.1 SLC35D2 "SQV7L, UGTrel8" ENSG00000130958 "Solute carrier family 35 member D2" Q76EJ3 9 96313444-96383711 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 117.2;Proximal enterocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 103.8;Hep G2: 132.3" HPA064047 Approved Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA064047: AB_2685182" "unprognostic (3.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.16e-2)" "unprognostic (3.17e-1)" "unprognostic (8.86e-3)" "unprognostic (4.25e-3)" "unprognostic (2.24e-2)" "unprognostic (4.12e-1)" "unprognostic (5.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-2)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.44e-1)" 14.7 8.8 13.5 14.4 20.6 11.4 16.4 17.8 20.6 16.5 12.3 49.1 65.1 14.9 12.1 13.7 14.6 20.6 12.2 14.3 16.0 32.1 56.4 19.2 12.4 25.5 19.7 17.3 31.4 16.4 7.2 25.5 22.1 14.2 46.4 4.3 13.0 11.0 3.9 9.4 65.8 13.9 16.6 10.0 43.1 7.2 20.1 7.5 29.5 6.9 11.7 17.2 13.1 27.8 33.2 27.6 15.8 30.2 20.3 37.3 27.9 14.7 30.2 21.6 17.5 60.4 103.8 0.6 24.5 13.5 49.9 47.6 22.2 21.8 18.7 16.4 16.8 11.3 9.8 132.3 32.5 0.1 0.0 32.2 27.6 16.3 48.7 51.0 46.7 0.0 22.3 0.4 23.7 27.2 0.3 0.1 13.2 67.5 28.5 0.1 0.0 0.0 54.4 21.3 5.5 35.9 11.9 24.8 68.5 53.3 16.4 24.7 41.3 14.5 16.2 21.2 13.8 0.0 0.9 0.1 30.2 0.1 20.4 1.2 0.9 0.6 1.3 1.1 1.6 0.7 2.1 2.9 1.2 0.9 0.7 1.4 0.1 1.8 2.1 0.2 3.9 0.5 13.5 20.6 17.8 20.6 14.3 16.0 25.5 19.7 22.1 16.6 20.1 27.8 14.5 9.6 11.0 12.1 4.3 5.2 8.9 2.1 1.8 1.1 15.1 13.1 7.2 27.1 4.6 12.9 2.1 28.1 12.9 61.7 11.7 8.1 0.2 21.0 14.0 12.6 9.6 1.3 0.8 24.5 45.1 9.5 20.4 31.6 4.5 20.0 13.2 43.2 20.5 1.7 1.1 42.0 4.1 23.0 9.7 0.6 10.8 17.7 17.8 20.6 8.9 10.2 7.2 11.1 117.2 25.4 43.5 6.0 6.3 15.5 67.0 23.6 6.7 3.6 13.1 6.8 11.2 1.4 4.4 8.6 5.4 26.5 14.6 7.0 34.9 17.9 SLC35E1 FLJ14251 ENSG00000127526 "Solute carrier family 35 member E1" Q96K37 19 16549831-16572415 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016570, HPA062214" Approved Enhanced "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA016570: AB_2190214, HPA062214: AB_2684713" "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.92e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.35e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (9.07e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (2.54e-1)" "unprognostic (3.75e-2)" 10.7 9.8 5.9 5.6 4.8 8.0 9.6 3.7 6.6 9.6 6.3 9.2 6.6 8.5 5.9 11.5 7.4 6.1 10.1 5.6 4.7 7.8 11.4 9.1 7.1 4.8 5.9 8.8 22.3 15.2 11.2 7.2 5.0 11.7 6.1 7.4 15.4 10.0 20.5 11.9 7.7 6.8 3.6 6.7 15.3 4.1 9.1 8.5 9.2 14.0 8.1 10.1 8.7 4.5 26.2 10.4 6.9 16.2 25.2 19.8 16.4 17.8 20.3 15.1 18.2 11.8 18.7 13.6 30.2 29.3 14.9 17.6 19.7 21.5 15.2 15.8 29.5 11.9 11.6 14.4 21.1 19.6 14.5 16.5 24.2 17.0 24.5 19.2 14.8 16.0 19.9 17.3 19.4 25.3 15.3 9.3 8.1 24.8 34.6 14.9 10.6 16.6 15.7 16.1 11.9 11.9 12.3 19.6 11.5 8.3 14.7 9.9 15.3 19.5 9.6 26.9 21.2 23.6 26.9 15.1 29.3 21.4 12.6 1.8 1.3 3.2 1.3 0.9 1.8 2.2 1.4 1.3 1.0 0.8 1.0 0.8 1.3 1.8 2.0 1.1 1.8 1.1 5.9 4.8 3.7 6.6 5.6 4.7 4.8 5.9 5.0 3.6 9.1 4.5 21.7 38.5 42.5 6.8 14.9 21.9 15.3 22.1 5.7 28.8 34.1 21.5 16.1 22.8 31.3 29.5 35.5 14.4 43.3 25.2 0.0 20.4 3.6 26.6 20.1 20.2 18.5 13.7 13.9 36.8 29.8 14.8 13.3 50.8 8.2 21.2 22.9 26.9 17.4 30.3 13.9 29.7 8.2 21.1 28.0 4.2 17.1 23.3 8.8 10.3 22.8 19.4 17.5 9.0 6.2 41.7 13.1 21.1 29.3 30.9 22.1 7.0 24.0 29.4 6.6 30.1 14.3 10.2 14.3 13.6 25.9 32.6 29.4 16.2 20.4 28.4 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 37.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.0;Basal prostatic cells: 34.5;Suprabasal keratinocytes: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 188.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048185, HPA060150" Enhanced Approved "Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA048185: AB_2680304, HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 4.1 1.2 3.3 7.2 3.9 5.1 5.5 2.3 3.6 16.3 3.2 17.9 19.0 6.3 11.6 12.2 13.5 5.1 3.5 3.8 4.2 10.0 0.5 5.7 7.9 3.5 3.4 5.0 5.4 6.0 3.4 3.2 3.3 22.3 20.4 12.7 37.4 6.1 1.1 20.5 17.8 4.6 4.3 4.0 7.0 4.5 3.5 5.5 7.2 1.5 13.9 7.9 9.5 3.6 30.8 19.8 2.3 30.1 15.2 22.6 29.0 6.8 3.9 17.3 22.7 84.2 31.4 51.2 67.7 20.1 94.1 63.1 37.3 60.5 34.2 40.3 34.8 28.5 18.1 34.1 24.8 65.0 14.2 15.7 36.9 58.3 123.1 53.2 91.7 38.3 74.0 20.7 13.0 17.0 28.3 69.7 20.5 67.5 188.4 57.7 23.9 68.9 100.1 26.7 46.6 20.1 21.9 54.8 14.8 24.7 38.1 15.2 68.0 33.4 53.9 0.8 73.5 54.6 62.5 53.9 21.4 22.0 22.4 0.3 0.2 0.0 3.1 0.1 8.2 10.6 5.3 5.4 6.9 6.5 1.9 2.7 0.6 3.7 0.0 0.3 13.5 1.8 3.3 3.9 2.3 3.6 3.8 4.2 3.5 3.4 3.3 4.3 3.5 3.6 2.7 9.6 1.5 2.0 10.3 46.0 34.5 6.4 14.8 1.1 3.7 2.3 0.6 7.2 9.6 3.7 12.5 0.9 2.5 21.5 3.9 9.5 0.3 13.6 2.8 13.7 6.0 1.7 3.9 8.2 19.1 8.3 6.1 22.9 2.5 5.0 0.7 0.0 4.8 0.0 4.4 10.1 4.1 0.3 15.0 1.0 0.9 3.6 23.2 6.5 3.7 1.2 1.0 4.0 0.4 25.9 10.0 2.6 23.6 20.6 15.1 6.4 0.1 8.0 6.6 2.8 3.1 0.3 7.5 8.6 50.3 4.5 5.7 4.9 24.7 16.6 SLC38A10 "MGC15523, PP1744" ENSG00000157637 "Solute carrier family 38 member 10" Q9HBR0 17 81244811-81295547 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021374, HPA023161, HPA024631" Enhanced Enhanced "Golgi apparatus" NA NA 70000000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860" "unprognostic (2.18e-2)" "unprognostic (1.54e-1)" "unprognostic (7.40e-2)" "unprognostic (3.00e-3)" "unprognostic (2.06e-2)" "unprognostic (1.69e-1)" "unprognostic (2.12e-1)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.92e-4)" "unprognostic (8.39e-2)" "prognostic unfavorable (5.34e-7)" "unprognostic (6.55e-2)" "unprognostic (3.15e-1)" "unprognostic (1.31e-1)" "unprognostic (2.45e-1)" 37.6 37.0 12.7 23.4 14.0 30.8 31.2 12.7 16.1 33.0 14.7 31.7 31.8 35.3 17.3 24.0 31.7 25.8 36.8 10.5 13.8 31.6 75.2 31.4 21.4 21.5 14.9 37.7 91.4 15.6 62.1 24.6 15.7 34.2 9.5 4.4 51.1 20.8 20.0 25.2 34.7 15.4 13.3 43.8 38.8 30.5 16.6 12.9 41.3 6.3 10.6 37.6 26.8 19.4 45.2 77.5 13.3 70.2 49.8 23.3 77.6 53.7 48.2 32.5 38.2 36.1 73.0 34.4 59.2 37.3 36.0 53.0 13.5 27.1 12.0 34.7 40.0 34.6 28.5 61.2 44.4 34.1 78.4 40.7 19.7 29.2 18.9 26.2 62.2 24.5 26.3 51.3 24.6 56.5 21.0 59.4 12.9 41.3 37.6 33.8 27.8 34.8 22.2 42.3 25.7 65.7 43.2 26.9 59.2 18.3 38.1 70.0 61.9 52.2 29.9 38.9 29.4 44.6 21.4 20.0 30.9 51.8 54.5 12.7 10.6 18.6 7.4 11.9 8.7 6.2 7.1 9.1 6.2 7.0 4.8 5.4 8.0 4.6 15.9 9.8 5.6 9.5 12.7 14.0 12.7 16.1 10.5 13.8 21.5 14.9 15.7 13.3 16.6 19.4 24.4 25.6 35.6 25.8 28.6 8.3 12.3 21.9 13.6 10.9 25.3 18.0 19.3 31.5 24.6 11.0 18.8 61.0 29.8 66.4 5.9 31.9 25.4 17.3 13.7 22.4 45.0 22.3 12.3 26.9 62.4 35.9 44.9 32.8 15.2 64.6 27.5 79.2 49.3 25.2 14.3 58.8 12.2 40.6 15.1 75.6 32.9 35.7 14.2 28.1 29.1 27.7 23.7 9.0 20.5 25.1 53.1 27.4 96.5 16.0 59.1 23.9 21.4 9.1 32.9 17.0 21.2 19.7 22.8 11.8 7.2 62.5 25.0 39.9 48.2 11.4 SLC6A16 NTT5 ENSG00000063127 "Solute carrier family 6 member 16" Q9GZN6 19 49289638-49325215 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 94.2" "Group enriched" "Detected in many" 8 "Early spermatids: 125.9;Late spermatids: 46.8;Spermatocytes: 153.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 18.2;SuSa: 9.9" "Not detected" "Not detected" HPA076812 Supported "Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA076812: AB_2686816" "unprognostic (1.98e-1)" "unprognostic (7.15e-3)" "unprognostic (6.39e-3)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.83e-3)" "unprognostic (7.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.55e-3)" "unprognostic (1.63e-1)" "unprognostic (3.23e-2)" "unprognostic (3.31e-1)" "unprognostic (2.10e-1)" "unprognostic (8.93e-2)" "unprognostic (4.18e-2)" 4.5 2.0 2.8 2.9 2.2 4.5 3.2 1.2 2.1 4.6 17.9 3.8 1.2 4.0 2.4 1.7 5.8 2.3 2.5 2.2 1.8 8.5 10.0 4.9 7.3 5.0 4.9 7.0 6.9 0.9 1.6 3.2 4.3 5.0 1.1 5.0 1.5 2.9 1.0 2.2 3.7 1.8 2.9 4.7 3.5 94.2 2.5 2.3 3.2 0.5 5.5 3.6 3.4 2.1 0.0 7.3 18.2 6.5 0.3 2.8 3.3 0.9 1.5 0.6 2.0 0.2 0.6 8.5 1.1 0.8 0.3 0.3 2.0 0.3 2.2 1.3 2.1 0.7 0.7 1.7 1.4 0.6 3.0 2.8 1.1 1.4 1.0 5.2 1.6 1.5 1.7 1.1 2.4 1.6 0.5 0.3 6.4 0.3 0.9 0.3 4.4 1.6 1.0 0.0 0.2 0.4 2.9 0.1 0.6 9.9 2.9 0.3 9.3 1.4 6.7 4.2 0.0 4.0 4.6 7.5 0.1 2.0 0.4 0.2 0.3 2.6 1.6 1.2 1.5 4.5 0.5 1.6 0.4 2.2 1.4 0.9 1.9 1.8 2.1 1.1 0.9 1.3 2.8 2.2 1.2 2.1 2.2 1.8 5.0 4.9 4.3 2.9 2.5 2.1 4.4 0.0 1.1 3.6 5.8 1.5 0.9 0.4 2.2 8.6 1.7 1.7 1.5 2.8 0.1 1.8 2.1 0.0 1.7 0.1 11.7 0.8 125.9 2.3 1.6 3.9 0.0 0.0 4.1 0.6 0.0 1.7 0.0 1.5 1.3 0.3 2.2 5.5 0.9 0.0 8.1 0.1 0.0 1.4 1.8 46.8 3.7 0.8 5.4 12.2 1.2 0.5 5.2 2.5 1.7 0.2 0.0 3.4 1.5 0.5 0.0 0.3 11.3 1.2 0.0 1.7 4.9 153.5 8.3 0.3 1.3 0.0 1.1 1.8 0.1 0.3 SLPI "ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4" ENSG00000124107 "Secretory leukocyte peptidase inhibitor" P03973 20 45252239-45254564 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 27919.2;salivary gland: 14140.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 4134.5;Basal respiratory cells: 18759.4;Club cells: 20435.8;Respiratory ciliated cells: 8096.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 79 "neutrophil: 321.8" "Lineage enriched" "Detected in many" 79 "granulocytes: 321.8" "Cell line enhanced" "Detected in many" "EFO-21: 1719.5;hTCEpi: 2037.1;OE19: 767.9;SiHa: 622.1;THP-1: 531.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002303, HPA027774" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 26400000 9600000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "CAB002303: AB_564008, HPA027774: AB_10602405" "unprognostic (2.31e-2)" "unprognostic (3.07e-1)" "unprognostic (3.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.16e-2)" "unprognostic (9.98e-2)" "unprognostic (2.90e-1)" "unprognostic (3.23e-1)" "unprognostic (1.83e-3)" "unprognostic (4.01e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (6.91e-5)" "unprognostic (1.53e-1)" "unprognostic (2.15e-1)" "unprognostic (8.81e-2)" "unprognostic (8.31e-2)" 259.4 13.8 4.1 70.8 4.3 353.5 306.7 5.0 22.5 27919.2 28.9 97.8 4.5 107.1 16.5 1372.7 714.2 294.7 68.4 4.5 4.8 382.6 268.0 1181.7 2.0 5.6 5.5 11.5 36.1 5.5 470.2 8.3 5.5 112.6 106.7 0.6 14140.1 2946.3 599.9 272.4 19.9 14.0 4.8 22.5 154.7 28.1 10.4 47.7 30.4 51.5 215.8 226.6 685.3 4.8 4.9 19.4 0.0 0.3 0.2 0.0 1.1 0.1 0.0 0.1 0.0 1.5 318.7 0.9 1719.5 0.2 23.9 132.8 0.0 64.1 0.0 8.6 0.3 0.3 227.1 0.2 326.4 0.5 1.0 8.8 2037.1 0.1 134.0 0.0 0.2 0.0 0.2 0.3 0.0 0.4 0.4 24.4 0.4 767.9 120.1 0.6 0.7 0.1 355.5 14.6 0.3 0.0 622.1 131.4 1.8 0.4 2.8 531.8 0.3 0.4 8.5 1.2 1.1 1.2 9.7 6.1 0.0 33.0 0.5 3.6 0.9 0.4 0.1 3.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 321.8 0.0 4.0 0.0 0.0 7.9 4.1 4.3 5.0 22.5 4.5 4.8 5.6 5.5 5.5 4.8 10.4 4.8 6.3 1807.7 4134.5 0.3 5.4 100.7 1330.7 18759.4 2.2 0.0 594.2 607.6 3.9 1609.9 20435.8 3428.2 0.0 2.3 10.1 225.8 0.0 407.5 381.6 632.0 170.7 43.3 200.2 18.7 0.0 258.9 1.2 326.0 193.7 1398.8 77.0 0.0 15.7 508.5 6.8 0.0 0.0 74.7 2616.3 8.5 73.3 69.8 25.4 27.1 39.2 0.0 5.3 0.0 0.0 1.0 0.1 901.6 370.3 0.0 1.3 1289.4 2.7 3.4 8096.4 0.0 0.0 8.6 971.2 1.8 1.8 347.3 138.9 2.1 29.5 0.0 224.5 3338.5 SMIM7 "C19orf42, MGC2747" ENSG00000214046 "Small integral membrane protein 7" Q9BQ49 19 16630751-16660442 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043127 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "HPA043127: AB_10806378" "unprognostic (6.61e-2)" "unprognostic (1.61e-2)" "unprognostic (1.90e-1)" "unprognostic (3.71e-2)" "unprognostic (2.52e-1)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "unprognostic (1.79e-2)" "unprognostic (6.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-1)" "unprognostic (1.76e-3)" "unprognostic (8.29e-3)" "unprognostic (2.94e-1)" "unprognostic (2.29e-1)" "unprognostic (8.38e-2)" "unprognostic (7.64e-2)" 41.6 39.5 39.6 24.8 41.8 19.9 47.2 41.4 48.5 36.7 39.8 34.1 34.4 32.5 72.9 30.0 36.9 30.5 35.8 37.8 41.3 52.7 66.7 33.5 33.7 42.9 41.1 32.2 47.7 54.1 16.1 34.7 42.2 46.5 42.0 18.6 52.3 39.3 18.7 32.1 25.4 36.4 43.0 26.7 38.2 21.0 41.7 29.3 50.0 21.0 34.0 32.8 17.9 44.2 60.6 52.1 48.7 42.3 74.4 64.4 48.9 50.4 69.4 70.7 68.8 45.2 111.8 44.4 67.7 69.3 50.5 48.0 44.5 69.8 86.7 38.1 34.4 42.4 34.9 48.5 43.3 64.2 46.5 49.3 49.8 51.5 52.9 43.0 68.9 40.3 59.9 53.7 81.6 120.2 42.4 55.1 45.2 121.5 77.4 41.3 32.9 43.4 83.4 66.3 26.0 48.2 37.8 41.0 51.2 26.8 59.9 80.5 41.5 55.4 35.7 130.3 83.2 46.4 72.6 56.0 56.3 75.6 71.2 47.5 73.3 38.3 37.1 65.8 35.3 49.6 38.0 37.0 58.8 44.3 37.0 33.6 31.0 42.8 78.3 79.2 44.9 45.3 39.6 41.8 41.4 48.5 37.8 41.3 42.9 41.1 42.2 43.0 41.7 44.2 63.5 67.3 64.5 29.0 75.5 34.2 62.8 114.3 70.6 70.1 69.0 84.6 38.5 57.2 68.8 57.0 95.9 144.1 68.5 67.6 129.1 85.2 18.4 58.2 60.8 61.5 73.0 54.7 35.3 86.3 105.2 74.9 57.1 51.5 50.1 42.3 66.0 85.7 115.6 63.9 32.1 78.3 77.3 77.2 43.9 21.6 88.9 64.6 48.0 21.5 102.4 101.3 98.9 21.6 44.8 87.6 87.0 83.1 76.5 77.6 85.1 140.0 54.6 121.4 72.3 42.3 64.8 84.0 81.0 74.7 35.8 156.4 54.7 66.7 62.7 57.7 SPAG11A "EDDM2A, HE2" ENSG00000178287 "Sperm associated antigen 11A" Q6PDA7 8 7847876-7868867 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11461 "epididymis: 4564.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 5.7;RPMI-8226: 1.7" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4564.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG11B "EDDM2B, EP2, EP2C, EP2D, HE2" ENSG00000164871 "Sperm associated antigen 11B" Q08648 8 7442684-7463674 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1636 "epididymis: 864.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 864.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SPATA25 "C20orf165, dJ337O18.8, TSG23" ENSG00000149634 "Spermatogenesis associated 25" Q9BR10 20 45886489-45887635 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 304.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 6.7;HeLa: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA041386 Approved "Golgi apparatus" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 39: CACO-2 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA041386: AB_2677446" "unprognostic (1.88e-1)" "unprognostic (2.66e-1)" "unprognostic (1.60e-1)" "unprognostic (4.92e-3)" "unprognostic (2.36e-1)" "unprognostic (1.84e-2)" "unprognostic (2.75e-3)" "unprognostic (1.57e-2)" "unprognostic (2.57e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (1.67e-2)" "unprognostic (3.14e-1)" "unprognostic (5.07e-2)" "unprognostic (2.62e-1)" "unprognostic (5.93e-5)" "unprognostic (1.12e-1)" 3.0 1.8 1.9 1.8 3.2 0.6 1.6 4.2 2.4 2.4 3.3 2.6 4.5 3.2 2.3 2.2 2.8 2.1 3.2 1.7 1.7 5.5 5.2 1.1 1.5 2.3 2.2 6.5 2.3 2.5 1.6 1.7 1.9 2.1 2.2 4.3 2.5 3.1 9.9 2.6 3.3 3.6 1.5 1.8 1.6 24.0 2.5 6.8 2.9 3.4 1.1 3.1 2.1 2.8 0.6 2.1 1.5 1.7 2.3 1.4 1.7 0.4 1.8 0.9 0.3 6.7 3.7 1.2 0.5 0.8 1.9 2.8 0.8 0.5 0.3 0.4 1.4 0.6 6.2 4.4 1.7 0.1 1.0 3.2 1.0 0.4 0.5 2.4 0.6 2.0 0.9 1.6 0.7 1.4 0.8 0.0 0.9 0.6 1.1 1.6 1.0 0.8 0.1 0.9 2.9 1.6 1.9 1.3 1.9 0.6 2.2 1.6 0.5 1.1 1.2 0.8 0.6 1.4 0.9 0.3 1.5 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.2 4.2 2.4 1.7 1.7 2.3 2.2 1.9 1.5 2.5 2.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 304.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 58.3 2.1 0.1 0.0 1.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 1.1 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425616-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 571 "testis: 128.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain Approved "Golgi apparatus" NA NA "Cluster 36: Testis - Spermatogenesis" "Golgi apparatus" "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 128.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPP1 "BNSP, BSPI, ETA-1, OPN" ENSG00000118785 "Secreted phosphoprotein 1" P10451 4 87975650-87983426 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Biomineralization, Cell adhesion" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9" "Cell type enriched" "Detected in many" 8 "Hofbauer cells: 60702.5" "Group enriched" "Detected in all" 4 "glioma: 1690.9;renal cancer: 1385.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "neutrophil: 24.8" "Lineage enriched" "Detected in single" 249 "granulocytes: 24.8" "Cell line enhanced" "Detected in many" "EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3" "Region enhanced" "Detected in all" "pons and medulla: 316.8" "Low region specificity" "Detected in all" "HPA027540, HPA027541" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 114000000 73000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" "HPA027540: AB_10600222, HPA027541: AB_10601446" "unprognostic (4.74e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.13e-3)" "unprognostic (2.04e-1)" "unprognostic (2.31e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.84e-6)" "unprognostic (2.46e-3)" "unprognostic (7.86e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (4.31e-2)" "unprognostic (2.55e-1)" "unprognostic (7.19e-2)" "unprognostic (1.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.63e-2)" 113.1 24.4 276.0 59.5 490.3 1.0 70.2 652.0 736.4 27.5 265.0 44.9 9.5 131.2 9.8 4.8 52.8 2424.4 37.0 301.6 417.1 3587.6 35.6 18.8 9.1 813.2 645.3 9.9 292.0 19.2 20.6 2791.9 781.8 15.7 7.6 745.5 88.7 22.1 16.0 2.7 14.4 38.3 472.6 9.2 11.0 11.7 633.1 8.4 8.3 0.4 5.7 25.0 6.0 855.0 2.2 144.0 19.1 1.1 0.0 0.2 0.3 5.6 4.4 1.4 9.1 0.6 0.2 0.2 4825.8 2.3 371.5 1.4 0.0 0.0 3.1 11.2 0.0 0.0 1.8 2469.7 0.3 6.8 5.1 0.5 0.3 34.9 0.1 118.8 4.2 0.2 0.1 10.8 1.3 0.2 1.2 21.3 227.5 0.3 0.0 2.4 0.5 1189.8 10348.3 1.8 1.1 0.9 0.3 0.8 339.1 441.9 0.5 5.2 0.3 11.5 27.1 0.4 25.8 0.9 7.9 13.9 436.3 1.1 457.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 276.0 490.3 652.0 736.4 301.6 417.1 813.2 645.3 781.8 472.6 633.1 855.0 35.7 3.2 4.7 5.2 34.0 1.5 5.2 0.1 1.2 46.6 1767.7 22.4 17.9 1584.2 0.3 2183.1 27.1 335.6 6.9 0.0 1003.7 7273.8 0.1 61.2 25.2 367.9 0.0 2.7 1.4 71.7 294.5 48.9 0.0 154.2 0.0 1.7 5.7 5.0 60702.5 785.7 9.9 0.0 0.0 57.4 7.7 1.0 0.9 247.7 1.8 99.3 69.2 3862.9 0.0 4.5 532.1 215.4 0.0 0.0 0.1 0.4 0.0 5594.0 1.6 169.7 0.0 0.9 21.6 0.5 0.2 1.1 1.0 667.8 30.0 0.4 0.0 9.9 SPTBN1 ENSG00000115306 "Spectrin beta, non-erythrocytic 1" Q01082 2 54456317-54671446 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 615.4;Peritubular cells: 663.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012685, HPA013149" Supported Approved "Golgi apparatus" NA Yes 1500000 "Cluster 39: Non-specific - mRNA processing" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "HPA012685: AB_1857433, HPA013149: AB_1857434" "unprognostic (2.72e-1)" "unprognostic (4.44e-3)" "unprognostic (3.00e-2)" "unprognostic (3.25e-1)" "unprognostic (4.09e-2)" "unprognostic (7.95e-2)" "unprognostic (9.24e-2)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (1.67e-1)" "unprognostic (2.26e-2)" "unprognostic (7.25e-2)" "prognostic favorable (2.59e-5)" "unprognostic (2.31e-1)" "unprognostic (2.73e-1)" "unprognostic (1.68e-3)" "unprognostic (5.18e-3)" 187.3 70.9 210.6 34.7 205.1 37.6 78.7 97.4 166.1 54.1 94.2 62.8 32.7 52.0 36.3 41.7 56.2 69.2 135.9 156.2 99.7 65.3 83.8 131.6 28.9 141.2 154.4 73.2 45.5 129.2 27.8 97.4 120.4 43.8 52.4 56.0 55.1 74.4 54.0 39.4 46.8 59.9 134.8 58.7 55.6 32.6 214.6 29.3 72.8 87.2 30.0 45.6 38.6 163.6 96.5 150.5 60.4 57.2 234.7 158.8 74.8 40.2 82.3 63.7 61.4 101.7 66.6 0.4 112.1 142.0 55.1 110.9 85.1 128.0 66.0 0.8 35.6 43.7 118.4 166.2 97.7 59.7 24.4 62.3 64.8 193.8 119.7 77.6 151.6 95.1 50.0 64.0 86.1 21.6 105.0 14.5 66.3 129.6 70.2 116.2 95.0 37.2 92.2 120.6 36.3 113.3 121.5 39.5 88.1 58.9 19.6 9.9 235.2 89.9 79.0 110.2 58.2 62.8 42.8 32.7 98.1 17.7 163.7 2.3 0.4 2.8 3.7 0.0 3.9 3.7 3.4 3.6 1.3 3.5 5.0 3.6 0.6 5.2 0.0 1.1 3.2 3.1 210.6 205.1 97.4 166.1 156.2 99.7 141.2 154.4 120.4 134.8 214.6 163.6 615.4 407.1 124.6 233.4 45.7 83.1 50.0 64.7 42.7 94.4 60.8 58.0 262.9 144.4 100.6 145.3 73.0 28.3 31.7 343.6 7.9 223.7 12.1 140.4 80.3 426.4 83.1 21.5 231.3 121.9 42.0 271.6 139.7 115.7 35.4 68.2 228.5 184.6 14.2 141.3 195.4 135.5 77.3 17.7 47.0 31.5 503.2 16.6 147.7 294.2 9.7 131.9 36.0 154.8 283.1 243.3 109.9 663.5 76.3 75.6 142.8 44.1 187.3 93.6 164.3 340.3 171.9 54.7 53.3 79.7 68.2 11.1 49.2 56.6 151.9 88.1 SRGN "PPG, PRG, PRG1" ENSG00000122862 Serglycin P10124 10 69088103-69104805 "Plasma proteins, Predicted secreted proteins" "Apoptosis, Biomineralization" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 8096.7" "Cell type enhanced" "Detected in many" "dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 5714.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 5714.1" "Cell line enhanced" "Detected in many" "HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000759 Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 100000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA000759: AB_1079675" "unprognostic (3.61e-2)" "unprognostic (1.62e-2)" "unprognostic (2.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (4.50e-2)" "unprognostic (1.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.63e-1)" "unprognostic (8.22e-2)" "unprognostic (5.80e-2)" "unprognostic (9.82e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.65e-1)" "unprognostic (2.32e-2)" "unprognostic (4.07e-2)" "unprognostic (4.08e-2)" 404.6 114.9 48.8 799.8 50.5 8096.7 136.4 55.5 99.6 93.2 70.1 101.8 77.9 63.5 25.9 91.0 96.8 316.4 111.9 48.2 67.8 98.3 239.4 347.3 437.2 82.4 59.3 30.7 68.4 131.6 62.1 355.6 67.8 58.9 118.9 15.5 40.1 57.4 37.5 18.9 111.4 219.4 65.5 362.8 95.0 18.3 64.7 228.9 72.7 117.1 314.6 508.3 46.1 71.0 5.3 43.0 0.2 0.4 768.1 749.7 1.2 94.9 63.9 235.1 283.5 0.1 18.2 9.1 117.4 4.1 134.4 1.1 0.0 20.6 799.9 535.7 0.4 87.1 29.8 0.3 312.7 4442.1 914.9 306.8 1.1 641.5 39.2 223.8 1227.8 13.3 82.5 419.9 1239.9 0.2 18.7 2549.7 0.7 0.1 84.6 2.4 2.3 446.7 0.6 6.0 0.3 0.8 2.3 0.6 16.0 0.0 2.2 4346.8 2609.1 187.9 12.9 3.8 20.1 486.4 508.4 57.3 112.2 3546.9 1.2 2349.8 1105.3 2730.6 474.9 774.6 313.4 73.5 228.5 362.8 583.0 39.0 125.5 268.4 5714.1 962.8 693.6 631.9 392.6 1590.5 48.8 50.5 55.5 99.6 48.2 67.8 82.4 59.3 67.8 65.5 64.7 71.0 1081.4 112.2 198.1 0.7 592.0 175.9 12.5 38.3 8.6 1.1 16.0 28.2 21.2 21.5 57.5 33.1 0.0 10.2 2922.2 2.9 0.0 4.2 4.1 4.6 15.0 566.8 1.8 277.8 0.2 9.8 10.2 87.9 70.3 6.6 2343.1 0.4 636.1 22.1 847.1 0.0 0.5 1.7 0.0 1789.9 6618.2 8.4 7.5 3639.1 556.7 80.6 3188.2 1.4 1292.5 0.0 0.2 1.3 1.2 18.0 1740.9 12.2 0.3 4.7 45.6 5.0 72.3 22.8 97.5 0.9 2.2 8.7 141.8 14.2 2235.9 1.2 5.5 18.1 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57352557-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.7;pituitary gland: 8.1;retina: 7.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" No NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA063398: AB_2685004, HPA066783: AB_2685721" "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.0 4.3 8.0 0.0 21.7 0.0 0.0 6.7 15.6 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.9 0.0 12.5 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 8.1 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 9.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 21.7 6.7 15.6 12.5 14.5 0.0 0.0 0.0 0.0 2.1 4.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 1.6 5.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 63.9 56.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.7 0.0 1.2 0.0 22.1 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST8SIA4 "PST, PST1, SIAT8D" ENSG00000113532 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4" Q92187 5 100806933-100903282 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.0" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 73.3;Kupffer cells: 92.4;Langerhans cells: 149.3;Microglial cells: 101.2;monocytes: 97.5;Plasma cells: 73.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 91.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 41.1;HDLM-2: 69.3;Karpas-707: 57.2;NB-4: 27.9;RPMI-8226: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051126, HPA053995" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 980000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA051126: AB_2681352, HPA053995: AB_2682336" "unprognostic (2.25e-1)" "unprognostic (2.04e-2)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.14e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-1)" "unprognostic (5.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.49e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.80e-7)" "unprognostic (6.07e-2)" "unprognostic (4.38e-2)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" 5.8 1.9 2.2 14.0 2.4 7.6 2.2 1.6 2.4 1.9 2.5 3.3 3.2 1.6 0.5 1.1 1.8 5.0 2.3 1.8 4.5 0.7 2.6 5.7 12.3 4.8 3.6 0.5 0.8 1.0 0.6 11.1 5.2 1.3 4.2 0.6 1.2 0.8 0.8 0.8 4.5 2.8 2.7 11.8 3.0 0.4 4.3 9.5 2.0 1.7 10.3 5.5 1.1 4.5 0.0 6.1 41.1 0.0 2.6 3.9 1.0 0.0 0.0 0.0 0.3 0.0 0.0 3.3 0.1 0.0 1.0 0.1 1.0 0.1 0.1 69.3 0.0 2.5 0.4 0.0 0.0 13.0 5.0 3.2 0.0 0.1 0.1 5.3 7.7 10.1 0.0 57.2 2.4 0.6 18.6 27.9 0.3 0.0 0.3 10.3 0.7 44.8 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.0 11.6 2.7 0.4 0.2 0.0 0.6 18.6 20.3 3.9 1.0 15.8 5.1 58.0 18.5 22.9 13.1 21.7 9.9 11.1 8.7 11.1 12.2 9.9 5.4 10.1 91.7 10.6 24.0 3.7 17.4 12.2 2.2 2.4 1.6 2.4 1.8 4.5 4.8 3.6 5.2 2.7 4.3 4.5 35.8 6.4 14.1 1.6 49.7 8.3 0.4 2.1 2.2 0.6 0.9 0.9 2.3 1.5 10.1 0.0 0.0 9.4 44.0 0.0 1.9 0.2 0.2 0.9 1.6 28.4 0.0 8.2 6.8 0.0 42.4 5.0 1.1 0.3 24.1 0.1 7.1 0.1 22.6 0.0 73.3 0.2 4.1 92.4 149.3 0.7 0.0 57.5 14.2 101.2 97.5 3.2 34.0 4.5 1.6 0.0 0.0 0.4 73.8 0.2 0.0 0.3 16.6 0.9 13.1 1.2 3.7 0.5 0.8 0.4 5.5 19.2 37.7 0.7 0.0 0.5 SUN3 "MGC33329, SUNC1" ENSG00000164744 "Sad1 and UNC84 domain containing 3" Q8TAQ9 7 47987148-48029119 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 41.6" "Cell type enriched" "Detected in some" 7 "Early spermatids: 582.2" "Cancer enriched" "Detected in single" 4 "testis cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 7.0;U-2 OS: 20.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA008344, HPA076890" Enhanced Approved "Golgi apparatus" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA008344: AB_1857656, HPA076890: " "unprognostic (5.11e-2)" "unprognostic (4.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-4)" "unprognostic (2.31e-2)" "unprognostic (5.62e-2)" "unprognostic (1.35e-2)" "unprognostic (2.24e-2)" "unprognostic (1.59e-5)" "unprognostic (4.88e-1)" "unprognostic (1.47e-1)" "unprognostic (2.65e-1)" "unprognostic (1.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.48e-1)" "unprognostic (2.58e-1)" 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 3.1 0.1 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 1.3 20.6 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.1 1.9 0.0 582.2 0.1 0.0 0.1 0.0 0.0 3.6 0.0 25.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 3.4 0.0 0.0 0.0 0.0 79.3 2.1 0.3 0.0 1.0 0.1 0.0 0.0 1.0 0.4 0.2 0.1 1.5 0.1 0.0 0.0 0.6 0.0 0.0 6.6 0.0 0.2 19.1 7.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 SYNGR2 ENSG00000108639 "Synaptogyrin 2" O43760 17 78168581-78173527 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 434.8;monocytes: 836.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 672.3;OE19: 547.9;SK-BR-3: 630.6;T-47d: 502.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014742 Approved Approved "Golgi apparatus" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 59: Non-specific - Translation" "Cluster 2: Karpas-707 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus" "HPA014742: AB_2669079" "unprognostic (2.19e-2)" "unprognostic (1.05e-3)" "unprognostic (2.84e-1)" "unprognostic (6.77e-3)" "unprognostic (9.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-3)" "unprognostic (4.98e-2)" "unprognostic (1.26e-2)" "unprognostic (1.20e-2)" "unprognostic (9.44e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (4.74e-2)" "unprognostic (5.21e-2)" "unprognostic (3.51e-2)" "unprognostic (1.78e-2)" 92.9 59.7 50.9 99.4 74.0 112.9 105.5 75.1 63.5 59.2 53.5 118.0 86.4 56.7 22.6 133.8 75.5 70.7 150.1 51.5 61.2 113.0 101.0 158.1 143.9 88.1 70.7 45.3 188.9 52.9 91.2 61.7 86.0 130.7 71.1 2.8 184.8 45.6 369.9 161.4 125.4 33.2 67.3 148.1 141.7 31.8 68.0 68.2 68.7 122.6 112.6 92.0 87.9 92.5 172.5 334.5 9.0 73.9 3.2 1.1 52.5 58.6 60.2 55.0 31.4 200.9 173.6 136.9 123.2 33.5 47.8 245.5 39.9 95.0 16.2 97.2 177.2 47.0 46.9 140.8 76.1 77.3 356.5 3.4 105.1 17.5 47.2 77.9 118.7 50.4 193.9 672.3 5.3 337.4 77.3 79.6 24.4 547.9 140.1 44.3 19.2 391.4 166.7 155.5 53.8 60.2 48.6 630.6 60.3 31.7 502.8 122.2 31.7 1.1 54.2 28.1 77.8 280.7 109.7 79.8 39.7 52.8 9.5 694.4 656.1 237.9 173.6 944.7 202.1 970.0 231.0 200.2 907.6 972.1 204.6 168.6 282.5 219.8 1139.9 530.1 314.6 837.0 50.9 74.0 75.1 63.5 51.5 61.2 88.1 70.7 86.0 67.3 68.0 92.5 56.1 128.2 113.4 3.3 226.6 124.1 136.1 170.9 79.1 3.3 126.5 84.1 63.0 68.6 153.2 171.0 6.2 169.7 63.1 125.2 9.8 313.6 3.6 41.2 9.6 83.5 72.6 70.2 2.4 434.8 59.1 27.9 104.5 89.7 103.0 25.3 56.4 46.9 255.5 5.0 1.2 327.6 193.3 137.9 330.6 4.9 22.1 150.3 74.7 16.9 836.7 5.1 24.7 2.5 31.3 286.5 160.9 17.0 159.2 282.4 77.5 36.2 63.4 3.9 39.5 26.0 46.2 13.4 12.3 120.1 163.4 179.5 58.8 11.4 212.8 216.8 SYNGR4 ENSG00000105467 "Synaptogyrin 4" O95473 19 48364367-48376377 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 54.4" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 159.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 9.8;SCLC-21H: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030075, HPA059286" Enhanced Approved "Golgi apparatus" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA030075: AB_10610559, HPA059286: AB_2683965" "unprognostic (1.58e-2)" "unprognostic (3.44e-2)" "unprognostic (3.18e-2)" "unprognostic (9.49e-4)" "unprognostic (2.51e-2)" "unprognostic (7.10e-2)" "unprognostic (2.52e-3)" "unprognostic (3.72e-3)" "unprognostic (2.87e-2)" "unprognostic (6.19e-2)" "unprognostic (6.69e-2)" "unprognostic (2.41e-2)" "unprognostic (2.02e-7)" "unprognostic (1.06e-2)" "unprognostic (1.74e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" 0.0 0.0 0.4 0.0 0.4 0.1 0.0 3.0 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 0.4 0.5 0.0 1.0 3.9 0.3 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.0 54.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 9.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.5 3.2 0.5 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.1 3.6 0.1 0.3 0.5 0.2 0.0 0.7 1.8 0.7 0.0 2.8 0.0 0.0 24.1 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.8 0.0 0.0 3.2 1.1 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 3.0 1.0 0.8 0.6 0.4 0.5 0.4 0.4 0.4 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 32.6 0.0 0.1 0.1 9.1 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 24.6 0.9 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 6.6 0.0 0.0 159.5 33.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 54.5;Alveolar cells type 2: 49.5;Endothelial cells: 20.4;Hepatic stellate cells: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-BR-3: 14.6" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 3.7 2.3 3.5 3.4 3.8 0.8 3.2 1.9 9.3 4.5 0.0 1.6 1.8 2.9 3.9 3.3 4.5 2.7 4.1 7.6 1.8 2.1 1.4 9.6 5.4 6.9 1.7 2.6 4.8 2.3 0.9 5.1 6.7 2.5 2.1 3.4 3.6 3.5 2.2 11.6 1.5 3.7 0.2 3.5 1.2 1.5 4.3 1.8 2.6 4.1 4.0 2.9 3.4 3.9 2.8 2.9 1.5 0.7 1.7 1.6 2.1 2.9 5.3 2.2 2.5 6.8 5.2 0.6 2.2 2.5 2.1 9.4 0.0 0.8 2.9 1.4 3.2 1.7 2.8 4.5 4.4 3.0 2.1 3.2 0.9 1.4 4.2 2.7 1.2 2.2 0.7 1.7 1.0 4.6 1.5 4.7 1.2 0.5 1.2 1.9 0.0 1.9 3.3 1.3 0.9 1.4 2.4 14.6 1.3 1.4 4.3 1.3 3.8 0.8 3.3 2.0 2.1 2.6 2.9 2.3 1.8 1.9 0.6 0.0 0.6 0.3 0.7 1.4 0.6 0.4 0.6 0.3 0.6 0.2 0.4 0.5 0.0 0.5 1.1 0.4 0.1 0.3 3.5 3.8 1.9 9.3 7.6 1.8 6.9 1.7 6.7 0.2 4.3 3.9 8.0 54.5 49.5 0.7 0.3 6.1 2.2 2.0 0.6 2.2 2.8 1.5 3.6 0.0 3.0 1.8 2.1 1.1 0.6 0.9 1.9 2.0 0.4 0.8 1.2 20.4 1.2 2.7 0.7 5.8 1.4 2.7 0.0 1.0 2.5 1.1 26.4 1.5 0.1 0.0 0.8 1.6 0.0 2.2 3.5 0.6 3.7 0.6 3.6 1.9 0.5 0.6 1.0 1.0 1.1 4.5 0.9 3.8 0.4 5.6 1.1 2.5 1.5 1.8 6.6 3.6 2.7 1.3 1.4 0.5 5.5 1.2 0.8 0.4 1.4 2.4 TBC1D23 FLJ11046 ENSG00000036054 "TBC1 domain family member 23" Q9NUY8 3 100260992-100325251 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038151, HPA038152" Approved Enhanced "Golgi apparatus" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA038151: AB_10672405, HPA038152: AB_10672620" "unprognostic (9.23e-3)" "unprognostic (6.01e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (1.79e-2)" "unprognostic (6.18e-2)" "unprognostic (7.87e-3)" "unprognostic (6.16e-2)" "unprognostic (7.92e-2)" "unprognostic (2.02e-2)" "unprognostic (2.98e-3)" "unprognostic (3.66e-3)" "unprognostic (1.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.51e-1)" "unprognostic (5.64e-2)" "unprognostic (2.32e-1)" 15.1 17.4 4.8 12.7 7.0 23.0 14.8 10.8 6.7 13.5 5.0 15.1 17.9 14.3 10.2 16.2 9.3 13.9 14.3 5.9 6.4 17.1 22.7 12.6 12.5 6.6 5.4 16.2 18.2 17.9 5.1 21.6 7.1 11.7 15.5 16.8 15.2 9.9 17.2 13.5 18.4 14.1 7.0 12.5 15.2 17.1 6.7 14.4 14.1 15.3 15.5 15.6 8.2 10.9 72.9 15.0 17.4 9.8 34.4 44.3 17.5 40.4 45.7 46.6 53.6 28.6 13.3 18.3 20.6 46.9 26.0 25.5 64.5 29.4 72.4 9.0 15.1 49.9 16.6 19.3 33.9 23.2 39.1 35.9 23.7 23.3 38.1 39.0 25.2 14.1 41.0 26.8 30.1 16.3 17.9 11.4 20.3 26.2 27.8 14.8 37.9 21.6 27.3 16.3 24.8 13.5 23.4 18.4 29.8 22.7 19.6 22.0 24.1 32.9 30.9 15.5 26.9 25.6 28.1 31.8 42.1 21.2 27.4 27.8 17.8 22.7 12.2 20.5 12.4 12.0 11.7 10.7 18.7 12.7 10.3 10.9 10.2 21.8 24.8 8.2 17.4 17.4 4.8 7.0 10.8 6.7 5.9 6.4 6.6 5.4 7.1 7.0 6.7 10.9 24.0 41.7 12.6 19.6 24.5 31.5 18.6 14.8 16.5 18.6 17.9 11.7 26.1 11.5 20.5 12.9 14.6 20.1 19.1 24.8 31.3 26.8 46.8 17.5 28.4 22.5 7.2 54.1 50.9 29.5 19.3 31.9 13.7 31.7 29.8 19.0 13.9 19.0 13.9 35.3 42.4 17.5 18.3 17.1 20.2 44.2 20.5 21.9 24.9 48.7 14.0 18.7 12.3 41.7 56.4 36.1 16.9 14.3 34.5 22.3 21.1 19.9 19.3 30.2 13.1 27.6 25.9 20.8 15.2 20.4 38.8 65.8 21.1 21.8 14.3 30.2 TEX26 "C13orf26, MGC40178" ENSG00000175664 "Testis expressed 26" Q8N6G2 13 30932656-30975500 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 21.5" "Group enriched" "Detected in some" 19 "Early spermatids: 847.1;Late spermatids: 1640.3" "Cancer enriched" "Detected in single" 7 "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA079709 Approved "Golgi apparatus" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA079709: " "unprognostic (2.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (1.53e-2)" "unprognostic (9.27e-2)" 0.1 0.4 1.2 0.0 1.3 0.0 0.0 0.9 1.2 0.8 4.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 1.1 4.5 0.0 0.1 0.2 0.0 2.3 2.3 0.0 0.0 0.0 1.3 0.0 2.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 21.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.9 1.2 1.1 4.5 2.3 2.3 2.1 2.0 4.6 1.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 28.6 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 847.1 19.0 0.1 0.4 0.0 0.0 4.3 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.0 6.1 0.0 0.0 1640.3 8.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 7.9 0.0 0.0 0.0 0.0 65.4 0.0 0.0 1.1 1.1 15.5 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TFR2 "HFE3, TFRC2" ENSG00000106327 "Transferrin receptor 2" Q9UP52 7 100620416-100642779 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 346.1" "Group enriched" "Detected in some" 13 "Erythroid cells: 152.8;Hepatocytes: 455.7" "Cancer enriched" "Detected in many" 70 "liver cancer: 136.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "basophil: 2.5;eosinophil: 1.9" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Group enriched" "Detected in some" 11 "HEL: 69.7;HMC-1: 92.7;K-562: 65.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016255, HPA017171, HPA073125" Enhanced Approved "Golgi apparatus" NA NA 410000 "Cluster 46: Basophils - DNA binding" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "CAB016255: AB_628395, HPA017171: , HPA073125: " "unprognostic (4.18e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" "unprognostic (4.13e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.29e-2)" "unprognostic (4.49e-2)" "unprognostic (9.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.90e-1)" "unprognostic (1.18e-9)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" 0.0 0.1 0.0 0.0 0.0 22.5 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 346.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.7 0.0 7.2 0.0 1.6 92.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 65.8 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 2.1 0.3 0.9 0.4 0.0 8.5 0.3 0.6 1.2 10.0 0.8 0.0 8.4 0.1 1.7 0.1 0.0 0.4 5.8 0.1 0.6 1.2 0.0 152.8 5.4 0.2 1.1 0.5 1.5 0.2 0.0 0.2 7.1 455.7 0.3 21.9 5.4 0.3 0.0 8.6 1.7 8.4 0.0 0.4 0.0 1.0 0.2 0.4 6.2 1.5 0.7 0.1 0.1 0.0 0.4 0.6 0.1 0.1 0.3 1.9 0.0 0.4 0.7 0.7 2.9 0.2 0.6 0.1 2.6 0.1 0.6 0.5 TIMP1 "CLGI, EPO, TIMP" ENSG00000102265 "TIMP metallopeptidase inhibitor 1" P01033 X 47582408-47586789 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 2277.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 2325.3;Hepatic stellate cells: 2681.5;Langerhans cells: 2307.7;Leydig cells: 1776.0;Macrophages: 1705.0;Peritubular cells: 1561.7;Smooth muscle cells: 2043.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 3225.4;ASC TERT1: 4323.2;fHDF/TERT166: 2762.5;HSkMC: 2960.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022360, HPA053417" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 127000000 520000000 "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "CAB022360: , HPA053417: AB_2682142" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.09e-4)" "unprognostic (4.68e-2)" "unprognostic (1.81e-2)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" "unprognostic (8.24e-3)" "unprognostic (9.12e-3)" "unprognostic (9.69e-2)" "unprognostic (9.10e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (2.90e-11)" "unprognostic (1.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (2.66e-1)" 1043.9 895.8 110.6 1713.4 110.5 122.2 253.0 114.1 329.6 630.5 160.0 228.0 68.3 342.1 237.4 130.8 570.2 1220.1 995.3 113.5 119.9 469.6 458.6 1221.2 150.4 132.9 125.2 820.8 170.1 224.1 510.7 589.3 130.1 749.1 204.0 25.9 518.6 412.7 61.8 132.4 180.0 741.1 118.9 239.9 208.9 267.7 286.5 80.3 340.0 78.9 119.7 2277.2 303.3 115.6 194.7 295.9 150.4 1850.9 3225.4 4323.2 36.4 2079.0 1728.4 632.5 514.0 118.9 360.1 1.8 269.6 2762.5 355.3 187.2 82.9 896.0 394.8 387.0 193.8 204.1 191.7 174.9 2097.2 136.6 2440.9 2960.8 227.7 1951.9 410.1 743.6 292.1 0.7 315.8 142.9 1088.6 343.1 2.5 518.0 166.8 229.8 647.9 2.5 318.3 173.8 1038.8 120.4 2.5 8.6 1243.6 8.2 276.9 277.6 15.3 257.6 284.8 943.7 1012.1 1108.3 206.3 58.8 135.0 7.4 2688.9 322.6 634.2 331.9 488.4 8.3 139.4 853.2 137.8 21.9 224.6 122.9 511.4 10.1 73.0 65.4 504.5 88.4 817.9 15.0 104.0 431.4 110.6 110.5 114.1 329.6 113.5 119.9 132.9 125.2 130.1 118.9 286.5 115.6 145.9 109.0 170.1 6.2 57.5 231.2 591.5 937.3 132.6 25.4 147.8 133.2 22.5 374.6 355.5 132.4 0.0 25.2 59.3 53.6 0.0 538.6 21.6 34.7 511.9 772.1 277.2 102.7 0.4 411.3 280.1 2325.3 53.5 66.7 491.4 163.7 2681.5 345.1 329.7 0.0 0.4 73.0 297.0 741.4 2307.7 86.9 1776.0 1705.0 512.3 6.5 289.0 141.7 73.2 8.5 0.6 802.1 42.4 1561.7 257.4 741.4 1.1 12.9 109.1 8.4 690.2 304.1 2043.5 52.8 10.6 25.8 174.7 45.0 126.5 231.9 50.5 513.7 TJAP1 "PILT, TJP4" ENSG00000137221 "Tight junction associated protein 1" Q5JTD0 6 43477523-43506556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Oligodendrocytes: 117.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030164, HPA030165, HPA030166" Supported Enhanced "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858" "unprognostic (5.05e-3)" "unprognostic (2.82e-2)" "unprognostic (6.89e-3)" "unprognostic (1.03e-3)" "unprognostic (3.09e-2)" "unprognostic (4.50e-3)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.27e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (5.53e-3)" "unprognostic (1.61e-3)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (5.15e-3)" "unprognostic (7.51e-3)" 24.4 32.1 25.5 17.3 36.6 18.5 24.4 28.2 32.8 31.8 23.5 30.1 20.3 31.1 10.1 16.7 28.8 13.4 24.8 26.3 29.3 21.8 25.9 21.7 20.6 34.0 33.3 37.2 33.2 13.2 24.5 14.9 31.2 31.3 9.2 11.3 24.0 14.5 44.1 19.7 25.9 15.1 25.7 32.2 26.0 20.3 35.1 17.1 30.4 16.7 14.9 28.7 23.5 49.4 40.6 15.7 27.1 40.7 21.5 20.1 30.0 25.1 26.8 26.2 28.4 23.8 17.2 22.4 18.6 23.3 25.0 35.0 22.9 30.0 16.8 38.7 35.2 28.5 30.8 26.3 25.8 29.2 39.6 23.0 39.7 32.6 28.6 20.7 17.4 28.6 24.9 41.2 23.5 22.5 28.7 48.3 23.7 69.0 23.9 34.2 17.8 24.0 16.3 22.1 17.8 24.7 21.4 13.0 33.5 16.7 23.2 56.7 15.3 34.9 26.9 29.3 37.9 30.0 26.9 40.0 15.3 33.1 30.2 13.6 7.1 5.7 7.1 8.2 9.2 6.3 5.8 6.2 5.4 6.7 6.5 7.2 4.0 5.5 7.5 5.7 3.5 7.1 25.5 36.6 28.2 32.8 26.3 29.3 34.0 33.3 31.2 25.7 35.1 49.4 10.9 12.8 10.3 12.1 10.3 7.5 14.7 9.3 13.6 11.1 9.9 13.0 7.7 10.0 6.3 12.9 29.2 21.3 7.3 7.2 3.9 10.0 1.4 7.3 10.6 10.5 11.4 7.8 11.6 8.4 18.6 10.6 8.6 9.8 14.7 21.9 8.2 8.3 9.8 8.4 9.4 8.5 14.2 7.7 8.7 2.2 10.5 9.1 5.4 14.0 8.3 10.0 6.2 19.6 117.1 9.5 7.2 12.8 10.2 14.9 7.9 6.2 5.9 15.2 6.6 9.5 10.0 14.1 14.8 4.9 3.7 18.7 9.8 10.6 7.0 9.0 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189149-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.27e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 28.0 35.2 7.5 10.5 7.6 3.7 25.6 7.9 7.9 29.2 18.2 23.9 12.7 31.1 31.3 25.4 27.9 17.5 21.7 7.4 7.7 25.1 34.6 26.7 7.7 8.8 9.4 24.8 46.8 36.6 20.0 18.1 8.4 23.4 15.5 5.9 35.6 21.3 19.5 24.2 21.4 18.1 8.5 19.4 29.4 20.2 8.3 8.3 30.7 11.1 12.4 23.8 23.6 8.4 22.0 45.1 17.7 18.0 59.4 40.4 22.4 37.6 55.4 53.7 60.5 19.1 49.0 12.5 25.2 50.3 30.7 50.5 14.9 29.7 39.3 18.4 15.4 9.4 21.3 56.2 41.8 18.5 22.8 41.3 56.1 36.9 50.5 42.3 32.3 7.9 11.2 30.7 43.6 51.2 12.1 15.7 8.4 62.1 39.2 15.6 22.1 24.7 42.5 37.9 16.3 18.6 39.0 44.3 24.5 16.8 28.8 14.1 26.0 47.5 21.2 23.1 28.1 31.0 25.5 7.4 18.1 11.5 39.5 33.4 20.5 25.0 14.1 18.1 15.3 15.0 14.6 12.6 23.4 16.3 13.0 12.9 28.3 23.1 18.5 39.2 17.2 13.5 7.5 7.6 7.9 7.9 7.4 7.7 8.8 9.4 8.4 8.5 8.3 8.4 5.5 16.0 5.3 8.8 11.2 3.3 6.1 7.3 18.8 4.4 6.1 5.0 1.5 7.2 7.6 1.8 14.6 9.8 5.0 4.0 0.0 8.2 13.9 5.2 7.4 8.7 1.8 5.5 6.6 4.9 10.4 14.9 13.7 6.3 2.5 5.3 5.0 4.8 4.1 0.0 7.1 3.5 6.1 2.5 4.5 6.2 5.3 5.6 1.8 4.7 5.3 5.4 4.1 9.0 7.3 5.3 6.1 4.5 54.3 7.7 3.5 3.0 30.0 7.6 6.6 10.1 7.4 7.0 5.4 19.5 4.7 11.9 9.1 5.7 4.1 3.8 TMBIM4 "CGI-119, GAAP, LFG4, S1R, ZPRO" ENSG00000155957 "Transmembrane BAX inhibitor motif containing 4" Q9HC24 12 66135846-66170072 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077642 Supported "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA077642: AB_2686849" "unprognostic (5.41e-2)" "unprognostic (1.27e-1)" "unprognostic (3.19e-1)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (5.62e-2)" "unprognostic (7.18e-3)" "unprognostic (8.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.33e-2)" "unprognostic (3.36e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.68e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-3)" 79.7 88.6 28.0 75.3 34.3 61.5 81.4 34.0 29.7 67.3 47.6 90.5 59.5 61.0 68.6 62.6 65.8 70.1 70.8 27.1 35.6 94.0 109.6 76.7 74.5 38.5 32.1 56.7 103.5 104.7 40.1 74.2 39.1 72.8 70.2 39.7 89.3 73.7 46.7 52.2 69.8 58.5 34.7 74.4 93.3 85.1 31.0 63.1 97.9 61.5 56.0 80.0 42.9 41.5 49.1 62.4 39.7 72.8 131.4 122.7 41.9 74.4 129.1 56.7 45.8 32.8 78.7 45.6 86.3 105.2 42.6 78.9 20.1 65.7 36.6 74.5 27.3 87.7 30.0 38.6 66.6 106.9 109.2 86.9 92.8 27.7 31.1 79.0 87.2 51.8 65.9 160.3 94.3 79.5 41.1 37.5 47.4 76.1 63.3 21.5 26.5 50.8 126.8 80.3 20.1 47.6 84.5 154.5 102.3 34.2 146.3 146.7 106.0 69.1 25.9 50.5 44.8 82.7 48.5 32.2 94.8 103.7 84.1 420.7 372.7 371.6 136.0 381.4 137.9 205.9 139.7 139.4 256.2 196.6 157.9 139.1 662.3 135.3 434.3 171.7 159.8 483.9 28.0 34.3 34.0 29.7 27.1 35.6 38.5 32.1 39.1 34.7 31.0 41.5 232.8 150.6 147.2 34.0 131.3 0.0 64.1 0.0 84.2 47.8 202.2 152.1 37.0 0.0 66.2 244.6 45.9 137.0 128.2 191.4 103.7 213.8 330.6 116.2 96.4 114.5 74.7 32.0 15.8 338.1 116.9 140.7 85.1 105.8 179.0 72.7 0.0 0.0 210.7 45.4 25.2 172.4 0.0 0.0 0.0 143.8 104.4 193.2 0.0 62.8 205.5 114.1 123.6 42.7 77.0 202.9 176.9 91.0 126.8 87.9 128.9 214.5 99.1 65.9 59.2 67.8 75.7 391.0 40.8 112.5 0.0 130.8 99.3 142.7 182.2 62.8 TMC8 "EVER2, EVIN2" ENSG00000167895 "Transmembrane channel like 8" Q8IU68 17 78130770-78142968 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0" "Cell type enhanced" "Detected in many" "B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047387, HPA054429" Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA047387: , HPA054429: AB_2682485" "unprognostic (8.54e-3)" "prognostic favorable (8.45e-6)" "unprognostic (1.32e-1)" "unprognostic (2.33e-3)" "unprognostic (3.59e-1)" "prognostic favorable (4.19e-5)" "unprognostic (6.38e-3)" "unprognostic (6.47e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-1)" "unprognostic (6.06e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.24e-2)" "unprognostic (1.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" 7.8 3.0 3.6 56.0 4.4 91.8 3.7 3.7 5.1 3.7 3.5 8.2 10.3 2.5 0.7 4.8 4.0 7.4 2.7 3.6 4.8 5.2 7.1 18.4 100.5 5.8 4.7 1.3 2.0 0.5 2.2 3.9 5.6 4.9 4.5 0.1 5.8 1.3 1.8 3.6 54.6 2.4 5.0 117.0 10.4 1.2 7.8 60.1 6.4 0.9 46.7 6.4 5.0 7.2 0.5 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.3 46.3 2.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.1 16.4 0.1 0.8 0.0 63.0 119.9 0.0 0.0 0.0 0.0 0.0 0.0 22.1 4.0 103.9 0.0 1.3 20.9 2.8 0.2 3.5 0.5 1.4 0.3 66.6 0.0 0.2 0.0 0.1 0.0 2.2 0.6 0.1 6.9 12.7 0.1 0.0 0.1 0.1 0.0 49.3 2.0 4.6 0.1 51.9 0.1 2.6 2.0 6.6 13.4 3.4 9.7 5.5 10.8 13.3 2.3 4.8 9.4 8.6 3.3 7.5 7.9 2.1 6.5 5.5 3.6 4.4 3.7 5.1 3.6 4.8 5.8 4.7 5.6 5.0 7.8 7.2 3.6 3.2 10.2 1.0 44.9 5.4 10.4 4.9 4.6 0.2 1.2 1.5 1.9 1.5 6.5 0.0 0.0 0.4 52.3 3.7 0.0 1.0 0.7 1.0 0.6 3.2 1.2 17.1 0.4 1.3 1.4 2.3 2.0 1.8 41.2 0.1 5.7 0.5 30.5 0.0 0.4 1.4 14.2 28.2 44.6 0.5 0.0 22.0 7.2 24.4 30.2 0.2 85.5 1.0 2.7 0.6 3.6 0.4 20.2 2.9 0.9 0.4 2.1 0.2 0.0 0.3 2.0 0.4 0.6 8.4 4.5 0.5 68.6 2.7 7.0 10.7 TMED10 "p23, P24(DELTA), p24d1, p24delta1, TMP21" ENSG00000170348 "Transmembrane p24 trafficking protein 10" P49755 14 75131469-75176612 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034442, CAB037251, HPA047139, HPA050539" Enhanced Supported "Golgi apparatus" NA NA 220000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163" "unprognostic (2.00e-1)" "unprognostic (1.73e-2)" "unprognostic (2.02e-1)" "unprognostic (2.51e-3)" "unprognostic (4.06e-1)" "unprognostic (1.17e-3)" "unprognostic (5.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (1.01e-2)" "unprognostic (1.27e-2)" "unprognostic (1.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.06e-2)" 68.0 70.3 51.8 55.2 55.8 18.0 93.2 52.6 60.7 137.9 61.2 77.0 62.3 92.6 133.1 59.9 100.6 69.2 82.3 49.5 66.1 62.7 126.9 68.0 61.0 65.8 54.3 99.7 131.9 91.4 53.6 76.3 63.2 91.0 82.3 48.8 130.7 85.9 73.7 56.0 58.8 78.9 57.5 54.6 78.3 40.0 58.2 73.7 146.0 61.0 65.9 66.9 59.7 69.6 93.3 52.2 85.5 142.5 197.5 183.7 110.9 96.5 159.5 99.5 111.2 51.8 161.2 82.5 80.6 167.5 56.8 90.8 80.4 140.6 160.5 43.7 36.2 50.5 31.1 79.2 167.1 101.7 50.2 135.1 221.5 77.0 220.1 196.0 176.9 91.7 44.6 177.8 145.0 104.6 71.0 80.7 51.9 145.2 55.8 70.6 55.3 116.6 119.7 94.8 82.9 87.1 89.0 147.0 175.9 81.0 138.3 163.3 122.3 97.0 62.9 65.9 50.7 98.9 99.3 91.3 177.0 88.3 95.8 107.4 46.4 28.9 60.8 39.4 93.8 39.7 58.7 59.3 62.9 30.3 51.9 55.9 20.4 101.8 42.6 70.9 38.2 91.4 51.8 55.8 52.6 60.7 49.5 66.1 65.8 54.3 63.2 57.5 58.2 69.6 80.8 64.1 106.3 32.0 141.8 114.2 180.4 488.1 107.0 55.6 182.5 130.6 155.3 187.3 279.9 200.5 27.1 181.0 186.7 186.2 62.6 319.1 14.5 147.7 177.5 107.3 140.7 75.5 26.9 385.7 609.9 164.4 145.8 172.0 100.1 170.9 123.1 339.7 255.0 77.4 30.0 276.2 272.6 159.4 166.3 31.5 179.3 151.6 297.1 38.4 129.5 137.9 130.7 50.8 84.2 225.8 148.9 209.9 538.8 218.7 120.3 138.9 304.8 63.1 78.9 112.7 132.2 317.7 116.5 151.7 135.1 309.2 122.1 145.8 161.9 207.7 TMED3 "C15orf22, p24B, p24g4, p24gamma4" ENSG00000166557 "Transmembrane p24 trafficking protein 3" Q9Y3Q3 15 79311112-79427432 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 409.4" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049314, HPA076949" Enhanced Supported "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA049314: AB_2680708, HPA076949: AB_2686820" "prognostic unfavorable (7.71e-4)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (8.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.03e-3)" "unprognostic (2.42e-2)" "unprognostic (2.49e-1)" "unprognostic (4.85e-1)" "unprognostic (9.06e-2)" "unprognostic (8.09e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.16e-1)" "unprognostic (2.88e-1)" "unprognostic (2.50e-1)" "unprognostic (1.52e-1)" 25.9 26.2 19.6 23.1 19.2 37.0 66.4 21.5 20.5 56.6 30.6 49.9 25.4 38.3 138.7 132.3 38.7 37.8 41.9 20.8 31.9 34.7 12.4 30.9 26.0 22.4 22.0 30.9 246.7 54.9 89.6 42.4 26.5 60.0 55.4 11.3 409.4 54.6 4.6 106.8 26.6 37.3 21.6 32.4 73.1 35.0 22.6 23.1 76.3 7.2 37.8 48.7 75.1 25.1 68.1 169.0 31.9 63.6 220.3 167.5 69.0 153.0 206.7 103.3 126.9 141.4 123.3 31.5 117.3 236.0 135.9 124.5 95.7 98.5 53.0 62.7 145.6 104.5 143.0 110.3 131.5 112.2 200.4 126.5 144.4 59.6 86.9 123.5 120.8 105.9 47.1 0.6 101.4 144.3 32.1 106.0 45.7 251.6 92.2 39.1 47.4 158.9 94.2 51.4 99.4 48.8 80.6 162.1 159.3 103.5 141.5 81.7 98.5 85.2 75.7 2.2 111.4 61.7 78.8 44.1 109.8 180.7 103.1 74.9 69.8 95.1 58.1 85.3 62.7 75.5 57.2 63.9 106.7 63.6 71.4 69.1 6.0 61.4 95.7 109.1 73.1 92.2 19.6 19.2 21.5 20.5 20.8 31.9 22.4 22.0 26.5 21.6 22.6 25.1 9.9 28.9 43.6 6.8 41.2 95.8 109.4 125.6 64.9 14.9 153.8 132.8 16.9 55.8 108.5 57.0 8.4 167.8 40.7 67.7 23.5 143.4 48.9 31.6 39.6 31.7 83.9 33.7 10.0 250.5 294.5 68.1 54.6 70.4 47.0 44.0 65.7 6.4 100.5 13.5 10.2 219.3 87.5 52.7 54.4 118.6 49.7 49.2 85.4 9.4 60.0 38.0 44.3 17.1 12.9 173.3 79.9 27.4 71.1 165.2 43.9 28.9 37.7 17.0 19.7 25.6 57.0 51.1 60.3 104.7 121.8 172.4 30.4 64.6 126.4 200.1 TMEM115 PL6 ENSG00000126062 "Transmembrane protein 115" Q12893 3 50354750-50359521 "Plasma proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006319, HPA015497" Supported Supported "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB006319: AB_425880, HPA015497: AB_1858076" "unprognostic (1.62e-2)" "unprognostic (2.37e-1)" "unprognostic (1.59e-2)" "unprognostic (1.65e-3)" "unprognostic (2.32e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.00e-2)" "unprognostic (6.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.75e-3)" "unprognostic (2.65e-2)" "prognostic favorable (1.04e-7)" "unprognostic (4.88e-3)" "unprognostic (3.00e-1)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" 29.4 34.3 23.5 12.0 24.4 11.7 28.6 24.6 26.5 25.2 26.9 29.5 23.4 33.3 17.6 27.2 26.3 15.6 31.9 23.3 23.1 28.9 32.3 26.6 11.3 25.7 24.1 25.4 29.9 32.0 20.3 22.8 24.7 30.7 12.8 6.7 29.1 20.6 27.1 42.6 27.1 17.0 23.2 24.3 31.2 17.0 24.4 10.8 34.6 18.2 9.6 28.0 25.6 24.0 26.6 31.9 20.4 33.6 56.9 45.2 26.4 40.3 59.3 50.2 38.3 24.0 30.4 12.9 33.1 53.1 46.2 27.8 24.7 32.7 14.1 23.9 42.9 19.5 27.8 32.9 79.7 21.4 27.2 68.4 41.6 41.5 30.1 43.3 38.6 15.7 21.3 21.7 37.9 24.5 14.8 33.8 36.4 17.4 49.9 7.2 16.3 28.8 38.3 24.7 22.7 48.7 24.5 26.9 34.5 17.8 22.3 22.4 40.4 45.3 22.8 48.1 42.9 32.0 19.9 7.3 41.6 23.3 30.5 52.5 27.9 41.4 26.5 25.1 17.5 18.2 17.5 21.2 23.2 18.5 18.7 18.2 37.9 27.3 24.5 26.1 24.1 23.8 23.5 24.4 24.6 26.5 23.3 23.1 25.7 24.1 24.7 23.2 24.4 24.0 24.0 16.0 12.4 4.2 14.3 30.2 19.7 26.1 29.6 17.1 25.3 24.9 7.0 25.8 15.8 11.0 6.2 58.8 15.9 39.9 3.9 44.7 1.1 17.9 17.2 22.9 15.7 18.5 2.9 26.5 42.2 31.5 20.4 16.3 11.4 23.6 26.0 19.5 36.3 18.5 3.7 26.6 28.5 11.4 12.4 1.2 29.2 15.5 10.6 2.8 20.4 25.7 13.4 6.6 4.4 35.6 32.5 25.2 18.8 33.8 43.9 26.9 14.3 15.1 26.3 19.3 26.5 17.0 8.0 17.5 34.9 92.8 14.3 36.4 24.9 25.6 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.1;brain: 141.0;pituitary gland: 100.3;testis: 37.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 51.2;Excitatory neurons: 43.8;Inhibitory neurons: 53.9" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.7;EFO-21: 6.4;GAMG: 6.9;hTERT-RPE1: 11.0;NTERA-2: 3.8;SH-SY5Y: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Uncertain Supported "Golgi apparatus" NA NA 9400 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 0.5 37.1 63.7 1.5 64.2 0.6 1.2 0.0 116.6 3.2 0.0 3.9 0.8 1.1 9.4 1.6 1.0 1.8 0.6 67.3 141.0 3.4 0.1 6.2 2.3 11.6 8.2 0.9 0.8 2.7 100.3 0.5 17.0 2.4 1.2 17.9 0.4 6.7 2.0 0.4 1.5 0.8 7.2 0.7 1.4 37.4 55.7 1.8 0.5 0.1 0.3 0.9 4.9 42.4 0.0 0.6 0.0 0.0 0.2 0.0 0.3 2.9 6.7 0.5 0.4 0.1 0.1 0.1 6.4 1.7 6.9 0.1 0.0 0.0 0.1 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 11.0 0.3 0.2 0.1 0.4 0.3 0.5 0.1 0.2 3.8 0.0 0.2 0.1 0.0 0.6 0.0 0.1 0.4 7.8 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.1 0.4 0.4 0.2 0.8 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 1.6 0.3 0.2 0.2 0.1 0.1 63.7 64.2 0.0 116.6 67.3 141.0 11.6 8.2 17.0 7.2 55.7 42.4 0.1 0.0 0.0 2.6 0.0 0.4 0.4 0.1 0.0 51.2 0.3 0.4 1.0 1.5 2.0 1.8 2.1 0.1 1.5 0.1 0.0 0.0 1.6 0.1 0.2 0.5 0.0 0.0 43.8 0.2 0.1 2.1 0.0 0.2 0.0 0.5 0.7 0.0 0.1 0.0 53.9 0.0 2.0 0.0 1.2 2.7 0.9 0.3 0.0 3.7 0.0 1.7 0.0 11.6 4.2 0.0 0.0 6.8 0.0 0.3 0.2 0.1 0.3 4.3 0.0 0.6 0.8 0.6 0.6 0.0 0.3 0.3 0.2 0.0 0.1 0.2 TMEM165 "GDT1, TMPT27, TPARL" ENSG00000134851 "Transmembrane protein 165" Q9HC07 4 55395957-55453397 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 1021.6;Urothelial cells: 601.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038299, HPA062424" Supported Enhanced "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA038299: AB_10675793, HPA062424: AB_2732682" "unprognostic (2.53e-2)" "unprognostic (1.08e-3)" "unprognostic (3.46e-3)" "unprognostic (7.07e-3)" "unprognostic (5.97e-2)" "unprognostic (9.84e-2)" "prognostic unfavorable (2.08e-5)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.55e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.18e-8)" "unprognostic (9.05e-2)" "unprognostic (8.96e-2)" "unprognostic (2.72e-1)" "unprognostic (2.18e-2)" 53.4 61.3 39.2 42.6 75.1 11.3 35.2 62.0 70.8 45.9 36.0 32.4 32.0 34.0 31.1 55.8 31.6 46.0 37.3 40.8 51.1 41.6 19.3 52.7 32.6 84.8 72.0 22.3 40.1 32.3 24.0 60.5 78.9 37.8 33.3 15.0 40.4 30.6 17.1 26.2 27.9 40.0 54.5 37.0 39.2 13.7 65.8 24.0 37.8 17.2 42.5 78.8 42.7 117.4 74.6 30.4 47.1 50.2 143.5 105.4 50.0 138.6 212.7 98.0 106.7 34.2 108.3 76.9 98.3 85.9 56.2 53.8 50.0 56.8 98.9 43.8 46.4 66.0 50.1 66.6 89.1 92.1 75.1 109.1 72.7 55.9 37.3 82.4 113.2 25.6 112.8 47.8 116.5 54.5 73.0 76.5 51.7 97.8 70.6 52.0 35.5 42.1 148.6 70.2 48.3 64.7 69.8 261.0 85.8 46.3 41.2 65.3 98.3 83.1 49.6 37.0 102.5 44.4 38.5 48.3 98.9 77.2 67.9 23.7 40.4 26.0 15.2 35.7 17.0 19.0 14.3 17.8 36.5 11.5 12.1 14.4 28.6 18.1 35.9 28.4 18.3 30.2 39.2 75.1 62.0 70.8 40.8 51.1 84.8 72.0 78.9 54.5 65.8 117.4 119.6 54.5 52.4 42.7 87.9 245.1 277.8 295.0 147.4 50.6 85.8 42.7 32.2 71.4 214.9 79.1 81.3 112.5 97.7 42.4 17.6 171.1 32.1 123.6 99.1 108.0 50.4 79.1 58.2 163.5 157.2 110.4 76.0 173.8 21.0 57.6 113.8 18.4 105.7 28.6 71.5 69.4 77.3 97.9 145.7 24.7 58.7 109.5 88.9 59.0 117.5 53.2 123.6 71.4 1021.6 248.0 48.6 63.6 117.1 239.3 51.3 50.0 125.2 91.9 98.6 92.2 129.0 37.8 24.6 169.4 268.8 80.6 81.6 90.6 61.6 601.6 TMEM80 FLJ38216 ENSG00000177042 "Transmembrane protein 80" Q96HE8 11 695428-705028 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.2;Spermatogonia: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059592, HPA067046" Uncertain Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA059592: AB_2684076, HPA067046: AB_2685769" "unprognostic (1.48e-1)" "unprognostic (6.55e-3)" "unprognostic (1.70e-2)" "unprognostic (2.64e-2)" "unprognostic (2.71e-3)" "unprognostic (1.68e-3)" "unprognostic (4.36e-2)" "unprognostic (5.39e-3)" "unprognostic (3.85e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-3)" "unprognostic (1.03e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (3.27e-1)" "unprognostic (4.23e-3)" 21.0 23.0 18.4 14.7 18.2 6.5 23.8 19.5 22.0 30.5 17.3 30.2 23.7 27.8 24.8 42.5 30.1 8.4 15.3 19.3 16.5 36.0 20.2 17.5 21.2 21.2 18.1 29.7 29.7 17.8 34.3 8.7 19.0 29.9 17.5 9.1 31.5 19.4 19.7 31.0 31.1 12.7 18.9 34.3 30.8 24.8 19.0 19.7 47.6 11.8 21.3 27.8 30.6 19.9 37.8 17.5 11.0 14.3 23.6 11.1 19.0 8.5 4.7 8.9 9.6 23.9 42.0 16.0 7.3 13.2 15.8 26.8 16.2 9.7 6.3 11.0 41.7 9.7 19.0 14.5 13.9 12.8 16.8 25.7 19.9 4.0 6.2 17.5 10.5 18.9 12.1 17.7 11.4 12.2 16.8 8.7 10.4 29.9 8.4 12.2 7.6 31.5 12.7 5.7 31.1 9.8 12.8 23.5 12.3 7.3 18.2 11.9 15.0 14.9 7.8 3.4 6.4 8.4 3.2 14.8 15.6 15.9 6.5 8.3 26.5 35.4 21.0 25.9 18.4 26.7 15.7 16.0 21.8 30.1 22.3 20.0 12.8 21.4 32.0 22.0 21.4 20.7 18.4 18.2 19.5 22.0 19.3 16.5 21.2 18.1 19.0 18.9 19.0 19.9 15.1 6.4 20.7 13.7 24.0 15.3 15.9 25.6 17.6 22.7 31.7 36.8 19.3 15.7 20.2 20.2 8.4 33.9 19.4 15.4 11.7 13.0 9.2 17.1 15.8 14.4 12.1 8.6 13.9 17.1 9.8 20.8 9.7 19.9 7.0 15.9 12.8 6.2 17.6 55.5 13.1 22.7 28.5 13.2 13.6 9.5 42.6 12.7 12.4 11.2 19.7 23.2 26.8 16.6 16.7 10.6 10.3 28.6 11.5 12.3 22.1 8.1 19.4 9.1 32.9 23.4 21.2 82.2 87.2 13.7 17.2 15.2 16.7 21.6 19.5 12.3 TMEM87A DKFZP564G2022 ENSG00000103978 "Transmembrane protein 87A" Q8NBN3 15 42210447-42273584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018104, HPA018189" Enhanced Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA018104: AB_1858135, HPA018189: AB_2205198" "unprognostic (7.07e-2)" "unprognostic (1.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.05e-2)" "unprognostic (2.49e-1)" "unprognostic (6.39e-3)" "unprognostic (1.19e-2)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-3)" "unprognostic (1.38e-1)" "unprognostic (3.41e-2)" "unprognostic (7.90e-2)" "unprognostic (2.19e-1)" "unprognostic (5.49e-3)" "unprognostic (3.63e-1)" 31.8 26.3 23.7 26.1 37.7 88.2 97.7 32.0 29.5 40.2 17.7 56.5 26.6 38.6 49.3 48.2 45.3 32.4 19.7 23.5 26.3 27.1 24.5 72.8 25.4 36.7 29.4 35.4 34.9 47.9 14.2 42.7 38.7 79.8 60.9 26.1 64.7 36.6 24.9 50.2 26.9 38.0 32.5 23.1 38.6 33.0 28.8 24.8 75.9 22.2 30.9 42.0 34.3 59.1 41.0 20.5 30.5 27.0 58.5 50.3 47.7 55.1 82.0 53.5 52.0 29.8 87.5 17.4 52.9 59.9 60.5 104.0 28.3 51.2 42.8 46.8 25.0 35.6 51.5 33.5 63.4 65.6 48.3 52.3 112.1 39.5 65.3 50.6 41.9 30.1 39.4 67.4 51.7 26.3 21.3 38.8 25.7 60.8 29.3 33.5 46.6 36.8 34.5 127.4 33.7 41.2 53.1 70.1 49.9 24.0 27.4 62.4 41.3 104.4 25.5 68.1 82.6 46.8 95.0 36.5 40.1 47.9 66.8 58.3 26.9 31.2 29.0 32.3 33.3 27.6 35.6 34.0 24.4 24.4 33.6 33.5 15.2 42.4 34.7 22.4 42.2 26.0 23.7 37.7 32.0 29.5 23.5 26.3 36.7 29.4 38.7 32.5 28.8 59.1 66.2 125.0 264.0 46.0 48.9 68.6 90.2 78.8 58.1 31.2 148.7 105.9 13.9 45.8 98.0 49.7 50.1 78.1 57.5 77.7 1.9 63.7 5.6 57.0 67.0 54.6 32.2 34.5 41.7 64.2 72.7 64.0 50.0 124.7 59.5 42.9 51.0 34.4 41.6 20.2 48.2 74.1 67.1 39.2 37.0 7.9 41.0 41.3 62.2 45.0 60.1 61.8 52.5 74.4 177.5 56.1 62.4 53.8 47.6 118.5 36.6 15.5 86.4 63.0 85.5 77.0 59.0 59.4 61.4 79.1 65.5 110.4 54.8 53.3 76.9 105.6 TMF1 "ARA160, TMF" ENSG00000144747 "TATA element modulatory factor 1" P82094 3 69019827-69052339 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 508.1;Late spermatids: 544.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008729 Approved Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA008729: AB_1080310" "unprognostic (2.71e-1)" "unprognostic (2.11e-2)" "unprognostic (8.02e-3)" "unprognostic (7.19e-2)" "unprognostic (2.74e-1)" "unprognostic (6.75e-3)" "unprognostic (6.73e-3)" "unprognostic (1.79e-1)" "unprognostic (4.62e-2)" "unprognostic (2.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.83e-2)" "unprognostic (1.50e-1)" "unprognostic (1.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.51e-2)" "unprognostic (1.01e-1)" 10.3 10.6 4.4 14.0 5.2 26.2 14.1 6.2 5.5 13.3 12.3 12.5 12.9 14.8 14.1 11.5 12.9 14.1 9.2 4.3 5.3 12.6 11.0 12.0 16.0 5.3 5.1 12.6 13.6 15.6 9.9 16.5 5.2 14.5 14.2 12.5 17.4 10.3 9.8 9.7 14.8 11.6 5.1 12.8 14.0 19.4 5.4 9.6 20.9 8.3 14.8 13.5 7.9 6.1 19.5 8.3 7.8 7.9 20.7 26.4 17.5 24.6 23.6 16.1 19.2 11.9 14.1 7.4 3.9 25.1 11.3 10.5 10.2 10.8 26.4 14.3 7.6 14.4 11.0 14.1 18.5 16.3 19.7 15.6 17.0 21.4 19.3 17.1 17.5 6.0 8.8 11.8 21.2 11.1 9.5 14.1 6.8 12.3 4.4 7.8 9.9 10.4 21.0 15.4 5.4 8.3 20.2 14.2 15.4 10.4 10.7 19.4 23.1 15.8 6.7 27.9 14.8 13.2 13.6 7.2 24.1 16.6 13.1 4.8 2.4 5.1 3.1 2.0 2.1 2.6 2.8 2.7 2.1 3.1 2.9 2.6 5.3 2.7 3.4 2.4 3.1 1.6 4.4 5.2 6.2 5.5 4.3 5.3 5.3 5.1 5.2 5.1 5.4 6.1 49.2 64.1 78.9 21.9 84.7 37.5 37.6 41.7 39.3 43.4 46.2 35.8 36.9 38.6 86.4 42.3 37.5 39.6 108.4 48.8 15.6 52.4 508.1 150.4 92.8 43.1 55.6 45.0 32.2 56.2 58.7 70.0 54.6 86.2 74.7 51.7 29.3 19.7 28.4 35.3 38.4 61.6 38.7 31.8 54.4 544.8 51.0 55.1 35.6 32.8 66.7 41.5 59.8 36.2 40.9 50.6 40.8 62.1 129.3 64.8 49.4 25.1 200.5 52.1 32.9 62.8 56.8 116.2 39.3 30.6 39.5 80.6 94.5 54.5 38.5 85.7 TMPRSS11E "DESC1, TMPRSS11E2" ENSG00000087128 "Transmembrane serine protease 11E" Q9UL52 4 68447463-68497604 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 89.5;esophagus: 220.2;salivary gland: 56.7;vagina: 156.3" "Cell type enriched" "Detected in some" 14 "Ionocytes: 476.0" "Group enriched" "Detected in many" 6 "cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.5;OE19: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043816, HPA051062" Enhanced Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA043816: , HPA051062: AB_2681329" "unprognostic (2.53e-1)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" "unprognostic (9.14e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (9.70e-3)" "unprognostic (2.16e-1)" "unprognostic (3.74e-2)" "unprognostic (4.03e-2)" "unprognostic (8.39e-2)" "unprognostic (1.27e-1)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 89.5 0.0 0.0 0.0 0.0 18.2 220.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.2 0.0 0.0 56.7 0.7 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 24.5 6.5 156.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 12.9 0.7 0.0 0.0 0.5 0.3 0.3 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 476.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.2 6.6 0.3 1.1 0.7 0.0 0.0 32.6 TNFSF9 "4-1BB-L, 4-1BBL" ENSG00000125657 "TNF superfamily member 9" P41273 19 6531026-6535924 "Plasma proteins, Predicted intracellular proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 9.8;esophagus: 9.8;vagina: 9.5" "Cell type enhanced" "Detected in many" "B-cells: 57.5;dendritic cells: 51.6;Gastric mucus-secreting cells: 23.0;Macrophages: 22.5;T-cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 85.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA059857 Approved "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA059857: AB_2684144" "unprognostic (2.21e-1)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "unprognostic (7.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-1)" "unprognostic (2.93e-2)" "unprognostic (2.41e-3)" "unprognostic (4.88e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (8.07e-3)" 1.8 0.6 3.5 1.0 3.0 3.7 0.8 3.7 7.6 9.8 2.3 1.2 0.3 0.3 0.3 9.8 1.1 1.0 0.6 3.9 3.3 0.9 0.4 4.9 1.1 3.6 2.9 0.5 0.3 0.5 0.3 0.9 3.4 0.3 1.8 0.3 1.5 0.1 0.7 1.4 1.2 0.4 3.1 2.2 0.6 3.3 3.1 0.5 0.4 0.3 0.7 0.7 9.5 6.3 10.7 13.4 0.2 4.8 2.5 6.0 0.4 1.5 4.8 3.6 17.1 0.3 18.0 11.3 6.8 3.0 0.0 19.2 5.4 2.3 0.9 0.0 2.6 1.8 18.4 4.4 0.4 0.3 85.8 1.0 10.1 20.1 5.5 2.6 0.6 1.6 10.9 0.2 1.3 1.5 0.9 1.8 1.8 0.7 9.5 1.2 0.0 2.8 22.9 0.4 0.0 0.0 29.8 1.7 5.0 0.6 1.2 16.4 6.2 0.0 9.6 26.0 0.0 26.9 10.2 20.9 10.2 5.9 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.5 3.0 3.7 7.6 3.9 3.3 3.6 2.9 3.4 3.1 3.1 6.3 11.3 0.0 4.5 0.0 57.5 2.7 0.3 4.3 6.2 0.2 4.0 3.8 8.1 0.0 1.6 0.0 0.0 0.1 51.6 4.3 0.0 0.3 0.1 5.7 3.9 6.8 14.2 0.0 2.2 0.2 0.0 12.6 23.0 9.2 8.9 0.6 1.8 0.0 4.5 0.0 2.5 3.4 2.0 1.9 15.9 0.0 0.0 22.5 3.6 0.0 1.6 0.8 0.0 1.5 2.9 0.8 4.9 0.0 17.2 0.9 0.2 0.1 0.9 0.2 0.0 2.5 7.5 0.1 0.4 12.7 1.3 0.1 31.5 0.9 5.7 0.3 TPST1 TANGO13A ENSG00000169902 "Tyrosylprotein sulfotransferase 1" O60507 7 66205317-66420543 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 76.5;Excitatory neurons: 101.9;Inhibitory neurons: 107.1;Spermatocytes: 97.1" "Cancer enhanced" "Detected in all" "glioma: 36.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 52.2;neutrophil: 35.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047415, HPA061837" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA047415: AB_10964056, HPA061837: AB_2732672" "unprognostic (7.46e-2)" "unprognostic (1.45e-1)" "unprognostic (8.62e-2)" "unprognostic (3.43e-2)" "unprognostic (3.52e-2)" "unprognostic (1.78e-3)" "unprognostic (5.71e-2)" "unprognostic (8.21e-2)" "unprognostic (3.59e-1)" "unprognostic (9.25e-3)" "unprognostic (4.12e-2)" "unprognostic (4.98e-1)" "prognostic unfavorable (8.16e-6)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.48e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.73e-5)" 16.9 15.8 22.1 10.8 20.5 6.0 13.4 18.4 21.6 35.4 12.3 11.1 3.2 21.8 14.3 10.8 11.2 38.1 8.5 19.4 36.7 23.1 46.0 11.5 5.9 37.2 25.0 13.5 7.8 11.0 19.5 26.4 24.7 15.1 8.0 5.2 6.8 16.4 2.7 8.2 8.7 16.2 22.9 12.0 10.9 23.0 33.8 2.1 11.3 5.6 5.3 36.8 22.1 22.5 12.1 6.5 16.5 22.4 52.7 42.0 5.7 22.3 49.8 25.7 37.1 21.9 6.6 1.4 17.7 45.1 38.9 8.9 16.2 24.8 33.3 3.5 9.3 2.3 15.1 16.5 62.3 1.8 1.9 59.5 19.0 50.2 22.1 27.8 32.7 2.9 1.0 10.2 40.2 6.2 0.1 3.1 15.5 0.4 9.6 7.8 14.6 11.4 27.3 11.5 10.4 44.5 27.8 2.1 62.2 32.4 8.6 4.7 62.3 33.1 21.3 24.2 40.6 9.2 13.3 4.7 29.6 6.8 48.2 52.2 2.3 23.9 0.8 0.1 0.8 6.1 0.5 0.6 0.3 14.0 2.2 4.1 35.2 8.8 0.0 0.0 0.0 1.9 22.1 20.5 18.4 21.6 19.4 36.7 37.2 25.0 24.7 22.9 33.8 22.5 33.8 0.0 8.9 38.8 11.5 10.8 7.7 24.4 33.6 8.5 4.0 13.3 1.6 5.7 9.6 31.3 2.1 1.8 3.8 0.2 9.8 23.0 11.2 13.3 76.5 17.9 7.7 1.3 101.9 47.6 4.3 58.5 12.2 9.7 4.5 12.2 10.0 34.1 16.2 6.7 107.1 0.8 8.2 8.9 8.9 11.6 48.1 6.2 14.2 32.8 15.8 5.0 1.0 61.3 38.8 23.7 0.1 37.2 7.1 5.3 0.0 3.2 19.5 3.6 6.6 16.4 21.6 97.1 41.3 15.1 7.5 3.8 2.8 12.6 0.7 7.7 TREM1 "CD354, TREM-1" ENSG00000124731 "Triggering receptor expressed on myeloid cells 1" Q9NP99 6 41267926-41286682 "CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 96.0;lung: 65.3;lymphoid tissue: 44.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9" "Cancer enhanced" "Detected in many" "lung cancer: 9.6" "Region enhanced" "Detected in some" "cerebral cortex: 8.5" "Immune cell enriched" "Detected in many" 7 "neutrophil: 615.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 615.1" "Group enriched" "Detected in some" 4 "SuSa: 6.2;U-87 MG: 24.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005563, HPA053612" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA005563: AB_1858259, HPA053612: " "unprognostic (6.41e-2)" "unprognostic (1.47e-3)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (6.07e-3)" "unprognostic (2.97e-2)" "unprognostic (5.73e-5)" "unprognostic (1.29e-1)" "unprognostic (1.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.24e-3)" "unprognostic (7.65e-2)" "unprognostic (3.18e-7)" "unprognostic (6.32e-3)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (7.26e-2)" 20.4 1.4 0.4 44.1 0.4 96.0 1.2 0.4 8.5 0.8 2.3 0.9 0.4 2.2 0.0 1.5 3.9 9.9 3.8 0.4 0.6 1.1 6.9 65.3 0.4 0.9 0.7 0.5 3.9 1.1 2.4 7.7 1.9 0.7 0.3 0.6 1.2 0.5 0.5 0.2 1.0 8.4 0.6 11.1 0.8 0.3 2.6 3.1 0.7 2.6 1.3 12.6 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 1.6 0.0 0.1 82.7 2.3 0.0 20.7 0.1 0.6 0.1 0.0 32.8 1.5 0.2 0.0 615.1 0.2 10.1 0.7 0.0 32.5 0.4 0.4 0.4 8.5 0.4 0.6 0.9 0.7 1.9 0.6 2.6 0.9 0.0 6.4 26.1 0.0 1.8 0.4 0.4 5.4 0.0 0.0 0.1 0.1 0.3 2.8 12.4 0.0 0.0 0.4 0.3 0.1 0.0 0.3 12.1 0.3 1.8 3.8 0.0 0.0 0.0 0.2 1.1 2.5 1.1 0.1 6.3 0.0 0.7 0.5 25.1 0.0 0.0 0.0 2.0 35.5 21.5 20.6 0.0 104.2 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.2 0.0 0.3 13.3 0.1 0.0 0.8 2.8 0.0 0.1 0.0 0.1 14.6 2.0 0.0 0.0 0.1 TTR "CTS, CTS1, HsT2651, PALB" ENSG00000118271 Transthyretin P02766 18 31557009-31598833 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Transport "Hormone, Thyroid hormone" "Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "choroid plexus: 142023.1" "Cell type enriched" "Detected in many" 30 "Hepatocytes: 23659.3" "Group enriched" "Detected in many" 28 "liver cancer: 928.2;pancreatic cancer: 666.0" "Group enriched" "Detected in all" 7 "cerebellum: 621.7;hippocampal formation: 1730.9;thalamus: 688.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0" "Group enriched" "Detected in all" 5 "basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4" "Region enhanced" "Detected in all" "medulla oblongata: 1381.8" "CAB002517, HPA002550, CAB062567, CAB073406" Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 345000000000 99000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419" "unprognostic (6.79e-3)" "unprognostic (3.38e-2)" "unprognostic (4.10e-1)" "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (8.15e-2)" "unprognostic (3.74e-2)" "unprognostic (9.66e-3)" "unprognostic (8.72e-2)" "unprognostic (1.23e-2)" "unprognostic (8.35e-3)" "unprognostic (5.26e-1)" "unprognostic (3.52e-2)" 4.2 0.6 148.5 0.5 56.7 9.6 0.4 621.7 83.7 2.0 142023.1 6.0 14.9 1.3 0.9 2.2 0.8 51.2 2.9 1730.9 37.3 18.4 21288.1 0.8 2.4 106.5 86.0 1.1 1785.1 186.8 6.0 2.7 27.1 1.6 4.5 80.1 1.8 0.4 1.1 15.6 6.8 0.3 12.3 3.8 49.8 2.3 688.2 1.1 1.3 0.0 0.1 2.3 0.6 133.9 1.6 0.4 0.6 0.5 0.8 0.1 1.0 0.8 0.3 0.0 0.0 160.1 0.0 2.9 39.6 0.5 0.6 0.4 0.0 0.3 0.0 5.9 0.8 5.2 1.8 249.0 0.4 11.2 1.0 0.1 0.1 0.1 0.0 0.7 0.0 0.3 2.8 0.4 0.0 0.5 0.4 0.7 0.6 4.5 0.3 0.3 7.4 0.2 0.3 1.6 0.9 1.1 5.8 0.0 0.2 1.7 0.6 0.2 1.7 2.4 57.0 0.5 4.3 1.0 2.6 17.6 0.7 4.3 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 148.5 56.7 621.7 83.7 1730.9 37.3 106.5 86.0 27.1 12.3 688.2 133.9 0.0 0.0 0.0 0.0 15.1 0.5 0.0 0.0 0.0 144.8 0.0 0.0 1.8 779.2 0.0 5.5 162.6 0.3 0.0 1.5 5.9 3.1 6.8 0.5 0.5 14.1 356.2 192.5 0.0 2.0 3.6 0.7 13.3 0.0 0.0 0.2 192.4 23659.3 2.4 26.9 0.1 19.6 0.0 313.7 0.0 8.7 0.3 1.2 0.0 0.0 0.0 24.9 0.0 0.0 0.0 130.5 5.2 0.0 0.0 0.2 1.3 26.9 0.0 56.0 0.0 0.0 0.3 3.3 1.1 0.0 0.1 4.0 10.9 0.0 1.7 0.0 TVP23B "CGI-148, FAM18B, FAM18B1, YDR084C" ENSG00000171928 "Trans-golgi network vesicle protein 23 homolog B" Q9NYZ1 17 18781111-18806714 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019585, HPA065603" Uncertain Supported "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA019585: AB_1848385, HPA065603: AB_2685517" "unprognostic (1.91e-1)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (9.32e-3)" "unprognostic (1.13e-2)" "unprognostic (8.51e-2)" "unprognostic (2.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (2.30e-1)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (3.54e-1)" "unprognostic (5.27e-1)" "unprognostic (7.78e-2)" "unprognostic (8.55e-2)" 26.4 43.2 11.1 20.0 11.7 19.9 30.3 12.8 15.1 38.2 23.3 25.8 29.9 26.5 40.4 52.3 34.5 30.4 22.8 10.6 13.5 31.0 44.0 20.8 25.4 12.3 13.0 30.1 33.6 47.8 32.7 29.6 13.0 33.5 31.2 32.1 34.3 24.4 17.3 19.3 23.8 21.7 13.1 17.4 40.5 34.9 12.4 20.4 46.9 16.2 31.4 32.7 34.2 13.3 55.0 63.8 23.6 26.2 68.8 60.9 56.1 93.5 75.0 42.8 54.6 37.6 38.7 17.9 33.9 60.3 42.6 74.1 19.2 40.2 63.2 44.3 39.7 17.0 47.1 46.3 48.0 13.0 35.6 31.6 95.7 46.0 67.7 78.7 36.0 12.6 14.0 13.1 62.9 27.6 17.2 18.3 11.0 99.2 25.6 17.4 52.1 23.1 52.7 36.0 13.4 29.9 49.8 32.4 60.4 129.0 46.9 19.7 41.6 32.7 28.1 69.8 57.5 25.9 31.7 9.5 50.2 22.2 68.2 54.4 20.4 44.6 29.7 27.4 40.5 32.1 33.0 32.1 17.3 26.9 34.8 34.8 24.2 32.3 27.1 27.9 26.3 32.1 11.1 11.7 12.8 15.1 10.6 13.5 12.3 13.0 13.0 13.1 12.4 13.3 10.0 12.8 13.2 9.4 29.4 25.2 28.1 70.4 54.7 8.6 16.5 9.7 4.2 10.0 42.4 9.2 10.4 13.3 15.7 8.5 11.7 13.9 8.6 21.7 16.1 12.9 6.1 17.2 8.1 11.6 30.3 19.1 40.2 16.2 22.2 7.1 11.0 10.3 10.0 1.7 8.8 14.6 44.7 10.3 10.7 4.2 16.8 16.0 26.6 11.2 9.1 9.1 17.5 14.1 12.8 16.5 10.7 17.0 62.1 28.5 12.0 14.0 60.0 11.1 13.1 9.0 17.0 50.8 43.0 65.5 30.5 26.1 23.7 8.9 8.6 32.4 TVP23C "FAM18B2, MGC8763" ENSG00000175106 "Trans-golgi network vesicle protein 23 homolog C" Q96ET8 17 15502264-15563595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA019585, HPA065603" Uncertain Supported "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Golgi apparatus" "HPA019585: AB_1848385, HPA065603: AB_2685517" "unprognostic (2.87e-3)" "unprognostic (5.35e-3)" "unprognostic (1.01e-1)" "unprognostic (8.39e-3)" "unprognostic (1.33e-3)" "unprognostic (3.00e-1)" "unprognostic (6.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-3)" "unprognostic (3.43e-1)" "unprognostic (8.09e-5)" "unprognostic (2.42e-2)" "unprognostic (1.61e-1)" "unprognostic (3.50e-1)" "unprognostic (2.45e-2)" 3.8 6.6 4.2 2.3 3.5 10.9 4.5 6.9 3.9 7.4 8.0 3.3 2.1 4.6 3.3 5.9 4.2 2.4 4.1 3.1 4.7 6.4 3.9 4.6 2.8 5.5 5.2 8.8 5.2 3.7 10.1 4.0 3.9 6.4 2.1 4.1 6.0 2.0 3.0 4.5 3.8 2.2 3.0 4.7 3.8 5.2 5.2 1.9 6.8 1.5 2.4 3.9 5.7 6.5 8.3 7.3 2.7 3.9 3.5 1.8 4.2 6.9 11.6 12.1 14.2 9.3 3.3 0.0 3.7 5.8 6.6 3.5 8.4 5.2 8.6 5.2 4.5 5.5 6.7 13.2 3.2 2.0 5.0 2.4 2.0 12.2 7.2 10.2 11.1 2.9 6.7 3.5 5.3 2.7 3.5 5.6 3.0 3.3 2.5 0.6 0.3 0.4 3.3 4.8 0.9 2.3 8.7 1.0 1.8 11.3 4.8 1.1 7.9 2.0 2.8 2.9 2.2 2.2 2.1 0.0 2.3 0.0 1.8 11.3 1.8 8.4 3.3 4.1 4.5 6.4 4.5 5.0 3.0 4.6 5.5 5.1 2.9 5.0 2.9 3.3 4.7 4.3 4.2 3.5 6.9 3.9 3.1 4.7 5.5 5.2 3.9 3.0 5.2 6.5 3.5 3.2 8.2 0.0 2.9 4.0 5.4 4.3 4.6 5.9 4.2 2.7 17.2 0.0 7.0 0.0 14.6 5.9 5.5 3.8 1.9 2.9 1.3 6.6 4.4 5.8 1.8 3.0 0.0 0.6 11.7 5.6 6.6 6.5 2.5 6.2 1.8 0.7 3.2 6.7 0.0 4.0 6.1 1.9 3.3 0.9 3.4 2.3 1.8 0.0 2.4 2.6 4.1 0.0 0.0 1.6 2.9 2.2 9.2 5.2 4.3 0.8 4.3 10.5 0.0 3.3 5.6 10.0 7.9 5.5 2.8 5.5 4.7 7.2 4.9 7.0 TVP23C-CDRT4 FAM18B2-CDRT4 ENSG00000259024 "TVP23C-CDRT4 readthrough" 17 15436021-15563561 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 10 "Astrocytes: 16.0;Excitatory neurons: 18.0;Inhibitory neurons: 23.9;Microglial cells: 21.5;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 29.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 35.1" HPA065603 Approved "Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA065603: AB_2685517" "unprognostic (3.95e-3)" "unprognostic (1.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.59e-1)" "unprognostic (8.67e-3)" "unprognostic (9.05e-2)" "unprognostic (4.71e-2)" "unprognostic (9.40e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.57e-1)" "unprognostic (2.07e-1)" "unprognostic (2.08e-1)" 3.1 6.0 1.3 1.6 1.4 1.4 2.2 1.4 2.4 5.4 2.7 2.4 3.5 3.3 6.0 3.2 5.9 2.2 2.1 1.0 2.0 3.2 1.3 1.8 1.8 1.9 2.0 5.7 4.9 5.3 5.0 3.1 2.5 3.6 2.5 8.4 5.1 4.4 1.4 2.0 3.9 2.1 1.8 1.8 3.1 0.1 1.5 2.3 5.8 1.2 2.9 2.1 2.4 2.4 6.3 4.8 3.8 7.0 3.5 4.3 9.1 3.9 15.8 7.0 8.2 5.2 1.1 0.0 8.2 8.5 2.6 5.5 4.3 3.5 6.7 7.4 3.8 2.3 3.6 9.5 8.3 3.0 6.4 3.0 1.6 4.1 16.8 18.4 6.6 3.9 3.4 3.0 2.2 2.6 4.4 6.6 2.9 4.6 3.3 0.7 0.0 0.0 3.8 4.0 2.3 5.6 4.0 0.8 2.1 35.1 3.1 1.8 2.8 0.3 2.7 1.9 2.7 6.4 3.6 0.0 0.7 0.0 1.0 5.3 0.4 5.1 2.8 0.2 3.1 1.2 2.3 2.6 1.1 0.7 1.4 1.7 0.1 3.3 0.2 1.3 2.3 1.1 1.3 1.4 1.4 2.4 1.0 2.0 1.9 2.0 2.5 1.8 1.5 2.4 0.3 0.0 2.0 16.0 0.1 0.0 0.1 0.0 1.2 0.4 0.2 0.3 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.1 0.0 0.5 0.1 0.4 0.1 0.0 0.0 0.0 18.0 0.0 0.4 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.5 0.0 0.0 0.0 29.1 29.5 0.0 0.0 0.0 0.9 0.3 0.0 0.1 2.2 0.2 0.0 0.0 0.1 1.0 0.5 0.4 0.0 0.3 0.5 0.2 0.0 0.3 TXNDC15 "2310047H23Rik, C5orf14, FLJ22625" ENSG00000113621 "Thioredoxin domain containing 15" Q96J42 5 134874371-134901635 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015483 Approved Approved "Golgi apparatus" NA NA 49000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA015483: AB_1845722" "unprognostic (1.56e-1)" "unprognostic (1.22e-2)" "unprognostic (2.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.68e-2)" "unprognostic (9.71e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (2.36e-1)" "unprognostic (4.37e-1)" "unprognostic (1.41e-3)" "unprognostic (1.50e-1)" 34.1 44.7 20.3 34.9 23.2 8.9 33.9 22.8 23.2 42.5 39.1 37.3 23.7 35.0 56.1 22.3 29.5 32.5 35.8 20.8 24.2 29.0 33.7 30.5 25.4 25.9 21.6 31.4 49.7 43.7 42.9 37.1 21.6 38.2 26.2 36.5 46.8 44.0 41.9 19.1 21.7 43.7 21.5 35.9 32.3 18.8 21.8 20.3 59.9 30.4 31.1 35.9 24.7 23.8 28.8 77.8 47.8 76.9 75.8 102.7 5.5 117.7 135.1 42.3 93.7 56.8 38.5 38.1 64.3 108.6 78.8 21.0 33.0 48.6 38.6 81.5 36.6 20.0 46.7 46.1 58.7 13.6 51.2 61.7 39.6 56.0 35.2 70.6 65.8 18.0 10.1 106.8 65.6 36.5 20.8 30.7 21.4 31.3 31.7 30.0 58.1 117.7 35.5 29.4 27.7 35.6 70.3 19.4 63.9 22.7 27.3 19.8 83.0 62.5 35.3 62.0 42.7 70.7 120.3 31.8 93.0 28.5 41.3 32.7 34.3 19.8 31.0 33.7 32.7 32.3 25.2 32.8 31.0 23.8 20.8 24.5 9.3 29.5 33.8 30.1 29.8 32.7 20.3 23.2 22.8 23.2 20.8 24.2 25.9 21.6 21.6 21.5 21.8 23.8 47.8 60.9 31.9 11.8 49.9 25.4 30.5 41.5 22.8 37.6 25.1 29.0 36.4 27.1 36.3 23.9 20.9 32.4 31.9 10.0 13.7 33.5 4.2 12.1 49.4 38.7 12.6 6.7 13.7 33.1 54.3 65.7 12.8 19.2 30.4 33.1 45.3 29.7 33.9 63.9 19.7 17.0 44.7 31.3 32.3 6.7 63.3 27.3 69.4 19.7 39.2 43.0 29.9 19.6 20.1 19.2 14.0 45.5 203.2 25.1 17.4 28.3 26.7 36.6 46.0 45.2 44.1 36.5 61.6 17.4 23.4 30.0 36.3 45.1 13.3 21.5 VAMP4 ENSG00000117533 "Vesicle associated membrane protein 4" O75379 1 171700160-171742074 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050418 Enhanced Approved "Golgi apparatus" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA050418: AB_2681121" "unprognostic (9.38e-2)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (9.66e-2)" "unprognostic (6.97e-2)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (5.10e-2)" "unprognostic (3.14e-2)" "unprognostic (2.87e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (5.43e-6)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (1.15e-1)" 10.9 12.0 11.2 8.6 11.3 5.2 8.8 14.1 13.5 8.9 8.0 8.2 7.9 8.5 7.4 8.4 7.7 8.1 7.7 11.5 13.8 8.1 8.2 10.3 10.9 13.4 13.6 7.0 9.9 12.7 15.2 10.1 13.6 7.3 7.1 10.0 10.5 7.0 6.3 10.0 8.1 7.4 13.3 10.1 8.5 11.7 14.3 7.1 11.4 6.1 8.4 7.3 8.3 12.8 9.5 3.3 8.1 6.6 12.1 14.0 5.2 16.8 13.7 4.1 5.2 2.6 12.2 6.1 14.9 13.5 6.2 6.2 3.3 5.8 5.9 10.9 5.4 5.0 4.1 2.2 7.3 4.4 4.1 6.9 10.0 5.2 9.6 11.9 7.6 8.1 12.4 7.1 8.9 3.1 10.6 6.2 3.9 18.1 12.9 8.7 6.3 15.6 8.6 3.0 5.1 9.6 8.6 8.8 7.3 8.9 12.0 8.1 8.9 12.7 4.3 18.3 16.2 25.8 23.4 8.4 19.6 3.9 10.4 11.0 8.8 11.9 8.6 7.6 11.9 8.2 11.3 9.9 4.5 6.6 7.8 8.6 3.4 9.5 7.8 6.4 11.3 8.8 11.2 11.3 14.1 13.5 11.5 13.8 13.4 13.6 13.6 13.3 14.3 12.8 22.3 22.4 9.3 18.3 21.4 15.4 13.8 18.0 26.7 12.3 12.9 9.7 11.6 10.0 14.8 3.7 22.9 10.8 18.2 9.7 15.6 7.5 35.1 7.8 8.4 20.3 10.2 30.9 23.5 7.7 13.4 20.4 6.6 8.9 24.7 8.9 18.2 11.8 14.8 10.1 24.1 12.3 16.2 15.4 12.1 38.6 9.3 20.1 12.4 19.7 17.1 17.0 25.7 18.6 23.0 10.0 14.9 13.2 20.8 19.7 13.4 13.7 11.4 9.4 19.7 15.2 15.0 42.7 20.2 16.1 17.3 13.4 23.1 8.5 7.4 17.5 WDR44 "DKFZp686L20145, RAB11BP, RPH11, SYM-4" ENSG00000131725 "WD repeat domain 44" Q5JSH3 X 118346073-118449961 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038084, HPA046719" Approved Supported "Golgi apparatus" NA NA 1800000 "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA038084: AB_10675626, HPA046719: AB_2679772" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-1)" "unprognostic (6.09e-2)" "unprognostic (1.91e-1)" "unprognostic (1.88e-2)" "unprognostic (1.46e-1)" "unprognostic (1.08e-1)" "unprognostic (4.98e-2)" "unprognostic (5.52e-2)" 8.4 7.3 6.6 8.2 8.9 6.0 6.3 7.9 7.6 8.0 2.5 6.8 8.3 7.8 6.7 11.3 5.8 11.8 8.3 7.1 6.9 6.0 12.8 7.9 9.4 6.0 6.5 7.6 6.7 10.1 5.2 7.2 6.1 7.5 6.2 8.4 5.6 10.5 9.7 5.1 7.7 10.4 5.7 8.1 8.6 9.8 7.2 10.6 6.9 8.9 9.2 10.0 6.9 10.1 16.4 9.4 10.0 5.8 16.7 13.6 5.5 25.2 17.6 17.9 25.2 6.4 18.4 4.6 14.4 18.1 15.1 12.6 19.7 12.0 20.6 18.6 8.8 18.5 23.3 4.2 11.5 11.7 12.4 8.1 12.6 17.0 11.4 18.2 16.1 8.5 14.8 15.8 17.3 8.0 9.2 6.9 18.1 12.3 15.1 7.2 8.6 7.2 14.6 10.3 4.3 6.7 23.9 8.3 7.9 17.7 7.4 8.3 20.5 13.3 5.1 18.2 14.4 5.9 10.0 6.5 11.2 13.7 9.1 8.0 3.2 7.3 5.4 4.9 5.5 3.6 4.4 5.4 5.1 3.2 5.1 5.6 2.0 7.2 5.5 3.7 7.1 4.0 6.6 8.9 7.9 7.6 7.1 6.9 6.0 6.5 6.1 5.7 7.2 10.1 14.3 22.4 15.0 18.3 11.0 14.8 7.2 6.3 9.1 8.9 7.6 6.3 11.4 10.0 6.2 12.9 10.4 2.3 9.9 9.6 1.9 5.2 0.4 10.9 10.8 12.0 1.2 5.0 35.2 5.3 2.2 11.1 14.3 17.8 8.8 9.8 5.7 16.7 8.6 1.7 41.2 5.2 4.1 13.6 17.7 1.3 7.2 17.2 7.2 40.3 10.3 7.5 11.3 35.2 89.6 11.0 5.8 11.3 12.1 10.2 6.2 4.2 9.1 7.0 26.3 9.3 11.1 17.5 17.6 12.3 9.2 1.2 14.7 5.7 4.6 7.4 WNT10B "SHFM6, WNT-12" ENSG00000169884 "Wnt family member 10B" O00744 12 48965340-48971735 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 17.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 7.3;Extravillous trophoblasts: 21.7;Fibroblasts: 4.8;Inhibitory neurons: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 7.3;T-47d: 8.2;U-266/84: 7.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA055048, HPA062539" Enhanced Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA055048: AB_2682683, HPA062539: AB_2684793" "unprognostic (1.13e-1)" "unprognostic (2.14e-2)" "unprognostic (5.73e-4)" "unprognostic (2.27e-2)" "unprognostic (3.09e-2)" "unprognostic (3.33e-2)" "unprognostic (6.08e-2)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.14e-1)" "unprognostic (4.99e-3)" "unprognostic (3.05e-2)" "unprognostic (5.39e-6)" "unprognostic (4.29e-2)" "unprognostic (3.74e-2)" "unprognostic (4.50e-1)" "unprognostic (1.25e-1)" 1.5 0.2 13.1 1.5 14.9 1.2 0.6 4.2 17.9 0.8 3.2 1.4 1.4 0.3 1.5 1.4 1.0 0.5 1.5 15.3 7.3 0.4 0.4 1.1 1.7 8.6 7.6 0.2 0.3 0.1 2.4 0.3 8.2 0.8 0.7 0.1 0.9 0.6 0.7 3.4 4.3 0.1 5.1 4.1 1.1 3.3 10.4 1.9 1.0 0.4 1.5 1.3 1.0 9.8 1.9 1.2 0.0 1.7 0.0 0.0 4.6 1.3 2.4 0.5 0.1 3.6 4.0 0.0 0.3 0.2 1.5 2.2 4.8 0.3 0.2 1.1 6.3 2.1 1.7 0.1 0.0 0.7 2.9 0.0 0.4 0.1 2.1 4.1 0.0 1.5 7.3 0.3 0.7 2.4 0.1 2.5 0.0 1.3 2.5 0.0 0.6 2.2 0.0 0.4 0.1 0.0 0.3 0.1 0.6 2.2 8.2 2.7 0.0 2.5 4.9 0.4 0.6 2.6 7.8 0.0 1.0 5.4 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.1 14.9 4.2 17.9 15.3 7.3 8.6 7.6 8.2 5.1 10.4 9.8 0.2 0.0 0.0 0.7 0.2 0.4 0.0 0.0 1.8 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.8 0.2 0.1 0.0 0.0 0.0 7.3 0.0 21.7 4.8 0.0 0.1 0.0 0.0 0.7 0.0 0.3 0.0 4.7 0.2 0.0 0.0 1.2 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.7 3.0 0.9 1.3 1.4 1.6 0.0 0.0 0.1 WWC1 "KIAA0869, KIBRA, PPP1R168" ENSG00000113645 "WW and C2 domain containing 1" Q8IX03 5 168291645-168472303 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 142.3" "Cell type enhanced" "Detected in many" "Astrocytes: 162.2;Cone photoreceptor cells: 91.8;Endometrial ciliated cells: 81.8;Glandular and luminal cells: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 120.2;RPTEC TERT1: 260.4;SK-BR-3: 136.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038016, HPA038017" Approved Approved "Golgi apparatus" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA038016: AB_10697091, HPA038017: AB_10669513" "unprognostic (3.60e-1)" "unprognostic (2.24e-2)" "unprognostic (1.08e-1)" "unprognostic (9.92e-2)" "unprognostic (1.51e-1)" "unprognostic (6.77e-3)" "unprognostic (2.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.31e-2)" "unprognostic (7.38e-2)" "prognostic favorable (1.95e-8)" "unprognostic (2.81e-3)" "unprognostic (1.80e-1)" "unprognostic (2.77e-1)" "unprognostic (1.50e-1)" 7.8 0.6 41.8 2.9 43.3 0.1 21.2 41.0 39.7 6.0 50.4 6.4 24.3 2.8 6.8 22.9 17.2 8.7 1.6 40.3 41.3 73.3 38.1 20.2 3.0 56.8 47.0 0.8 28.3 23.5 7.8 10.2 43.6 16.4 6.1 17.8 142.3 11.8 0.0 19.9 20.2 1.1 46.6 0.7 22.9 1.7 54.3 1.3 29.7 0.0 6.9 9.3 10.1 38.6 50.6 56.4 9.2 0.4 0.0 0.0 96.8 3.7 0.9 17.1 15.3 120.2 73.6 0.0 58.6 1.2 47.4 35.0 18.9 46.1 20.1 0.1 18.6 0.0 28.6 29.9 0.9 4.4 0.0 6.0 13.9 32.3 28.5 13.2 0.0 3.0 0.0 7.2 1.3 56.4 0.0 0.1 13.3 60.8 8.2 0.0 0.4 29.1 260.4 68.8 30.7 11.4 66.5 136.4 17.1 11.6 67.8 4.3 0.0 3.0 34.2 0.4 36.9 0.8 0.4 0.2 3.4 0.1 8.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 41.8 43.3 41.0 39.7 40.3 41.3 56.8 47.0 43.6 46.6 54.3 38.6 0.3 64.1 72.3 162.2 1.3 11.9 14.7 6.0 1.8 1.4 35.7 25.7 1.8 34.3 42.1 58.8 91.8 11.6 0.6 17.9 13.7 44.9 0.4 81.8 10.8 1.3 7.8 0.0 50.1 40.5 2.3 5.3 15.3 149.2 1.3 5.6 1.1 16.9 1.3 0.0 27.9 7.8 6.1 0.6 1.1 0.1 1.2 4.2 10.6 8.4 1.1 18.1 0.0 17.6 1.9 73.1 10.9 0.7 0.1 38.8 18.9 61.8 36.7 9.1 0.0 0.2 5.6 0.3 5.0 7.3 13.9 18.2 2.1 2.5 12.2 16.5 XKR8 FLJ10307 ENSG00000158156 "XK related 8" Q9H6D3 1 27959588-27968093 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "eosinophil: 202.8;neutrophil: 101.6" "Lineage enriched" "Detected in all" 13 "granulocytes: 202.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049984, HPA053529" Uncertain Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" "HPA049984: AB_2680982, HPA053529: AB_2682179" "prognostic favorable (8.63e-4)" "unprognostic (2.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-3)" "unprognostic (1.97e-2)" "unprognostic (1.38e-2)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (7.87e-2)" "unprognostic (8.41e-2)" "unprognostic (1.83e-3)" "unprognostic (6.29e-2)" "unprognostic (8.55e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-2)" 5.8 4.4 17.7 8.6 18.0 22.7 6.6 18.7 19.1 6.2 18.5 6.0 7.0 5.7 8.1 5.3 7.7 6.7 8.1 18.3 19.3 6.8 15.3 7.4 8.8 18.9 18.6 9.1 14.0 9.7 4.5 15.2 18.0 6.3 6.1 5.4 10.3 8.0 6.2 5.6 6.0 9.3 17.9 9.4 9.0 6.3 19.1 6.9 6.5 11.7 7.4 7.0 4.7 17.9 10.9 8.6 12.4 13.4 10.5 15.5 13.5 8.8 17.1 19.5 18.7 18.2 7.6 4.1 9.1 21.1 14.5 4.6 19.0 9.5 9.8 15.0 18.2 13.8 5.2 15.4 15.7 6.8 4.7 16.9 18.8 21.8 15.2 19.7 19.3 12.5 21.6 8.9 14.1 10.0 8.5 19.7 40.3 9.1 12.6 15.1 4.0 8.8 15.6 6.3 2.9 4.1 3.8 9.6 6.2 21.7 6.2 16.8 8.0 11.4 10.2 23.9 8.0 13.1 13.6 6.5 29.3 9.2 8.7 20.3 11.9 202.8 15.1 11.9 14.8 7.6 15.7 14.1 13.0 7.1 14.4 13.5 101.6 14.0 10.2 6.3 14.8 11.2 17.7 18.0 18.7 19.1 18.3 19.3 18.9 18.6 18.0 17.9 19.1 17.9 4.4 3.2 1.1 2.6 8.8 1.9 3.8 3.5 1.8 4.5 5.2 3.4 3.3 5.7 4.4 3.7 0.0 62.0 15.5 4.7 3.9 7.8 0.5 1.8 2.9 6.8 1.8 2.1 2.2 11.4 15.8 6.1 5.6 2.4 1.3 5.2 8.6 5.6 14.0 3.3 2.2 6.1 2.0 6.6 3.7 0.9 3.4 8.0 1.8 1.0 21.1 14.0 16.5 3.5 5.5 7.2 2.8 3.8 14.0 5.1 7.2 4.5 1.7 1.3 6.6 5.1 4.0 0.6 7.8 2.2 3.0 22.4 9.1 4.4 5.2 4.1 ZBBX FLJ23049 ENSG00000169064 "Zinc finger B-box domain containing" A8MT70 3 167239843-167407874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 13.5;choroid plexus: 28.9;fallopian tube: 23.2;testis: 35.9" "Cell type enhanced" "Detected in some" "Early spermatids: 423.4;Endometrial ciliated cells: 107.4;Excitatory neurons: 80.1;Late spermatids: 232.4;Respiratory ciliated cells: 226.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036327, HPA036328" Enhanced Approved "Golgi apparatus" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA036327: AB_10672240, HPA036328: AB_2675063" "unprognostic (2.68e-3)" "unprognostic (4.49e-2)" "unprognostic (6.94e-2)" "unprognostic (3.99e-1)" "unprognostic (4.08e-2)" "unprognostic (7.61e-2)" "unprognostic (1.24e-1)" "unprognostic (1.75e-3)" "unprognostic (1.29e-1)" "unprognostic (2.30e-3)" "unprognostic (1.15e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" 0.0 0.2 3.7 0.0 2.6 0.0 0.0 0.7 1.5 0.7 28.9 0.0 0.0 0.8 0.1 0.0 23.2 0.0 0.0 2.4 2.7 0.2 0.0 3.5 0.0 13.5 11.1 0.0 0.0 0.3 2.0 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 35.9 3.5 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.6 0.7 1.5 2.4 2.7 13.5 11.1 6.6 10.5 3.5 6.1 0.0 0.0 1.1 7.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 423.4 107.4 0.6 0.6 0.0 0.0 80.1 0.0 0.0 0.5 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 23.8 0.0 6.1 0.0 0.0 232.4 1.5 0.4 0.0 1.9 0.0 0.0 0.0 4.5 1.1 0.1 0.0 1.5 0.0 0.1 0.0 0.2 226.2 0.0 0.0 0.0 1.2 37.4 11.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 ZCWPW1 "DKFZp434N0510, FLJ10057, ZCW1" ENSG00000078487 "Zinc finger CW-type and PWWP domain containing 1" Q9H0M4 7 100400826-100428992 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 42.4" "Group enriched" "Detected in many" 12 "Spermatocytes: 996.6;Spermatogonia: 361.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 15.6;hTERT-HME1: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020911 Approved "Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA020911: AB_1858990" "unprognostic (1.86e-2)" "prognostic favorable (1.99e-4)" "unprognostic (1.92e-3)" "unprognostic (6.74e-2)" "unprognostic (2.58e-2)" "unprognostic (8.46e-3)" "unprognostic (1.99e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "prognostic favorable (1.93e-4)" "unprognostic (2.43e-3)" "unprognostic (1.72e-2)" "unprognostic (2.84e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-2)" "prognostic favorable (5.26e-4)" 3.7 2.6 6.3 2.5 7.5 2.9 4.4 9.0 9.0 2.8 5.2 3.5 1.2 4.0 4.5 2.4 5.0 2.9 4.0 6.3 6.9 3.5 6.0 2.6 3.8 7.7 7.0 6.2 2.2 4.4 2.1 1.9 7.4 3.1 1.9 3.2 2.1 3.8 3.9 4.5 2.6 2.9 7.0 4.1 2.5 42.4 7.1 2.8 5.1 4.6 3.7 3.8 2.3 8.3 5.8 2.6 1.3 2.2 7.2 5.7 0.8 2.9 3.3 2.4 3.1 1.0 1.8 15.6 11.5 2.2 5.5 1.5 1.3 0.9 3.8 1.2 1.1 4.8 0.6 0.8 2.3 2.0 2.9 3.2 6.1 1.9 13.8 1.2 0.2 3.1 3.4 4.6 2.3 5.4 1.6 4.4 0.5 2.9 0.7 3.6 1.0 1.0 2.1 1.3 4.2 1.8 7.4 2.0 4.7 1.1 3.0 3.2 0.3 6.3 2.5 5.4 1.0 1.6 2.1 7.0 2.4 5.2 5.5 3.6 1.6 15.9 2.1 3.2 3.4 14.6 2.7 3.0 1.9 12.8 4.5 3.3 5.5 3.3 9.6 3.6 1.6 2.1 6.3 7.5 9.0 9.0 6.3 6.9 7.7 7.0 7.4 7.0 7.1 8.3 7.5 0.0 7.4 14.4 13.1 8.0 10.3 5.2 12.5 10.9 9.3 11.8 7.3 0.0 8.5 5.5 2.1 1.3 7.5 2.1 11.7 5.8 36.1 11.3 5.2 5.3 2.4 1.7 6.7 3.6 0.7 7.6 12.8 4.0 21.0 8.6 5.7 9.7 3.4 5.0 9.1 3.3 0.0 9.5 7.6 52.5 16.4 5.8 1.8 2.8 4.0 13.6 8.2 5.0 20.7 3.8 4.6 7.9 2.9 5.5 4.6 12.5 23.0 5.2 46.0 11.0 4.6 996.6 361.4 4.2 4.5 1.4 6.4 5.4 3.9 5.9 ZDHHC3 "DHHC3, GODZ, ZNF373" ENSG00000163812 "Zinc finger DHHC-type palmitoyltransferase 3" Q9NYG2 3 44915257-44976185 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 570.7;Late spermatids: 1564.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012465, HPA016616" Approved Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "CAB012465: , HPA016616: AB_1859004" "unprognostic (2.80e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.43e-4)" "unprognostic (3.10e-2)" "unprognostic (2.47e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.20e-2)" "unprognostic (1.04e-1)" "unprognostic (6.37e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "prognostic favorable (1.81e-8)" "unprognostic (2.64e-1)" "unprognostic (1.49e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-2)" 50.1 48.6 23.0 25.7 21.5 82.8 36.3 27.9 22.9 42.2 25.8 70.6 44.1 35.4 24.5 58.0 27.5 32.0 36.3 25.8 21.1 40.3 32.3 41.9 21.9 28.7 25.1 28.9 22.2 46.0 13.4 28.7 29.8 35.6 64.6 16.6 33.3 40.1 43.7 70.0 58.1 36.3 25.8 29.6 55.3 80.8 27.0 26.9 38.6 52.8 33.3 53.6 42.5 25.3 62.5 53.3 41.0 49.1 219.2 100.5 46.8 58.8 80.7 78.3 66.5 61.0 85.1 58.7 31.4 107.9 52.8 80.7 68.4 104.3 74.6 61.7 29.3 55.9 57.9 45.7 50.6 136.3 43.0 92.5 111.6 73.6 67.2 59.8 79.6 63.8 73.8 51.3 78.1 42.9 46.2 73.6 60.7 155.9 96.7 29.9 40.6 47.0 66.7 176.7 14.6 52.8 70.3 70.5 36.4 70.4 57.4 88.2 78.0 55.4 55.2 60.2 66.3 32.2 66.6 59.6 55.2 198.9 39.4 53.7 24.5 32.6 14.6 12.3 13.3 10.7 11.0 16.1 26.8 12.6 10.2 14.4 25.4 14.5 17.5 15.3 17.1 13.6 23.0 21.5 27.9 22.9 25.8 21.1 28.7 25.1 29.8 25.8 27.0 25.3 41.5 41.7 82.1 7.5 17.8 48.2 42.1 40.8 48.9 9.8 24.4 20.8 29.2 24.3 27.1 53.3 6.2 47.7 23.4 105.6 72.4 46.6 570.7 18.8 31.2 34.1 35.9 68.8 15.7 79.0 59.4 26.4 69.3 26.6 19.0 21.5 35.7 29.4 49.5 15.2 15.6 78.2 38.7 34.0 26.7 1564.3 51.9 37.4 24.9 18.7 35.6 25.1 34.0 15.1 11.2 115.8 73.1 44.8 26.2 73.7 112.9 30.1 20.9 10.6 19.7 15.6 31.9 104.5 45.3 70.5 60.2 101.7 25.0 26.1 72.8 128.9 ZDHHC7 "DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370" ENSG00000153786 "Zinc finger DHHC-type palmitoyltransferase 7" Q9NXF8 16 84974175-85011535 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019215, HPA059054, HPA059642" Uncertain Supported "Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093" "unprognostic (9.77e-2)" "unprognostic (2.12e-1)" "unprognostic (6.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (8.76e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.41e-2)" "unprognostic (5.78e-2)" "unprognostic (2.21e-2)" "unprognostic (7.79e-3)" "unprognostic (8.04e-2)" "prognostic favorable (1.12e-5)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.45e-1)" "unprognostic (5.42e-2)" 33.0 28.1 19.0 24.7 18.8 64.2 26.8 21.4 18.6 40.0 27.1 42.5 27.1 36.8 12.8 27.6 27.7 31.2 31.2 19.1 19.8 35.4 30.0 37.2 26.5 20.1 21.0 27.7 26.9 35.5 19.6 33.4 20.3 32.8 32.4 10.3 24.1 20.0 56.5 31.8 33.5 30.0 19.1 35.4 44.7 14.1 23.5 16.1 25.5 58.4 23.5 37.4 33.1 19.6 63.8 55.0 28.5 34.5 123.1 92.3 38.9 57.4 110.8 88.4 43.7 58.3 72.4 29.1 32.7 93.5 29.0 65.6 37.1 76.1 110.9 16.4 29.7 21.0 22.0 66.5 51.5 40.0 21.2 76.7 85.4 72.5 41.5 56.0 46.1 26.7 68.9 9.7 56.8 75.8 27.0 38.1 44.3 53.2 39.5 33.6 26.2 15.7 86.4 82.5 24.2 29.8 74.3 40.9 36.1 43.0 77.6 24.0 67.9 53.1 39.9 49.8 34.3 33.5 51.0 65.5 50.1 29.1 43.0 7.5 9.7 8.3 2.1 8.2 2.6 1.4 2.0 1.7 6.3 2.2 1.5 2.2 6.4 1.4 7.2 4.3 0.5 3.6 19.0 18.8 21.4 18.6 19.1 19.8 20.1 21.0 20.3 19.1 23.5 19.6 13.3 32.1 25.2 12.1 10.8 13.3 21.5 25.4 17.1 9.2 16.2 13.2 22.5 12.8 17.9 16.5 6.2 18.5 15.7 37.7 1.9 14.1 9.7 15.5 20.1 12.2 12.6 11.6 16.4 15.6 24.9 23.0 28.5 29.1 3.8 14.3 15.0 11.6 28.1 15.2 16.2 29.4 14.2 46.8 26.7 10.9 17.4 36.2 16.0 19.7 42.9 5.9 21.6 13.6 14.7 30.0 33.9 21.1 15.2 26.2 22.1 9.5 32.6 6.7 13.1 13.7 14.9 8.3 13.0 20.1 12.8 16.1 13.4 6.8 34.7 35.3 ZFAND4 "ANUBL1, FLJ40185" ENSG00000172671 "Zinc finger AN1-type containing 4" Q86XD8 10 45615500-45672780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 37.4" "Group enriched" "Detected in many" 6 "Early spermatids: 414.6;Late spermatids: 689.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "Daudi: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057543, HPA074103" Enhanced Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 83: Testis - Spermatogenesis" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA057543: AB_2683461, HPA074103: " "unprognostic (1.57e-1)" "unprognostic (1.53e-2)" "unprognostic (6.90e-2)" "unprognostic (3.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.46e-3)" "unprognostic (2.55e-1)" "unprognostic (3.16e-1)" "unprognostic (8.85e-5)" "unprognostic (3.23e-1)" "unprognostic (9.15e-3)" "unprognostic (1.18e-1)" "unprognostic (6.19e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-3)" 2.2 3.3 1.8 2.0 1.9 2.2 3.0 4.0 2.1 2.6 1.9 2.1 2.1 2.4 1.5 1.6 2.7 1.4 2.5 1.5 2.4 2.1 3.8 2.2 4.9 2.3 2.4 2.4 2.4 1.4 3.0 1.2 2.3 2.6 2.2 2.2 2.3 1.7 2.2 3.2 2.0 1.8 2.1 2.5 1.9 37.4 2.3 3.2 3.4 1.6 4.7 2.1 2.2 2.4 1.0 0.7 1.4 2.1 3.2 2.5 0.0 1.4 2.4 1.3 1.4 0.0 1.0 34.6 1.7 0.9 1.9 0.3 1.1 0.9 1.6 5.6 1.7 1.0 1.1 0.8 2.4 0.0 6.8 2.2 1.7 0.5 1.3 1.0 1.2 4.5 0.9 5.8 1.5 0.1 3.3 0.7 1.4 1.1 0.9 0.5 1.1 0.0 1.1 0.9 2.7 1.8 1.1 1.3 1.1 1.5 2.9 1.9 1.1 0.5 2.5 2.1 1.7 4.6 8.2 0.0 1.0 3.4 0.6 0.3 0.2 0.0 0.4 0.1 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.4 0.0 0.7 0.4 0.1 0.3 0.1 1.8 1.9 4.0 2.1 1.5 2.4 2.3 2.4 2.3 2.1 2.3 2.4 2.5 6.4 3.1 22.5 7.6 0.8 3.3 1.0 5.7 7.9 4.0 2.2 3.9 4.3 0.7 1.8 27.1 0.3 7.1 3.7 1.9 1.1 414.6 6.5 3.4 2.8 1.8 5.7 3.3 1.8 0.4 3.1 4.6 1.8 2.5 3.0 3.3 5.6 2.2 3.3 23.2 2.5 0.0 2.5 1.0 689.8 6.5 2.3 3.6 13.1 2.2 4.1 1.0 47.3 39.7 1.3 0.5 3.0 10.3 3.9 1.6 3.7 8.9 8.7 6.6 4.5 2.2 86.3 13.5 3.2 2.3 0.1 7.0 4.0 2.7 1.9 ZFPL1 "D11S750, MCG4" ENSG00000162300 "Zinc finger protein like 1" O95159 11 65084210-65088398 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014909, HPA017347" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA014909: AB_1859055, HPA017347: AB_1859056" "unprognostic (2.03e-1)" "unprognostic (5.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.12e-6)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (3.63e-1)" "unprognostic (7.34e-2)" "prognostic favorable (2.73e-5)" "unprognostic (1.88e-1)" "unprognostic (1.44e-1)" "unprognostic (4.34e-2)" "unprognostic (6.94e-2)" 30.8 32.5 23.0 11.5 25.7 29.3 29.3 24.9 29.8 29.5 22.6 30.4 17.9 31.4 18.7 30.0 27.8 10.0 30.7 22.4 23.9 27.9 32.6 21.4 11.9 25.1 24.5 29.3 32.0 15.6 40.5 12.8 24.0 31.5 9.1 7.6 30.8 16.8 37.8 35.2 28.1 12.7 23.8 25.4 30.4 27.5 25.2 11.0 27.1 20.4 8.3 31.1 26.5 26.3 60.3 41.1 25.4 26.5 22.3 31.5 40.5 26.0 33.8 31.8 25.2 27.5 40.9 19.5 51.2 39.5 31.0 30.8 15.0 34.4 11.1 27.7 25.0 20.0 29.3 54.3 48.0 14.8 27.0 29.7 45.2 24.0 40.6 20.2 31.2 30.4 24.3 29.4 23.9 83.1 25.6 35.8 17.2 19.9 35.7 23.3 14.5 53.7 25.0 27.9 27.6 22.3 21.5 41.8 63.5 12.1 61.7 25.4 30.1 21.2 35.0 47.2 21.4 19.4 21.0 24.0 33.2 14.6 41.2 77.1 19.7 42.2 15.1 21.4 16.3 18.0 14.0 15.9 20.0 20.1 15.3 13.8 27.3 23.8 21.2 19.6 26.1 12.0 23.0 25.7 24.9 29.8 22.4 23.9 25.1 24.5 24.0 23.8 25.2 26.3 22.6 12.8 18.4 6.8 16.1 11.0 29.6 45.0 19.4 20.4 27.4 27.1 4.4 21.5 35.3 12.9 4.2 49.9 19.0 49.6 58.7 39.4 18.6 24.1 17.9 17.9 22.8 14.5 6.4 47.9 47.1 19.4 25.0 29.6 9.5 30.0 16.4 20.7 32.1 23.5 6.1 40.1 32.6 15.7 11.9 47.0 20.5 12.8 17.8 3.7 25.0 39.2 18.6 5.0 23.7 44.0 44.4 20.3 29.5 29.8 55.0 32.6 25.8 19.5 19.7 17.5 27.5 35.7 18.3 24.4 12.5 68.3 13.6 17.0 37.5 36.1 ZNF287 "ZKSCAN13, ZSCAN45" ENSG00000141040 "Zinc finger protein 287" Q9HBT7 17 16546954-16569204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029290 Uncertain Approved "Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA029290: AB_10603465" "unprognostic (4.74e-2)" "unprognostic (1.77e-2)" "unprognostic (2.88e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.99e-2)" "unprognostic (4.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.78e-3)" "unprognostic (1.19e-1)" "prognostic favorable (5.28e-5)" "unprognostic (5.69e-3)" "unprognostic (5.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.87e-1)" 2.4 3.3 1.3 2.0 2.1 0.7 3.2 4.2 2.0 3.1 0.4 1.9 0.8 2.7 4.0 1.9 2.8 2.1 4.9 1.6 1.4 2.8 0.3 2.3 2.6 1.0 1.4 4.2 2.1 6.7 3.5 1.5 1.4 3.1 1.9 5.0 1.7 3.6 3.0 3.1 1.5 3.0 1.4 2.5 2.4 2.7 1.4 2.6 3.7 4.4 2.9 2.3 1.6 2.5 3.9 7.0 6.1 6.4 4.0 7.8 1.5 3.2 5.7 6.0 7.5 1.3 2.8 1.7 3.5 5.2 4.1 6.1 3.7 5.7 7.3 2.7 3.1 0.0 0.5 0.0 5.0 0.0 5.6 5.8 3.8 2.6 3.8 5.8 3.7 7.9 0.4 0.0 8.9 3.5 5.5 0.2 1.3 3.3 3.3 0.0 6.8 0.2 3.5 1.9 3.5 5.8 10.2 1.3 4.1 16.5 4.8 0.6 3.0 3.8 2.0 5.0 4.3 3.1 2.4 0.0 5.5 0.0 4.7 0.1 0.6 0.5 8.0 0.7 6.8 10.9 8.6 8.1 2.9 7.7 9.3 9.4 0.1 6.7 3.1 1.8 7.0 4.4 1.3 2.1 4.2 2.0 1.6 1.4 1.0 1.4 1.4 1.4 1.4 2.5 2.3 3.2 1.7 4.6 4.2 0.6 1.5 6.0 2.2 3.7 1.4 1.8 10.0 1.5 4.9 0.0 4.2 0.2 3.3 0.1 5.9 5.2 3.0 1.8 2.3 3.8 2.4 0.4 7.2 9.1 0.7 4.0 2.0 0.9 7.0 3.5 1.8 0.1 1.3 16.8 8.4 0.6 0.0 1.0 0.9 2.9 2.1 1.1 0.0 1.0 1.0 3.8 4.1 8.0 9.2 4.6 0.2 3.4 0.8 0.6 0.1 2.3 7.2 3.7 6.6 2.6 3.1 12.6 5.9 1.7 1.4 0.0 4.3 6.3 0.9 0.7 ZNF564 MGC26914 ENSG00000249709 "Zinc finger protein 564" Q8TBZ8 19 12525373-12551542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 13.1;Oligodendrocyte precursor cells: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043998 Uncertain Approved "Golgi apparatus" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA043998: AB_10969446" "unprognostic (3.85e-2)" "unprognostic (1.40e-3)" "unprognostic (4.61e-2)" "unprognostic (2.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.26e-3)" "unprognostic (4.25e-1)" "unprognostic (2.53e-2)" "unprognostic (1.76e-3)" "unprognostic (8.69e-2)" "unprognostic (3.94e-2)" "unprognostic (5.24e-3)" "unprognostic (1.26e-5)" "unprognostic (5.77e-3)" "unprognostic (3.07e-1)" "unprognostic (4.51e-3)" "unprognostic (1.83e-2)" 4.7 3.5 4.2 3.7 5.4 4.4 7.4 11.8 6.2 5.5 3.0 7.4 6.3 6.7 6.1 3.0 6.5 3.4 5.1 5.0 3.6 7.7 5.7 4.3 6.9 5.5 4.2 6.0 3.7 7.6 3.1 5.0 5.2 6.3 7.3 7.1 4.8 6.0 6.2 5.3 7.1 4.3 3.5 6.9 6.7 3.0 4.4 7.5 7.9 8.0 7.5 5.3 4.2 9.2 4.3 1.2 4.9 6.2 7.4 5.5 6.0 4.3 6.0 5.3 7.0 3.2 2.7 5.3 5.8 3.9 3.2 4.9 2.5 4.1 5.6 4.3 4.1 3.7 3.9 6.7 5.4 6.6 6.8 5.5 10.3 2.5 6.3 5.5 4.5 5.5 7.8 2.2 6.6 5.7 5.4 3.9 5.0 4.8 5.5 3.2 5.4 4.4 5.9 6.9 3.4 3.0 5.2 2.9 6.2 7.2 4.5 11.4 4.6 8.0 2.5 5.0 3.3 7.6 9.2 4.2 2.4 4.4 3.4 15.2 7.3 18.6 11.9 10.1 11.0 14.7 10.2 10.9 9.4 11.1 11.5 10.6 13.7 11.3 13.1 7.3 9.3 7.1 4.2 5.4 11.8 6.2 5.0 3.6 5.5 4.2 5.2 3.5 4.4 9.2 1.8 0.0 1.5 6.5 6.9 0.0 0.9 0.8 2.8 2.1 1.0 1.1 0.5 5.7 1.5 0.0 4.2 1.3 3.6 1.5 3.9 1.2 0.1 2.0 1.7 1.8 0.0 4.0 8.4 0.7 0.9 1.5 7.7 1.6 0.0 4.9 2.5 1.1 1.1 0.0 8.6 1.0 0.0 1.6 0.4 0.3 0.6 1.4 1.8 13.1 2.0 2.4 5.2 11.1 8.8 1.6 1.0 0.7 5.9 1.7 2.0 0.8 6.3 4.4 0.0 2.2 1.3 1.2 2.3 1.1 0.0 1.2 4.0 1.4 0.9 1.5 ZNF682 BC39498_3 ENSG00000197124 "Zinc finger protein 682" O95780 19 19997058-20039505 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 22.2" "Cancer enhanced" "Detected in many" "testis cancer: 7.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 14.4;AN3-CA: 21.8" HPA055998 Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA055998: AB_2683002" "unprognostic (8.96e-2)" "unprognostic (3.93e-2)" "unprognostic (4.78e-2)" "unprognostic (1.10e-1)" "unprognostic (6.16e-2)" "unprognostic (6.95e-3)" "unprognostic (1.69e-2)" "unprognostic (1.71e-2)" "unprognostic (6.44e-2)" "unprognostic (1.24e-3)" "unprognostic (7.70e-4)" "unprognostic (1.77e-3)" "unprognostic (4.06e-7)" "unprognostic (2.07e-1)" "unprognostic (2.10e-1)" "unprognostic (1.19e-1)" "prognostic favorable (3.51e-4)" 2.0 2.5 4.0 2.4 4.5 2.1 3.4 4.5 7.2 2.7 1.9 2.4 1.5 2.4 3.5 3.3 3.0 2.2 6.2 4.5 5.2 5.1 4.1 3.7 3.9 4.3 4.4 2.0 3.0 3.0 4.1 3.0 4.4 4.8 2.5 3.2 1.8 4.0 3.4 6.5 2.9 1.3 3.6 4.0 3.0 3.3 4.1 3.1 8.0 1.6 4.5 3.5 3.1 6.0 0.0 0.0 14.4 21.8 1.1 1.5 0.6 3.1 1.4 5.1 8.1 2.5 3.1 0.1 5.2 4.4 1.5 2.6 5.9 0.5 5.7 0.0 6.3 0.0 0.1 1.6 2.0 0.0 5.1 2.1 1.7 2.8 0.0 0.8 0.0 5.7 0.0 0.1 3.9 4.3 8.7 1.3 7.9 0.0 1.9 5.3 7.5 0.1 2.7 9.7 7.9 8.5 0.0 2.8 0.0 7.8 5.4 2.9 0.0 7.5 1.2 12.7 5.4 0.0 9.0 1.4 0.0 0.0 2.4 7.1 0.4 0.9 2.5 0.5 1.8 4.1 3.7 2.0 1.5 2.7 4.0 4.1 1.5 1.4 0.7 1.3 4.2 1.3 4.0 4.5 4.5 7.2 4.5 5.2 4.3 4.4 4.4 3.6 4.1 6.0 5.2 9.6 15.1 7.2 7.0 3.4 2.1 0.6 5.2 5.4 4.6 5.2 10.3 4.3 4.6 3.7 0.0 6.8 8.2 2.7 5.9 4.0 1.8 1.8 2.9 4.4 1.2 4.4 9.8 7.5 6.8 3.5 2.6 3.0 2.5 5.9 5.0 3.0 2.9 3.3 10.1 2.8 0.0 3.5 2.7 0.9 1.8 2.3 1.8 6.5 0.6 4.0 5.2 6.6 22.2 4.8 1.2 4.5 3.1 1.5 1.7 3.8 1.5 2.3 0.0 3.1 3.4 4.3 4.2 3.7 3.4 2.5 6.9 9.2 2.1 2.5 ZNRF3 "BK747E2.3, FLJ22057, KIAA1133, RNF203" ENSG00000183579 "Zinc and ring finger 3" Q9ULT6 22 28883572-29057488 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Astrocytes: 504.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036702, HPA036703" Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Golgi apparatus" "HPA036702: , HPA036703: AB_10672227" "unprognostic (1.07e-1)" "unprognostic (2.13e-3)" "unprognostic (7.48e-3)" "unprognostic (5.72e-2)" "unprognostic (6.81e-2)" "unprognostic (1.36e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-2)" "unprognostic (5.18e-2)" "unprognostic (3.94e-1)" "unprognostic (9.55e-5)" "unprognostic (6.49e-2)" "unprognostic (1.02e-1)" "unprognostic (3.70e-2)" "unprognostic (2.55e-2)" 2.8 7.1 11.3 1.3 11.2 0.3 2.6 8.1 13.8 4.4 1.0 3.9 3.0 5.1 13.4 3.4 4.8 2.1 2.6 12.1 5.5 8.2 6.6 4.3 0.5 13.2 9.2 5.9 3.3 8.7 2.7 5.0 4.2 7.2 3.4 1.1 7.5 7.7 3.8 5.3 2.7 4.6 5.1 1.2 4.4 5.0 13.6 1.3 4.1 1.9 0.6 3.2 3.3 6.2 5.8 13.7 12.5 3.5 2.3 2.6 23.7 3.5 1.7 2.7 2.6 20.8 3.2 0.1 5.4 1.8 4.9 9.8 8.7 5.5 3.3 7.8 8.9 2.3 2.5 46.1 2.0 6.9 2.3 2.7 5.0 4.3 4.3 2.3 2.4 4.1 5.0 3.2 3.9 5.6 0.2 3.5 4.6 7.3 5.4 6.9 8.2 5.3 11.6 8.5 20.6 7.6 6.2 6.1 3.5 3.8 4.1 3.1 2.3 10.3 8.8 8.2 5.8 4.3 6.3 8.1 4.4 3.9 5.5 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 11.3 11.2 8.1 13.8 12.1 5.5 13.2 9.2 4.2 5.1 13.6 6.2 4.2 12.8 23.6 504.1 0.3 12.6 5.2 4.9 15.9 3.7 5.7 9.5 7.5 8.6 5.3 12.9 0.0 28.1 0.5 2.1 1.9 5.0 12.7 8.0 8.0 5.8 8.4 4.0 62.9 2.5 2.5 5.8 5.6 15.5 0.0 5.4 2.2 17.6 3.5 1.7 37.4 9.4 0.0 1.0 3.1 15.0 10.8 0.8 0.0 82.4 0.0 6.0 0.0 54.8 34.4 3.7 2.1 12.8 0.6 9.6 2.4 11.6 4.9 3.9 0.0 16.0 6.6 4.6 3.2 7.8 7.5 7.7 0.7 14.5 12.9 2.8